
<html lang="en"     class="pb-page"  data-request-id="df2b5e60-da7d-42cc-97c5-12632aaa41f8"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";article:article:10.1021/acs.jmedchem.6b00415;requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;issue:issue:10.1021/jmcmar.2016.59.issue-13;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Indole-2-carboxamide-based MmpL3 Inhibitors Show Exceptional Antitubercular Activity in an Animal Model of Tuberculosis Infection" /></meta><meta name="dc.Creator" content="Jozef  Stec" /></meta><meta name="dc.Creator" content="Oluseye K.  Onajole" /></meta><meta name="dc.Creator" content="Shichun  Lun" /></meta><meta name="dc.Creator" content="Haidan  Guo" /></meta><meta name="dc.Creator" content="Benjamin  Merenbloom" /></meta><meta name="dc.Creator" content="Giulio  Vistoli" /></meta><meta name="dc.Creator" content="William R.  Bishai" /></meta><meta name="dc.Creator" content="Alan P.  Kozikowski" /></meta><meta name="dc.Description" content="Our team had previously identified certain indolecarboxamides that represented a new chemical scaffold that showed promising anti-TB activity at both an in vitro and in vivo level. Based on mutatio..." /></meta><meta name="Description" content="Our team had previously identified certain indolecarboxamides that represented a new chemical scaffold that showed promising anti-TB activity at both an in vitro and in vivo level. Based on mutatio..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="June 22, 2016" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.6b00415" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2016 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.6b00415" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.6b00415" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.6b00415" /></link>
        
    
    

<title>Indole-2-carboxamide-based MmpL3 Inhibitors Show Exceptional Antitubercular Activity in an Animal Model of Tuberculosis Infection | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.6b00415" /></meta><meta property="og:title" content="Indole-2-carboxamide-based MmpL3 Inhibitors Show Exceptional Antitubercular Activity in an Animal Model of Tuberculosis Infection" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00415/20160708/images/large/jm-2016-004153_0011.jpeg" /></meta><meta property="og:description" content="Our team had previously identified certain indolecarboxamides that represented a new chemical scaffold that showed promising anti-TB activity at both an in vitro and in vivo level. Based on mutational analysis using bacteria found resistant to one of these indolecarboxamides, we identified the trehalose monomycolate transporter MmpL3 as the likely target of these compounds. In the present work, we now further elaborate on the SAR of these compounds, which has led in turn to the identification of a new analog, 4,6-difluoro-N-((1R,2R,3R,5S)-2,6,6-trimethylbicyclo[3.1.1]heptan-3-yl)-1H-indole-2-carboxamide (26), that shows excellent activity against drug-sensitive (MIC = 0.012 μM; SI ≥ 16000), multidrug-resistant (MDR), and extensively drug-resistant (XDR) Mycobacterium tuberculosis strains, has superior ADMET properties, and shows excellent activity in the TB aerosol lung infection model. Compound 26 is also shown to work in synergy with rifampin. Because of these properties, we believe that indolecarboxamide 26 is a possible candidate for advancement to human clinical trials." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.6b00415"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.6b00415">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.6b00415&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.6b00415&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.6b00415&amp;href=/doi/10.1021/acs.jmedchem.6b00415" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2016</span><span class="cit-fg-volume">, 59</span><span class="cit-fg-issue">, 13</span><span class="cit-fg-pageRange">, 6232-6247</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/59/13" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.6b00406" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.6b00373" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Indole-2-carboxamide-based MmpL3 Inhibitors Show Exceptional Antitubercular Activity in an Animal Model of Tuberculosis Infection</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jozef++Stec">Jozef Stec</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>⊥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Oluseye+K.++Onajole">Oluseye K. Onajole</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>#</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Shichun++Lun">Shichun Lun</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Haidan++Guo">Haidan Guo</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Benjamin++Merenbloom">Benjamin Merenbloom</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Giulio++Vistoli">Giulio Vistoli</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∇</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=William+R.++Bishai">William R. Bishai</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Alan+P.++Kozikowski">Alan P. Kozikowski</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">†</span> <span class="aff-text">Drug Discovery Program, Department of Medicinal Chemistry and Pharmacognosy, College of Pharmacy, University of Illinois at Chicago, 833 South Wood Street, Chicago, Illinois 60612, United States</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">‡</span> <span class="aff-text">Center for Tuberculosis Research, Department of Medicine, Division of Infectious Disease, Johns Hopkins School of Medicine, 1550 Orleans Street, Baltimore, Maryland 21231-1044, United States</span></div><div class="aff-info" id="aff3"><span class="aff-symbol">§</span> <span class="aff-text">Howard Hughes Medical Institute, 4000 Jones Bridge Road, Chevy Chase, Maryland 20815-6789, United States</span></div><div class="aff-info" id="aff4"><span class="aff-symbol">∥</span> <span class="aff-text">Department of Pharmaceutical Sciences, College of Pharmacy, Chicago State University, 9501 South King Drive, Chicago, Illinois 60628, United States</span></div><div class="aff-info" id="aff5"><span class="aff-symbol">⊥</span> <span class="aff-text">Department of Pharmaceutical Sciences, College of Pharmacy, Marshall B. Ketchum University, 2575 Yorba Linda Boulevard, Fullerton, California 92831, United States</span></div><div class="aff-info" id="aff6"><span class="aff-symbol">#</span> <span class="aff-text">Department of Biological, Chemical, and Physical Sciences, Roosevelt University, 425 S. Wabash Avenue, Chicago, Illinois 60605, United States</span></div><div class="aff-info" id="aff7"><span class="aff-symbol">∇</span> <span class="aff-text">Department of Pharmaceutical Sciences, Università degli Studi di Milano, via Mangiagalli 25, I-20133 Milan, Italy</span></div><div class="corresp-info"><strong>*</strong>Alan P. Kozikowski. Phone: +1-312-996-7577. Fax: +1-312-996-7107. E-mail: <a href="/cdn-cgi/l/email-protection#d0bbbfaab9bbbfa7b190a5b9b3feb5b4a5"><span class="__cf_email__" data-cfemail="573c382d3e3c38203617223e3479323322">[email protected]</span></a></div><div class="corresp-info"><strong>*</strong>William R. Bishai. Phone: +1-410-955-3507. E-mail: <a href="/cdn-cgi/l/email-protection#512633382239303860113b393c387f343524"><span class="__cf_email__" data-cfemail="e493868d978c858dd5a48e8c898dca818091">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.6b00415&amp;href=/doi/10.1021%2Facs.jmedchem.6b00415" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2016</span></span><span class="cit-volume">, 59</span><span class="cit-issue">, 13</span><span class="cit-pageRange">, 6232–6247</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">June 8, 2016</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>19 March 2016</li><li><span class="item_label"><b>Published</b> online</span>22 June 2016</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 14 July 2016</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.6b00415" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b00415</a></div><div class="article_header-article-copyright"><strong>Copyright © 2016 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D6232%26pageCount%3D16%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DJozef%2BStec%252C%2BOluseye%2BK.%2BOnajole%252C%2BShichun%2BLun%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D59%26issueNum%3D13%26contentID%3Dacs.jmedchem.6b00415%26title%3DIndole-2-carboxamide-based%2BMmpL3%2BInhibitors%2BShow%2BExceptional%2BAntitubercular%2BActivity%2Bin%2Ban%2BAnimal%2BModel%2Bof%2BTuberculosis%2BInfection%26numPages%3D16%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D6247%26publicationDate%3DJuly%2B2016">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.6b00415"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2104</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">75</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.6b00415" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Indole-2-carboxamide-based MmpL3 Inhibitors Show Exceptional Antitubercular Activity in an Animal Model of Tuberculosis Infection&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Jozef&quot;,&quot;last_name&quot;:&quot;Stec&quot;},{&quot;first_name&quot;:&quot;Oluseye&quot;,&quot;last_name&quot;:&quot;K. Onajole&quot;},{&quot;first_name&quot;:&quot;Shichun&quot;,&quot;last_name&quot;:&quot;Lun&quot;},{&quot;first_name&quot;:&quot;Haidan&quot;,&quot;last_name&quot;:&quot;Guo&quot;},{&quot;first_name&quot;:&quot;Benjamin&quot;,&quot;last_name&quot;:&quot;Merenbloom&quot;},{&quot;first_name&quot;:&quot;Giulio&quot;,&quot;last_name&quot;:&quot;Vistoli&quot;},{&quot;first_name&quot;:&quot;William&quot;,&quot;last_name&quot;:&quot;R. Bishai&quot;},{&quot;first_name&quot;:&quot;Alan&quot;,&quot;last_name&quot;:&quot;P. Kozikowski&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2016&quot;,&quot;month&quot;:&quot;06&quot;,&quot;day&quot;:&quot;22&quot;,&quot;issue&quot;:&quot;13&quot;,&quot;volume&quot;:&quot;59&quot;,&quot;pages&quot;:&quot;6232-6247&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.6b00415&quot;},&quot;abstract&quot;:&quot;Our team had previously identified certain indolecarboxamides that represented a new chemical scaffold that showed promising anti-TB activity at both an in vitro and in vivo level. Based on mutational analysis using bacteria found resistant to one of these indolecarboxamides, we identified the trehalose monomycolate transporter MmpL3 as the likely target of these compounds. In the present work, we now further elaborate on the SAR of these compounds, which has led in turn to the identification of a new analog, 4,6-difluoro-N-((1R,2R,3R,5S)-2,6,6-trimethylbicyclo[3.1.1]heptan-3-yl)-1H-indole-2-carboxamide (26), that shows excellent activity against drug-sensitive (MIC = 0.012 μM; SI ≥ 16000), multidrug-resistant (MDR), and extensively drug-resistant (XDR) Mycobacterium tuberculosis strains, has superior ADMET properties, and shows excellent activity in the TB aerosol lung infection model. Compound 26 is also shown to work in synergy with rifampin. Because of these properties, we believe that indolecarboxamide 2&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.6b00415&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b00415" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.6b00415&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b00415" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.6b00415&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b00415" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.6b00415&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b00415&amp;href=/doi/10.1021/acs.jmedchem.6b00415" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.6b00415" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.6b00415" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (5 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b00415&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.6b00415%26sid%3Dliteratum%253Aachs%26pmid%3D27275668%26genre%3Darticle%26aulast%3DStec%26date%3D2016%26atitle%3DIndole-2-carboxamide-based%2BMmpL3%2BInhibitors%2BShow%2BExceptional%2BAntitubercular%2BActivity%2Bin%2Ban%2BAnimal%2BModel%2Bof%2BTuberculosis%2BInfection%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D59%26issue%3D13%26spage%3D6232%26epage%3D6247%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291553" title="Granular materials">Granular materials</a>,</li><li><a href="/action/doSearch?ConceptID=291235" title="Column chromatography">Column chromatography</a>,</li><li><a href="/action/doSearch?ConceptID=291862" title="Indoles">Indoles</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=292506" title="Materials">Materials</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/59/13" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/jmcmar.2016.59.issue-13/20160714/jmcmar.2016.59.issue-13.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00415/20160708/images/medium/jm-2016-004153_0011.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00415/20160708/images/large/jm-2016-004153_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00415&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Our team had previously identified certain indolecarboxamides that represented a new chemical scaffold that showed promising anti-TB activity at both an <i>in vitro</i> and <i>in vivo</i> level. Based on mutational analysis using bacteria found resistant to one of these indolecarboxamides, we identified the trehalose monomycolate transporter MmpL3 as the likely target of these compounds. In the present work, we now further elaborate on the SAR of these compounds, which has led in turn to the identification of a new analog, 4,6-difluoro-<i>N</i>-((1<i>R</i>,2<i>R</i>,3<i>R</i>,5<i>S</i>)-2,6,6-trimethylbicyclo[3.1.1]heptan-3-yl)-1<i>H</i>-indole-2-carboxamide (<b>26</b>), that shows excellent activity against drug-sensitive (MIC = 0.012 μM; SI ≥ 16000), multidrug-resistant (MDR), and extensively drug-resistant (XDR) <i>Mycobacterium tuberculosis</i> strains, has superior ADMET properties, and shows excellent activity in the TB aerosol lung infection model. Compound <b>26</b> is also shown to work in synergy with rifampin. Because of these properties, we believe that indolecarboxamide <b>26</b> is a possible candidate for advancement to human clinical trials.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_72550" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_72550" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Tuberculosis (TB) is an airborne infectious disease caused by <i>Mycobacterium tuberculosis</i> (<i>Mtb</i>) that predominantly affects the lungs. Statistics show an inexorable increase in global health problems and socioeconomic burden brought about by TB worldwide. The regions consisting of South-East Asia, the Western Pacific, and Africa are the most impacted and in 2014 accounted for nearly 86% out of the estimated 9.6 million new TB cases.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> Given the fact that TB predominantly occurs among men (over 60% of TB cases and deaths due to TB) during their economically most productive years, the economic loss in productivity due to TB is predicted to be 1–3 trillion dollars over the next 10 years.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> Major challenges that prevent the eradication of TB include the inappropriate use or overuse of prescribed medications, inadequate diagnosis, and failure to adhere to the required drug regimen, as well as financial factors that may preclude access to the required medicines. Moreover, the improper use of TB antibiotics has led to the emergence of multidrug-resistant (MDR) and extensively drug-resistant (XDR) TB. An estimated 317 000 (∼3.3%) of new TB cases in 2014 were identified as MDR-TB. Among those patients with MDR-TB, approximately 31 000 (∼9.7%) were found to be infected with XDR-TB.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a></div><div class="NLM_p">The current TB drug pipeline includes several chemical entities representing various known and novel chemical scaffolds that interfere with the function of molecular targets operating within essential metabolic pathways such as cell envelope biosynthesis, nucleic acid and protein synthesis, and membrane energy production/transport.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> These chemical entities are currently being evaluated at various stages spanning from preclinical development to phase III clinical trials.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> Of special importance is the approval of bedaquiline by the U.S. Food and Drug Administration in December 2012,<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> as well as delamanid and <i>para</i>-aminosalicylic acid by the European Medicines Agency in November 2013.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> All three drugs were approved for combination therapy against pulmonary MDR-TB infections when other effective treatment options are not useful due to resistance or tolerability. However, as with many known anti-TB drugs, the use of bedaquiline is accompanied by various adverse effects with irregular heart rhythm being the most pronounced.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> Thus, the need for safe, highly effective, and fast acting anti-TB drugs with novel modes of action cannot be overemphasized.</div><div class="NLM_p">The elucidation of essential molecular targets within <i>Mtb</i> and the elaboration of novel chemical scaffolds possessing desirable physicochemical and ADME/Tox properties are at the forefront of the discovery and development pipeline to identify better antitubercular therapeutics. Recently, MmpL3, a protein that belongs to the resistance, nodulation, and cell division (RND) family of membrane transporters, has been identified as a druggable molecular target essential for <i>Mtb</i>’s survival.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> MmpL3, encoded by the <i>Rv0206c</i> gene, is a large protein anchored in the inner lipid bilayer that is comprised of 11 transmembrane helices, two extracellular domains (E1, E2), and one intracellular domain (C1).<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> MmpL3 is responsible for translocation of mycolic acids in the form of trehalose monomycolate (TMM) from their production site in the cytoplasm into the cell envelope. Subsequently TMM is processed in the extracytoplasmic space by mycolyl transferases of the antigen 85 complex, which transfer the lipid portion of TMM to another TMM molecule to afford trehalose dimycolate (TDM) or to arabinogalactan yielding wall-bound mycolates.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> The released trehalose is recycled by ATP-binding cassette transporters (LpqY-SugA-SugB-SugC), a process known to be essential for the virulence of <i>Mtb</i>.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> The arabinogalactan-bound mycolates are long α-branched β-hydroxy fatty acids that make up the thick, waxy, and difficult-to-permeate outer coating of the bacterial envelope.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> Accordingly, inactivation of the MmpL3 transporter prevents the translocation of the mycolic acids to the outer layer thus weakening the bacterial cell wall and impacting the viability and virulence of <i>Mtb</i>. Additionally, other recent studies reveal that MmpL3 along with another family member MmpL11 plays a role in the transport of heme-iron.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> The precise extent to which MmpL11 and MmpL3-mediated iron uptake contributes to TB virulence is still under study.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> Lastly, a more recent paper has provided evidence that a number of the MmpL3 inhibitors may actually work by causing the dissipation of the proton motive force that is required for the function of MmpL3 and other MmpL-driven processes.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a></div><div class="NLM_p">In our previous work, based on phenotypic screening, we identified the indole-2-carboxamide <b>1</b> as a highly potent scaffold against drug-susceptible and drug-resistant <i>Mtb</i> strains (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>).<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> Employing a standard medicinal chemistry approach, a number of analogs were made, which lead to compound <b>3</b> that was found to show superior activity against susceptible, MDR, and XDR <i>Mtb</i> strains in comparison to <b>1</b>.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> Using genome sequencing methodology, we also determined that compound <b>3</b> targets the MmpL3 transporter protein, which has consequences for the viability of <i>Mtb</i> as detailed above.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> Herein we report further SAR studies on these indolecarboxamides, together with pharmacokinetic (PK) analysis, as well as <i>in vivo</i> TB mouse efficacy studies for the best of these new indoles. These data point to compound <b>26</b> as a possible candidate for further advancement through the development pipeline.<a onclick="showRef(event, 'ref100'); return false;" href="javascript:void(0);" class="ref ref100">(17)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00415/20160708/images/medium/jm-2016-004153_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00415/20160708/images/large/jm-2016-004153_0002.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Hit compound <b>1</b>, lead compounds <b>2</b> and <b>3</b>, and strategy for additional chemical modifications of the indole-2-carboxamide scaffold <b>3</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00415/20160708/images/large/jm-2016-004153_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00415&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Results</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_04056" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_04056" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Following the amide coupling protocol (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>), 40 novel indolecarboxamides and related compounds were efficiently generated. Briefly, the substituted indole-2-carboxylic acids were reacted under an argon atmosphere with an alkyl- or cycloalkylamine in the presence of 1-ethyl-3-(3-(dimethylamino)propyl)carbodiimide hydrochloride (EDC·HCl) and hydroxybenzotriazole (HOBt) as coupling agents and triethylamine as a base to obtain compounds <b>3</b>–<b>39</b> (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>). To prepare compounds <b>6</b> and <b>9</b>, the starting materials <b>52</b> and <b>53</b> were reacted with cyclooctylamine under standard amide coupling conditions followed by catalytic hydrogenation of the nitro groups (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>). To prepare intermediate <b>55</b>, 3,5-dimethoxyaniline (<b>54</b>) was reacted with ethyl bromoacetate to afford ethyl 2-[(3,5-dimethoxyphenyl)amino]acetate which was reacted in turn with <i>N</i>,<i>N</i>-dimethylformamide dimethyl acetal (DMFDMA) under microwave irradiation. Next, Lewis acid (AlCl<sub>3</sub>)-promoted cyclization of <b>55</b> afforded the cyclized indole-2-carboxylate, which after basic hydrolysis gave the corresponding acid <b>56</b>. The indole carboxylic acid <b>56</b> was reacted with cycloheptylamine and cyclooctylamine to afford compounds <b>18</b> and <b>19</b>, respectively.</div><figure id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00415/20160708/images/medium/jm-2016-004153_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00415/20160708/images/large/jm-2016-004153_0007.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Indole-2-carboxamides<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00415/20160708/images/large/jm-2016-004153_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00415&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) EDC·HCl, HOBt, corresponding amines, Et<sub>3</sub>N, CH<sub>2</sub>Cl<sub>2</sub>, rt, 12–16 h; (b) ethyl bromoacetate, K<sub>2</sub>CO<sub>3</sub>, acetone, 60 °C, overnight; (c) DMFDMA, microwave, 150 °C, 10 min; (d) AlCl<sub>3</sub>, CH<sub>2</sub>Cl<sub>2</sub>, 24 h, rt; (e) LiOH, EtOH, reflux, 3 h; (f) 10% Pd/C, MeOH/EtOAc (4:1), H<sub>2</sub>.</p></p></figure><div class="NLM_p">4,6-Dimethyl-1<i>H</i>-indole-2-carboxylic acid (<b>43</b>)<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> (<a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>) was reacted with ammonium chloride to afford compound <b>57</b>, which was reduced to its corresponding primary amine and reacted with cycloheptanecarbonyl chloride to afford compound <b>40</b>. The amide group of compound <b>3</b><a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> was reduced to the corresponding amine <b>41</b>. The benzothiazole analog <b>42</b> was obtained from the benzo[<i>d</i>]thiazol-2-amine <b>58</b> by reaction with cycloheptanecarbonyl chloride (<a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>).</div><figure id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00415/20160708/images/medium/jm-2016-004153_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00415/20160708/images/large/jm-2016-004153_0008.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Analogs Containing Indole and Benzothiazole Skeleton<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00415/20160708/images/large/jm-2016-004153_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00415&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) EDC·HCl, HOBt, NH<sub>4</sub>Cl, Et<sub>3</sub>N, CH<sub>2</sub>Cl<sub>2</sub>, rt, 12–16 h; (b) LiAlH<sub>4</sub>, THF, reflux, overnight; (c) EDC·HCl, HOBt, cycloheptanecarboxylic acid, Et<sub>3</sub>N, CH<sub>2</sub>Cl<sub>2</sub>, rt, 12–16 h; (d) cycloheptanecarbonyl chloride, CH<sub>2</sub>Cl<sub>2</sub>, rt, overnight.</p></p></figure></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i5">Discussion and Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_70023" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_70023" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec3_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i6" class="anchor-spacer"></div><h3 class="article-section__title" id="_i6"> Structure–Activity Relationships</h3><div class="NLM_p">In general, the biological activity of the analogs was found to depend upon the polarity of the substituents introduced, and thus the more lipophilic compounds were found to be the most active. Compounds possessing monosubstitution such as a methyl group at position 4 of the indole moiety (<b>4</b>, <b>5</b>) retained antitubercular activity, with compound <b>5</b> bearing the <i>N</i>-cyclooctyl group being over 8-fold more active than its closest analog <b>4</b> bearing the <i>N</i>-cycloheptyl group. On the other hand, the more polar 4-aminoindole derivative <b>6</b> showed inferior activity. A similar trend in activity was observed for compounds <b>7</b>–<b>9</b> possessing methyl or amino substitution at position 5 of the indole ring. However, these compounds were consistently less potent than their corresponding counterparts <b>4</b>–<b>6</b>, which further confirms the lipophilicity-driven activity of these analogs but also indicates that position 4 is preferred for functionalization. In the case of position 6, mixed results were obtained as compound <b>11</b> bearing the more lipophilic bromo group was only slightly more active than its close analog <b>10</b> possessing the 6-methyl group. On the other hand, compound <b>12</b> bearing an <i>N</i>-adamantyl group was 2.6- and 2-fold more active than compounds <b>10</b> and <b>11,</b> respectively, although it has a ClogP comparable to that of <b>10</b>, which is lower than that of analog <b>11</b>. In line with the activity of the adamantyl derivative, we were also interested in evaluating bicyclic substituents. Our attention was drawn to the pinene skeleton because this structure is known for its broad antimicrobial activity.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(18)</a> It was pleasing to find that compound <b>13</b> bearing the <i>N</i>-(1<i>R</i>,2<i>R</i>,3<i>R</i>,5<i>S</i>)-(−)-isopinocampheyl group is 4-fold more active than compound <b>12</b> and 9-fold more active than analog <b>11</b>. Again, compound <b>13</b> is the most lipophilic molecule among compounds <b>10</b>–<b>13</b> supporting the requirement of high lipophilicity for bioactivity. To complete the investigation of the effect of monosubstitution of the indole ring on activity, a methyl group was installed at position 7 in compounds <b>14</b> and <b>15</b>. As observed earlier for compound pairs <b>4</b>/<b>5</b> and <b>7</b>/<b>8</b>, compound <b>15</b> bearing the <i>N</i>-cyclooctyl group was more active than its counterpart <b>14</b> possessing the <i>N</i>-cycloheptyl substituent.</div><div class="NLM_p">Next, we examined the effect of disubstitution with methyl and methoxy groups on the indole ring. As expected, the <i>N</i>-cyclooctyl indoles <b>17</b> and <b>19</b> were more active than their <i>N</i>-cycloheptyl counterparts (<b>16</b> and <b>18</b>). Surprisingly, the 4,6-dimethoxy compounds (<b>18</b> and <b>19</b>) had almost the same activity as the 5,7-dimethyl analogs (<b>16</b> and <b>17</b>), although the latter pair has higher ClogP values than compounds <b>18</b> and <b>19</b>, respectively. Knowing that biological activity of this series of compounds is lipophilicity-driven and that the methyl groups on the indole core present a potential metabolic liability (susceptible to metabolic oxidation),<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> we replaced the 4,6-dimethyl substituents with more lipophilic and at the same time metabolism-resistant 4,6-dihalo-groups.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(19)</a> Compound <b>20</b> containing a 4,6-dichloro-indole scaffold was the first to be prepared, and this analog showed similar activity as the lead compound <b>3</b>. Derivative <b>21</b> bearing the <i>N</i>-adamantyl group was equally potent as compound <b>20</b>, although its ClogP value is lower than that of <b>20</b>. Another structurally close analog <b>22</b> bearing the <i>N</i>-<i>exo</i>-2-norbornyl substituent showed a greater than 30-fold drop in activity compared with <b>20</b>. This result is most likely associated with the substantial difference in lipophilicity observed between the two molecules. Introduction of the <i>N</i>-(<i>R</i>)-(+)-bornyl group provided compound <b>23</b>, which was 9-fold more potent than <b>22</b> but approximately 4-fold less active than <b>20</b>. Interesting results were obtained with compounds <b>24</b>–<b>27</b>, which bear an isopinocampheyl moiety on the amide nitrogen atom. The 4,6-dichloroindole nucleus with the <i>N</i>-(1<i>R</i>,2<i>R</i>,3<i>R</i>,5<i>S</i>)-(−)-isopinocampheyl group <b>24</b> proved to be 2-fold more active than compound <b>23</b> but also was approximately 2-fold less active than compound <b>20</b> having the <i>N</i>-cyclooctyl group. Of note is the fact that compound <b>24</b> is more lipophilic than <b>20</b> and has the same ClogP value as molecule <b>23</b>. On the other hand, the <i>N</i>-(1<i>S</i>,2<i>S</i>,3<i>S</i>,5<i>R</i>)-(+)-isomer <b>25</b> turned out to be 2-, 4-, and 7-fold less potent compared with indoles <b>23</b>, <b>24</b>, and <b>20</b>, respectively. Given the fact that all three compounds <b>23</b>–<b>25</b> have the same ClogP values, it is apparent that the stereochemical orientation of the amide nitrogen substituent plays some role in the biological activity of this series of compounds. Even more pronounced results were obtained for the pair of enantiomers <b>26</b> and <b>27</b> possessing the 4,6-difluoro indole scaffold. In this case, the dextrorotatory isomer <b>27</b> was nearly 16-fold less potent than the levorotatory isomer <b>26</b>, while the latter showed about the same potency as <b>20</b> and about a 2-fold improvement in activity compared with <b>24</b>. This is a noteworthy result because the lipophilicity of compound <b>26</b> is lower than that of analogs <b>20</b> and <b>24</b>, yet it shows an <i>in vitro</i> antitubercular potency comparable to that of <b>20</b>. Based on their satisfactory <i>in vitro</i> activity, all three compounds, <b>20</b>, <b>24</b>, and <b>26</b>, were selected for further <i>in vivo</i> studies in the serum inhibitory titer assay (SIT).</div><div class="NLM_p">Appendage of a simple <i>n</i>-heptyl or <i>n</i>-octyl aliphatic chain on the amide nitrogen yielded the highly lipophilic compounds <b>28</b> and <b>29</b>, but surprisingly these were nearly inactive. These findings clearly support the importance of a more compact, α-branched cycloaliphatic group on the amide nitrogen in order to observe high activity. Compounds <b>30</b> and <b>31</b> containing the <i>N</i>-geranyl moiety provided mixed results with compound <b>30</b> possessing inferior activity and compound <b>31</b> being inactive. Compounds <b>30</b> and <b>31</b> depict once again the apparent impact of lipophilicity on activity. The β-branched <i>N</i>-substituent in compound <b>32</b> also led to loss of activity while a similar α-branched <i>N</i>-substituent gave the reasonably active compound <b>33</b> and the modestly active compound <b>34</b>. This result clearly supports the importance of a lipophilic branched cycloaliphatic group for the bioactivity since it is likely to be more resistant to metabolism than the nonbranched substituents. Compound <b>35</b> with a 5,6-fused amide substituent retained activity. In contrast, compound <b>36</b> possessing the same <i>N</i>-substituent as <b>35</b> turned out to be inactive most likely due to a drastic decrease in lipophilicity. The spiro compounds <b>37</b> and <b>38</b> provided the highest <i>in vitro</i> antitubercular activity identified in this set of compounds. Given their high potency, these compounds were also selected for <i>in vivo</i> SIT assay. The azabicylic compound <b>39</b> bearing a tertiary amine showed a significant decrease in activity. Furthermore, compound <b>40</b> featuring a reversed amide linker and the benzothiazole derivative <b>42</b> were inactive against a susceptible strain of <i>Mtb</i>. Reduction of the amide group of <b>3</b> to obtain the amine <b>41</b> resulted in a 24-fold drop in TB activity thus highlighting the importance of the carboxamide linker for anti-TB activity.</div><div class="NLM_p">Overall, the SAR for this set of compounds is complex with several factors being decisive for high antitubercular activity (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>). The indole nucleus possessing 4,6-disubstitution with lipophilic groups is crucial for activity. Halogen substituents such as F or Cl are preferred over methyl groups, which may constitute a metabolic liability. Carbocyclic groups with an α-branched carbon on the <i>N</i>-indolecarboxamide atom yielded the best compounds. The dependence of activity on the absolute configuration of this substituent suggests that it may be involved in specific interactions with the target, rather than just enhancing the compound’s lipophilicity.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. MIC and ClogP Values of Indole-2-carboxamide Analogs</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00415/20160708/images/medium/jm-2016-004153_0009.gif" alt="" id="fx1" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00415/20160708/images/medium/jm-2016-004153_0010.gif" alt="" id="fx2" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>Table a</sup><p class="last">The lowest concentration of drug leading to at least a 90% reduction of bacterial growth signal by the microplate alamarBlue assay (MABA). MIC values are reported as an average of three individual measurements.</p></div><div class="footnote" id="t1fn2"><sup>Table b</sup><p class="last">Calculated using ChemBioDraw Ultra 13.0.</p></div><div class="footnote" id="t1fn3"><sup>Table c</sup><p class="last">INH = Isoniazid.</p></div></div><div></div></div></div><div id="sec3_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8"> <i>In Vivo</i> Bioavailability and <i>in Vitro</i> Activity of Selected Indole-2-carboxamides against Clinical Isolates of <i>Mtb</i></h3><div class="NLM_p">The most promising compounds in this series, namely, <b>20</b>, <b>21</b>, <b>24</b>, <b>26</b>, <b>37</b>, and <b>38</b>, and the comparator compound <b>2</b> reported by Novartis<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(20)</a> (prepared in-house) were further evaluated for their <i>in vivo</i> bioavailability in the serum inhibition titration (SIT) assay (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>).<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(21)</a> As depicted in <a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>, compound <b>24</b> showed much higher bioavailability and thus <i>in vivo</i> efficacy compared with <b>2</b> and <b>20</b>, but it was less effective than the reference drug isoniazid. On the other hand, compound <b>26</b> showed excellent <i>in vivo</i> efficacy that was comparable to that of isoniazid when tested at a dose of 100 mg/kg. Compound <b>26</b> also showed significant improvement in bioavailability compared with the lead compound <b>3</b> (results not shown).<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> The other compounds selected for SIT analysis, namely, <b>21</b>, <b>37</b>, and <b>38</b> turned out to be inactive (results not shown) in this assay, and thus they were dropped from further studies.</div><figure id="fig2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00415/20160708/images/medium/jm-2016-004153_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00415/20160708/images/large/jm-2016-004153_0013.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Activity of selected indole-2-carboxamides in the SIT assay.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00415/20160708/images/large/jm-2016-004153_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00415&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Based on their activity in the SIT screening assays, compounds <b>20</b>, <b>24</b>, and <b>26</b> were next tested against a panel of clinical isolates<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(22)</a> of <i>Mtb</i> originally obtained from pulmonary TB patients (<a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>). Among those strains, one was drug-sensitive (DS) (V4207), two were MDR <i>Mtb</i> (KZN494, V2475), and two were XDR <i>Mtb</i> (TF274, R506). Compound toxicity against mammalian cells was tested on Vero cells, and a selectivity index (SI) was subsequently calculated (<a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>). All three compounds retained their high activity or showed only a moderate (up to 4- and 8-fold for <b>26</b> and <b>24</b>, respectively) decrease in activity against the tested clinical isolates of <i>Mtb</i>. Of note is the fact that compounds <b>20</b> and <b>26</b> showed a 2-fold increase in activity against the XDR <i>Mtb</i> strains R506 and TF274, respectively. The high activity of these compounds against MDR and XDR TB indicates not only their potential to treat drug-resistant <i>Mtb</i> strains but also suggests the likelihood that these compounds will not exhibit cross-resistance with currently used medications. Additionally, all the three compounds exhibited high IC<sub>50</sub> values against Vero cells, thus resulting in high SI indices, and thus indicating their potential lack of toxicity toward mammalian cells. We also tested <b>26</b> against the TSK54R mutant, which we had generated in our initial studies and used in the DNA deep sequencing efforts to identify MmpL3 as the target of the indolecarboxamides. The MIC was 0.0625–0.125 μg/mL, which corresponds to a 16–32-fold loss of activity against the mutant indicating MmpL3 as the potential target. Based on its excellent <i>in vitro</i> activity, superior SI, and high efficacy in the SIT assay, compound <b>26</b> was selected for further development.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Activity [MIC (μM)] of Indole-2-carboxamides against Selected Clinical Isolates of <i>Mtb</i> and Vero Cells [IC<sub>50</sub> (μM)]</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="−" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="6" align="center" char="."><i><i>Mtb</i></i> MIC (mM)</th><th class="colsep0 rowsep0" align="center" char="."> </th><th class="colsep0 rowsep0" align="center" char="−"> </th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">strain/ phenotype</th><th class="colsep0 rowsep0" align="center" char=".">H37Rv/DS</th><th class="colsep0 rowsep0" align="center" char=".">V4207/DS</th><th class="colsep0 rowsep0" align="center" char=".">KZN494/MDR<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center" char=".">V2475/MDR<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center" char=".">TF274/XDR<a class="ref internalNav" href="#t2fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center" char=".">R506/XDR<a class="ref internalNav" href="#t2fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center" char=".">Vero cells IC<sub>50</sub></th><th class="colsep0 rowsep0" align="center" char="−">SI<a class="ref internalNav" href="#t2fn4" aria-label="d">d</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0"><b>20</b></td><td class="colsep0 rowsep0" align="char" char=".">0.011</td><td class="colsep0 rowsep0" align="char" char=".">0.011</td><td class="colsep0 rowsep0" align="char" char="."><a class="ref internalNav" href="#t2fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="char" char=".">0.011</td><td class="colsep0 rowsep0" align="char" char=".">0.011</td><td class="colsep0 rowsep0" align="char" char=".">0.006</td><td class="colsep0 rowsep0" align="char" char=".">23.5–47</td><td class="colsep0 rowsep0" align="char" char="−">2136–4272</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0"><b>24</b></td><td class="colsep0 rowsep0" align="char" char=".">0.021</td><td class="colsep0 rowsep0" align="char" char=".">0.043</td><td class="colsep0 rowsep0" align="char" char=".">0.043</td><td class="colsep0 rowsep0" align="char" char=".">0.171</td><td class="colsep0 rowsep0" align="char" char=".">0.021</td><td class="colsep0 rowsep0" align="char" char=".">0.021</td><td class="colsep0 rowsep0" align="char" char=".">43.8</td><td class="colsep0 rowsep0" align="char" char="−">2085</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0"><b>26</b></td><td class="colsep0 rowsep0" align="char" char=".">0.012</td><td class="colsep0 rowsep0" align="char" char=".">0.023</td><td class="colsep0 rowsep0" align="char" char=".">0.012</td><td class="colsep0 rowsep0" align="char" char=".">0.047</td><td class="colsep0 rowsep0" align="char" char=".">0.006</td><td class="colsep0 rowsep0" align="char" char=".">0.012</td><td class="colsep0 rowsep0" align="char" char=".">≥192</td><td class="colsep0 rowsep0" align="char" char="−">≥16000</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>a</sup><p class="last">Resistance to isoniazid and rifampin.</p></div><div class="footnote" id="t2fn2"><sup>b</sup><p class="last">Resistance to isoniazid, rifampin, levofloxacin, ofloxacin, and kanamycin.</p></div><div class="footnote" id="t2fn3"><sup>c</sup><p class="last">Data not available due to growth defect.</p></div><div class="footnote" id="t2fn4"><sup>d</sup><p class="last">Selectivity index (SI) = IC<sub>50</sub>(Vero)/MIC.</p></div></div></div></div><div id="sec3_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> Preliminary ADMET Studies on Compound <b>26</b></h3><div class="NLM_p">Based on the encouraging biological results described above, we conducted some ADMET studies on compound <b>26</b> to assess its drug-like properties (<a class="ref internalNav" href="#tbl3" aria-label="Table 3">Table 3</a>). When incubated with human, mouse, rat, or dog liver hepatocytes, at least 50% of compound <b>26</b> remains unchanged after 2 h incubation using a starting concentration of 1 μM and the human hepatocytes. More substantial degradation was found using hepatocytes from the other species. Using liver microsomes, almost 70% of the compound remained unchanged after 1 h using a starting concentration of 3 μM.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. ADMET Data for Indole-2-carboxamide <b>26</b></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">assay</th><th class="colsep0 rowsep0" align="center"><b>26</b></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">hepatocytes, % remaining at 2 h, starting concentration 1 μM</td><td class="colsep0 rowsep0" align="left">52 (human), 0.7 (rat), 15 (mouse), 18 (dog)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">liver microsomes, % remaining after 1 h, starting concentration 3 μM</td><td class="colsep0 rowsep0" align="left">69.5 (human)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="2" align="left">CYP inhibition (% inhibition)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CYP2C9</td><td class="colsep0 rowsep0" align="left">–5.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CYP2D6</td><td class="colsep0 rowsep0" align="left">36.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CY3A4</td><td class="colsep0 rowsep0" align="left">–6.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="2" align="left">Caco-2 permeability</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">A–B (cm/s)</td><td class="colsep0 rowsep0" align="left">0.19 × 10<sup>–6</sup></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">B–A (cm/s)</td><td class="colsep0 rowsep0" align="left">0.25 × 10<sup>–6</sup></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">hERG IC<sub>50</sub> (μM)</td><td class="colsep0 rowsep0" align="left">>30</td></tr></tbody></table></div></div><div class="NLM_p last">As shown in <a class="ref internalNav" href="#tbl3" aria-label="Table 3">Table 3</a>, in the presence of compound <b>26</b> none of the tested CYP isoforms (CYP2D6, CYP2C19, and CYP3A4) showed more than 40% inhibition. Low inhibition of hERG (IC<sub>50</sub> > 30 μM) suggests low potential risk for blocking the cardiac calcium channel and causing QT-prolongation. Because the xenobiotic-sensing transcription factors that include the pregnane X receptor (PXR), aryl hydrocarbon receptor (AhR), and the constitutive androstane receptor (CAR) upregulate the expression of drug-metabolizing genes (CYP3A4, CYP1A2, and CYP2B6, respectively), the potential of <b>26</b> to cause transactivation of the human PXR, CAR, and AhR receptors was assessed. At low concentrations of the compound tested (0.1–1 μg/mL), no significant induction of the respective reporter genes coupled to these nuclear receptors was observed. Only at higher concentrations (3 and 8 μg/mL) was <b>26</b> able to upregulate the induction of metabolizing genes by these receptors. However, the levels of induction produced by <b>26</b> were still lower than those of the positive controls, that is, rifampin for PXR, CITCO for CAR, and 3-methylcholanthrene for AhR. We also carried out the bacterial reverse mutation assay in <i>Salmonella typhimurium</i> tester strains TA98, TA100, TA1535, and TA1537 and <i>Escherichia coli</i> tester strain WP2 uvrA for compound <b>26</b> to evaluate its intrinsic mutagenic activity, and for the most part these results were negative. Only in the case of the TA98 tester strain with the S9 liver fraction present was an increase in the ratio of the revertant colony count for the drug compared with the DMSO solvent control observed. This ratio was 2.5 with 500 μg/plate of drug. Even at 5000 μg/plate of the <b>26</b>, this ratio was only 2.0, whereas this ratio was 173 for the positive control 2-aminoanthracene. Thus, we believe the genotoxicity risk of this compound to be negligible although further studies to detect chromosomal aberrations should be done.</div></div><div id="sec3_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> Pharmacokinetic Comparisons of <b>26</b> and <b>2</b> Using LC-MS</h3><div class="NLM_p">Next, we carried out comparative pharmacokinetic studies on <b>26</b> and the comparator compound <b>2</b> using traditional liquid chromatography–mass spectrometry (LC-MS) analysis (<a class="ref internalNav" href="#tbl4" aria-label="Table 4">Table 4</a>). A single dose of 100 mg/kg was administered orally to female Balb/c mice. As shown in the table below, <b>26</b> showed significantly better PK parameters than <b>2</b> as reflected by higher AUC<sub>last</sub> (area under the curve up to the last measurable concentration) and higher AUMC<sub>last</sub> (area under the first moment curve to the last measurable concentration; this is a measure of AUC that emphasizes mean residence time).</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Pharmacokinetic Comparisons of Compounds <b>2</b> and <b>26</b></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compound</th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center" char="."><i>t</i><sub>max</sub> (h)</th><th class="colsep0 rowsep0" align="center" char="."><i>C</i><sub>max</sub> (μg/unit)</th><th class="colsep0 rowsep0" align="center" char=".">AUC<sub>last</sub> (h·μg/unit)<a class="ref internalNav" href="#t4fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center" char=".">AUMC<sub>last</sub> (h<sup>2</sup>·μg/unit)<a class="ref internalNav" href="#t4fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center" char=".">MRT<sub>last</sub> (h)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>26</b></td><td class="colsep0 rowsep0" align="left">plasma</td><td class="colsep0 rowsep0" align="char" char=".">4</td><td class="colsep0 rowsep0" align="char" char=".">1.71</td><td class="colsep0 rowsep0" align="char" char=".">18.9</td><td class="colsep0 rowsep0" align="char" char=".">137</td><td class="colsep0 rowsep0" align="char" char=".">7.28</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">lung</td><td class="colsep0 rowsep0" align="char" char=".">4</td><td class="colsep0 rowsep0" align="char" char=".">3.50</td><td class="colsep0 rowsep0" align="char" char=".">51.0</td><td class="colsep0 rowsep0" align="char" char=".">433</td><td class="colsep0 rowsep0" align="char" char=".">8.49</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2</b></td><td class="colsep0 rowsep0" align="left">plasma</td><td class="colsep0 rowsep0" align="char" char=".">2</td><td class="colsep0 rowsep0" align="char" char=".">0.67</td><td class="colsep0 rowsep0" align="char" char=".">5.62</td><td class="colsep0 rowsep0" align="char" char=".">36.4</td><td class="colsep0 rowsep0" align="char" char=".">6.47</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">lung</td><td class="colsep0 rowsep0" align="char" char=".">2</td><td class="colsep0 rowsep0" align="char" char=".">1.30</td><td class="colsep0 rowsep0" align="char" char=".">18.1</td><td class="colsep0 rowsep0" align="char" char=".">150</td><td class="colsep0 rowsep0" align="char" char=".">8.30</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup>a</sup><p class="last">unit = mL for plasma samples; unit = gram for lung samples; AUMC = area under the first moment curve; MRT = mean residence time.</p></div></div></div></div><div id="sec3_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> Mouse Efficacy Comparisons of <b>26</b> and <b>2</b></h3><div class="NLM_p">Lastly, we completed <i>in vivo</i> efficacy studies for <b>26</b> and <b>2</b> using two different mouse infection and monotherapy models. In order to enable head-to-head comparisons, we deliberately used 0.5% carboxymethylcellulose (CMC) for both of the test compounds although we are aware that more advanced formulations are now available. A minimum effective dose (MED) model was conducted using Balb/c mice that had been aerosol-infected and treated from day 1 at 12.5, 25, 50, and 100 mg/kg for both compounds. While both compounds were protective, <b>26</b> showed more obvious dose-dependent effects than <b>2</b> on both CFU enumerations in the lungs (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>) and gross pathology such as lung weight and spleen weight. For comparison, at 100 mg/kg dosage level, there was a CFU reduction of 1.71- and 2.12-log in the lungs after treatment with <b>26</b> for 2 weeks and 4 weeks, respectively. For <b>2</b>, the CFU reduction was 0.45- and 1.08-log for the same dosage level and treatment durations, respectively (<i>p</i> < 0.0001). A minimum bactericidal dose (MBD) model was also carried out. After 4 weeks of treatment at 200 mg/kg, <b>26</b> achieved 0.6-log CFU reduction while <b>2</b> left the CFU count unchanged compared with that of initiation (<i>p</i> = 0.0002). All treatment levels (25, 50, 100, and 200 mg/kg) of both indolecarboxamides protected mice from death. In these studies, we used the universal formulation, which is 0.5% carboxymethylcellulose in water. The universal formulation used in this study differs from the optimized customized proprietary formulation used by Novartis, which in turn might have contributed to the observed difference in the efficacy between compound <b>26</b> and <b>2</b> in mice model.</div><figure id="fig3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00415/20160708/images/medium/jm-2016-004153_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00415/20160708/images/large/jm-2016-004153_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. <i>In vivo</i> efficacy comparisons of compounds <b>26</b> and <b>2</b> in a mouse infection model. After aerosol <i><i>Mtb</i></i> infection with 10<sup>3</sup> CFU, mice were treated orally with 12.5, 25, 50, and 100 mg/kg of <b>26</b> or <b>2</b> daily. EMB was at 100 mg/(kg·d). Lung CFU counts were determined on days 1, 14, and 28 (5 mice/grp).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00415/20160708/images/large/jm-2016-004153_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00415&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> <i>In Vitro</i> and <i>in Vivo</i> Synergy between Indole-2-carboxamide <b>26</b> and Rifampin</h3><div class="NLM_p">Previous studies suggested that mutation in the <i>mmpL3</i> gene confers increased susceptibility of <i>Mtb</i> to rifampin.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> Since indolecarboxamides target a molecular channel, we hypothesized that the antibacterial effect of dual exposure to indolecarboxamide and rifampin might meet the criteria for true synergy rather than being two independent, additive effects. To address this question, we applied the Bliss independence model, which evaluates multiplicative effects in growth measures and has been used extensively in evaluating pharmacologic drug–drug interactions.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> As shown in <a class="ref internalNav" href="#tbl5" aria-label="Table 5">Table 5</a>, Bliss synergy was observed in multiple sub-MIC concentration combinations as highlighted. For instance, 0.5 × MIC of <b>26</b> combined with 0.0313 × MIC of rifampin achieved 99.2% inhibition (MIC cutoff = 90%). Similarly, 0.25 × or 0.0313 × MIC of <b>26</b> plus 0.25 × or 0.5 × MIC of rifampin also achieved MIC level of inhibition (99.4% or 90.5% respectively, <a class="ref internalNav" href="#tbl5" aria-label="Table 5">Table 5</a>). Rifampin is a key component of multidrug TB therapy and is considered particularly important for clearance of <i>M. tuberculosis</i> persisters and to achieving a relapse-free cure in six-months. However, rifampin is a potent inducer of both cytochrome P-450 oxidative enzymes and the P-glycoprotein transport system.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> Because of these interactions, dose adjustments are necessary when rifampin is used with numerous drugs including warfarin, contraceptives, cyclosporine, quinidine sulfate, and verapamil, to name a few.<a onclick="showRef(event, 'cit24b ref25'); return false;" href="javascript:void(0);" class="ref cit24b ref25">(24b, 25)</a> Importantly, rifampin also interacts with HIV-related protease inhibitors and significantly reduces the concentration of many standard-dose protease inhibitors, compromising HIV treatment efficacy.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> Our findings of synergy between <b>26</b> and rifampin are important because it raises the possibility that indolecarboxamide-containing treatment regimens with lower rifampin doses could be efficacious. Reduced rifampin exposures could be especially important for patients with HIV/TB co-infection who require antiretroviral therapy.</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. <i>In Vitro</i> Drug Combination of Indole-2-carboxamide <b>26</b> and Rifampin<a class="ref internalNav" href="#t5fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="8" align="center" char=".">compound <b>26</b></th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center" char=".">0.0313</th><th class="colsep0 rowsep0" align="center" char=".">0.0625</th><th class="colsep0 rowsep0" align="center" char=".">0.125</th><th class="colsep0 rowsep0" align="center" char=".">0.25</th><th class="colsep0 rowsep0" align="center" char=".">0.5</th><th class="colsep0 rowsep0" align="center" char=".">1.0</th><th class="colsep0 rowsep0" align="center" char=".">2.0</th><th class="colsep0 rowsep0" align="center" char=".">4.0</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" rowspan="8" align="left">Rif</td><td class="colsep0 rowsep0" align="left">4.0</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">2.0</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">1.0</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">0.5</td><td class="colsep0 rowsep0" align="char" char=".">0.0</td><td class="colsep0 rowsep0" align="char" char="."><b>0.1</b></td><td class="colsep0 rowsep0" align="char" char="."><b>0.1</b></td><td class="colsep0 rowsep0" align="char" char="."><b>0.1</b></td><td class="colsep0 rowsep0" align="char" char="."><b>0.1</b></td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">0.25</td><td class="colsep0 rowsep0" align="char" char="."><b>0.1</b></td><td class="colsep0 rowsep0" align="char" char="."><b>0.1</b></td><td class="colsep0 rowsep0" align="char" char="."><b>0.4</b></td><td class="colsep0 rowsep0" align="char" char="."><b>0.6</b></td><td class="colsep0 rowsep0" align="char" char="."><b>0.6</b></td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">0.125</td><td class="colsep0 rowsep0" align="char" char="."><b>0.1</b></td><td class="colsep0 rowsep0" align="char" char="."><b>0.1</b></td><td class="colsep0 rowsep0" align="char" char="."><b>0.1</b></td><td class="colsep0 rowsep0" align="char" char="."><b>0.8</b></td><td class="colsep0 rowsep0" align="char" char="."><b>1.0</b></td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">0.0625</td><td class="colsep0 rowsep0" align="char" char=".">0.0</td><td class="colsep0 rowsep0" align="char" char=".">0.0</td><td class="colsep0 rowsep0" align="char" char=".">0.0</td><td class="colsep0 rowsep0" align="char" char="."><b>0.1</b></td><td class="colsep0 rowsep0" align="char" char="."><b>1.0</b></td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">0.0313</td><td class="colsep0 rowsep0" align="char" char=".">0.0</td><td class="colsep0 rowsep0" align="char" char=".">0.0</td><td class="colsep0 rowsep0" align="char" char=".">0.0</td><td class="colsep0 rowsep0" align="char" char=".">0.0</td><td class="colsep0 rowsep0" align="char" char="."><b>1.0</b></td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup>a</sup><p class="last">Note: Checkerboard synergy study showing the calculated effect of the combination of <b>26</b> and rifampin. Bliss independence modeling was applied to wells containing <1 × MIC concentration of either compound. Synergy (Δ<i>f</i><sub>axy</sub> > 0) was observed in multiple combinations and highlighted in bold.</p></div></div></div><div class="NLM_p">Most interestingly, in an acute mouse infection and chemotherapy model, treatment with a combination of <b>26</b> and rifampin achieved synergistic effects, as evaluated using the Bliss synergy model (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>). This implies a great potential for indolecarboxamide <b>26</b> and analogs to be used in the standard regimen for shortening the duration of TB treatment.</div><figure id="fig4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00415/20160708/images/medium/jm-2016-004153_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00415/20160708/images/large/jm-2016-004153_0004.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Bliss synergy model using rifampin and <b>26</b>. Compound <b>26</b> synergizes with rifampin in an acute mouse infection and chemotherapy model.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00415/20160708/images/large/jm-2016-004153_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00415&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> Molecular Docking of Compound <b>26</b> and Related Indole-2-carboxamides</h3><div class="NLM_p">In order to gain some understanding of how the indolecarboxamides interact with the MmpL3 transporter, we constructed a possible model of the transporter using methods provided in the <a href="/doi/suppl/10.1021/acs.jmedchem.6b00415/suppl_file/jm6b00415_si_001.pdf" class="ext-link">Supporting Information</a>. As shown in <a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>, the overall folding of the MmpL3 transporter is characterized by a complex TM bundle, including 12 TM helices, and two large periplasmic domains: the first domain (D1) is located between TM1 and TM2 and the second (D2) between TM7 and TM8. Compared with the selected template (MexB transporter, see Table S1 in <a href="/doi/suppl/10.1021/acs.jmedchem.6b00415/suppl_file/jm6b00415_si_001.pdf" class="ext-link">SI</a>), MmpL3 conserves the two periplasmic domains, which define the so-called pore domain and are characterized by β–α–β motifs, while it lacks the so-called docking domains (DN and DC) which are usually involved in contacting modulating proteins. The overall folding can be divided into two halves, each composed of six TM helices and one periplasmic domain. The two halves are connected by an intracellular helical domain (D3). <a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a> also shows the bound compound <b>3</b> thus revealing the location of the putative binding pocket, which is on the cytoplasmic side of the TM bundle mostly lined by TM4 and TM10.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a></div><figure id="fig5" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00415/20160708/images/medium/jm-2016-004153_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00415/20160708/images/large/jm-2016-004153_0005.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Cartoon structure of the MmpL3 homology model as colored by N (blue) to C (red) sequence. The bound inhibitor <b>3</b> is also depicted as the gray-colored CPK model.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00415/20160708/images/large/jm-2016-004153_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00415&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Moreover, since the considered template (MexB transporter) includes an asymmetric homotrimer where each subunit adopts a different conformation, which may represent snapshots of the transport process, it is worth noting that the monomer utilized as the template is the so-called binding monomer (monomer B) since the <i>n</i>-dodecyl-<span class="smallcaps smallerCapital">d</span>-maltoside (DDM) ligand is bound in the cavity defined by its periplasmic domains and the channel is open to the periplasm from which it can capture the substrates. Although the considered pocket for the inhibitors does not correspond to that lined by the periplasmic domains, one may conjecture that the generated homology model (for details see Table S1 in <a href="/doi/suppl/10.1021/acs.jmedchem.6b00415/suppl_file/jm6b00415_si_001.pdf" class="ext-link">SI</a>) would be in a conformation suitable to investigate the binding of the transported substrates. Notably, the last discarded MmpL3 model (model no. 5, Table S1 in <a href="/doi/suppl/10.1021/acs.jmedchem.6b00415/suppl_file/jm6b00415_si_001.pdf" class="ext-link">SI</a>) was generated by using the so-called extrusion monomer (monomer C) of its template, which shows a wider TM bundle to allow the substrate release. This may explain why the pocket of model no. 5 is clearly wider and suggests that this cavity, albeit less functional, can be seen as an alternative binding conformation that the transporter can assume during the transport cycle.</div><div class="NLM_p"><a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a>A shows the main interactions stabilizing the putative complex between the MmpL3 model and <b>3</b>, which can be schematized as follows. The first subpocket accommodates the indole ring, which elicits an extended charge transfer interaction with Arg259 reinforced by π–π stacking with Phe644 plus a set of hydrophobic contacts with surrounding apolar residues such as Ile256, Val278, Ala281, Val285, and Pro330. Moreover the indole NH group stabilizes a H-bond with Ser325. A central subpocket stabilizes a rich set of H-bonds with the ligand’s amide moiety: the carbonyl oxygen atom contacts Tyr252, Ser288, and Ser325, while the amide NH group interacts with Asp640, which in turn establishes an ion-pair with the above-cited Arg259. Notably, Tyr252 is highly conserved among the MmpL isoforms and is adjacent to another residue (Gly253), the mutation of which was found to decrease the inhibition activity of known MmpL3-targeting compounds such as SQ109 and AU1235. Again, Arg259 and Asp640 are supposed to be involved in the electrochemical proton gradient that provides energy to the transporter.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> The last hydrophobic subpocket harbors the cyclooctyl ring, which approaches a set of alkyl side chains including Ile248, Ile291, Ile292, and Val643.</div><figure id="fig6" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00415/20160708/images/medium/jm-2016-004153_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00415/20160708/images/large/jm-2016-004153_0006.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Main interactions stabilizing the putative MmpL3 complex with compounds <b>3</b> (A), <b>21</b> (B), and <b>26</b> (C).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00415/20160708/images/large/jm-2016-004153_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00415&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Even though the considered MIC values are clearly influenced by lipophilicity as evidenced by <a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a> and as discussed above, docking results are in line with the reported activity values and allow in-depth rationalization of the obtained SARs. Thus, the above-mentioned apolar residues surrounding the indole ring can easily explain the negative influence of polar substituents as seen in the amino derivatives (e.g., <b>6</b>) and indeed the computed complexes confirm that the amino group is never involved in clear polar contacts but at most bumps against Phe644. Again, the disfavored status of position 5 (see, for example, compound <b>8</b>) on the indole ring can be explained by considering that the substituent approaches the less flexible backbone atoms of Thr277 and Val288. Halogen substituents clearly make a positive contribution to binding due to their lipophilicity although the computed complexes do not show clear halogen bonds involving these substituents (see <a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a>B). The relevance of the H-bond involving the indole NH group is witnessed by the inactivity of the benzothiazole derivative (<b>42</b>).</div><div class="NLM_p">The rich set of H-bonds stabilized by the amide moiety easily explains why even subtle modifications in that moiety have marked detrimental effects. Notably, the amide moiety determines the overall pose of the bound inhibitor, and indeed the computed complex for <b>40</b> shows a flipped pose in which the cycloheptyl ring takes the place of the indole moiety to allow the amide interactions to be properly elicited. Finally, the role of the <i>N</i>-linked moiety appears to be completely governed by its lipophilicity, a finding easily explainable when considering the above-mentioned set of surrounding apolar residues. <a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a>C shows the putative complex for <b>26</b> and reveals that the isopinocampheyl moiety is conveniently arranged within the apolar subpocket with all the methyl substituents suitably approaching alkyl side chains, which also provides the basis for the observed stereoselectivity of these derivatives. The inactivity of the noncyclic derivatives (<b>28</b>–<b>31</b>) may have three explanations since (a) linear substituents are less able to contact the surrounding apolar residues, (b) their flexibility may play a disfavoring entropic role, and (c) they can bump against Phe635, which restricts this subpocket. By contrast, even extended cyclic moieties (as seen in the spiro compounds <b>37</b> and <b>38</b>) are able to maximize their hydrophobic contacts while remaining reasonably far from Phe365.</div><div class="NLM_p">The performed MD simulations are unsuitable for exploring large protein conformational shifts induced by the bound inhibitors but can be conveniently utilized to analyze the relevance (and stability) of each monitored interaction. The dynamic profile of these interactions as assessed by their distance average and standard deviation (see Table S2 in <a href="/doi/suppl/10.1021/acs.jmedchem.6b00415/suppl_file/jm6b00415_si_001.pdf" class="ext-link">SI</a>) allows for some interesting considerations. All H-bonds show similar profiles that are suggestive of an overall marked stability of such interactions. Indeed, the distance profile of these H-bonds shows a roughly constant trend, apart from the contact involving Asp640, which reveals two distinct and alternating distance clusters around 2.7 and 4.5 Å, respectively. Notably, the best correlations (see Figure S1 in <a href="/doi/suppl/10.1021/acs.jmedchem.6b00415/suppl_file/jm6b00415_si_001.pdf" class="ext-link">SI</a>) are obtained by the frames where this contact assumes the larger distance values probably because such an overall arrangement allows a proper accommodation even of the bulkiest inhibitors. Finally, the standard deviation values, which can be seen as descriptors of the interaction stability, reveal that the charge transfer interaction and the hydrophobic contacts possess the highest stability, thus confirming the pivotal role of such interactions in stabilizing the simulated complexes.</div><div class="NLM_p last">The present work serves to underscore the importance of conducting a more comprehensive SAR program in order to identify the best candidate drug for advancement to clinical studies. We have assembled a total of over 80 indolecarboxamides to date, and we believe that compound <b>26</b> identified in the present work represents a potential clinical candidate. As in our earlier work, it is likely that this compound acts as an inhibitor of the mycolic acid transporter MmpL3, although this activity may indirectly stem from its initial action on the proton motive force, which leads in turn to inhibition of MmpL3. A putative homology model for the MmpL3 transporter has also been generated, and while this model can only be deemed approximate at this stage, it is useful in providing further possible insights into the SAR of the indolecarboxamides. In any event, compound <b>26</b> shows superior pharmaceutical properties, because by and large the compound displays acceptable ADMET parameters as well as <i>in vivo</i> activity. Additionally, the findings of synergy between <b>26</b> and rifampin are notable since this raises the possibility that indolecarboxamide-containing treatment regimens with lower rifampin doses could be efficacious. Thus, in comparison to the Novartis compound <b>2</b> (NITD-304) that is under development by the TB Global Alliance, we believe that <b>26</b> may in fact represent a better candidate, since it is more effective in reducing the CFU count using the TB aerosol lung infection model.</div></div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i18">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_43108" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_43108" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> Chemistry</h3><div id="sec4_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i20" class="anchor-spacer"></div><h4 class="article-section__title" id="_i20"> General Information</h4><div class="NLM_p last">The following carboxylic acids were purchased from Sigma-Aldrich, Chem-Impex, Combi-blocks, and Ark Pharma: 4-methyl-1<i>H</i>-indole-2-carboxylic acid, 5-methyl-1<i>H</i>-indole-2-carboxylic acid, 6-methyl-1<i>H</i>-indole-2-carboxylic acid, 7-methyl-1<i>H</i>-indole-2-carboxylic acid, 4,6-dichloro-1<i>H</i>-indole-2-carboxylic acid, and 6-bromo-1<i>H</i>-indole-2-carboxylic acid. Anhydrous dichloromethane (CH<sub>2</sub>Cl<sub>2</sub>) was obtained by distillation over calcium hydride. <sup>1</sup>H NMR and <sup>13</sup>C NMR spectra were recorded on Bruker or JEOL spectrometers at 400 and 100 MHz, respectively. NMR spectra were reprocessed by ACDNMR Processor Academic Edition. Standard abbreviations indicating multiplicity were used as follows: s = singlet, d = doublet, dd = doublet of doublets, t = triplet, q = quadruplet, m = multiplet, and br = broad. HR-MS experiments were performed on Q-TOF-2TM (Micromass) and IT-TOF (Shimadzu) instruments. TLC was performed on Merck 60 F<sub>254</sub> silica gel plates. Flash chromatography was performed using a CombiFlash Rf system with RediSep columns or manually using Merck silica gel (40–60 mesh). Final compounds were purified by preparative HPLC unless otherwise stated. Preparative HPLC employed an ACE 5-AQ (21.2 mm × 150 mm) column with detection at 254 and 280 nm on a Shimadzu SCL-10A VP detector, flow rate = 17.0 mL/min: method 1, 50–100% CH<sub>3</sub>OH/H<sub>2</sub>O in 30 min, 100% CH<sub>3</sub>OH for 5 min, 100–50% CH<sub>3</sub>OH/H<sub>2</sub>O in 4 min; method 2, 25–100% CH<sub>3</sub>OH/H<sub>2</sub>O in 30 min, 100% CH<sub>3</sub>OH for 5 min, 100–25% CH<sub>3</sub>OH/H<sub>2</sub>O in 4 min; method 3, 15–100% CH<sub>3</sub>OH/H<sub>2</sub>O in 30 min, 100% CH<sub>3</sub>OH for 5 min, 100–15% CH<sub>3</sub>OH/H<sub>2</sub>O in 4 min. Both solvents contained 0.05 vol % of trifluoroacetic acid (TFA). Purities of final compounds were established by analytical HPLC, which was carried out using an Agilent 1100 HPLC system with a Synergi 4 μm Hydro-RP 80A column, on a variable wavelength detector G1314A: method 1, flow rate = 1.4 mL/min, gradient elution over 20 min, from 30% MeOH–H<sub>2</sub>O to 100% MeOH with 0.05% TFA; method 2, flow rate = 1.4 mL/min, gradient elution over 20 min, from 50% MeOH–H<sub>2</sub>O to 70% MeOH with 0.05% TFA. The purity of all tested compounds was ≥95% as determined by the method described above (see <a href="/doi/suppl/10.1021/acs.jmedchem.6b00415/suppl_file/jm6b00415_si_001.pdf" class="ext-link">Supporting Information</a>).</div></div><div id="sec4_1_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i21" class="anchor-spacer"></div><h4 class="article-section__title" id="_i21"> General Procedure for the Synthesis of <b>4</b>–<b>42</b></h4><div class="NLM_p">To a solution of the appropriate carboxylic acid (1 equiv) in anhydrous dichloromethane (CH<sub>2</sub>Cl<sub>2</sub>) (4 mL/mmol) at room temperature were added anhydrous hydroxybenzotriazole (HOBt, 1 equiv) and 1-ethyl-3-(3-(dimethylamino)propyl)carbodiimide hydrochloride (EDC·HCl, 1 equiv) under an argon atmosphere. After stirring for 10 min, the appropriate substituted amine (1 equiv) and triethylamine (1.5 equiv) were added, and the reaction mixture was stirred at room temperature until disappearance of the starting material (usually 12–16 h). After this time water (2 mL) was added, and the mixture was extracted with EtOAc (3 × 10 mL). The organic layers were separated, washed with brine, dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated under reduced pressure. The residue was purified by flash chromatography on SiO<sub>2</sub> using 0–40% EtOAc–hexane gradient (unless specified differently) to obtain the indolecarboxamides in yields ranging from 34% to 95%, which were further purified by preparative HPLC unless otherwise stated.</div><div id="sec4_1_2_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i22" class="anchor-spacer"></div><h5 class="article-section__title" id="_i22"> <i>N</i>-Cycloheptyl-4-methyl-1<i>H</i>-indole-2-carboxamide (<b>4</b>)</h5><div class="NLM_p last">Yield 84% (white powder). <sup>1</sup>H NMR (400 MHz, <i>d</i><sub>6</sub><i>-</i>DMSO) δ 11.5 (s, 1H), 8.24 (d, <i>J</i> = 8.0 Hz, 1H), 7.25 (d, <i>J</i> = 8.4 Hz, 1H), 7.22 (s, 1H), 7.05 (dd, <i>J</i> = 7.2, 8.0 Hz, 1H), 6.83 (d, <i>J</i> = 7.2 Hz, 1H), 4.01 (m, 1H), 2.48 (s, 3H), 1.91–1.87 (m, 2H), 1.71–1.54 (m, 10H); <sup>13</sup>C NMR (100 MHz, <i>d</i><sub>6</sub>-DMSO) δ 159.9, 136.1, 131.4, 130.2, 127.3, 123.2, 119.5, 109.8, 101.2, 49.9, 34.4 (2C), 27.9 (2C), 23.8 (2C), 18.5. HRMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>17</sub>H<sub>23</sub>N<sub>2</sub>O ([M + H]<sup>+</sup>) 271.1805; found 271.1808.</div></div><div id="sec4_1_2_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i23" class="anchor-spacer"></div><h5 class="article-section__title" id="_i23"> <i>N</i>-Cyclooctyl-4-methyl-1<i>H</i>-indole-2-carboxamide (<b>5</b>)</h5><div class="NLM_p last">Yield 74% (white powder). <sup>1</sup>H NMR (400 MHz, <i>d</i><sub>6</sub><i>-</i>DMSO) δ 11.5 (s, 1H), 8.22 (d, <i>J</i> = 8.0 Hz, 1H), 7.25 (d, <i>J</i> = 9.2 Hz, 1H), 7.22 (s, 1H), 7.05 (t, <i>J</i> = 7.6 Hz, 1H), 6.83 (d, <i>J</i> = 7.2 Hz, 1H), 4.05 (m, 1H), 2.49 (s, 3H), 1.82–1.67 (m, 6H), 1.61–1.52 (m, 8H); <sup>13</sup>C NMR (100 MHz, <i>d</i><sub>6</sub>-DMSO) δ 159.9, 136.1, 131.4, 130.2, 127.3, 123.2, 119.5, 109.8, 101.2, 48.9, 31.6 (2C), 26.9 (2C), 25.0, 23.4 (2C), 18.5. HRMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>18</sub>H<sub>25</sub>N<sub>2</sub>O ([M + H]<sup>+</sup>) 285.1961; found 285.1967.</div></div><div id="sec4_1_2_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i24" class="anchor-spacer"></div><h5 class="article-section__title" id="_i24"> 4-Amino-<i>N</i>-cyclooctyl-1<i>H</i>-indole-2-carboxamide (<b>6</b>)</h5><div class="NLM_p last">Yield 78% (white powder). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 7.45 (d, <i>J</i> = 8.4 Hz, 1H), 7.26 (m, 1H), 7.21 (s, 1H), 7.00 (d, <i>J</i> = 7.2 Hz, 1H), 4.18 (m, 1H), 1.94–1.64 (m, 14H); <sup>13</sup>C NMR (100 MHz, CD<sub>3</sub>OD) δ 162.2, 139.4, 134.0, 125.4, 125.3, 122.3, 113.3, 112.4, 100.9, 51.4, 33.7 (2C), 28.3 (2C), 27.0, 25.3 (2C). HRMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>17</sub>H<sub>24</sub>N<sub>3</sub>O ([M + H]<sup>+</sup>) 286.1914; found 286.1918.</div></div><div id="sec4_1_2_4" class="NLM_sec NLM_sec_level_4"><div id="ac_i25" class="anchor-spacer"></div><h5 class="article-section__title" id="_i25"> <i>N</i>-Cycloheptyl-5-methyl-1<i>H</i>-indole-2-carboxamide (<b>7</b>)</h5><div class="NLM_p last">Yield 78% (off-white powder). <sup>1</sup>H NMR (400 MHz, <i>d</i><sub>6</sub><i>-</i>DMSO) δ 11.4 (s, 1H), 8.18 (d, <i>J</i> = 7.6 Hz, 1H), 7.36 (s, 1H), 7.33 (d, <i>J</i> = 8.4 Hz, 1H), 7.07 (s, 1H), 7.00 (d, <i>J</i> = 8 Hz, 1H), 4.00 (m, 1H), 2.36 (s, 3H), 1.88 (m, 2H), 1.66–1.43 (m, 10H); <sup>13</sup>C NMR (100 MHz, <i>d</i><sub>6</sub>-DMSO) δ 159.9, 134.7, 132.0, 128.1, 127.3, 124.9, 120.6, 111.9, 102.0, 50.0, 34.4 (2C), 27.8 (2C), 23.9 (2C), 21.1. HRMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>17</sub>H<sub>23</sub>N<sub>2</sub>O ([M + H]<sup>+</sup>) 271.1805; found 271.1805.</div></div><div id="sec4_1_2_5" class="NLM_sec NLM_sec_level_4"><div id="ac_i26" class="anchor-spacer"></div><h5 class="article-section__title" id="_i26"> <i>N</i>-Cyclooctyl-5-methyl-1<i>H</i>-indole-2-carboxamide (<b>8</b>)</h5><div class="NLM_p last">Yield 74% (off-white powder). <sup>1</sup>H NMR (400 MHz, <i>d</i><sub>6</sub><i>-</i>DMSO) δ 11.4 (s, 1H), 8.16 (d, <i>J</i> = 7.6 Hz, 1H), 7.36 (s, 1H), 7.32 (d, <i>J</i> = 8.4 Hz, 1H), 7.07 (s, 1H), 7.00 (d, <i>J</i> = 8.4 Hz, 1H), 4.04 (m, 1H), 2.36 (s, 3H), 1.81–1.68 (m, 6H), 1.60–1.53 (m, 8H); <sup>13</sup>C NMR (100 MHz, <i>d</i><sub>6</sub>-DMSO) δ 159.9, 134.7, 132.0, 128.1, 127.3, 124.9, 120.6, 111.9, 102.0, 48.9, 31.6 (2C), 26.9 (2C), 25.0, 23.5 (2C), 21.1. HRMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>18</sub>H<sub>25</sub>N<sub>2</sub>O ([M + H]<sup>+</sup>) 285.1961; found 285.1958.</div></div><div id="sec4_1_2_6" class="NLM_sec NLM_sec_level_4"><div id="ac_i27" class="anchor-spacer"></div><h5 class="article-section__title" id="_i27"> 5-Amino-<i>N</i>-cyclooctyl-1<i>H</i>-indole-2-carboxamide (<b>9</b>)</h5><div class="NLM_p last">Yield 71% (white powder). <sup>1</sup>H NMR (400 MHz, <i>d</i><sub>6</sub><i>-</i>DMSO) δ 11.79 (s, 1H), 9.85 (s, 2H), 8.31 (d, <i>J</i> = 8.0 Hz, 1H), 7.57 (s, 1H), 7.52 (d, <i>J</i> = 8.8 Hz, 1H), 7.22 (s, 1H), 7.14 (d, <i>J</i> = 8.4 Hz, 1H), 4.04 (m, 1H), 1.81–1.51 (m, 14H); <sup>13</sup>C NMR (100 MHz, <i>d</i><sub>6</sub>-DMSO) δ 159.4, 135.1, 133.9, 127.0, 118.0, 114.8, 133.4, 102.6, 49.0, 31.6 (2C), 26.9 (2C), 25.0, 23.4 (2C). HRMS (ESI) calcd for C<sub>17</sub>H<sub>24</sub>N<sub>3</sub>O ([M + H]<sup>+</sup>) <i>m</i>/<i>z</i> 286.1914; found 286.1912.</div></div><div id="sec4_1_2_7" class="NLM_sec NLM_sec_level_4"><div id="ac_i28" class="anchor-spacer"></div><h5 class="article-section__title" id="_i28"> <i>N</i>-Cyclooctyl-6-methyl-1<i>H</i>-indole-2-carboxamide (<b>10</b>)</h5><div class="NLM_p last">Yield 78% (white powder). <sup>1</sup>H NMR (400 MHz, <i>d</i><sub>6</sub><i>-</i>DMSO) δ 11.31 (s, 1H), 8.12 (d, <i>J</i> = 8.4 Hz, 1H), 7.47 (d, <i>J</i> = 8.4 Hz, 1H), 7.20 (s, 1H), 7.09 (s, 1H), 6.86 (d, <i>J</i> = 8.4 Hz, 1H), 4.03 (m, 1H), 2.38 (s, 3H), 1.77–1.51 (m, 14H); <sup>13</sup>C NMR (100 MHz, <i>d</i><sub>6</sub>-DMSO) δ 159.9, 136.7, 132.3, 131.5, 125.0, 121.6, 121.0, 111.7, 102.4, 48.8, 31.6 (2C), 26.9 (2C), 25.0, 23.4 (2C), 21.5. HRMS (ESI) calcd for C<sub>18</sub>H<sub>25</sub>N<sub>2</sub>O ([M + H]<sup>+</sup>) <i>m</i>/<i>z</i> 285.1961; found 285.1959.</div></div><div id="sec4_1_2_8" class="NLM_sec NLM_sec_level_4"><div id="ac_i29" class="anchor-spacer"></div><h5 class="article-section__title" id="_i29"> 6-Bromo-<i>N</i>-cyclooctyl-1<i>H</i>-indole-2-carboxamide (<b>11</b>)</h5><div class="NLM_p last">The title compound was obtained by following the general procedure. The crude material was purified by flash column chromatography on SiO<sub>2</sub> with a hexane–EtOAc gradient as the eluent followed by recrystallization from ethyl acetate to give an off-white solid (155 mg, 44% on a 1.0 mM scale). <sup>1</sup>H NMR (<i>d</i><sub>6</sub>-DMSO) δ 11.61 (s, 1H), 8.26 (d, <i>J</i> = 7.8 Hz, 1H), 7.54 (d, <i>J</i> = 8.3 Hz, 1H), 7.53 (overlapping d, <i>J</i> = 1.1 Hz, 1H), 7.15 (s, 1H), 7.11 (dd, <i>J</i> = 8.5, 1.4 Hz, 1H), 1.75–1.40 (m, 15H); <sup>13</sup>C NMR (<i>d</i><sub>6</sub>-DMSO) δ 160.0, 137.6, 133.5, 126.6, 123.8, 123.1, 116.3, 115.2, 103.1, 49.5, 32.1 (2C), 27.4 (2C), 25.5, 24.0 (2C). HRMS (ESI) calcd for C<sub>17</sub>H<sub>22</sub>BrN<sub>2</sub>O ([M + H]<sup>+</sup>) <i>m</i>/<i>z</i> 349.0915; found 349.0925.</div></div><div id="sec4_1_2_9" class="NLM_sec NLM_sec_level_4"><div id="ac_i30" class="anchor-spacer"></div><h5 class="article-section__title" id="_i30"> <i>N</i>-(1-Adamantanyl)-6-bromo-1<i>H</i>-indole-2-carboxamide (<b>12</b>)</h5><div class="NLM_p last">The title compound was obtained by following the general procedure. The crude material was purified by flash column chromatography on SiO<sub>2</sub> with a hexane–EtOAc gradient as the eluent followed by recrystallization from ethyl acetate to give an off-white solid (238 mg, 64% on a 1.0 mM scale). <sup>1</sup>H NMR (<i>d</i><sub>6</sub>-DMSO) δ 11.55 (s, 1H), 7.62 (s, 1H), 7.53 (s, 1H), 7.52 (overlapping d, <i>J</i> = 8.8 Hz, 1H), 7.15 (s, 1H), 7.10 (dd, <i>J</i> = 8.6, 1.6 Hz, 1H), 2.09–2.00 (m, 9H), 1.62 (br s, 6H); <sup>13</sup>C NMR (<i>d</i><sub>6</sub>-DMSO) δ 160.6, 137.5, 134.0, 126.6, 123.8, 123.1, 116.3, 115.1, 103.4, 52.2, 41.5 (3C), 36.6 (3C), 29.4 (3C). HRMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>19</sub>H<sub>22</sub>BrN<sub>2</sub>O ([M + H]<sup>+</sup>) 373.0915; found 373.0918.</div></div><div id="sec4_1_2_10" class="NLM_sec NLM_sec_level_4"><div id="ac_i31" class="anchor-spacer"></div><h5 class="article-section__title" id="_i31"> 6-Bromo-<i>N</i>-((1<i>R</i>,2<i>R</i>,3<i>R</i>,5<i>S</i>)-2,6,6-trimethylbicyclo[3.1.1]heptan-3-yl)-1<i>H</i>-indole-2-carboxamide (<b>13</b>)</h5><div class="NLM_p last">The title compound was obtained by following the general procedure. The crude material was purified by flash column chromatography on SiO<sub>2</sub> with a hexane–EtOAc gradient as the eluent followed by recrystallization from ethyl acetate to give a white solid (260 mg, 69% on a 1.0 mM scale). <sup>1</sup>H NMR (<i>d</i><sub>6</sub>-DMSO) δ 11.64 (s, 1H), 8.36 (d, <i>J</i> = 8.7 Hz, 1H), 7.55 (overlapping d, <i>J</i> = 8.7 Hz, 1H), 7.54 (s, 1H), 7.17 (d, <i>J</i> = 1.4 Hz, 1H), 7.12 (dd, <i>J</i> = 8.7, 1.8 Hz, 1H), 4.33 (m, 1H), 2.41–2.29 (m, 2H), 2.02 (quintuplet-d, <i>J</i> = 7.3, 0.9 Hz, 1H), 1.90–1.89 (m, 1H), 1.76 (t, <i>J</i> = 5.3 Hz, 1H), 1.65 (ddd, <i>J</i> = 13.6, 6.5, 1.8 Hz, 1H), 1.18 (s, 3H), 1.17 (overlapping d, <i>J</i> = 12.3 Hz, 1H), 1.02 (s, 3H), 1.01 (overlapping d, <i>J</i> = 8.7 Hz, 3H); <sup>13</sup>C NMR (<i>d</i><sub>6</sub>-DMSO) δ 160.7, 137.6, 133.4, 126.6, 123.9, 123.1, 116.4, 115.2, 103.0, 47.8, 47.6, 44.4, 41.6, 38.9, 36.4, 34.3, 28.4, 23.8, 21.2. HRMS (ESI) calcd for C<sub>19</sub>H<sub>24</sub>BrN<sub>2</sub>O ([M + H]<sup>+</sup>) <i>m</i>/<i>z</i> 375.1072; found 375.1053.</div></div><div id="sec4_1_2_11" class="NLM_sec NLM_sec_level_4"><div id="ac_i32" class="anchor-spacer"></div><h5 class="article-section__title" id="_i32"> <i>N</i>-Cycloheptyl-7-methyl-1<i>H</i>-indole-2-carboxamide (<b>14</b>)</h5><div class="NLM_p last">Yield 71% (white powder). <sup>1</sup>H NMR (400 MHz, <i>d</i><sub>6</sub><i>-</i>DMSO) δ 11.2 (s, 1H), 8.20 (d, <i>J</i> = 8.0 Hz, 1H), 7.43 (d, <i>J</i> = 7.2 Hz, 1H), 7.14 (s, 1H), 6.98 (m, 2H), 4.00 (m, 1H), 2.51 (s, 3H), 1.93–1.88 (m, 2H), 1.71–1.42 (m, 10H); <sup>13</sup>C NMR (100 MHz, <i>d</i><sub>6</sub>-DMSO) δ 159.8, 136.0, 132.2, 126.7, 123.7, 121.6, 119.9, 118.8, 103.9, 50.0, 34.4 (2C), 27.9 (2C), 23.9 (2C), 17.1. HRMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>17</sub>H<sub>23</sub>N<sub>2</sub>O ([M + H]<sup>+</sup>) 271.1805; found 271.1803.</div></div><div id="sec4_1_2_12" class="NLM_sec NLM_sec_level_4"><div id="ac_i33" class="anchor-spacer"></div><h5 class="article-section__title" id="_i33"> <i>N</i>-Cyclooctyl-7-methyl-1<i>H</i>-indole-2-carboxamide (<b>15</b>)</h5><div class="NLM_p last">Yield 74% (white powder). <sup>1</sup>H NMR (400 MHz, <i>d</i><sub>6</sub><i>-</i>DMSO) δ 11.2 (s, 1H), 8.18 (d, <i>J</i> = 8.0 Hz, 1H), 7.43 (d, <i>J</i> = 7.2 Hz, 1H), 7.14 (s, 1H), 6.96 (m, 2H), 4.06 (m, 1H), 2.51 (s, 3H), 1.83–1.67 (m, 6H), 1.62–1.50 (m, 8H); <sup>13</sup>C NMR (100 MHz, <i>d</i><sub>6</sub>-DMSO) δ 159.8, 136.0, 132.2, 126.7, 123.7, 121.6, 119.8, 118.8, 103.9, 48.9, 31.7 (2C), 26.9 (2C), 25.1, 23.5 (2C), 17.1. HRMS (ESI) calcd for C<sub>18</sub>H<sub>25</sub>N<sub>2</sub>O ([M + H]<sup>+</sup>) <i>m</i>/<i>z</i> 285.1961; found 285.1958.</div></div><div id="sec4_1_2_13" class="NLM_sec NLM_sec_level_4"><div id="ac_i34" class="anchor-spacer"></div><h5 class="article-section__title" id="_i34"> <i>N</i>-Cycloheptyl-5,7-dimethyl-1<i>H</i>-indole-2-carboxamide (<b>16</b>)</h5><div class="NLM_p last">Yield 80% (off-white powder). <sup>1</sup>H NMR (400 MHz, <i>d</i><sub>6</sub><i>-</i>DMSO) δ 11.1 (s, 1H), 8.14 (d, <i>J</i> = 8.0 Hz, 1H), 7.18 (s, 1H), 7.03 (s, 1H), 6.80 (s, 1H), 3.99 (m, 1H), 2.46 (s, 3H), 2.32 (s, 3H), 1.92–1.87 (m, 2H), 1.70–1.53 (m, 10H); <sup>13</sup>C NMR (100 MHz, <i>d</i><sub>6</sub>-DMSO) δ 159.8, 134.5, 132.1, 128.3, 127.0, 125.6, 121.2, 118.1, 103.4, 50.0, 34.4 (2C), 27.9 (2C), 23.8 (2C), 21.0, 17.0. HRMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>18</sub>H<sub>25</sub>N<sub>2</sub>O ([M + H]<sup>+</sup>) 285.1961; found 285.1957.</div></div><div id="sec4_1_2_14" class="NLM_sec NLM_sec_level_4"><div id="ac_i35" class="anchor-spacer"></div><h5 class="article-section__title" id="_i35"> <i>N</i>-Cyclooctyl-5,7-dimethyl-1H-indole-2-carboxamide (<b>17</b>)</h5><div class="NLM_p last">Yield 82% (off-white powder). <sup>1</sup>H NMR (400 MHz, <i>d</i><sub>6</sub><i>-</i>DMSO) δ 11.1 (s, 1H), 8.14 (d, <i>J</i> = 8.0 Hz, 1H), 7.19 (s, 1H), 7.04 (s, 1H), 6.80 (s, 1H), 4.05 (m, 1H), 2.47 (s, 3H), 2.32 (s, 3H), 1.82–1.62 (m, 6H), 1.58–1.52 (m, 8H); <sup>13</sup>C NMR (100 MHz, <i>d</i><sub>6</sub>-DMSO) δ 159.8, 134.5, 132.1, 128.3, 127.0, 125.6, 121.2, 118.1, 103.4, 48.9, 31.7 (2C), 26.9 (2C), 25.1, 23.5 (2C), 21.0, 17.0. HRMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>19</sub>H<sub>27</sub>N<sub>2</sub>O ([M + H]<sup>+</sup>) 299.2118; found 299.2118.</div></div><div id="sec4_1_2_15" class="NLM_sec NLM_sec_level_4"><div id="ac_i36" class="anchor-spacer"></div><h5 class="article-section__title" id="_i36"> <i>N</i>-Cycloheptyl-4,6-dimethoxy-1<i>H</i>-indole-2-carboxamide (<b>18</b>)</h5><div class="NLM_p last">Yield 87% (white powder). <sup>1</sup>H NMR (400 MHz, <i>d</i><sub>6</sub><i>-</i>DMSO) δ 11.3 (s, 1H), 8.06 (d, <i>J</i> = 8.0 Hz, 1H), 7.19 (s, 1H), 6.49 (s, 1H), 6.16 (s, 1H), 3.98 (m, 1H), 3.84 (s, 3H), 3.75 (s, 3H), 1.89–1.84 (m, 2H), 1.67–1.39 (m, 10H); <sup>13</sup>C NMR (100 MHz, <i>d</i><sub>6</sub>-DMSO) δ 159.9, 158.1, 153.9, 137.8, 129.4, 112.7, 100.5, 91.8, 86.9, 55.2, 55.1, 49.8, 34.4 (2C), 27.9 (2C), 23.8 (2C). HRMS (ESI) calcd for C<sub>18</sub>H<sub>25</sub>N<sub>2</sub>O<sub>3</sub> ([M + H]<sup>+</sup>) 317.1860; found 317.1851.</div></div><div id="sec4_1_2_16" class="NLM_sec NLM_sec_level_4"><div id="ac_i37" class="anchor-spacer"></div><h5 class="article-section__title" id="_i37"> <i>N</i>-Cyclooctyl-4,6-dimethoxy-1<i>H</i>-indole-2-carboxamide (<b>19</b>)</h5><div class="NLM_p last">Yield 87% (white powder). <sup>1</sup>H NMR (400 MHz, <i>d</i><sub>6</sub><i>-</i>DMSO) δ 11.3 (s, 1H), 8.03 (d, <i>J</i> = 8.0 Hz, 1H), 7.18 (s, 1H), 6.48 (s, 1H), 6.16 (s, 1H), 3.99 (m, 1H), 3.84 (s, 3H), 3.75 (s, 3H), 1.79–1.50 (m, 14H); <sup>13</sup>C NMR (100 MHz, <i>d</i><sub>6</sub>-DMSO) δ 159.8, 158.1, 153.9, 137.8, 129.4, 112.7, 100.5, 91.7, 86.9, 55.2, 55.1, 48.7, 31.5 (2C), 26.9 (2C), 25.0, 23.4 (2C). HRMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>19</sub>H<sub>27</sub>N<sub>2</sub>O<sub>3</sub> ([M + H]<sup>+</sup>) 331.2016; found 331.2001.</div></div><div id="sec4_1_2_17" class="NLM_sec NLM_sec_level_4"><div id="ac_i38" class="anchor-spacer"></div><h5 class="article-section__title" id="_i38"> 4,6-Dichloro-<i>N</i>-cyclooctyl-1<i>H</i>-indole-2-carboxamide (<b>20</b>)</h5><div class="NLM_p last">Yield 75% (white powder). <sup>1</sup>H NMR (400 MHz, <i>d</i><sub>6</sub><i>-</i>DMSO) δ 12.02 (s, 1H), 8.46 (d, <i>J</i> = 8.4 Hz, 1H), 7.41 (s, 1H), 7.33 (s, 1H), 7.21 (s, 1H), 4.03 (m, 1H), 1.81–1.50 (m, 14H); <sup>13</sup>C NMR (100 MHz, <i>d</i><sub>6</sub>-DMSO) δ 158.9, 136.7, 133.8, 127.5, 126.2, 124.8, 119.3, 111.0, 100.6, 49.1, 31.4 (2C), 26.9 (2C), 25.0, 23.4 (2C). HRMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>17</sub>H<sub>21</sub>N<sub>2</sub>OCl<sub>2</sub> ([M + H]<sup>+</sup>) 339.1025; found 339.1013.</div></div><div id="sec4_1_2_18" class="NLM_sec NLM_sec_level_4"><div id="ac_i39" class="anchor-spacer"></div><h5 class="article-section__title" id="_i39"> <i>N</i>-(1-Adamantanyl)-4,6-dichloro-1<i>H</i>-indole-2-carboxamide (<b>21</b>)</h5><div class="NLM_p last">The title compound was obtained by following the general procedure. The crude material was purified by flash column chromatography on SiO<sub>2</sub> with a hexane–EtOAc gradient as the eluent followed by recrystallization from methanol to give an off-white solid (190 mg, 52% on a 1.0 mM scale). <sup>1</sup>H NMR (<i>d</i><sub>6</sub>-DMSO) δ 11.89 (s, 1H), 7.81 (s, 1H), 7.36 (s, 1H), 7.30 (s, 1H), 7.15 (s, 1H), 2.07–1.97 (m, 9H), 1.61 (br s, 6H); <sup>13</sup>C NMR (<i>d</i><sub>6</sub>-DMSO) δ 160.1, 137.1, 134.8, 128.0, 126.8, 125.4, 119.8, 111.5, 101.4, 52.4, 41.4 (3C), 36.5 (3C), 29.4 (3C). HRMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>19</sub>H<sub>21</sub>Cl<sub>2</sub>N<sub>2</sub>O ([M + H]<sup>+</sup>) 363.1031; found 363.1037.</div></div><div id="sec4_1_2_19" class="NLM_sec NLM_sec_level_4"><div id="ac_i40" class="anchor-spacer"></div><h5 class="article-section__title" id="_i40"> <i>N</i>-(<i>exo</i>-Bicyclo[2.2.1]heptan-2-yl)-4,6-dichloro-1<i>H</i>-indole-2-carboxamide (<b>22</b>)</h5><div class="NLM_p last">The title compound was obtained by following the general procedure. The crude material was purified by flash column chromatography on SiO<sub>2</sub> with a hexane–EtOAc gradient as the eluent followed by recrystallization from hexane to give a pale yellow solid (120 mg, 37% on a 1.0 mM scale). <sup>1</sup>H NMR (<i>d</i><sub>6</sub>-DMSO) δ 11.97 (s, 1H), 8.26 (d, <i>J</i> = 6.9 Hz, 1H), 7.37 (s, 1H), 7.33 (s, 1H), 7.17 (d, <i>J</i> = 1.4 Hz, 1H), 3.72 (m, 1H), 2.22 (br s, 1H), 2.15 (br s, 1H), 1.64–1.35 (m, 5H), 1.18–1.07 (m, 3H); <sup>13</sup>C NMR (<i>d</i><sub>6</sub>-DMSO) δ 160.1, 137.2, 134.1, 128.1, 126.8, 125.3, 119.8, 111.6, 101.4, 53.3, 42.5, 38.4, 35.7, 35.5, 28.6, 26.8. HRMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>16</sub>H<sub>17</sub>Cl<sub>2</sub>N<sub>2</sub>O ([M + H]<sup>+</sup>) 323.0718; found 323.0717.</div></div><div id="sec4_1_2_20" class="NLM_sec NLM_sec_level_4"><div id="ac_i41" class="anchor-spacer"></div><h5 class="article-section__title" id="_i41"> 4,6-Dichloro-<i>N</i>-(<i>endo</i>-(1<i>R</i>)-1,7,7-trimethylbicyclo[2.2.1]heptan-2-yl)-1<i>H</i>-indole-2-carboxamide (<b>23</b>)</h5><div class="NLM_p last">The title compound was obtained by following the general procedure. The crude material was purified by flash column chromatography on SiO<sub>2</sub> with a hexane–EtOAc gradient as the eluent followed by recrystallization from hexane to give an off-white solid (175 mg, 48% on a 1.0 mM scale). <sup>1</sup>H NMR (<i>d</i><sub>6</sub>-DMSO) δ 11.99 (s, 1H), 8.23 (d, <i>J</i> = 8.7 Hz, 1H), 7.42 (s, 1H), 7.37 (s, 1H), 7.18 (d, <i>J</i> = 1.4 Hz, 1H), 4.35 (m, 1H), 2.14 (tt, <i>J</i> = 12.2, 3.6 Hz, 1H), 1.77–1.61 (m, 3H), 1.38 (m, 1H), 1.21 (t, <i>J</i> = 12.1 Hz, 1H), 1.12 (dd, <i>J</i> = 12.8, 5.0 Hz, 1H), 0.92 (s, 3H), 0.81 (s, 3H), 0.72 (s, 3H); <sup>13</sup>C NMR (<i>d</i><sub>6</sub>-DMSO) δ 160.9, 137.2, 134.1, 128.1, 126.8, 125.3, 119.9, 111.6, 101.4, 54.0, 50.5, 48.5, 45.0, 35.0, 28.3, 28.2, 20.3, 19.1, 14.6. HRMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>19</sub>H<sub>23</sub>Cl<sub>2</sub>N<sub>2</sub>O ([M + H]<sup>+</sup>) 365.1187; found 365.1184.</div></div><div id="sec4_1_2_21" class="NLM_sec NLM_sec_level_4"><div id="ac_i42" class="anchor-spacer"></div><h5 class="article-section__title" id="_i42"> 4,6-Dichloro-<i>N</i>-((1<i>R</i>,2<i>R</i>,3<i>R</i>,5<i>S</i>)-2,6,6-trimethylbicyclo[3.1.1]heptan-3-yl)-1<i>H</i>-indole-2-carboxamide (<b>24</b>)</h5><div class="NLM_p last">The title compound was obtained by following the general procedure. The crude material was purified by flash column chromatography on SiO<sub>2</sub> with a hexane–EtOAc gradient as the eluent followed by recrystallization from hexane to give an off-white solid (5.11 g, 76% on a 18.4 mM scale). <sup>1</sup>H NMR (<i>d</i><sub>6</sub>-DMSO) δ 12.01 (s, 1H), 8.51 (d, <i>J</i> = 8.7 Hz, 1H), 7.38 (s, 1H), 7.30 (s, 1H), 7.18 (d, <i>J</i> = 1.4 Hz, 1H), 4.34 (m, 1H), 2.42–2.30 (m, 2H), 2.03 (quintuplet, <i>J</i> = 6.9 Hz, 1H), 1.90 (br s, 1H), 1.76 (t, <i>J</i> = 5.3 Hz, 1H), 1.66 (dd, <i>J</i> = 13.1, 5.7 Hz, 1H), 1.17 (s, 3H), 1.15–1.00 (m, 1H), 1.02 (s, 6H); <sup>13</sup>C NMR (<i>d</i><sub>6</sub>-DMSO) δ 160.1, 137.3, 134.3, 128.0, 126.8, 125.3, 119.9, 111.6, 101.1, 47.8, 47.6, 44.4, 41.6, 38.9, 36.3, 34.3, 28.4, 23.8, 21.2. HPLC: <i>t</i><sub>R</sub> 16.9 min, purity 98.4%. HRMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>19</sub>H<sub>23</sub>Cl<sub>2</sub>N<sub>2</sub>O ([M + H]<sup>+</sup>) 365.1187; found 365.1203.</div></div><div id="sec4_1_2_22" class="NLM_sec NLM_sec_level_4"><div id="ac_i43" class="anchor-spacer"></div><h5 class="article-section__title" id="_i43"> 4,6-Dichloro-<i>N</i>-((1<i>S</i>,2<i>S</i>,3<i>S</i>,5<i>R</i>)-2,6,6-trimethylbicyclo[3.1.1]heptan-3-yl)-1<i>H</i>-indole-2-carboxamide (<b>25</b>)</h5><div class="NLM_p last">Yield: 74% (white solid). <sup>1</sup>H NMR (400 MHz, <i>d</i><sub>6</sub><i>-</i>DMSO) δ 12.05 (s, 1H), 8.56 (d, <i>J</i> = 8.4 Hz, 1H), 7.43 (s, 1H), 7.35 (s, 1H), 7.22 (s, 1H), 4.39 (m, 1H), 2.47–2.36 (m, 2H), 2.08 (t, <i>J</i> = 6.8 Hz, 1H), 1.94 (br s, 1H), 1.81 (m, 1H), 1.72 (dd, J = 12.8, 5.2 Hz, 1H), 1.23 (s, 3H), 1.22–1.20 (m, 1H), 1.07 (s, 6H); <sup>13</sup>C NMR (100 MHz, <i>d</i><sub>6</sub>-DMSO) δ 159.6, 136.7, 133.7, 127.5, 126.2, 124.8, 119.3, 111.1, 100.6, 47.3, 47.1, 43.9, 41.1, 38.3, 35.8, 33.8, 27.9, 23.3, 20.6. HRMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>19</sub>H<sub>23</sub>Cl<sub>2</sub>N<sub>2</sub>O ([M + H]<sup>+</sup>) 365.1187; found 365.1166.</div></div><div id="sec4_1_2_23" class="NLM_sec NLM_sec_level_4"><div id="ac_i44" class="anchor-spacer"></div><h5 class="article-section__title" id="_i44"> 4,6-Difluoro-<i>N</i>-((1<i>R</i>,2<i>R</i>,3<i>R</i>,5<i>S</i>)-2,6,6-trimethylbicyclo[3.1.1]heptan-3-yl)-1<i>H</i>-indole-2-carboxamide (<b>26</b>)</h5><div class="NLM_p last">The title compound was obtained by following the general procedure. The crude material was purified by flash column chromatography on SiO<sub>2</sub> with a hexane–EtOAc gradient as the eluent followed by recrystallization from ethyl acetate to give white solid (5.03 g, 82% on a 18.4 mM scale). <sup>1</sup>H NMR (<i>d</i><sub>6</sub>-DMSO) δ 11.92 (s, 1H), 8.37 (d, <i>J</i> = 8.2 Hz, 1H), 7.27 (d, <i>J</i> = 1.4 Hz, 1H), 6.98 (dd, <i>J</i> = 9.6, 1.8 Hz, 1H), 6.84 (td, <i>J</i> = 10.4, 2.1 Hz, 1H), 4.32 (m, 1H), 2.42–2.30 (m, 2H), 2.02 (quintuplet-d, <i>J</i> = 7.2, 0.9 Hz, 1H), 1.90–1.89 (m, 1H), 1.76 (td, <i>J</i> = 5.8, 1.1 Hz, 1H), 1.65 (ddd, <i>J</i> = 13.6, 6.5, 1.8 Hz, 1H), 1.18 (s, 3H), 1.15 (d, <i>J</i> = 9.6 Hz, 1H), 1.02 (s, 3H), 1.01 (overlapping d, <i>J</i> = 7.8 Hz, 3H); <sup>13</sup>C NMR (<i>d</i><sub>6</sub>-DMSO) δ 160.2, 159.6 (dd, <i>J</i> = 238.2, 12.0 Hz), 156.2 (dd, <i>J</i> = 248.2, 15.3 Hz), 138.1 (t, <i>J</i> = 13.9 Hz), 135.5 (d, <i>J</i> = 2.9 Hz), 113.6 (d, <i>J</i> = 22.0 Hz), 98.7, 95.7 (dd, <i>J</i> = 29.7, 23.0 Hz), 95.1 (dd, <i>J</i> = 25.4, 4.3 Hz), 47.8, 47.5, 44.5, 41.6, 38.8, 36.4, 34.3, 28.4, 23.8, 21.2. HRMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>19</sub>H<sub>23</sub>F<sub>2</sub>N<sub>2</sub>O ([M + H]<sup>+</sup>) 333.1778; found 333.1764.</div></div><div id="sec4_1_2_24" class="NLM_sec NLM_sec_level_4"><div id="ac_i45" class="anchor-spacer"></div><h5 class="article-section__title" id="_i45"> 4,6-Difluoro-<i>N</i>-((1<i>S</i>,2<i>S</i>,3<i>S</i>,5<i>R</i>)-2,6,6-trimethylbicyclo[3.1.1]heptan-3-yl)-1<i>H</i>-indole-2-carboxamide (<b>27</b>)</h5><div class="NLM_p last">Yield: 72% (white solid). <sup>1</sup>H NMR (400 MHz, <i>d</i><sub>6</sub><i>-</i>DMSO) δ 11.95 (s, 1H), 8.40 (d, <i>J</i> = 8.8 Hz, 1H), 7.32 (s, 1H), 7.35 (dd, <i>J</i> = 9.6, 1.6 Hz, 1H), 6.87 (td, <i>J</i> = 10.4, 2.0 Hz, 1H), 4.37 (m, 1H), 2.46–2.33 (m, 2H), 2.06 (quintuplet-d, <i>J</i> = 7.2, 1.2 Hz, 1H), 1.94–1.93 (m, 1H), 1.80 (t, <i>J</i> = 5.2 Hz, 1H) 1.69 (ddd, <i>J</i> = 13.6, 6.4, 2.0 Hz, 1H), 1.22 (s, 3H), 1.21 (d, <i>J</i> = 9.6 Hz, 1H), 1.18 (m, 4H), 1.06–1.04 (m, 6H); <sup>13</sup>C NMR (100 MHz, <i>d</i><sub>6</sub>-DMSO) δ 160.2 (dd, <i>J</i> = 236.7, 12.2 Hz) 159.7, 157.0 (dd, <i>J</i> = 246.7, 15.3 Hz), 137.7 (t, <i>J</i> = 13.3 Hz), 133.0 (d, <i>J</i> = 3.3 Hz), 113.2 (d, <i>J</i> = 21.7 Hz), 98.2, 95.3 (dd, <i>J</i> = 29.6, 23.1 Hz), 94.7 (dd, <i>J</i> = 25.7, 4.4 Hz), 47.3, 47.0, 43.9, 41.1, 38.3, 35.9, 33.8, 27.9, 23.2, 20.6. HRMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>19</sub>H<sub>23</sub>F<sub>2</sub>N<sub>2</sub>O ([M + H]<sup>+</sup>) 333.1778; found 333.1757.</div></div><div id="sec4_1_2_25" class="NLM_sec NLM_sec_level_4"><div id="ac_i46" class="anchor-spacer"></div><h5 class="article-section__title" id="_i46"> 4,6-Dichloro-<i>N</i>-heptyl-1<i>H</i>-indole-2-carboxamide (<b>28</b>)</h5><div class="NLM_p last">The title compound was obtained by following the general procedure. The crude material was purified by flash column chromatography on SiO<sub>2</sub> with a hexane–EtOAc gradient as the eluent followed by recrystallization from hexane to give an off-white solid (175 mg, 53% on a 1.0 mM scale). <sup>1</sup>H NMR (<i>d</i><sub>6</sub>-DMSO) δ 12.03 (s, 1H), 8.61 (t, <i>J</i> = 5.5 Hz, 1H), 7.37 (s, 1H), 7.20 (s, 1H), 7.18 (d, <i>J</i> = 1.4 Hz, 1H), 3.25–3.20 (m, 2H), 1.49 (apparent quintuplet, <i>J</i> = 6.6 Hz, 2H), 1.26–1.22 (m, 8H), 0.81 (t, <i>J</i> = 6.9 Hz, 3H); <sup>13</sup>C NMR (<i>d</i><sub>6</sub>-DMSO) δ 160.6, 137.2, 134.2, 128.1, 126.8, 125.3, 119.9, 111.6, 100.9, 39.4, 31.8, 29.6, 29.0, 26.9, 22.6, 14.5. HRMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>16</sub>H<sub>21</sub>Cl<sub>2</sub>N<sub>2</sub>O ([M + H]<sup>+</sup>) 327.1031; found 327.1032.</div></div><div id="sec4_1_2_26" class="NLM_sec NLM_sec_level_4"><div id="ac_i47" class="anchor-spacer"></div><h5 class="article-section__title" id="_i47"> 4,6-Dichloro-<i>N</i>-octyl-1<i>H</i>-indole-2-carboxamide (<b>29</b>)</h5><div class="NLM_p last">The title compound was obtained by following the general procedure. The crude material was purified by flash column chromatography on SiO<sub>2</sub> with a hexane–EtOAc gradient as the eluent followed by recrystallization from hexane to give an off-white solid (253 mg, 74% on a 1.0 mM scale). <sup>1</sup>H NMR (<i>d</i><sub>6</sub>-DMSO) δ 12.01 (s, 1H), 8.59 (t, <i>J</i> = 5.5 Hz, 1H), 7.37 (s, 1H), 7.20 (s, 1H), 7.18 (d, <i>J</i> = 1.8 Hz, 1H), 3.26–3.20 (m, 2H), 1.49 (quin, <i>J</i> = 6.5 Hz, 2H), 1.25–1.21 (m, 10H), 0.81 (t, <i>J</i> = 6.6 Hz, 3H); <sup>13</sup>C NMR (<i>d</i><sub>6</sub>-DMSO) δ 160.6, 137.2, 134.2, 128.1, 126.8, 125.4, 119.9, 111.6, 100.9, 39.4, 31.8, 29.6, 29.2 (2C), 27.0, 22.6, 14.5. HRMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>17</sub>H<sub>23</sub>Cl<sub>2</sub>N<sub>2</sub>O ([M + H]<sup>+</sup>) 341.1187; found 341.1205.</div></div><div id="sec4_1_2_27" class="NLM_sec NLM_sec_level_4"><div id="ac_i48" class="anchor-spacer"></div><h5 class="article-section__title" id="_i48"> (<i>E</i>)-4,6-Dichloro-<i>N</i>-(3,7-dimethylocta-2,6-dien-1-yl)-1<i>H</i>-indole-2-carboxamide (<b>30</b>)</h5><div class="NLM_p last">The title compound was obtained by following the general procedure. The crude material was purified by flash column chromatography on SiO<sub>2</sub> with a hexane–EtOAc gradient as the eluent to give an off-white solid upon concentration (180 mg, 49% on a 1.0 mM scale). <sup>1</sup>H NMR (<i>d</i><sub>6</sub>-DMSO) δ 12.04 (br s, 1H), 8.72 (t, <i>J</i> = 5.5 Hz, 1 H), 7.36 (m, 1H), 7.22 (d, <i>J</i> = 0.9 Hz, 1 H), 7.18 (d, <i>J</i> = 1.6 Hz, 1 H), 5.20 (t, <i>J</i> = 6.2 Hz, 1 H), 5.04 (t, <i>J</i> = 6.9 Hz, 1 H), 3.85 (t, <i>J</i> = 6.2 Hz, 2 H), 2.05–1.99 (m, 2H), 1.96–1.92 (m, 2H), 1.65 (s, 3H), 1.58 (s, 3H), 1.51 (s, 3H); <sup>13</sup>C NMR (<i>d</i><sub>6</sub>-DMSO) δ 160.4, 137.8, 137.2, 134.1, 131.4, 128.1, 126.8, 125.4, 124.4, 121.5, 119.9, 111.6, 101.1, 39.5, 37.4, 26.5, 26.0, 18.1, 16.6. HRMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>19</sub>H<sub>23</sub>Cl<sub>2</sub>N<sub>2</sub>O ([M + H]<sup>+</sup>) 365.1187; found 365.1157.</div></div><div id="sec4_1_2_28" class="NLM_sec NLM_sec_level_4"><div id="ac_i49" class="anchor-spacer"></div><h5 class="article-section__title" id="_i49"> (<i>E</i>)-<i>N</i>-(3,7-Dimethylocta-2,6-dien-1-yl)-4,6-difluoro-1<i>H</i>-indole-2-carboxamide (<b>31</b>)</h5><div class="NLM_p last">The title compound was obtained by following the general procedure. The crude material was purified by flash column chromatography on SiO<sub>2</sub> with a hexane–EtOAc gradient as the eluent to give white powder upon concentration (250 mg, 75% on a 1.0 mM scale). <sup>1</sup>H NMR (<i>d</i><sub>6</sub>-DMSO) δ 11.95 (br s, 1H), 8.60 (t, <i>J</i> = 5.5 Hz, 1 H), 7.18 (d, <i>J</i> = 1.4 Hz, 1 H), 6.97 (dd, <i>J</i> = 9.4, 1.6 Hz, 1 H), 6.82 (td, <i>J</i> = 10.3, 1.8 Hz, 1 H), 5.20 (t, <i>J</i> = 6.2 Hz, 1 H), 5.03 (t, <i>J</i> = 6.6 Hz, 1 H), 3.85 (t, <i>J</i> = 6.0 Hz, 2 H), 2.04–1.99 (m, 2H), 1.95–1.92 (m, 2H), 1.64 (s, 3H), 1.57 (s, 3H), 1.51 (s, 3H); <sup>13</sup>C NMR (<i>d</i><sub>6</sub>-DMSO) δ 160.5, 159.6 (dd, <i>J</i> = 238.2, 12.0 Hz), 156.2 (dd, <i>J</i> = 248.7, 15.8 Hz), 138.0 (t, <i>J</i> = 14.4 Hz), 137.7, 133.4 (d, <i>J</i> = 3.8 Hz), 131.4, 124.4, 121.7, 113.6 (d, <i>J</i> = 21.1 Hz), 98.6, 95.6 (dd, <i>J</i> = 29.7, 24.0 Hz), 95.1 (dd, <i>J</i> = 25.9, 4.8 Hz), 39.5, 37.3, 26.5, 26.0, 18.1, 16.6. HRMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>19</sub>H<sub>23</sub>F<sub>2</sub>N<sub>2</sub>O ([M + H]<sup>+</sup>) 333.1778; found 333.1758.</div></div><div id="sec4_1_2_29" class="NLM_sec NLM_sec_level_4"><div id="ac_i50" class="anchor-spacer"></div><h5 class="article-section__title" id="_i50"> 4,6-Dichloro-<i>N</i>-[((1<i>R</i>,2<i>R</i>,5<i>R</i>)-6,6-dimethylbicyclo[3.1.1]heptan-2-yl)methyl]-1<i>H</i>-indole-2-carboxamide (<b>32</b>)</h5><div class="NLM_p last">The title compound was obtained by following the general procedure. The crude material was purified by flash column chromatography on SiO<sub>2</sub> with a hexane–EtOAc gradient as the eluent followed by recrystallization from ethyl acetate to give an off-white solid (215 mg, 59% on a 1.0 mM scale). <sup>1</sup>H NMR (<i>d</i><sub>6</sub>-DMSO) δ 12.05 (s, 1H), 8.63 (t, <i>J</i> = 5.7 Hz, 1H), 7.36 (br s, 1H), 7.20 (br s, 1H), 7.18 (d, <i>J</i> = 1.8 Hz, 1H), 3.30–3.16 (m, 2H), 2.31–2.21 (m, 2H), 1.94–1.74 (m, 5H), 1.47 (m, 1H), 1.13 (s, 3H), 1.03 (s, 3H), 0.81 (d, <i>J</i> = 9.2 Hz, 1H); <sup>13</sup>C NMR (<i>d</i><sub>6</sub>-DMSO) δ 160.6, 137.2, 134.2, 128.1, 126.7, 125.3, 119.9, 111.6, 100.9, 44.7, 43.3, 41.3, 41.2, 38.8, 33.3, 28.3, 26.2, 23.4, 19.6. HRMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>19</sub>H<sub>23</sub>Cl<sub>2</sub>N<sub>2</sub>O ([M + H]<sup>+</sup>) 365.1187; found 365.1164.</div></div><div id="sec4_1_2_30" class="NLM_sec NLM_sec_level_4"><div id="ac_i51" class="anchor-spacer"></div><h5 class="article-section__title" id="_i51"> (<i>R</i>)-<i>N</i>-(1-Cyclohexylethyl)-4,6-dichloro-1<i>H</i>-indole-2-carboxamide (<b>33</b>)</h5><div class="NLM_p last">The title compound was obtained by following the general procedure. The crude material was purified by flash column chromatography on SiO<sub>2</sub> with a hexane–EtOAc gradient as the eluent to give a pale brown solid upon concentration (157 mg, 46% on a 1.0 mM scale). <sup>1</sup>H NMR (<i>d</i><sub>6</sub>-DMSO) δ 12.00 (s, 1H), 8.31 (d, <i>J</i> = 8.7 Hz, 1H), 7.36 (m, 1H), 7.29 (d, <i>J</i> = 1.4 Hz, 1H), 7.17 (d, <i>J</i> = 1.8 Hz, 1H), 3.81 (m, 1H), 1.73–1.65 (m, 4H), 1.56 (m, 1H), 1.36 (m, 1H), 1.16–1.04 (m, 6H), 0.96–0.88 (m, 2H); <sup>13</sup>C NMR (<i>d</i><sub>6</sub>-DMSO) δ 160.0, 137.2, 134.3, 128.0, 126.8, 125.3, 119.8, 111.6, 101.0, 49.6, 43.0, 29.7, 29.5, 26.5, 26.2 (2C), 18.2. HRMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>17</sub>H<sub>21</sub>Cl<sub>2</sub>N<sub>2</sub>O ([M + H]<sup>+</sup>) 339.1031; found 339.1011.</div></div><div id="sec4_1_2_31" class="NLM_sec NLM_sec_level_4"><div id="ac_i52" class="anchor-spacer"></div><h5 class="article-section__title" id="_i52"> (<i>R</i>)-<i>N</i>-(1-Cyclohexylethyl)-4,6-difluoro-1<i>H</i>-indole-2-carboxamide (<b>34</b>)</h5><div class="NLM_p last">The title compound was obtained by following the general procedure. The crude material was purified by flash column chromatography on SiO<sub>2</sub> with a hexane–EtOAc gradient as the eluent to give a pale yellow solid upon concentration (260 mg, 65% on a 1.0 mM scale). <sup>1</sup>H NMR (<i>d</i><sub>6</sub>-DMSO) δ 11.90 (s, 1H), 8.15 (d, <i>J</i> = 8.7 Hz, 1H), 7.25 (d, <i>J</i> = 1.4 Hz, 1H), 6.96 (dd, <i>J</i> = 9.1, 0.9 Hz, 1H), 6.83 (td, <i>J</i> = 10.3, 1.8 Hz, 1H), 3.80 (m, 1H), 1.72–1.54 (m, 5H), 1.35 (m, 1H), 1.18–1.04 (m, 6H), 0.95–0.89 (m, 2H); <sup>13</sup>C NMR (<i>d</i><sub>6</sub>-DMSO) δ 160.1, 159.6 (dd, <i>J</i> = 238.2, 12.0 Hz), 156.2 (dd, <i>J</i> = 248.2, 16.3 Hz), 138.0 (t, <i>J</i> = 14.4 Hz), 135.5 (d, <i>J</i> = 1.9 Hz), 113.6 (d, <i>J</i> = 22.0 Hz), 98.6, 95.6 (dd, <i>J</i> = 29.7, 23.0 Hz), 95.1 (dd, <i>J</i> = 25.9, 3.8 Hz), 49.5, 43.0, 29.7, 29.4, 26.5, 26.2 (2C), 18.2. HRMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>17</sub>H<sub>21</sub>F<sub>2</sub>N<sub>2</sub>O ([M + H]<sup>+</sup>) 307.1622; found 307.1609.</div></div><div id="sec4_1_2_32" class="NLM_sec NLM_sec_level_4"><div id="ac_i53" class="anchor-spacer"></div><h5 class="article-section__title" id="_i53"> 4,6-Dichloro-<i>N</i>-(2,3-dihydro-1<i>H</i>-inden-2-yl)-1<i>H</i>-indole-2-carboxamide (<b>35</b>)</h5><div class="NLM_p last">The title compound was obtained by following the general procedure. The crude material was purified by flash column chromatography on SiO<sub>2</sub> with a hexane–EtOAc gradient as the eluent to give a gray solid upon concentration (223 mg, 65% on a 1.0 mM scale). <sup>1</sup>H NMR (<i>d</i><sub>6</sub>-DMSO) δ 12.05 (br s, 1H), 8.85 (d, <i>J</i> = 6.9 Hz, 1H), 7.37 (br s, 1H), 7.28 (br s, 1H), 7.21 (dd, <i>J</i> = 5.3, 3.4 Hz, 2H), 7.18 (d, <i>J</i> = 1.8 Hz, 1H), 7.12 (d, <i>J</i> = 3.6 Hz, 2H), 4.67 (quintuplet, <i>J</i> = 6.8 Hz, 1H), 3.23 (dd, <i>J</i> = 16.0, 7.8 Hz, 2H), 2.92 (dd, <i>J</i> = 15.8, 6.2 Hz, 2H); <sup>13</sup>C NMR (<i>d</i><sub>6</sub>-DMSO) δ 160.6, 141.7 (2C), 137.3, 133.9, 128.2, 127.0 (2C), 126.8, 125.3, 125.0 (2C), 119.9, 111.6, 101.5, 50.9, 39.5 (2C). HRMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>18</sub>H<sub>15</sub>Cl<sub>2</sub>N<sub>2</sub>O ([M + H]<sup>+</sup>) 345.0561; found 345.0552.</div></div><div id="sec4_1_2_33" class="NLM_sec NLM_sec_level_4"><div id="ac_i54" class="anchor-spacer"></div><h5 class="article-section__title" id="_i54"> <i>N</i>-4,6-Difluoro-(2,3-dihydro-1<i>H</i>-inden-2-yl)-1<i>H</i>-indole-2-carboxamide (<b>36</b>)</h5><div class="NLM_p last">The title compound was obtained by following the general procedure. The crude material was purified by flash column chromatography on SiO<sub>2</sub> with a hexane–EtOAc gradient as the eluent to give a white powder upon concentration (204 mg, 65% on a 1.0 mM scale). <sup>1</sup>H NMR (<i>d</i><sub>6</sub>-DMSO) δ 11.97 (s, 1H), 8.70 (d, <i>J</i> = 6.9 Hz, 1H), 7.25 (br s, 1H), 7.22–7.19 (m, 2H), 7.14–7.10 (m, 2H), 6.98 (dd, <i>J</i> = 9.4, 1.6 Hz, 1H), 6.83 (td, <i>J</i> = 10.4, 2.1 Hz, 1H), 4.66 (m, 1H), 3.23 (dd, <i>J</i> = 16.0, 7.8 Hz, 2H), 2.92 (dd, <i>J</i> = 16.0, 6.0 Hz, 2H); <sup>13</sup>C NMR (<i>d</i><sub>6</sub>-DMSO) δ 160.7, 159.6 (dd, <i>J</i> = 238.6, 12.5 Hz), 156.2 (dd, <i>J</i> = 248.2, 15.3 Hz), 141.7 (2C), 138.1 (t, <i>J</i> = 14.4 Hz), 133.2 (d, <i>J</i> = 2.9 Hz), 127.0 (2C), 125.0 (2C), 113.6 (d, <i>J</i> = 21.1 Hz), 99.0, 95.6 (dd, <i>J</i> = 29.7, 23.0 Hz), 95.1 (dd, <i>J</i> = 25.9, 3.8 Hz), 50.8, 39.5 (2C). HRMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>18</sub>H<sub>15</sub>F<sub>2</sub>N<sub>2</sub>O ([M + H]<sup>+</sup>) 313.1152; found 313.1132.</div></div><div id="sec4_1_2_34" class="NLM_sec NLM_sec_level_4"><div id="ac_i55" class="anchor-spacer"></div><h5 class="article-section__title" id="_i55"> 4,6-Dichloro-<i>N</i>-(spiro[5.5]undecan-3-yl)-1<i>H</i>-indole-2-carboxamide (<b>37</b>)</h5><div class="NLM_p last">The title compound was obtained by following the general procedure. The crude material was purified by flash column chromatography on SiO<sub>2</sub> with a hexane–EtOAc gradient as the eluent to give a yellow powder upon concentration (151 mg, 65% on a 0.61 mM scale). <sup>1</sup>H NMR (<i>d</i><sub>6</sub>-DMSO) δ 12.01 (s, 1H), 8.38 (d, <i>J</i> = 6.2 Hz, 1H), 7.36 (dd, <i>J</i> = 1.8, 0.9 Hz, 1H), 7.24 (d, <i>J</i> = 1.4 Hz, 1H), 7.17 (d, <i>J</i> = 1.4 Hz, 1H), 3.71 (m, 1H), 1.63–1.56 (m, 4H), 1.51–1.44 (m, 2H), 1.42–1.34 (m, 8H), 1.16–1.14 (m, 2H), 1.10–1.03 (m, 2H); <sup>13</sup>C NMR (<i>d</i><sub>6</sub>-DMSO) δ 159.7, 137.2, 134.3, 128.0, 126.8, 125.3, 119.9, 111.6, 101.0, 49.0, 41.0, 35.4 (2C), 32.1, 31.8, 27.7 (2C), 27.0, 21.9, 21.6. HRMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>20</sub>H<sub>25</sub>Cl<sub>2</sub>N<sub>2</sub>O ([M + H]<sup>+</sup>) 379.1344; found 379.1316.</div></div><div id="sec4_1_2_35" class="NLM_sec NLM_sec_level_4"><div id="ac_i56" class="anchor-spacer"></div><h5 class="article-section__title" id="_i56"> 4,6-Difluoro-<i>N</i>-(spiro[5.5]undecan-3-yl)-1<i>H</i>-indole-2-carboxamide (<b>38</b>)</h5><div class="NLM_p last">The title compound was obtained by following the general procedure. The crude material was purified by flash column chromatography on SiO<sub>2</sub> with a hexane–EtOAc gradient as the eluent to give an off-white powder upon concentration (174 mg, 82% on a 0.61 mM scale). <sup>1</sup>H NMR (<i>d</i><sub>6</sub>-DMSO) δ 11.92 (br s, 1H), 8.24 (d, <i>J</i> = 8.2 Hz, 1H), 7.20 (s, 1H), 6.96 (dd, <i>J</i> = 9.2, 1.4 Hz, 1H), 6.83 (td, <i>J</i> = 10.4, 2.1 Hz, 1H), 3.70 (m, 1H), 1.63–1.57 (m, 4H), 1.50–1.35 (m, 10H), 1.17–1.15 (m, 2H), 1.13–1.04 (m, 2H); <sup>13</sup>C NMR (<i>d</i><sub>6</sub>-DMSO) δ 159.8, 159.6 (dd, <i>J</i> = 238.2, 12.0 Hz), 156.2 (dd, <i>J</i> = 248.2, 15.3 Hz), 138.0 (t, <i>J</i> = 13.9 Hz), 133.5 (d, <i>J</i> = 2.9 Hz), 113.6 (d, <i>J</i> = 22.0 Hz), 98.6, 95.6 (dd, <i>J</i> = 29.7, 23.9 Hz), 95.1 (dd, <i>J</i> = 25.9, 3.8 Hz), 48.9, 41.0, 35.4 (2C), 32.1, 31.9, 27.7 (2C), 27.0, 21.9, 21.6. HRMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>20</sub>H<sub>25</sub>F<sub>2</sub>N<sub>2</sub>O ([M + H]<sup>+</sup>) 347.1935; found 347.1914.</div></div><div id="sec4_1_2_36" class="NLM_sec NLM_sec_level_4"><div id="ac_i57" class="anchor-spacer"></div><h5 class="article-section__title" id="_i57"> 4,6-Dichloro-<i>N</i>-(9-methyl-9-azabicyclo[3.3.1]nonan-3-yl)-1<i>H</i>-indole-2-carboxamide (<b>39</b>)</h5><div class="NLM_p last">Yield: 81% (white solid). <sup>1</sup>H NMR (400 MHz, <i>d</i><sub>6</sub><i>-</i>DMSO) δ 12.2 (s, 1H), 8.65 (d, <i>J</i> = 8.0 Hz, 1H), 7.43 (s, 1H), 7.26 (s, 1H), 7.22 (d, <i>J</i> = 1.6 Hz, 1H), 4.60 (m, 1H), 3.67 (d, <i>J</i> = 8.0 Hz, 2H), 2.83 (s, 3H), 2.41 (m, 2H), 2.05 (m, 3H), 1.79 (t, <i>J</i> = 11.6 Hz, 2H), 1.58–1.43 (m, 3H); <sup>13</sup>C NMR (100 MHz, <i>d</i><sub>6</sub>-DMSO) δ 159.7, 158.5, 158.2, 136.9, 133.2, 127.9, 126.4, 124.8, 119.6, 111.2, 100.9, 52.5, 37.8, 37.3, 30.8, 22.8, 11.4. HRMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>18</sub>H<sub>22</sub>Cl<sub>2</sub>N<sub>3</sub>O ([M + H]<sup>+</sup>) 366.1108; found 366.1140.</div></div><div id="sec4_1_2_37" class="NLM_sec NLM_sec_level_4"><div id="ac_i58" class="anchor-spacer"></div><h5 class="article-section__title" id="_i58"> Ethyl (<i>E</i>)-2-[(3,5-Dimethoxyphenyl)amino]-3-(dimethylamino)acrylate (<b>55</b>)</h5><div class="NLM_p">A solution of the aniline <b>54</b> (3.00 g, 19.6 mmol) and K<sub>2</sub>CO<sub>3</sub> (4.06 g, 29.4 mmol) in acetone (40 mL) was heated at 60 °C for 1 h. Ethyl bromoacetate (2.60 mL, 23.5 mmol) was added slowly, and the resulting mixture was heated at 60 °C overnight. The mixture was cooled, filtered, and concentrated <i>in vacuo</i>. The obtained crude product was purified by flash column (SiO<sub>2</sub>) chromatography (hexane/EtOAc; gradient) to obtain ethyl (3,5-dimethoxyphenyl)glycinate (2.95 g, 63%). <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 5.91 (m, 1H), 5.79 (d, <i>J</i> = 2.0 Hz, 1H), 4.24 (q, <i>J</i> = 7.2 Hz, 2H), 3.86 (s, 2H), 3.74 (s, 6H), 1.29 (t, <i>J</i> = 7.2 Hz, 3H); <sup>13</sup>C NMR (CDCl<sub>3</sub>) δ 171.1, 161.9, 149.1, 92.0, 90.6, 61.5, 55.3, 45.9, 14.3.</div><div class="NLM_p last">Ethyl (3,5-dimethoxyphenyl)glycinate (2.95 g, 12.3 mmol) and dimethylformamide dimethyl acetal (2.45 mL, 18.5 mmol) were placed in a 20 mL microwave vessel with a stir bar. The mixture was irradiated for 10 min at 150 °C. The resulting yellowish-orange solution was concentrated <i>in vacuo</i>, dried in an oil vacuum pump, and purified by flash column (SiO<sub>2</sub>) chromatography (hexane/EtOAc; gradient) to obtain compound <b>55</b> (1.21 g, 33%). <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 7.34 (s, 1H), 5.89 (m, 1H), 5.83 (d, <i>J</i> = 2.0 Hz, 1H), 4.10 (q, <i>J</i> = 7.2 Hz, 2H), 3.72 (s, 6H), 3.02 (s, 6H), 1.19 (t, <i>J</i> = 7.2 Hz, 2H); <sup>13</sup>C NMR (CDCl<sub>3</sub>) δ 169.2, 161.8, 151.7, 146.2, 99.2, 92.7, 90.6, 59.9, 55.3, 42.0, 14.8.</div></div><div id="sec4_1_2_38" class="NLM_sec NLM_sec_level_4"><div id="ac_i59" class="anchor-spacer"></div><h5 class="article-section__title" id="_i59"> 4,6-Dimethoxy-1<i>H</i>-indole-2-carboxylic acid (<b>56</b>)</h5><div class="NLM_p last">Compound <b>55</b> (1.2 g, 4.1 mmol) was dissolved in CH<sub>2</sub>Cl<sub>2</sub> (50 mL). AlCl<sub>3</sub> (0.54 g, 4.1 mmol) was added, and the reaction mixture was stirred for 24–48 h. The resulting solution was washed with water and brine. The organic solution was dried over anhydrous Na<sub>2</sub>SO<sub>4</sub> and concentrated, and the residue was purified by flash column (SiO<sub>2</sub>) chromatography (hexane/EtOAc; gradient) to obtain the intermediate indolecarboxylate (0.83 g, 81%). A mixture of the indolecarboxylate (0.83 g, 3.33 mmol) and LiOH (0.40 g, 16.6 mol) in EtOH (10 mL) was refluxed with TLC monitoring until no starting material was observed. After completion, the mixture was concentrated, and H<sub>2</sub>O (10 mL) was added to dissolve the solid. The resulting solution was acidified to a pH > 3 with 6 N HCl solution, and the precipitate was filtered and dried to obtain the carboxylic acid <b>56</b> as a tan solid (0.67 g, 91%). <sup>1</sup>H NMR (<i>d</i><sub>6</sub>-DMSO) δ 12.63 (s, 1H), 11.57 (s, 1H), 6.96 (m, 1H), 6.46 (s, 1H), 6.18 (m, 1H), 3.84 (s, 3H), 3.76 (s, 3H); <sup>13</sup>C NMR (<i>d</i><sub>6</sub>-DMSO) δ 162.5, 159.1, 154.1, 138.9, 125.7, 112.8, 105.1, 92.2, 86.7, 55.2, 55.1.</div></div><div id="sec4_1_2_39" class="NLM_sec NLM_sec_level_4"><div id="ac_i60" class="anchor-spacer"></div><h5 class="article-section__title" id="_i60"> 4,6-Dimethyl-1<i>H</i>-indole-2-carboxamide (<b>57</b>)</h5><div class="NLM_p last">To a solution of the carboxylic acid <b>43</b> (0.30 g, 1.6 mmol) in anhydrous CH<sub>2</sub>Cl<sub>2</sub> (5 mL) at room temperature were added anhydrous hydroxybenzotriazole (0.26 g, 1.9 mmol) and 1-ethyl-3-(3-(dimethylamino)propyl)carbodiimide hydrochloride (0.36 g, 1.9 mmol) under an argon atmosphere. After stirring for 10 min, ammonium chloride (0.127 g, 2.38 mmol) and triethylamine (0.33 mL, 2.4 mmol) were added, and the reaction mixture was stirred at room temperature until disappearance of the starting material (usually 12–16 h). After this time water (2 mL) was added, and the mixture was extracted with EtOAc (3 × 10 mL). The organic layers were separated, washed with brine, dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated under reduced pressure. The residue was purified by flash column (SiO<sub>2</sub>) chromatography (0–10% CH<sub>3</sub>OH/CH<sub>2</sub>Cl<sub>2</sub>) to obtain the indolecarboxamide <b>57</b> (0.29 g, 96%). <sup>1</sup>H NMR (<i>d</i><sub>6</sub>-DMSO) δ 11.33 (s, indole NH), 7.86 (s, NH), 7.24 (s, NH), 7.11 (m, 1H), 7.02 (s, 1H), 6.66 (s, 1H), 2.43 (s, 3H), 2.34 (s, 3H); <sup>13</sup>C NMR (<i>d</i><sub>6</sub>-DMSO) δ 163.0, 136.7, 132.6, 130.5, 129.9, 125.3, 121.6, 109.4, 101.8, 21.5, 18.4.</div></div><div id="sec4_1_2_40" class="NLM_sec NLM_sec_level_4"><div id="ac_i61" class="anchor-spacer"></div><h5 class="article-section__title" id="_i61"> <i>N</i>-[(4,6-Dimethyl-1<i>H</i>-indol-2-yl)methyl]cycloheptanecarboxamide (<b>40</b>)</h5><div class="NLM_p">To a cooled solution of compound <b>57</b> (0.29 g, 1.5 mmol) in 15 mL of THF was added LiAlH<sub>4</sub> (6 equiv, 0.35g, 9.2 mmol) over 5 min. The ice bath was removed, and the resulting solution was heated to reflux under argon for 18 h. The mixture was cooled, and the reagent was quenched with aqueous Na<sub>2</sub>SO<sub>4</sub> solution. The resulting precipitate was filtered off, the filtrate was concentrated, and the residue was purified by flash column (SiO<sub>2</sub>) chromatography (0–10% CH<sub>3</sub>OH/CH<sub>2</sub>Cl<sub>2</sub>) to obtain (4,6-dimethyl-1<i>H</i>-indol-2-yl)methylamine (0.14 g, 54%). <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 8.98 (s, 1H), 6.98 (s, 1H), 6.85 (s, 1H), 6.36 (s, 1H), 3.98 (s, 2H), 2.59 (s, 3H), 2.51 (s, 3H), 2.05 (s, 2H); <sup>13</sup>C NMR (CDCl<sub>3</sub>) δ 138.6, 136.4, 131.4, 129.3, 126.1, 121.7, 108.5, 97.7, 39.6, 21.7, 18.8.</div><div class="NLM_p last">To a solution of the cycloheptanecarboxylic acid (0.13 g, 0.89 mmol) in anhydrous CH<sub>2</sub>Cl<sub>2</sub> (5 mL) at room temperature were added anhydrous hydroxybenzotriazole (0.13 g, 0.97 mmol) and 1-ethyl-3-(3-(dimethylamino)propyl)carbodiimide hydrochloride (0.19 g, 0.97 mmol) under an argon atmosphere. After stirring for 10 min, (4,6-dimethyl-1<i>H</i>-indol-2-yl)methylamine (0.14 g, 0.80 mmol) and triethylamine (0.17 mL, 1.2 mmol) were added, and the reaction mixture was stirred at room temperature until disappearance of the starting material (usually 12 to 16 h). After this time, water (2 mL) was added, and the mixture was extracted with EtOAc (3 × 10 mL). The organic layers were separated, washed with brine, dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated under reduced pressure. The crude product was initially purified by flash column (SiO<sub>2</sub>) chromatography eluting with 0–10% CH<sub>3</sub>OH/CH<sub>2</sub>Cl<sub>2</sub> and further purified by preparative HPLC to obtain compound <b>40</b> as a white powder (0.16 g, 67%). <sup>1</sup>H NMR (<i>d</i><sub>6</sub><i>-</i>DMSO) δ 10.65 (s, 1H), 8.12 (s, 1H), 6.93 (s, 1H), 6.58 (s, 1H), 6.17 (s, 1H), 4.34 (s, 2H), 2.37–2.32 (m, 7H), 1.75–1.42 (m, 12H); <sup>13</sup>C NMR (<i>d</i><sub>6</sub>-DMSO) δ 176.2, 136.2, 135.9, 129.5, 127.8, 125.6, 120.7, 108.6, 97.4, 45.4, 36.1, 31.1 (2C), 27.9 (2C), 26.1 (2C), 21.4, 18.5. HRMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>19</sub>H<sub>27</sub>N<sub>2</sub>O ([M + H]<sup>+</sup>) 299.2118; found 299.2118.</div></div><div id="sec4_1_2_41" class="NLM_sec NLM_sec_level_4"><div id="ac_i62" class="anchor-spacer"></div><h5 class="article-section__title" id="_i62"> <i>N</i>-[(4,6-Dimethyl-1<i>H</i>-indol-2-yl)methyl]cyclooctylamine (<b>41</b>)</h5><div class="NLM_p last">To a cooled solution of compound <b>3</b> (0.39 g, 0.98 mmol) in THF (15 mL) was added LiAlH<sub>4</sub> (6 equiv, 0.22 g, 5.9 mmol) over 5 min. The ice bath was removed, and the resulting solution was heated to reflux under argon for 18 h. The mixture was cooled, and the reagent was quenched with aqueous Na<sub>2</sub>SO<sub>4</sub> solution. The resulting precipitate was filtered off, the filtrate was concentrated, and the residue was purified by flash column (SiO<sub>2</sub>) chromatography eluting with 0–10% CH<sub>3</sub>OH/CH<sub>2</sub>Cl<sub>2</sub>. The crude product was further purified by prep HPLC to obtain compound <b>41</b> as a white powder (85% yield).<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a>H NMR (400 MHz, <i>d</i><sub>6</sub><i>-</i>DMSO) δ 11.1 (s, 1H), 8.89 (s, 1H), 7.02 (s, 1H), 6.66 (s, 1H), 6.55 (s, 1H), 4.31 (s, 2H), 3.25 (m, 1H), 2.41 (s, 3H), 2.35 (s, 3H), 1.99 (m, 2H), 1.70–1.38 (m, 14H); <sup>13</sup>C NMR (100 MHz, <i>d</i><sub>6</sub>-DMSO) δ 136.4, 131.1, 128.6, 128.1, 125.4, 121.4, 108.8, 101.7, 57.2, 41.0, 28.5 (2C), 25.9 (2C), 25.1, 23.2 (2C), 21.3, 18.4. HRMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>19</sub>H<sub>29</sub>N<sub>2</sub> ([M + H]<sup>+</sup>) 285.2325; found 285.2316.</div></div><div id="sec4_1_2_42" class="NLM_sec NLM_sec_level_4"><div id="ac_i63" class="anchor-spacer"></div><h5 class="article-section__title" id="_i63"> <i>N</i>-[6-(Trifluoromethoxy)benzothiazol-2-yl]cycloheptanecarboxamide (<b>42</b>)</h5><div class="NLM_p last">Yield 73% (white powder). <sup>1</sup>H NMR (400 MHz, <i>d</i><sub>6</sub><i>-</i>DMSO) δ 12.38 (s, 1H), 8.10 (s, 1H), 7.81 (d, <i>J</i> = 8.0 Hz, 1H), 7.41 (d, <i>J</i> = 8.0 Hz, 1H), 2.73 (m, 1H), 1.88 (m, 2H), 1.69–1.52 (m, 10H); <sup>13</sup>C NMR (100 MHz, <i>d</i><sub>6</sub>-DMSO) δ 176.3, 159.6, 147.6, 143.9, 132.7, 121.3, 119.7, 114.9, 44.9, 30.5 (2C), 27.9 (2C), 25.9 (2C). HRMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>16</sub>H<sub>17</sub>N<sub>2</sub>O<sub>2</sub>F<sub>3</sub>S ([M – H]<sup>−</sup>) 357.0890; found 357.0906.</div></div></div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i64" class="anchor-spacer"></div><h3 class="article-section__title" id="_i64"> Biological Methods</h3><div id="sec4_2_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i65" class="anchor-spacer"></div><h4 class="article-section__title" id="_i65"> Minimum Inhibitory Concentration (MIC)</h4><div class="NLM_p last"><i>M. tuberculosis</i> H37Rv was cultured to mid log phase in 7H9 broth complemented with 10% OADC, 0.05% Tween 80, and 0.1% cholesterol. MIC determination was done as reported previously.<a onclick="showRef(event, 'ref16 ref28'); return false;" href="javascript:void(0);" class="ref ref16 ref28">(16, 28)</a></div></div><div id="sec4_2_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i66" class="anchor-spacer"></div><h4 class="article-section__title" id="_i66"> Pharmacokinetic Study in Mice</h4><div class="NLM_p last">Female BALB/c mice (20 g each, Charles River Laboratories) were given a single dose of compound <b>26</b> or <b>2</b> at 100 mg/kg by oral gavage in a volume of 0.2 mL. At 0, 0.25, 0.5, 1, 2, 4, 8, and 24 h after compound administration, animals (<i>n</i> = 3 per time point) were euthanized, and cardiac blood (∼0.7 mL) was collected. Mouse lungs were removed, weighed, and stored at −80 °C. Plasma was separated by centrifugation at 12 000<i>g</i> for 20 min at 4 °C and stored at −80 °C. For analysis, the lungs were homogenized by bead-beating in 0.5 mL of liquid chromatography/mass spectrometry (LC/MS) grade water, and supernatants were recovered by centrifugation at 12 000<i>g</i> at 4 °C for 20 min. Concentrations of compounds <b>26</b> and <b>2</b> in plasma and lung homogenate supernatants were analyzed with LC–tandem MS (LC-MS/MS, AB SCIEX QTRAP 5500 system) with the 4,6-dimethylindole-2-carboxamide analog (compound <b>2</b> in Lun et al.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a>) as internal standard. MS detection of mass transitions 81.0/333.1 and 154.1/333.1 for compound <b>26</b> and 186.0/339.1 and 151.0/339.1 for compound <b>2</b> was carried out. Concentration calculation was carried out using MultiQuant Software (Version 2.1, AB SCIEX). The pharmacokinetic profiles of the test compounds were analyzed from plasma and lung concentration–time data. Analyses of PK parameters were performed using noncompartmental modeling (WinNonlin PK software package, Version 6.4.0).</div></div><div id="sec4_2_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i67" class="anchor-spacer"></div><h4 class="article-section__title" id="_i67"> Serum Inhibition Titration (SIT)</h4><div class="NLM_p last">To test oral bioavailability in a biological-function assay, 6-week-old female BALB/c mice (20 g each) were used. Compounds <b>20</b>, <b>24</b>, and <b>26</b> were ground into homogeneous suspensions in water containing 0.5% carboxymethylcellulose (CMC). A single dose at 100 mg/kg was delivered orally. At 30, 60, and 120 min after administration, the mice were sacrificed,cardiac blood was collected, and serum samples were obtained. Isoniazid at 10 mg/kg was used as positive control. The vehicle (0.5% CMC) was used as negative control. Samples from three mice were pooled for each time point. The serum samples were 2-fold serially diluted in a 96-well microplate format and 10<sup>4</sup> CFU of <i>M. tuberculosis</i> H37Rv in 100 μL was added to each well. After incubation for 7 days at 37 °C, 32.5 μL of alamarBlue working reagent (1 part of 10% alamarBlue and 0.625 parts of 20% Tween 80) was added to each well, and the plates were further incubated for 16–18 h and then read at Ex<sub>544nm</sub>/Em<sub>590nm</sub>. Relative fluorescence units were plotted against the serum titration.</div></div><div id="sec4_2_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i68" class="anchor-spacer"></div><h4 class="article-section__title" id="_i68"> Mouse Infection and Monotherapy Model</h4><div class="NLM_p last">Four-to-six-week-old female BALB/c mice were aerosol-infected with <i>M. tuberculosis</i> H37Rv using an inhalation system (Glas-Col Inc., Terre Haute, IN). At day 1, five mice were sacrificed for enumeration for CFU implantation in the lungs. From day 1 after infection, groups of five mice were treated with 12.5, 25, 50, or 100 mg/kg of compound <b>26</b> or <b>2</b> by daily oral gavage (5 days per week). Ethambutol at 100 mg/kg was administered as positive control. Infected but untreated mice were used as negative control. At day 14 and 28 after treatment initiation, 5 mice from each treatment were sacrificed, and the lungs were removed. The lungs were ground to a homogenate, diluted, and plated on 7H11 selective agar plates, and CFUs per lung were determined.</div></div><div id="sec4_2_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i69" class="anchor-spacer"></div><h4 class="article-section__title" id="_i69"> <i>In Vitro</i> Synergy Bliss Modeling</h4><div class="NLM_p last">Checkerboard design was carried out for an <i>in vitro</i> synergy study between <b>26</b> and rifampin. Serial dilution (2-fold) ranging from 4.0 to 0.0313 times the MIC for either compound was combined as shown in <a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a> in a 96-well microplate format. Wild type <i>M. tuberculosis</i> H37Rv (1 ×10<sup>4</sup> CFU) was added into each well to total volume of 200 μL. Controls consisting of the compound alone (<b>26</b> and rifampin) employing the same dilutions were included. Also included were a blank control and full growth control. The alamarBlue assay was conducted as reported previously.<a onclick="showRef(event, 'ref16 ref28'); return false;" href="javascript:void(0);" class="ref ref16 ref28">(16, 28)</a> Percentage inhibition was calculated. Bliss independence modeling<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> was applied to all wells with compound concentration below 1 × MIC. Observed effect (<i>f</i><sub>axyO</sub>) and predicted effect (<i>f</i><sub>axyP</sub>) were calculated. Synergy (Δ<i>f</i><sub>axy</sub> > 0), Bliss independence (Δ<i>f</i><sub>axy</sub> = 0), or antagonism (Δ<i>f</i><sub>axy</sub> < 0) was assessed according to a previous report.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a></div></div><div id="sec4_2_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i70" class="anchor-spacer"></div><h4 class="article-section__title" id="_i70"> <i>In Vivo</i> Synergy Bliss Modeling</h4><div class="NLM_p">Four-to-six-week-old female BALB/c mice were aerosol-infected with <i>M. tuberculosis</i> H37Rv as described above to achieve a day 1 implantation of 3.4-log CFU per lung. At day 14, four mice were sacrificed for CFU enumeration. From day 14 after infection, groups of four mice were treated with 100 mg/kg of compound <b>26</b> and rifampin at 10 mg/kg by oral gavage, separately with at least 1 h apart. Treatment was daily, 5 days per week. Compound <b>26</b> at 100 mg/kg alone and rifampin at 10 mg/kg alone were the control arms. Infected but untreated mice were negative control. At day 28 after treatment initiation, four mice from each treatment were sacrificed, and CFUs in the lungs were determined as above. Synergy between compound <b>26</b> and rifampicin was analyzed, and Bliss Modeling was applied.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a></div><div class="NLM_p last">The Institutional Animal Care and Use Committee of the Johns Hopkins University School of Medicine approved all animal procedures in this study with the approved protocol number as MO13M156.</div></div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-2"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i71"><a href="/doi/suppl/10.1021/acs.jmedchem.6b00415">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_00740" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_00740" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.6b00415" class="ext-link">10.1021/acs.jmedchem.6b00415</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Purity of the tested compounds and details on molecular model generation and optimization, and docking simulations (<a href="/doi/suppl/10.1021/acs.jmedchem.6b00415/suppl_file/jm6b00415_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Machine-readable representations of compounds and primary data (<a href="/doi/suppl/10.1021/acs.jmedchem.6b00415/suppl_file/jm6b00415_si_002.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b00415/suppl_file/jm6b00415_si_001.pdf">jm6b00415_si_001.pdf (1.42 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b00415/suppl_file/jm6b00415_si_002.csv">jm6b00415_si_002.csv (2.48 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.6b00415" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_74032" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_74032" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">William R. Bishai</span> - <span class="hlFld-Affiliation affiliation">Center
for Tuberculosis Research, Department of Medicine, Division of Infectious
Disease, Johns Hopkins School of Medicine, 1550 Orleans Street, Baltimore, Maryland 21231-1044, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Howard
Hughes Medical Institute, 4000 Jones Bridge Road, Chevy Chase, Maryland 20815-6789, United States</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#4d3a2f243e252c247c0d2725202463282938"><span class="__cf_email__" data-cfemail="b5c2d7dcc6ddd4dc84f5dfddd8dc9bd0d1c0">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Alan P. Kozikowski</span> - <span class="hlFld-Affiliation affiliation">Drug
Discovery Program, Department of Medicinal Chemistry and Pharmacognosy,
College of Pharmacy, University of Illinois
at Chicago, 833 South
Wood Street, Chicago, Illinois 60612, United States</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#97fcf8edfefcf8e0f6d7e2fef4b9f2f3e2"><span class="__cf_email__" data-cfemail="3c5753465557534b5d7c49555f12595849">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jozef Stec</span> - <span class="hlFld-Affiliation affiliation">Department
of Pharmaceutical Sciences, College of Pharmacy, Chicago State University, 9501 South King Drive, Chicago, Illinois 60628, United
States</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Pharmaceutical Sciences, College of Pharmacy, Marshall B. Ketchum University, 2575 Yorba Linda Boulevard, Fullerton, California 92831, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Oluseye K. Onajole</span> - <span class="hlFld-Affiliation affiliation">Drug
Discovery Program, Department of Medicinal Chemistry and Pharmacognosy,
College of Pharmacy, University of Illinois
at Chicago, 833 South
Wood Street, Chicago, Illinois 60612, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Biological, Chemical, and Physical Sciences, Roosevelt University, 425 S. Wabash Avenue, Chicago, Illinois 60605, United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Shichun Lun</span> - <span class="hlFld-Affiliation affiliation">Center
for Tuberculosis Research, Department of Medicine, Division of Infectious
Disease, Johns Hopkins School of Medicine, 1550 Orleans Street, Baltimore, Maryland 21231-1044, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Haidan Guo</span> - <span class="hlFld-Affiliation affiliation">Center
for Tuberculosis Research, Department of Medicine, Division of Infectious
Disease, Johns Hopkins School of Medicine, 1550 Orleans Street, Baltimore, Maryland 21231-1044, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Benjamin Merenbloom</span> - <span class="hlFld-Affiliation affiliation">Center
for Tuberculosis Research, Department of Medicine, Division of Infectious
Disease, Johns Hopkins School of Medicine, 1550 Orleans Street, Baltimore, Maryland 21231-1044, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Giulio Vistoli</span> - <span class="hlFld-Affiliation affiliation">Department
of Pharmaceutical Sciences, Università
degli Studi di Milano, via Mangiagalli 25, I-20133 Milan, Italy</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>J.S., O.K.O., and S.L. contributed equally to this work.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d7e5809-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i73">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_50050" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_50050" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">A.P.K. and W.B. acknowledge initial financial support for this project from the Howard Hughes Medical Institute. J.S. acknowledges Chicago State University College of Pharmacy and Chicago State University Center for Teaching and Research Excellence (Faculty Seed Grant) for generous financial support. The unlimited access to the NMR facility (JEOL 400) in the Department of Chemistry, Physics, and Engineering Studies at Chicago State University is acknowledged. A Faculty Development Stipend (J.S.) from Marshall B. Ketchum University College of Pharmacy is acknowledged. We acknowledge the Dean's office at the UIC College of Pharmacy for providing funding to cover some of the costs of the present study.</p></div><div class="postAsapNotesSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="postAsapNotesSection">Note Added After ASAP Publication</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_57645" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_57645" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="first last">After this paper was published ASAP on June 22, 2016, corrections were made to the TOC and abstract graphics and Table 1. The corrected version was reposted July 6, 2016.</p></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i74">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_01528" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_01528" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 29 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">World Health Organization</span><span> </span><span class="NLM_article-title">Global Tuberculosis Report 2015</span>. <a href="http://www.who.int/tb/publications/global_report/en/" class="extLink">http://www.who.int/tb/publications/global_report/en/</a>, Accessed November 11,<span class="NLM_x"> </span><span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=World+Health+Organization&title=Global+Tuberculosis+Report+2015"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26aulast%3D%26atitle%3DGlobal%2520Tuberculosis%2520Report%25202015%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><a href="http://www.tballiance.org/why/economic-impact.php" class="extLink">http://www.tballiance.org/why/economic-impact.php</a>, Accessed November 11,<span class="NLM_x"> </span><span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=http%3A%2F%2Fwww.tballiance.org%2Fwhy%2Feconomic-impact.php%2C+Accessed+November+11%2C+2015."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Koul, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arnoult, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lounis, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guillemont, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andries, K.</span><span> </span><span class="NLM_article-title">The challenge of new drug discovery for tuberculosis</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">469</span><span class="NLM_x"> (</span><span class="NLM_issue">7331</span><span class="NLM_x">) </span> <span class="NLM_fpage">483</span><span class="NLM_x">–</span> <span class="NLM_lpage">490</span><span class="refDoi"> DOI: 10.1038/nature09657</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00415&amp;key=10.1038%2Fnature09657" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=469&publication_year=2011&pages=483-490&issue=7331&author=A.+Koulauthor=E.+Arnoultauthor=N.+Lounisauthor=J.+Guillemontauthor=K.+Andries&title=The+challenge+of+new+drug+discovery+for+tuberculosis&doi=10.1038%2Fnature09657"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1038%2Fnature09657&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature09657%26sid%3Dliteratum%253Aachs%26aulast%3DKoul%26aufirst%3DA.%26aulast%3DArnoult%26aufirst%3DE.%26aulast%3DLounis%26aufirst%3DN.%26aulast%3DGuillemont%26aufirst%3DJ.%26aulast%3DAndries%26aufirst%3DK.%26atitle%3DThe%2520challenge%2520of%2520new%2520drug%2520discovery%2520for%2520tuberculosis%26jtitle%3DNature%26date%3D2011%26volume%3D469%26issue%3D7331%26spage%3D483%26epage%3D490%26doi%3D10.1038%2Fnature09657" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><a href="http://www.newtbdrugs.org/pipeline.php" class="extLink">http://www.newtbdrugs.org/pipeline.php</a>, Accessed November 11,<span class="NLM_x"> </span><span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=http%3A%2F%2Fwww.newtbdrugs.org%2Fpipeline.php%2C+Accessed+November+11%2C+2015."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">U.S. Food and Drug Administration</span><span class="NLM_x">. </span><a href="http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm333695.htm" class="extLink">http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm333695.htm</a> 2012, Accessed November 11,<span class="NLM_x"> </span><span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=U.S.+Food+and+Drug+Administration.+http%3A%2F%2Fwww.fda.gov%2FNewsEvents%2FNewsroom%2FPressAnnouncements%2Fucm333695.htm+2012%2C+Accessed+November+11%2C+2015."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26aulast%3D%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">European Medicines Agency</span><span class="NLM_x">. </span><a href="http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2013/11/news_detail_001972.jsp&amp;mid=WC0b01ac058004d5c1" class="extLink">http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2013/11/news_detail_001972.jsp&mid=WC0b01ac058004d5c1</a> 2013, Accessed November 11,<span class="NLM_x"> </span><span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=European+Medicines+Agency.+http%3A%2F%2Fwww.ema.europa.eu%2Fema%2Findex.jsp%3Fcurl%3Dpages%2Fnews_and_events%2Fnews%2F2013%2F11%2Fnews_detail_001972.jsp%26mid%3DWC0b01ac058004d5c1+2013%2C+Accessed+November+11%2C+2015."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26aulast%3D%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Cox, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laessig, K.</span><span> </span><span class="NLM_article-title">FDA approval of bedaquiline—the benefit-risk balance for drug-resistant tuberculosis</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">371</span><span class="NLM_x"> (</span><span class="NLM_issue">8</span><span class="NLM_x">) </span> <span class="NLM_fpage">689</span><span class="NLM_x">–</span> <span class="NLM_lpage">691</span><span class="refDoi"> DOI: 10.1056/NEJMp1314385</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00415&amp;key=10.1056%2FNEJMp1314385" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00415&amp;key=25140952" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00415&amp;key=1%3ACAS%3A528%3ADC%252BC2MXnvVWltLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=371&publication_year=2014&pages=689-691&issue=8&author=E.+Coxauthor=K.+Laessig&title=FDA+approval+of+bedaquiline%E2%80%94the+benefit-risk+balance+for+drug-resistant+tuberculosis&doi=10.1056%2FNEJMp1314385"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">FDA approval of bedaquiline - the benefit-risk balance for drug-resistant tuberculosis</span></div><div class="casAuthors">Cox, Edward; Laessig, Katherine</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">371</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">689-691</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">1533-4406</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoXrYdnneoFJ7Vg90H21EOLACvtfcHk0ljep3_aAOXD3w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXnvVWltLg%253D&md5=238837d8aa1edd289a3f720a18ccf337</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1056%2FNEJMp1314385&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMp1314385%26sid%3Dliteratum%253Aachs%26aulast%3DCox%26aufirst%3DE.%26aulast%3DLaessig%26aufirst%3DK.%26atitle%3DFDA%2520approval%2520of%2520bedaquiline%25E2%2580%2594the%2520benefit-risk%2520balance%2520for%2520drug-resistant%2520tuberculosis%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2014%26volume%3D371%26issue%3D8%26spage%3D689%26epage%3D691%26doi%3D10.1056%2FNEJMp1314385" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Domenech, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barry, C. E.,  III</span><span> </span><span class="NLM_article-title">Contribution of the <i>Mycobacterium tuberculosis</i> MmpL protein family to virulence and drug resistance</span> <span class="citation_source-journal">Infect. Immun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">73</span><span class="NLM_x"> (</span><span class="NLM_issue">6</span><span class="NLM_x">) </span> <span class="NLM_fpage">3492</span><span class="NLM_x">–</span> <span class="NLM_lpage">3501</span><span class="refDoi"> DOI: 10.1128/IAI.73.6.3492-3501.2005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00415&amp;key=10.1128%2FIAI.73.6.3492-3501.2005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00415&amp;key=15908378" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00415&amp;key=1%3ACAS%3A528%3ADC%252BD2MXkvFCns70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=2005&pages=3492-3501&issue=6&author=P.+Domenechauthor=M.+B.+Reedauthor=C.+E.+Barry&title=Contribution+of+the+Mycobacterium+tuberculosis+MmpL+protein+family+to+virulence+and+drug+resistance&doi=10.1128%2FIAI.73.6.3492-3501.2005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Contribution of the Mycobacterium tuberculosis MmpL protein family to virulence and drug resistance</span></div><div class="casAuthors">Domenech, Pilar; Reed, Michael B.; Barry, Clifton E., III</div><div class="citationInfo"><span class="NLM_cas:title">Infection and Immunity</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">73</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">3492-3501</span>CODEN:
                <span class="NLM_cas:coden">INFIBR</span>;
        ISSN:<span class="NLM_cas:issn">0019-9567</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">The genome sequence of Mycobacterium tuberculosis revealed the presence of 12 membrane proteins proposed to have a function in the transport of lipids.  Insertional inactivation of 11 of these has revealed that only 1 (MmpL3) is apparently essential for viability.  Five of these proteins are conserved within the genome of Mycobacterium leprae.  The drug susceptibilities of these 11 mutants to a broad spectrum of agents are unaltered, suggesting that unlike their function in other organisms, these proteins do not play a significant role in intrinsic drug resistance.  Each of these mutants was assessed for growth kinetics and lethality in a murine low-dose aerosol model of tuberculosis, and four were found to be impaired in one or both measures of virulence.  Two of these, with mutations of MmpL4 and the previously characterized MmpL7, which transports phthiocerol dimycocerosate, were found to have both impaired growth kinetics and impaired lethality.  Mutants with inactivation of MmpL8, which transports a precursor of the sulfatides, or MmpL11, which transports an unknown substrate, were found to establish infection normally but to be significantly attenuated for lethality in time-to-death studies.  These studies support the concept that MmpL-mediated lipid secretion both contributes to the innate ability of the pathogen to survive intracellularly and also contributes directly to the host-pathogen dialogue that dets. the ultimate outcome of infection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp03L6daMmyALVg90H21EOLACvtfcHk0ljep3_aAOXD3w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXkvFCns70%253D&md5=97189c7bd3a6a8c5ca6d9fcac98161a2</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1128%2FIAI.73.6.3492-3501.2005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FIAI.73.6.3492-3501.2005%26sid%3Dliteratum%253Aachs%26aulast%3DDomenech%26aufirst%3DP.%26aulast%3DReed%26aufirst%3DM.%2BB.%26aulast%3DBarry%26aufirst%3DC.%2BE.%26atitle%3DContribution%2520of%2520the%2520Mycobacterium%2520tuberculosis%2520MmpL%2520protein%2520family%2520to%2520virulence%2520and%2520drug%2520resistance%26jtitle%3DInfect.%2520Immun.%26date%3D2005%26volume%3D73%26issue%3D6%26spage%3D3492%26epage%3D3501%26doi%3D10.1128%2FIAI.73.6.3492-3501.2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Owens, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chim, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graves, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harmston, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iniguez, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Contreras, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liptak, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goulding, C. W.</span><span> </span><span class="NLM_article-title">The Mycobacterium tuberculosis secreted protein Rv0203 transfers heme to membrane proteins MmpL3 and MmpL11</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">288</span><span class="NLM_x"> (</span><span class="NLM_issue">30</span><span class="NLM_x">) </span> <span class="NLM_fpage">21714</span><span class="NLM_x">–</span> <span class="NLM_lpage">21728</span><span class="refDoi"> DOI: 10.1074/jbc.M113.453076</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00415&amp;key=10.1074%2Fjbc.M113.453076" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=288&publication_year=2013&pages=21714-21728&issue=30&author=C.+P.+Owensauthor=N.+Chimauthor=A.+B.+Gravesauthor=C.+A.+Harmstonauthor=A.+Iniguezauthor=H.+Contrerasauthor=M.+D.+Liptakauthor=C.+W.+Goulding&title=The+Mycobacterium+tuberculosis+secreted+protein+Rv0203+transfers+heme+to+membrane+proteins+MmpL3+and+MmpL11&doi=10.1074%2Fjbc.M113.453076"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M113.453076&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M113.453076%26sid%3Dliteratum%253Aachs%26aulast%3DOwens%26aufirst%3DC.%2BP.%26aulast%3DChim%26aufirst%3DN.%26aulast%3DGraves%26aufirst%3DA.%2BB.%26aulast%3DHarmston%26aufirst%3DC.%2BA.%26aulast%3DIniguez%26aufirst%3DA.%26aulast%3DContreras%26aufirst%3DH.%26aulast%3DLiptak%26aufirst%3DM.%2BD.%26aulast%3DGoulding%26aufirst%3DC.%2BW.%26atitle%3DThe%2520Mycobacterium%2520tuberculosis%2520secreted%2520protein%2520Rv0203%2520transfers%2520heme%2520to%2520membrane%2520proteins%2520MmpL3%2520and%2520MmpL11%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2013%26volume%3D288%26issue%3D30%26spage%3D21714%26epage%3D21728%26doi%3D10.1074%2Fjbc.M113.453076" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Belisle, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vissa, V. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sievert, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takayama, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brennan, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Besra, G. S.</span><span> </span><span class="NLM_article-title">Role of the major antigen of <i>Mycobacterium tuberculosis</i> in cell wall biogenesis</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">276</span><span class="NLM_x">, </span> <span class="NLM_fpage">1420</span><span class="NLM_x">–</span> <span class="NLM_lpage">1422</span><span class="refDoi"> DOI: 10.1126/science.276.5317.1420</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00415&amp;key=10.1126%2Fscience.276.5317.1420" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00415&amp;key=9162010" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00415&amp;key=1%3ACAS%3A528%3ADyaK2sXjsFOjtLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=276&publication_year=1997&pages=1420-1422&author=J.+T.+Belisleauthor=V.+D.+Vissaauthor=T.+Sievertauthor=K.+Takayamaauthor=P.+J.+Brennanauthor=G.+S.+Besra&title=Role+of+the+major+antigen+of+Mycobacterium+tuberculosis+in+cell+wall+biogenesis&doi=10.1126%2Fscience.276.5317.1420"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10aR"><div class="casContent"><span class="casTitleNuber">10a</span><div class="casTitle"><span class="NLM_cas:atitle">Role of the major antigen of Mycobacterium tuberculosis in cell wall biogenesis</span></div><div class="casAuthors">Belisle, John T.; Vissa, Varalakshmi D.; Sievert, Todd; Takayama, Kuni; Brennan, Patrick J.; Besra, Gurdyal S.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, D. C.)</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">276</span>
        (<span class="NLM_cas:issue">5317</span>),
    <span class="NLM_cas:pages">1420-1422</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">The dominant exported proteins and protective antigens of Mycobacterium tuberculosis are a triad of related gene products called the antigen 85 (Ag85) complex.  Each has also been implicated in disease pathogenesis through its fibronectin-binding capacities.  A carboxylesterase domain was found within the amino acid sequences of Ag85A, B, and C, and each protein acted as a mycolyltransferase involved in the final stages of mycobacterial cell wall assembly, as shown by direct enzyme assay and site-directed mutagenesis.  Furthermore, the use of an antagonist (6-azido-6-deoxy-α,α'-trehalose) of this activity demonstrates that these proteins are essential and potential targets for new antimycobacterial drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoTmxZDea6XgbVg90H21EOLACvtfcHk0lguoqocHj7htg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXjsFOjtLg%253D&md5=b810258a42304fcb17cd57b2308aee85</span></div><a href="/servlet/linkout?suffix=cit10a&amp;dbid=16384&amp;doi=10.1126%2Fscience.276.5317.1420&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.276.5317.1420%26sid%3Dliteratum%253Aachs%26aulast%3DBelisle%26aufirst%3DJ.%2BT.%26aulast%3DVissa%26aufirst%3DV.%2BD.%26aulast%3DSievert%26aufirst%3DT.%26aulast%3DTakayama%26aufirst%3DK.%26aulast%3DBrennan%26aufirst%3DP.%2BJ.%26aulast%3DBesra%26aufirst%3DG.%2BS.%26atitle%3DRole%2520of%2520the%2520major%2520antigen%2520of%2520Mycobacterium%2520tuberculosis%2520in%2520cell%2520wall%2520biogenesis%26jtitle%3DScience%26date%3D1997%26volume%3D276%26spage%3D1420%26epage%3D1422%26doi%3D10.1126%2Fscience.276.5317.1420" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit10b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Puech, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guilhot, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perez, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tropis, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Armitige, L. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gicquel, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daffé, M.</span><span> </span><span class="NLM_article-title">, Evidence for a partial redundancy of the fibronectin-binding proteins for the transfer of mycoloyl residues onto the cell wall arabinogalactan termini of <i>Mycobacterium tuberculosis</i></span> <span class="citation_source-journal">Mol. Microbiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">1109</span><span class="NLM_x">–</span> <span class="NLM_lpage">1122</span><span class="refDoi"> DOI: 10.1046/j.1365-2958.2002.02953.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00415&amp;key=10.1046%2Fj.1365-2958.2002.02953.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00415&amp;key=12010501" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00415&amp;key=1%3ACAS%3A528%3ADC%252BD38XktlGgsLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2002&pages=1109-1122&author=V.+Puechauthor=C.+Guilhotauthor=E.+Perezauthor=M.+Tropisauthor=L.+Y.+Armitigeauthor=B.+Gicquelauthor=M.+Daff%C3%A9&title=%2C+Evidence+for+a+partial+redundancy+of+the+fibronectin-binding+proteins+for+the+transfer+of+mycoloyl+residues+onto+the+cell+wall+arabinogalactan+termini+of+Mycobacterium+tuberculosis&doi=10.1046%2Fj.1365-2958.2002.02953.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10bR"><div class="casContent"><span class="casTitleNuber">10b</span><div class="casTitle"><span class="NLM_cas:atitle">Evidence for a partial redundancy of the fibronectin-binding proteins for the transfer of mycoloyl residues onto the cell wall arabinogalactan termini of Mycobacterium tuberculosis</span></div><div class="casAuthors">Puech, Virginie; Guilhot, Christophe; Perez, Esther; Tropis, Marielle; Armitige, Lisa Y.; Gicquel, Brigitte; Daffe, Mamadou</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Microbiology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1109-1122</span>CODEN:
                <span class="NLM_cas:coden">MOMIEE</span>;
        ISSN:<span class="NLM_cas:issn">0950-382X</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Science Ltd.</span>)
        </div><div class="casAbstract">M. tuberculosis produces a series of major secreted proteins, the fibronectin-binding proteins (Fbps), also known as the antigen 85 complex, that are believed to play an essential role in the pathogenesis of tuberculosis through their mycoloyltransferase activity required for maintaining the integrity of the bacterial cell envelope.  Four different fbp genes are found in the genome of M. tuberculosis, but the reason for the existence of these Fbps sharing the same substrate specificity in vitro in mycobacteria is unknown.  We have shown previously that, in the heterologous host, Corynebacterium glutamicum, FbpA, FbpB and FbpC can all add mycoloyl residues to the cell wall arabinogalactan and that, in M. tuberculosis, the cell wall mycoloylation decreases by 40% when fbpC is knocked out.  To investigate whether the remaining 60% mycoloylation came from the activity of FbpA and/or FbpB, fbpA- and fbpB-inactivated mutant strains were biochem. characterized and compared with the previously studied fbpC-disrupted mutant.  Unexpectedly, both mutants produced normally mycoloylated cell walls.  Overprodn. of FbpA, FbpB or FbpC, but not FbpD, in the fbpC-inactivated mutant strain of M. tuberculosis restored both the cell wall-linked mycolate defect and the outer cell envelope permeability barrier property.  These results are consistent with all 3 enzymes being involved in cell wall mycoloylation and FbpC playing a more crit. role than the others or, alternatively, FbpC is able to compensate for FbpA and FbpB in ways that these enzymes cannot compensate for FbpC, pointing to a partial redundancy of Fbps.  In sharp contrast, FbpD does not appear to be an active mycoloyltransferase enzyme, as it cannot complement the fbpC-inactivated mutant.  Most importantly, application of Smith degrdn. to the cell walls of transformants demonstrated that the multiple Fbp enzymes are redundant rather than specific for the various arabinogalactan mycoloylation regions.  Neither FbpA nor FbpB attaches mycoloyl residues to specific sites but, like FbpC, each enzyme transfers mycoloyl residues onto the 4 sites present in the arabinogalactan non-reducing end hexaarabinosides.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGprs9TH3THPLrVg90H21EOLACvtfcHk0lguoqocHj7htg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XktlGgsLo%253D&md5=5335adf86936032ddfd1aac59335c7bb</span></div><a href="/servlet/linkout?suffix=cit10b&amp;dbid=16384&amp;doi=10.1046%2Fj.1365-2958.2002.02953.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1365-2958.2002.02953.x%26sid%3Dliteratum%253Aachs%26aulast%3DPuech%26aufirst%3DV.%26aulast%3DGuilhot%26aufirst%3DC.%26aulast%3DPerez%26aufirst%3DE.%26aulast%3DTropis%26aufirst%3DM.%26aulast%3DArmitige%26aufirst%3DL.%2BY.%26aulast%3DGicquel%26aufirst%3DB.%26aulast%3DDaff%25C3%25A9%26aufirst%3DM.%26atitle%3D%252C%2520Evidence%2520for%2520a%2520partial%2520redundancy%2520of%2520the%2520fibronectin-binding%2520proteins%2520for%2520the%2520transfer%2520of%2520mycoloyl%2520residues%2520onto%2520the%2520cell%2520wall%2520arabinogalactan%2520termini%2520of%2520Mycobacterium%2520tuberculosis%26jtitle%3DMol.%2520Microbiol.%26date%3D2002%26volume%3D44%26spage%3D1109%26epage%3D1122%26doi%3D10.1046%2Fj.1365-2958.2002.02953.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Kalscheuer, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weinrick, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Veeraraghavan, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Besra, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobs, W. R. J.</span><span> </span><span class="NLM_article-title">Trehalose-recycling ABC transporter LpqY-SugA-SugB-SugC is essential for virulence of <i>Mycobacterium tuberculosis</i></span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">107</span><span class="NLM_x"> (</span><span class="NLM_issue">50</span><span class="NLM_x">) </span> <span class="NLM_fpage">21761</span><span class="NLM_x">–</span> <span class="NLM_lpage">21766</span><span class="refDoi"> DOI: 10.1073/pnas.1014642108</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00415&amp;key=10.1073%2Fpnas.1014642108" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=107&publication_year=2010&pages=21761-21766&issue=50&author=R.+Kalscheuerauthor=B.+Weinrickauthor=U.+Veeraraghavanauthor=G.+S.+Besraauthor=W.+R.+J.+Jacobs&title=Trehalose-recycling+ABC+transporter+LpqY-SugA-SugB-SugC+is+essential+for+virulence+of+Mycobacterium+tuberculosis&doi=10.1073%2Fpnas.1014642108"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1014642108&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1014642108%26sid%3Dliteratum%253Aachs%26aulast%3DKalscheuer%26aufirst%3DR.%26aulast%3DWeinrick%26aufirst%3DB.%26aulast%3DVeeraraghavan%26aufirst%3DU.%26aulast%3DBesra%26aufirst%3DG.%2BS.%26aulast%3DJacobs%26aufirst%3DW.%2BR.%2BJ.%26atitle%3DTrehalose-recycling%2520ABC%2520transporter%2520LpqY-SugA-SugB-SugC%2520is%2520essential%2520for%2520virulence%2520of%2520Mycobacterium%2520tuberculosis%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2010%26volume%3D107%26issue%3D50%26spage%3D21761%26epage%3D21766%26doi%3D10.1073%2Fpnas.1014642108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Cole, S. T.</span><span> </span><span class="NLM_article-title">Infectious diseases: transporter targeted in tuberculosis</span> <span class="citation_source-journal">Nat. Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">326</span><span class="NLM_x">–</span> <span class="NLM_lpage">327</span><span class="refDoi"> DOI: 10.1038/nchembio.918</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00415&amp;key=10.1038%2Fnchembio.918" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00415&amp;key=22426192" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00415&amp;key=1%3ACAS%3A528%3ADC%252BC38XktVaku70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2012&pages=326-327&author=S.+T.+Cole&title=Infectious+diseases%3A+transporter+targeted+in+tuberculosis&doi=10.1038%2Fnchembio.918"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Infectious diseases Transporter targeted in tuberculosis</span></div><div class="casAuthors">Cole, Stewart T.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">326-327</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The cell wall of tubercle bacilli is targeted by many drugs.  A new adamantyl urea compd. unveils MmpL3, a member of the resistance, nodulation, and division protein family, as the long-sought trehalose monomycolate transporter, essential for translocation of mycolic acids into the cell envelope.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGok4notky3RHrVg90H21EOLACvtfcHk0lguoqocHj7htg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XktVaku70%253D&md5=9335f1db7767be2e9b3ec08d60f0dd53</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.918&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.918%26sid%3Dliteratum%253Aachs%26aulast%3DCole%26aufirst%3DS.%2BT.%26atitle%3DInfectious%2520diseases%253A%2520transporter%2520targeted%2520in%2520tuberculosis%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2012%26volume%3D8%26spage%3D326%26epage%3D327%26doi%3D10.1038%2Fnchembio.918" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Tullius, M. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harmston, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Owens, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chim, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morse, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McMath, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iniguez, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kimmey, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sawaya, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whitelegge, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horwitz, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goulding, C. W.</span><span> </span><span class="NLM_article-title">Discovery and characterization of a unique mycobacterial heme acquisition system</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">108</span><span class="NLM_x"> (</span><span class="NLM_issue">12</span><span class="NLM_x">) </span> <span class="NLM_fpage">5051</span><span class="NLM_x">–</span> <span class="NLM_lpage">5056</span><span class="refDoi"> DOI: 10.1073/pnas.1009516108</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00415&amp;key=10.1073%2Fpnas.1009516108" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00415&amp;key=21383189" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00415&amp;key=1%3ACAS%3A528%3ADC%252BC3MXktVChsbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=108&publication_year=2011&pages=5051-5056&issue=12&author=M.+V.+Tulliusauthor=C.+A.+Harmstonauthor=C.+P.+Owensauthor=N.+Chimauthor=R.+P.+Morseauthor=L.+M.+McMathauthor=A.+Iniguezauthor=J.+M.+Kimmeyauthor=M.+R.+Sawayaauthor=J.+P.+Whiteleggeauthor=M.+A.+Horwitzauthor=C.+W.+Goulding&title=Discovery+and+characterization+of+a+unique+mycobacterial+heme+acquisition+system&doi=10.1073%2Fpnas.1009516108"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and characterization of a unique mycobacterial heme acquisition system</span></div><div class="casAuthors">Tullius, Michael V.; Harmston, Christine A.; Owens, Cedric P.; Chim, Nicholas; Morse, Robert P.; McMath, Lisa M.; Iniguez, Angelina; Kimmey, Jacqueline M.; Sawaya, Michael R.; Whitelegge, Julian P.; Horwitz, Marcus A.; Goulding, Celia W.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">108</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">5051-5056, S5051/1-S5051/18</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Mycobacterium tuberculosis must import iron from its host for survival, and its siderophore-dependent iron acquisition pathways are well established.  Here we demonstrate a newly characterized pathway, whereby M. tuberculosis can use free heme and heme from Hb as an iron source.  Significantly, we identified the genomic region, Rv0202c-Rv0207c, responsible for the passage of heme iron across the mycobacterial membrane.  Key players of this heme uptake system were characterized including a secreted protein and two transmembrane proteins, all three specific to mycobacteria.  Furthermore, the crystal structure of the key heme carrier protein Rv0203 was found to have a unique fold.  The discovery of a unique mycobacterial heme acquisition pathway opens new avenues of exploration into mycobacterial therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqI_2E5hobkjbVg90H21EOLACvtfcHk0lgcj-Ra7gR_BQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXktVChsbw%253D&md5=ed7cbd79a3ed917f9dab3a86f306962d</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1009516108&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1009516108%26sid%3Dliteratum%253Aachs%26aulast%3DTullius%26aufirst%3DM.%2BV.%26aulast%3DHarmston%26aufirst%3DC.%2BA.%26aulast%3DOwens%26aufirst%3DC.%2BP.%26aulast%3DChim%26aufirst%3DN.%26aulast%3DMorse%26aufirst%3DR.%2BP.%26aulast%3DMcMath%26aufirst%3DL.%2BM.%26aulast%3DIniguez%26aufirst%3DA.%26aulast%3DKimmey%26aufirst%3DJ.%2BM.%26aulast%3DSawaya%26aufirst%3DM.%2BR.%26aulast%3DWhitelegge%26aufirst%3DJ.%2BP.%26aulast%3DHorwitz%26aufirst%3DM.%2BA.%26aulast%3DGoulding%26aufirst%3DC.%2BW.%26atitle%3DDiscovery%2520and%2520characterization%2520of%2520a%2520unique%2520mycobacterial%2520heme%2520acquisition%2520system%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2011%26volume%3D108%26issue%3D12%26spage%3D5051%26epage%3D5056%26doi%3D10.1073%2Fpnas.1009516108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Li, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Upadhyay, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fontes, F. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">North, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crans, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grzegorzewicz, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Franzblau, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crick, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jackson, M.</span><span> </span><span class="NLM_article-title">Novel insights into the mechanism of inhibition of MmpL3, a target of multiple pharmacophores in <i>Mycobacterium tuberculosis</i></span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x"> (</span><span class="NLM_issue">11</span><span class="NLM_x">) </span> <span class="NLM_fpage">6413</span><span class="NLM_x">–</span> <span class="NLM_lpage">6423</span><span class="refDoi"> DOI: 10.1128/AAC.03229-14</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00415&amp;key=10.1128%2FAAC.03229-14" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2014&pages=6413-6423&issue=11&author=W.+Liauthor=A.+Upadhyayauthor=F.+L.+Fontesauthor=E.+J.+Northauthor=Y.+Wangauthor=D.+C.+Cransauthor=A.+E.+Grzegorzewiczauthor=V.+Jonesauthor=S.+G.+Franzblauauthor=R.+E.+Leeauthor=D.+C.+Crickauthor=M.+Jackson&title=Novel+insights+into+the+mechanism+of+inhibition+of+MmpL3%2C+a+target+of+multiple+pharmacophores+in+Mycobacterium+tuberculosis&doi=10.1128%2FAAC.03229-14"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1128%2FAAC.03229-14&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.03229-14%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DW.%26aulast%3DUpadhyay%26aufirst%3DA.%26aulast%3DFontes%26aufirst%3DF.%2BL.%26aulast%3DNorth%26aufirst%3DE.%2BJ.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DCrans%26aufirst%3DD.%2BC.%26aulast%3DGrzegorzewicz%26aufirst%3DA.%2BE.%26aulast%3DJones%26aufirst%3DV.%26aulast%3DFranzblau%26aufirst%3DS.%2BG.%26aulast%3DLee%26aufirst%3DR.%2BE.%26aulast%3DCrick%26aufirst%3DD.%2BC.%26aulast%3DJackson%26aufirst%3DM.%26atitle%3DNovel%2520insights%2520into%2520the%2520mechanism%2520of%2520inhibition%2520of%2520MmpL3%252C%2520a%2520target%2520of%2520multiple%2520pharmacophores%2520in%2520Mycobacterium%2520tuberculosis%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2014%26volume%3D58%26issue%3D11%26spage%3D6413%26epage%3D6423%26doi%3D10.1128%2FAAC.03229-14" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Onajole, O. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pieroni, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tipparaju, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lun, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stec, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gunosewoyo, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ammerman, N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bishai, W. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kozikowski, A. P.</span><span> </span><span class="NLM_article-title">Preliminary structure-activity relationships and biological evaluation of novel antitubercular indolecarboxamide derivatives against drug-susceptible and drug-resistant <i>Mycobacterium tuberculosis</i> strains</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x"> (</span><span class="NLM_issue">10</span><span class="NLM_x">) </span> <span class="NLM_fpage">4093</span><span class="NLM_x">–</span> <span class="NLM_lpage">4103</span><span class="refDoi"> DOI: 10.1021/jm4003878</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm4003878" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=4093-4103&issue=10&author=O.+K.+Onajoleauthor=M.+Pieroniauthor=S.+K.+Tipparajuauthor=S.+Lunauthor=J.+Stecauthor=G.+Chenauthor=H.+Gunosewoyoauthor=H.+Guoauthor=N.+C.+Ammermanauthor=W.+R.+Bishaiauthor=A.+P.+Kozikowski&title=Preliminary+structure-activity+relationships+and+biological+evaluation+of+novel+antitubercular+indolecarboxamide+derivatives+against+drug-susceptible+and+drug-resistant+Mycobacterium+tuberculosis+strains&doi=10.1021%2Fjm4003878"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1021%2Fjm4003878&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm4003878%26sid%3Dliteratum%253Aachs%26aulast%3DOnajole%26aufirst%3DO.%2BK.%26aulast%3DPieroni%26aufirst%3DM.%26aulast%3DTipparaju%26aufirst%3DS.%2BK.%26aulast%3DLun%26aufirst%3DS.%26aulast%3DStec%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DG.%26aulast%3DGunosewoyo%26aufirst%3DH.%26aulast%3DGuo%26aufirst%3DH.%26aulast%3DAmmerman%26aufirst%3DN.%2BC.%26aulast%3DBishai%26aufirst%3DW.%2BR.%26aulast%3DKozikowski%26aufirst%3DA.%2BP.%26atitle%3DPreliminary%2520structure-activity%2520relationships%2520and%2520biological%2520evaluation%2520of%2520novel%2520antitubercular%2520indolecarboxamide%2520derivatives%2520against%2520drug-susceptible%2520and%2520drug-resistant%2520Mycobacterium%2520tuberculosis%2520strains%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26issue%3D10%26spage%3D4093%26epage%3D4103%26doi%3D10.1021%2Fjm4003878" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Lun, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Onajole, O. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pieroni, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gunosewoyo, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tipparaju, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ammerman, N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kozikowski, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bishai, W. R.</span><span> </span><span class="NLM_article-title">Indoleamides are active against drug-resistant <i>Mycobacterium tuberculosis</i></span> <span class="citation_source-journal">Nat. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">2907</span><span class="refDoi"> DOI: 10.1038/ncomms3907</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00415&amp;key=10.1038%2Fncomms3907" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00415&amp;key=24352433" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00415&amp;key=1%3ACAS%3A280%3ADC%252BC2c3oslKgtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=2907&author=S.+Lunauthor=H.+Guoauthor=O.+K.+Onajoleauthor=M.+Pieroniauthor=H.+Gunosewoyoauthor=G.+Chenauthor=S.+K.+Tipparajuauthor=N.+C.+Ammermanauthor=A.+P.+Kozikowskiauthor=W.+R.+Bishai&title=Indoleamides+are+active+against+drug-resistant+Mycobacterium+tuberculosis&doi=10.1038%2Fncomms3907"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Indoleamides are active against drug-resistant Mycobacterium tuberculosis</span></div><div class="casAuthors">Lun Shichun; Guo Haidan; Onajole Oluseye K; Gunosewoyo Hendra; Chen Gang; Kozikowski Alan P; Pieroni Marco; Tipparaju Suresh K; Ammerman Nicole C; Bishai William R</div><div class="citationInfo"><span class="NLM_cas:title">Nature communications</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">2907</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Responsible for nearly two million deaths each year, the infectious disease tuberculosis remains a serious global health challenge.  The emergence of multidrug- and extensively drug-resistant strains of Mycobacterium tuberculosis confounds control efforts, and new drugs with novel molecular targets are desperately needed.  Here we describe lead compounds, the indoleamides, with potent activity against both drug-susceptible and drug-resistant strains of M. tuberculosis by targeting the mycolic acid transporter MmpL3.  We identify a single mutation in mmpL3, which confers high resistance to the indoleamide class while remaining susceptible to currently used first- and second-line tuberculosis drugs, indicating a lack of cross-resistance.  Importantly, an indoleamide derivative exhibits dose-dependent antimycobacterial activity when orally administered to M. tuberculosis-infected mice.  The bioavailability of the indoleamides, combined with their ability to kill tubercle bacilli, indicates great potential for translational developments of this structure class for the treatment of drug-resistant tuberculosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR4ame_FVdejL7NkxioyDXTfW6udTcc2eb77NLjTnywirntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2c3oslKgtw%253D%253D&md5=29323f5b10dff540b38973491545d1c5</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1038%2Fncomms3907&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms3907%26sid%3Dliteratum%253Aachs%26aulast%3DLun%26aufirst%3DS.%26aulast%3DGuo%26aufirst%3DH.%26aulast%3DOnajole%26aufirst%3DO.%2BK.%26aulast%3DPieroni%26aufirst%3DM.%26aulast%3DGunosewoyo%26aufirst%3DH.%26aulast%3DChen%26aufirst%3DG.%26aulast%3DTipparaju%26aufirst%3DS.%2BK.%26aulast%3DAmmerman%26aufirst%3DN.%2BC.%26aulast%3DKozikowski%26aufirst%3DA.%2BP.%26aulast%3DBishai%26aufirst%3DW.%2BR.%26atitle%3DIndoleamides%2520are%2520active%2520against%2520drug-resistant%2520Mycobacterium%2520tuberculosis%26jtitle%3DNat.%2520Commun.%26date%3D2013%26volume%3D4%26spage%3D2907%26doi%3D10.1038%2Fncomms3907" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref100"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref100'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit100"><span><span class="NLM_contrib-group">Bishai, W.R.; Lun, S.; Guo, H.; Kozikowski, A.; Onajole, O.; Stec, J.</span><span> </span><span class="NLM_article-title">Inhibitors of drug-resistant mycobacterium tuberculosis</span>. WO/2015/164482</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Bishai%2C+W.R.%3B+Lun%2C+S.%3B+Guo%2C+H.%3B+Kozikowski%2C+A.%3B+Onajole%2C+O.%3B+Stec%2C+J.+Inhibitors+of+drug-resistant+mycobacterium+tuberculosis.+WO%2F2015%2F164482"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit100&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBishai%26aufirst%3DW.R.%26atitle%3DInhibitors%2520of%2520drug-resistant%2520mycobacterium%2520tuberculosis" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit17a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Andrews, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parks, L. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spence, K. D.</span><span> </span><span class="NLM_article-title">Some effects of douglas fir terpenes on certain microorganisms</span> <span class="citation_source-journal">Appl. Environ. Microbiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1980</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">301</span><span class="NLM_x">–</span> <span class="NLM_lpage">304</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=1980&pages=301-304&issue=2&author=R.+E.+Andrewsauthor=L.+W.+Parksauthor=K.+D.+Spence&title=Some+effects+of+douglas+fir+terpenes+on+certain+microorganisms"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAndrews%26aufirst%3DR.%2BE.%26aulast%3DParks%26aufirst%3DL.%2BW.%26aulast%3DSpence%26aufirst%3DK.%2BD.%26atitle%3DSome%2520effects%2520of%2520douglas%2520fir%2520terpenes%2520on%2520certain%2520microorganisms%26jtitle%3DAppl.%2520Environ.%2520Microbiol.%26date%3D1980%26volume%3D40%26issue%3D2%26spage%3D301%26epage%3D304" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit17b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Sikkema, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Bont, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poolman, B.</span><span> </span><span class="NLM_article-title">Mechanisms of membrane toxicity of hydrocarbons</span> <span class="citation_source-journal">Microbiol Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">201</span><span class="NLM_x">–</span> <span class="NLM_lpage">222</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00415&amp;key=10.1128%2FMMBR.59.2.201-222.1995" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00415&amp;key=7603409" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00415&amp;key=1%3ACAS%3A528%3ADyaK2MXms1SntLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=1995&pages=201-222&issue=2&author=J.+Sikkemaauthor=J.+A.+de+Bontauthor=B.+Poolman&title=Mechanisms+of+membrane+toxicity+of+hydrocarbons"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17bR"><div class="casContent"><span class="casTitleNuber">18b</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanisms of membrane toxicity of hydrocarbons</span></div><div class="casAuthors">Sikkema, Jan; de Bont, Jan A. M.; Poolman, Bert</div><div class="citationInfo"><span class="NLM_cas:title">Microbiological Reviews</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">201-22</span>CODEN:
                <span class="NLM_cas:coden">MBRED3</span>;
        ISSN:<span class="NLM_cas:issn">0146-0749</span>.
    </div><div class="casAbstract">A review and discussion with 366 refs. on the toxicity of cyclic hydrocarbons to microorganisms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoY_TX2o7EQsLVg90H21EOLACvtfcHk0ljm7wY60d3waA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXms1SntLw%253D&md5=a43ce359b8dcf9e3967368dcadfccc54</span></div><a href="/servlet/linkout?suffix=cit17b&amp;dbid=16384&amp;doi=10.1128%2FMMBR.59.2.201-222.1995&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMMBR.59.2.201-222.1995%26sid%3Dliteratum%253Aachs%26aulast%3DSikkema%26aufirst%3DJ.%26aulast%3Dde%2BBont%26aufirst%3DJ.%2BA.%26aulast%3DPoolman%26aufirst%3DB.%26atitle%3DMechanisms%2520of%2520membrane%2520toxicity%2520of%2520hydrocarbons%26jtitle%3DMicrobiol%2520Rev.%26date%3D1995%26volume%3D59%26issue%3D2%26spage%3D201%26epage%3D222" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Kondreddi, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiricek, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rao, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lakshminarayana, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Camacho, L. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rao, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herve, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bifani, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, N. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuhen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goh, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chatterjee, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dick, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diagana, T. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manjunatha, U. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, P. W.</span><span> </span><span class="NLM_article-title">Design, synthesis, and biological evaluation of indole-2-carboxamides: a promising class of antituberculosis agents</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x"> (</span><span class="NLM_issue">21</span><span class="NLM_x">) </span> <span class="NLM_fpage">8849</span><span class="NLM_x">–</span> <span class="NLM_lpage">8859</span><span class="refDoi"> DOI: 10.1021/jm4012774</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm4012774" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=8849-8859&issue=21&author=R.+R.+Kondreddiauthor=J.+Jiricekauthor=S.+P.+Raoauthor=S.+B.+Lakshminarayanaauthor=L.+R.+Camachoauthor=R.+Raoauthor=M.+Herveauthor=P.+Bifaniauthor=N.+L.+Maauthor=K.+Kuhenauthor=A.+Gohauthor=A.+K.+Chatterjeeauthor=T.+Dickauthor=T.+T.+Diaganaauthor=U.+H.+Manjunathaauthor=P.+W.+Smith&title=Design%2C+synthesis%2C+and+biological+evaluation+of+indole-2-carboxamides%3A+a+promising+class+of+antituberculosis+agents&doi=10.1021%2Fjm4012774"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Fjm4012774&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm4012774%26sid%3Dliteratum%253Aachs%26aulast%3DKondreddi%26aufirst%3DR.%2BR.%26aulast%3DJiricek%26aufirst%3DJ.%26aulast%3DRao%26aufirst%3DS.%2BP.%26aulast%3DLakshminarayana%26aufirst%3DS.%2BB.%26aulast%3DCamacho%26aufirst%3DL.%2BR.%26aulast%3DRao%26aufirst%3DR.%26aulast%3DHerve%26aufirst%3DM.%26aulast%3DBifani%26aufirst%3DP.%26aulast%3DMa%26aufirst%3DN.%2BL.%26aulast%3DKuhen%26aufirst%3DK.%26aulast%3DGoh%26aufirst%3DA.%26aulast%3DChatterjee%26aufirst%3DA.%2BK.%26aulast%3DDick%26aufirst%3DT.%26aulast%3DDiagana%26aufirst%3DT.%2BT.%26aulast%3DManjunatha%26aufirst%3DU.%2BH.%26aulast%3DSmith%26aufirst%3DP.%2BW.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520biological%2520evaluation%2520of%2520indole-2-carboxamides%253A%2520a%2520promising%2520class%2520of%2520antituberculosis%2520agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26issue%3D21%26spage%3D8849%26epage%3D8859%26doi%3D10.1021%2Fjm4012774" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Rao, S. P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lakshminarayana, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kondreddi, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herve, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Camacho, L. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bifani, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalapala, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiricek, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, N. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tan, B. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ng, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nanjundappa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ravindran, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seah, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thayalan, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lim, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, B. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goh, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barnes, W. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gagaring, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chatterjee, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pethe, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuhen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feng, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Babu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blasco, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beer, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weaver, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dartois, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glynne, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dick, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, P. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diagana, T. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manjunatha, U. H.</span><span> </span><span class="NLM_article-title">Indolcarboxamide is a preclinical candidate for treating multidrug-resistant tuberculosis</span> <span class="citation_source-journal">Sci. Transl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x"> (</span><span class="NLM_issue">214</span><span class="NLM_x">) </span> <span class="NLM_fpage">214ra168</span><span class="refDoi"> DOI: 10.1126/scitranslmed.3007355</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00415&amp;key=10.1126%2Fscitranslmed.3007355" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00415&amp;key=24307692" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2013&pages=214ra168&issue=214&author=S.+P.+S.+Raoauthor=S.+B.+Lakshminarayanaauthor=R.+R.+Kondreddiauthor=M.+Herveauthor=L.+R.+Camachoauthor=P.+Bifaniauthor=S.+K.+Kalapalaauthor=J.+Jiricekauthor=N.+L.+Maauthor=B.+H.+Tanauthor=S.+H.+Ngauthor=M.+Nanjundappaauthor=S.+Ravindranauthor=P.+G.+Seahauthor=P.+Thayalanauthor=S.+H.+Limauthor=B.+H.+Leeauthor=A.+Gohauthor=W.+S.+Barnesauthor=Z.+Chenauthor=K.+Gagaringauthor=A.+K.+Chatterjeeauthor=K.+Petheauthor=K.+Kuhenauthor=J.+Walkerauthor=G.+Fengauthor=S.+Babuauthor=L.+Zhangauthor=F.+Blascoauthor=D.+Beerauthor=M.+Weaverauthor=V.+Dartoisauthor=R.+Glynneauthor=T.+Dickauthor=P.+W.+Smithauthor=T.+T.+Diaganaauthor=U.+H.+Manjunatha&title=Indolcarboxamide+is+a+preclinical+candidate+for+treating+multidrug-resistant+tuberculosis&doi=10.1126%2Fscitranslmed.3007355"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1126%2Fscitranslmed.3007355&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscitranslmed.3007355%26sid%3Dliteratum%253Aachs%26aulast%3DRao%26aufirst%3DS.%2BP.%2BS.%26aulast%3DLakshminarayana%26aufirst%3DS.%2BB.%26aulast%3DKondreddi%26aufirst%3DR.%2BR.%26aulast%3DHerve%26aufirst%3DM.%26aulast%3DCamacho%26aufirst%3DL.%2BR.%26aulast%3DBifani%26aufirst%3DP.%26aulast%3DKalapala%26aufirst%3DS.%2BK.%26aulast%3DJiricek%26aufirst%3DJ.%26aulast%3DMa%26aufirst%3DN.%2BL.%26aulast%3DTan%26aufirst%3DB.%2BH.%26aulast%3DNg%26aufirst%3DS.%2BH.%26aulast%3DNanjundappa%26aufirst%3DM.%26aulast%3DRavindran%26aufirst%3DS.%26aulast%3DSeah%26aufirst%3DP.%2BG.%26aulast%3DThayalan%26aufirst%3DP.%26aulast%3DLim%26aufirst%3DS.%2BH.%26aulast%3DLee%26aufirst%3DB.%2BH.%26aulast%3DGoh%26aufirst%3DA.%26aulast%3DBarnes%26aufirst%3DW.%2BS.%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DGagaring%26aufirst%3DK.%26aulast%3DChatterjee%26aufirst%3DA.%2BK.%26aulast%3DPethe%26aufirst%3DK.%26aulast%3DKuhen%26aufirst%3DK.%26aulast%3DWalker%26aufirst%3DJ.%26aulast%3DFeng%26aufirst%3DG.%26aulast%3DBabu%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DBlasco%26aufirst%3DF.%26aulast%3DBeer%26aufirst%3DD.%26aulast%3DWeaver%26aufirst%3DM.%26aulast%3DDartois%26aufirst%3DV.%26aulast%3DGlynne%26aufirst%3DR.%26aulast%3DDick%26aufirst%3DT.%26aulast%3DSmith%26aufirst%3DP.%2BW.%26aulast%3DDiagana%26aufirst%3DT.%2BT.%26aulast%3DManjunatha%26aufirst%3DU.%2BH.%26atitle%3DIndolcarboxamide%2520is%2520a%2520preclinical%2520candidate%2520for%2520treating%2520multidrug-resistant%2520tuberculosis%26jtitle%3DSci.%2520Transl.%2520Med.%26date%3D2013%26volume%3D5%26issue%3D214%26spage%3D214ra168%26doi%3D10.1126%2Fscitranslmed.3007355" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Chopra, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsuyama, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tran, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malerich, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wan, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Franzblau, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lun, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maiga, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bishai, W. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Madrid, P. B.</span><span> </span><span class="NLM_article-title">Evaluation of gyrase B as a drug target in <i>Mycobacterium tuberculosis</i></span> <span class="citation_source-journal">J. Antimicrob. Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">415</span><span class="NLM_x">–</span> <span class="NLM_lpage">421</span><span class="refDoi"> DOI: 10.1093/jac/dkr449</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00415&amp;key=10.1093%2Fjac%2Fdkr449" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00415&amp;key=22052686" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00415&amp;key=1%3ACAS%3A528%3ADC%252BC38Xos12qsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2012&pages=415-421&author=S.+Chopraauthor=K.+Matsuyamaauthor=T.+Tranauthor=J.+P.+Malerichauthor=B.+Wanauthor=S.+G.+Franzblauauthor=S.+Lunauthor=H.+Guoauthor=M.+C.+Maigaauthor=W.+R.+Bishaiauthor=P.+B.+Madrid&title=Evaluation+of+gyrase+B+as+a+drug+target+in+Mycobacterium+tuberculosis&doi=10.1093%2Fjac%2Fdkr449"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Evaluation of gyrase B as a drug target in Mycobacterium tuberculosis</span></div><div class="casAuthors">Chopra, Sidharth; Matsuyama, Karen; Tran, Tran; Malerich, Jeremiah P.; Wan, Baojie; Franzblau, Scott G.; Lun, Shichun; Guo, Haidan; Maiga, Mariama C.; Bishai, William R.; Madrid, Peter B.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Antimicrobial Chemotherapy</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">415-421</span>CODEN:
                <span class="NLM_cas:coden">JACHDX</span>;
        ISSN:<span class="NLM_cas:issn">0305-7453</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">New classes of drugs are needed to treat tuberculosis (TB) in order to combat the emergence of resistance to existing agents and shorten the duration of therapy.  Targeting DNA gyrase is a clin. validated therapeutic approach using fluoroquinolone antibiotics to target the gyrase subunit A (GyrA) of the heterotetramer.  Increasing resistance to fluoroquinolones has driven interest in targeting the gyrase subunit B (GyrB), which has not been targeted for TB.  The biol. activities of two potent small-mol. inhibitors of GyrB have been characterized to validate its targeting as a therapeutic strategy for treating TB.  Novobiocin and aminobenzimidazole 1 (AB-1) were tested for their activity against Mycobacterium tuberculosis (Mtb) H37Rv and other mycobacteria.  AB-1 and novobiocin were also evaluated for their interaction with rifampicin and isoniazid as well as their potential for cytotoxicity.  Finally, AB-1 was tested for in vivo efficacy in a murine model of TB.  Novobiocin and AB-1 have both been shown to be active against Mtb with MIC values of 4 and 1 mg/L, resp.  Only AB-1 exhibited time-dependent bactericidal activity against drug-susceptible and drug-resistant mycobacteria, including a fluoroquinolone-resistant strain.  AB-1 had potent activity in the low oxygen recovery assay model for non-replicating persistent Mtb.  Addnl., AB-1 has no interaction with isoniazid and rifampicin, and has no cross-resistance with fluoroquinolones.  In a murine model of TB, AB-1 significantly reduced lung cfu counts in a dose-dependent manner.  Aminobenzimidazole inhibitors of GyrB exhibit many of the characteristics required for their consideration as a potential front-line antimycobacterial therapeutic.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr5lZPib9RqPrVg90H21EOLACvtfcHk0ljbqd2fslD7Gg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xos12qsA%253D%253D&md5=61bac9b95aaf29c157f4eedeaf306561</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1093%2Fjac%2Fdkr449&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjac%252Fdkr449%26sid%3Dliteratum%253Aachs%26aulast%3DChopra%26aufirst%3DS.%26aulast%3DMatsuyama%26aufirst%3DK.%26aulast%3DTran%26aufirst%3DT.%26aulast%3DMalerich%26aufirst%3DJ.%2BP.%26aulast%3DWan%26aufirst%3DB.%26aulast%3DFranzblau%26aufirst%3DS.%2BG.%26aulast%3DLun%26aufirst%3DS.%26aulast%3DGuo%26aufirst%3DH.%26aulast%3DMaiga%26aufirst%3DM.%2BC.%26aulast%3DBishai%26aufirst%3DW.%2BR.%26aulast%3DMadrid%26aufirst%3DP.%2BB.%26atitle%3DEvaluation%2520of%2520gyrase%2520B%2520as%2520a%2520drug%2520target%2520in%2520Mycobacterium%2520tuberculosis%26jtitle%3DJ.%2520Antimicrob.%2520Chemother.%26date%3D2012%26volume%3D67%26spage%3D415%26epage%3D421%26doi%3D10.1093%2Fjac%2Fdkr449" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Ioerger, T. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">No, E.-G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Larsen, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobs, W. R.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pillay, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sturm, A. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sacchettini, J. C.</span><span> </span><span class="NLM_article-title">Genome analysis of multi- and extensively-drug-resistant tuberculosis from KwaZulu-Natal, South Africa</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">e7778</span><span class="refDoi"> DOI: 10.1371/journal.pone.0007778</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00415&amp;key=10.1371%2Fjournal.pone.0007778" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00415&amp;key=19890396" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2009&pages=e7778&author=T.+R.+Ioergerauthor=S.+Kooauthor=E.-G.+Noauthor=X.+Chenauthor=M.+H.+Larsenauthor=W.+R.+Jacobsauthor=M.+Pillayauthor=A.+W.+Sturmauthor=J.+C.+Sacchettini&title=Genome+analysis+of+multi-+and+extensively-drug-resistant+tuberculosis+from+KwaZulu-Natal%2C+South+Africa&doi=10.1371%2Fjournal.pone.0007778"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0007778&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0007778%26sid%3Dliteratum%253Aachs%26aulast%3DIoerger%26aufirst%3DT.%2BR.%26aulast%3DKoo%26aufirst%3DS.%26aulast%3DNo%26aufirst%3DE.-G.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DLarsen%26aufirst%3DM.%2BH.%26aulast%3DJacobs%26aufirst%3DW.%2BR.%26aulast%3DPillay%26aufirst%3DM.%26aulast%3DSturm%26aufirst%3DA.%2BW.%26aulast%3DSacchettini%26aufirst%3DJ.%2BC.%26atitle%3DGenome%2520analysis%2520of%2520multi-%2520and%2520extensively-drug-resistant%2520tuberculosis%2520from%2520KwaZulu-Natal%252C%2520South%2520Africa%26jtitle%3DPLoS%2520One%26date%3D2009%26volume%3D4%26spage%3De7778%26doi%3D10.1371%2Fjournal.pone.0007778" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Bliss, C. I.</span><span> </span><span class="NLM_article-title">The toxicity of poisons applied jointly</span> <span class="citation_source-journal">Ann. Appl. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1939</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">585</span><span class="NLM_x">–</span> <span class="NLM_lpage">615</span><span class="refDoi"> DOI: 10.1111/j.1744-7348.1939.tb06990.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00415&amp;key=10.1111%2Fj.1744-7348.1939.tb06990.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00415&amp;key=1%3ACAS%3A528%3ADyaH3cXhtFWq" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=1939&pages=585-615&author=C.+I.+Bliss&title=The+toxicity+of+poisons+applied+jointly&doi=10.1111%2Fj.1744-7348.1939.tb06990.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23aR"><div class="casContent"><span class="casTitleNuber">23a</span><div class="casTitle"><span class="NLM_cas:atitle">The toxicity of poisons applied jointly</span></div><div class="casAuthors">Bliss, C. I.</div><div class="citationInfo"><span class="NLM_cas:title">Annals of Applied Biology</span>
        (<span class="NLM_cas:date">1939</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">585-615</span>CODEN:
                <span class="NLM_cas:coden">AABIAV</span>;
        ISSN:<span class="NLM_cas:issn">0003-4746</span>.
    </div><div class="casAbstract">Methods for the statistical analysis of toxicity data from poisons administered jointly to animals are described.  Types of joint action recognized are: independent joint action; similar joint action; synergistic action.  Each is discussed and the statistical treatment is illustrated by an example from the entomological literature.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrv_A_4Ot3F57Vg90H21EOLACvtfcHk0ljbqd2fslD7Gg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaH3cXhtFWq&md5=5223d96533ab5d38d94127751e2ded82</span></div><a href="/servlet/linkout?suffix=cit23a&amp;dbid=16384&amp;doi=10.1111%2Fj.1744-7348.1939.tb06990.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1744-7348.1939.tb06990.x%26sid%3Dliteratum%253Aachs%26aulast%3DBliss%26aufirst%3DC.%2BI.%26atitle%3DThe%2520toxicity%2520of%2520poisons%2520applied%2520jointly%26jtitle%3DAnn.%2520Appl.%2520Biol.%26date%3D1939%26volume%3D26%26spage%3D585%26epage%3D615%26doi%3D10.1111%2Fj.1744-7348.1939.tb06990.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit23b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Greco, W. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bravo, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parsons, J. C.</span><span> </span><span class="NLM_article-title">The search for synergy: a critical review from a response surface perspective</span> <span class="citation_source-journal">Pharmacol. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">331</span><span class="NLM_x">–</span> <span class="NLM_lpage">385</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00415&amp;key=7568331" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00415&amp;key=1%3ACAS%3A280%3ADyaK28%252FjsFSgtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=1995&pages=331-385&author=W.+R.+Grecoauthor=G.+Bravoauthor=J.+C.+Parsons&title=The+search+for+synergy%3A+a+critical+review+from+a+response+surface+perspective"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23bR"><div class="casContent"><span class="casTitleNuber">23b</span><div class="casTitle"><span class="NLM_cas:atitle">The search for synergy: a critical review from a response surface perspective</span></div><div class="casAuthors">Greco W R; Bravo G; Parsons J C</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological reviews</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">331-85</span>
        ISSN:<span class="NLM_cas:issn">0031-6997</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRXywHk-SVAkdenUz0lpNqnfW6udTcc2eYFNzhzWk7hPrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK28%252FjsFSgtQ%253D%253D&md5=80f1b0c8e20e587625a5d68339d30709</span></div><a href="/servlet/linkout?suffix=cit23b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGreco%26aufirst%3DW.%2BR.%26aulast%3DBravo%26aufirst%3DG.%26aulast%3DParsons%26aufirst%3DJ.%2BC.%26atitle%3DThe%2520search%2520for%2520synergy%253A%2520a%2520critical%2520review%2520from%2520a%2520response%2520surface%2520perspective%26jtitle%3DPharmacol.%2520Rev.%26date%3D1995%26volume%3D47%26spage%3D331%26epage%3D385" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Branch, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adedoyin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frye, R. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romkes, M.</span><span> </span><span class="NLM_article-title"><i>In vivo</i> modulation of CYP enzymes by quinidine and rifampin</span> <span class="citation_source-journal">Clin. Pharmacol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">68</span><span class="NLM_x">, </span> <span class="NLM_fpage">401</span><span class="NLM_x">–</span> <span class="NLM_lpage">411</span><span class="refDoi"> DOI: 10.1067/mcp.2000.110561</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00415&amp;key=10.1067%2Fmcp.2000.110561" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00415&amp;key=11061580" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00415&amp;key=1%3ACAS%3A528%3ADC%252BD3cXot1Wjtrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2000&pages=401-411&author=R.+A.+Branchauthor=A.+Adedoyinauthor=R.+F.+Fryeauthor=J.+W.+Wilsonauthor=M.+Romkes&title=In+vivo+modulation+of+CYP+enzymes+by+quinidine+and+rifampin&doi=10.1067%2Fmcp.2000.110561"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24aR"><div class="casContent"><span class="casTitleNuber">24a</span><div class="casTitle"><span class="NLM_cas:atitle">In vivo modulation of CYP enzymes by quinidine and rifampin</span></div><div class="casAuthors">Branch, Robert A.; Adedoyin, Adedayo; Frye, Reginald F.; Wilson, John W.; Romkes, Marjorie</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Pharmacology & Therapeutics (St. Louis)</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">68</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">401-411</span>CODEN:
                <span class="NLM_cas:coden">CLPTAT</span>;
        ISSN:<span class="NLM_cas:issn">0009-9236</span>.
    
            (<span class="NLM_cas:orgname">Mosby, Inc.</span>)
        </div><div class="casAbstract">This study investigated the effect of 3 and 28 days of treatment with quinidine (200 mg daily) and rifampin (600 mg daily) on the activities of 4 cytochrome P (CYP) 450 enzymes and N-acetyltransferase in healthy young male volunteers receiving a cocktail of drug probes, including caffeine, mephenytoin, debrisoquine, and dapsone.  Quinidine selectively and almost completely inhibited the activity of CYP2D6 from day 3 through day 28 without affecting any of the other enzymes tested.  Rifampin showed evidence of time-dependent induction of the activities of all the oxidative routes of metab. measured but decreased the acetylation ratio in fast acetylators.  The quinidine/rifampin combination resulted in selective CYP2D6 inhibition and induction of all the other enzymes evaluated, suggesting that predictable complex interactions occur with the drug combination.  These observations illustrate the value of simultaneous assessment of the effect of modulators on the activities of multiple specific enzymes with the drug cocktail approach.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrep0k1tcxlpLVg90H21EOLACvtfcHk0lj458R7l2y5Ng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXot1Wjtrw%253D&md5=8ca341e25bf178005f9c11aa823aca02</span></div><a href="/servlet/linkout?suffix=cit24a&amp;dbid=16384&amp;doi=10.1067%2Fmcp.2000.110561&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1067%252Fmcp.2000.110561%26sid%3Dliteratum%253Aachs%26aulast%3DBranch%26aufirst%3DR.%2BA.%26aulast%3DAdedoyin%26aufirst%3DA.%26aulast%3DFrye%26aufirst%3DR.%2BF.%26aulast%3DWilson%26aufirst%3DJ.%2BW.%26aulast%3DRomkes%26aufirst%3DM.%26atitle%3DIn%2520vivo%2520modulation%2520of%2520CYP%2520enzymes%2520by%2520quinidine%2520and%2520rifampin%26jtitle%3DClin.%2520Pharmacol.%2520Ther.%26date%3D2000%26volume%3D68%26spage%3D401%26epage%3D411%26doi%3D10.1067%2Fmcp.2000.110561" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit24b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Baciewicz, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chrisman, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finch, C. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Self, T. H.</span><span> </span><span class="NLM_article-title">Update on rifampin, rifabutin, and rifapentine drug interactions</span> <span class="citation_source-journal">Curr. Med. Res. Opin.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">12</span><span class="refDoi"> DOI: 10.1185/03007995.2012.747952</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00415&amp;key=10.1185%2F03007995.2012.747952" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00415&amp;key=23136913" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00415&amp;key=1%3ACAS%3A528%3ADC%252BC38XhvVynsLjP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2013&pages=1-12&author=A.+M.+Baciewiczauthor=C.+R.+Chrismanauthor=C.+K.+Finchauthor=T.+H.+Self&title=Update+on+rifampin%2C+rifabutin%2C+and+rifapentine+drug+interactions&doi=10.1185%2F03007995.2012.747952"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24bR"><div class="casContent"><span class="casTitleNuber">24b</span><div class="casTitle"><span class="NLM_cas:atitle">Update on rifampin, rifabutin, and rifapentine drug interactions</span></div><div class="casAuthors">Baciewicz, Anne M.; Chrisman, Cary R.; Finch, Christopher K.; Self, Timothy H.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medical Research and Opinion</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-12</span>CODEN:
                <span class="NLM_cas:coden">CMROCX</span>;
        ISSN:<span class="NLM_cas:issn">0300-7995</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Background: Rifampin is a potent inducer of both cytochrome P 450 oxidative enzymes and the P-glycoprotein transport system.  Among numerous well documented, clin. significant interactions, examples include warfarin, oral contraceptives, itraconazole, digoxin, verapamil, simvastatin, and human immunodeficiency virus-related protease inhibitors.  Rifabutin reduces serum concns. of antiretroviral agents, but less so than rifampin.  Rifapentine is also an inducer of drug metab.  Methods: A literature search of English language journals from 2008 to March 2012 was completed using several databases, including PubMed, EMBASE, and SCOPUS.  Search terms included rifampin, rifabutin, rifapentine AND drug interactions.  Findings: Examples of clin. relevant interactions with rifampin demonstrated by recent reports include posaconazole, voriconazole, oxycodone, risperidone, mirodenafil, and ebastine.  Conclusions: To avoid a reduced therapeutic response, therapeutic failure, or toxic reactions when rifampin, rifabutin, or rifapentine are added to or discontinued from medication regimens, clinicians need to be aware of these interactions.  Recent studies have indicated that other transporter systems play a role in these drug interactions.  As reports of rifampin drug interactions continue to grow, this review is a reminder to clinicians to be vigilant.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqV6-1hI_PPv7Vg90H21EOLACvtfcHk0lj34b3v_pb4Ew"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhvVynsLjP&md5=44d0f28ae743f4695b23b1a243fb0271</span></div><a href="/servlet/linkout?suffix=cit24b&amp;dbid=16384&amp;doi=10.1185%2F03007995.2012.747952&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1185%252F03007995.2012.747952%26sid%3Dliteratum%253Aachs%26aulast%3DBaciewicz%26aufirst%3DA.%2BM.%26aulast%3DChrisman%26aufirst%3DC.%2BR.%26aulast%3DFinch%26aufirst%3DC.%2BK.%26aulast%3DSelf%26aufirst%3DT.%2BH.%26atitle%3DUpdate%2520on%2520rifampin%252C%2520rifabutin%252C%2520and%2520rifapentine%2520drug%2520interactions%26jtitle%3DCurr.%2520Med.%2520Res.%2520Opin.%26date%3D2013%26volume%3D29%26spage%3D1%26epage%3D12%26doi%3D10.1185%2F03007995.2012.747952" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Finch, C. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chrisman, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baciewicz, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Self, T. H.</span><span> </span><span class="NLM_article-title">Rifampin and rifabutin drug interactions: an update</span> <span class="citation_source-journal">Arch. Intern. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">162</span><span class="NLM_x">, </span> <span class="NLM_fpage">985</span><span class="NLM_x">–</span> <span class="NLM_lpage">992</span><span class="refDoi"> DOI: 10.1001/archinte.162.9.985</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00415&amp;key=10.1001%2Farchinte.162.9.985" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=162&publication_year=2002&pages=985-992&author=C.+K.+Finchauthor=C.+R.+Chrismanauthor=A.+M.+Baciewiczauthor=T.+H.+Self&title=Rifampin+and+rifabutin+drug+interactions%3A+an+update&doi=10.1001%2Farchinte.162.9.985"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1001%2Farchinte.162.9.985&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1001%252Farchinte.162.9.985%26sid%3Dliteratum%253Aachs%26aulast%3DFinch%26aufirst%3DC.%2BK.%26aulast%3DChrisman%26aufirst%3DC.%2BR.%26aulast%3DBaciewicz%26aufirst%3DA.%2BM.%26aulast%3DSelf%26aufirst%3DT.%2BH.%26atitle%3DRifampin%2520and%2520rifabutin%2520drug%2520interactions%253A%2520an%2520update%26jtitle%3DArch.%2520Intern.%2520Med.%26date%3D2002%26volume%3D162%26spage%3D985%26epage%3D992%26doi%3D10.1001%2Farchinte.162.9.985" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Acosta, E. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kendall, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gerber, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alston-Smith, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koletar, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zolopa, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agarwala, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Child, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bertz, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hosey, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haas, D. W.</span><span> </span><span class="NLM_article-title">Effect of concomitantly administered rifampin on the pharmacokinetics and safety of atazanavir administered twice daily</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">3104</span><span class="NLM_x">–</span> <span class="NLM_lpage">3110</span><span class="refDoi"> DOI: 10.1128/AAC.00341-07</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00415&amp;key=10.1128%2FAAC.00341-07" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2007&pages=3104-3110&author=E.+P.+Acostaauthor=M.+A.+Kendallauthor=J.+G.+Gerberauthor=B.+Alston-Smithauthor=S.+L.+Koletarauthor=A.+R.+Zolopaauthor=S.+Agarwalaauthor=M.+Childauthor=R.+Bertzauthor=L.+Hoseyauthor=D.+W.+Haas&title=Effect+of+concomitantly+administered+rifampin+on+the+pharmacokinetics+and+safety+of+atazanavir+administered+twice+daily&doi=10.1128%2FAAC.00341-07"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26a&amp;dbid=16384&amp;doi=10.1128%2FAAC.00341-07&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.00341-07%26sid%3Dliteratum%253Aachs%26aulast%3DAcosta%26aufirst%3DE.%2BP.%26aulast%3DKendall%26aufirst%3DM.%2BA.%26aulast%3DGerber%26aufirst%3DJ.%2BG.%26aulast%3DAlston-Smith%26aufirst%3DB.%26aulast%3DKoletar%26aufirst%3DS.%2BL.%26aulast%3DZolopa%26aufirst%3DA.%2BR.%26aulast%3DAgarwala%26aufirst%3DS.%26aulast%3DChild%26aufirst%3DM.%26aulast%3DBertz%26aufirst%3DR.%26aulast%3DHosey%26aufirst%3DL.%26aulast%3DHaas%26aufirst%3DD.%2BW.%26atitle%3DEffect%2520of%2520concomitantly%2520administered%2520rifampin%2520on%2520the%2520pharmacokinetics%2520and%2520safety%2520of%2520atazanavir%2520administered%2520twice%2520daily%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2007%26volume%3D51%26spage%3D3104%26epage%3D3110%26doi%3D10.1128%2FAAC.00341-07" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit26b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Kirby, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collier, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kharasch, E. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whittington, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thummel, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Unadkat, J. D.</span><span> </span><span class="NLM_article-title">Complex drug interactions of the HIV protease inhibitors 3: effect of simultaneous or staggered dosing of digoxin and ritonavir, nelfinavir, rifampin, or bupropion</span> <span class="citation_source-journal">Drug Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">610</span><span class="NLM_x">–</span> <span class="NLM_lpage">616</span><span class="refDoi"> DOI: 10.1124/dmd.111.042705</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00415&amp;key=10.1124%2Fdmd.111.042705" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2012&pages=610-616&author=B.+J.+Kirbyauthor=A.+C.+Collierauthor=E.+D.+Kharaschauthor=D.+Whittingtonauthor=K.+E.+Thummelauthor=J.+D.+Unadkat&title=Complex+drug+interactions+of+the+HIV+protease+inhibitors+3%3A+effect+of+simultaneous+or+staggered+dosing+of+digoxin+and+ritonavir%2C+nelfinavir%2C+rifampin%2C+or+bupropion&doi=10.1124%2Fdmd.111.042705"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26b&amp;dbid=16384&amp;doi=10.1124%2Fdmd.111.042705&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.111.042705%26sid%3Dliteratum%253Aachs%26aulast%3DKirby%26aufirst%3DB.%2BJ.%26aulast%3DCollier%26aufirst%3DA.%2BC.%26aulast%3DKharasch%26aufirst%3DE.%2BD.%26aulast%3DWhittington%26aufirst%3DD.%26aulast%3DThummel%26aufirst%3DK.%2BE.%26aulast%3DUnadkat%26aufirst%3DJ.%2BD.%26atitle%3DComplex%2520drug%2520interactions%2520of%2520the%2520HIV%2520protease%2520inhibitors%25203%253A%2520effect%2520of%2520simultaneous%2520or%2520staggered%2520dosing%2520of%2520digoxin%2520and%2520ritonavir%252C%2520nelfinavir%252C%2520rifampin%252C%2520or%2520bupropion%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2012%26volume%3D40%26spage%3D610%26epage%3D616%26doi%3D10.1124%2Fdmd.111.042705" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Sennhauser, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bukowska, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Briand, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grütter, M. G.</span><span> </span><span class="NLM_article-title">Crystal structure of the multidrug exporter MexB from <i>Pseudomonas aeruginosa</i></span> <span class="citation_source-journal">J. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">389</span><span class="NLM_x">, </span> <span class="NLM_fpage">134</span><span class="NLM_x">–</span> <span class="NLM_lpage">145</span><span class="refDoi"> DOI: 10.1016/j.jmb.2009.04.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00415&amp;key=10.1016%2Fj.jmb.2009.04.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00415&amp;key=19361527" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00415&amp;key=1%3ACAS%3A528%3ADC%252BD1MXls12gtro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=389&publication_year=2009&pages=134-145&author=G.+Sennhauserauthor=M.+A.+Bukowskaauthor=C.+Briandauthor=M.+G.+Gr%C3%BCtter&title=Crystal+structure+of+the+multidrug+exporter+MexB+from+Pseudomonas+aeruginosa&doi=10.1016%2Fj.jmb.2009.04.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal Structure of the Multidrug Exporter MexB from Pseudomonas aeruginosa</span></div><div class="casAuthors">Sennhauser, Gaby; Bukowska, Magdalena A.; Briand, Christophe; Grutter, Markus G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Biology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">389</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">134-145</span>CODEN:
                <span class="NLM_cas:coden">JMOBAK</span>;
        ISSN:<span class="NLM_cas:issn">0022-2836</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">We report here the crystal structure of the Pseudomonas aeruginosa multidrug exporter MexB, an intensively studied member of the resistance-nodulation-cell division family of secondary active transporters, at 3.0 Å.  MexB forms an asym. homotrimer where each subunit adopts a different conformation representing three snapshots of the transport cycle similar to the recently detd. structures of its close homolog AcrB from Escherichia coli, so far the sole structurally characterized member of the superfamily.  As for AcrB, the conformations of two subunits can be clearly assigned to either the binding step or the extrusion step in the transport process.  Unexpectedly, a remarkable conformational shift in the third subunit is obsd. in MexB, which has potential implications for the assembly of the tripartite MexAB-OprM drug efflux system.  Furthermore, an n-dodecyl--maltoside mol. was found bound to the internal multidrug-binding cavity, which might indicate that MexB binds and transports detergent mols. as substrates.  As the only missing piece of the puzzle in the MexAB-OprM system, the X-ray structure of MexB completes the mol. picture of the major pump mediating intrinsic and acquired multidrug resistance in P. aeruginosa.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqQ7gfz_c1UWrVg90H21EOLACvtfcHk0lj34b3v_pb4Ew"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXls12gtro%253D&md5=d658bb00316652146c1d3965200fe05f</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1016%2Fj.jmb.2009.04.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jmb.2009.04.001%26sid%3Dliteratum%253Aachs%26aulast%3DSennhauser%26aufirst%3DG.%26aulast%3DBukowska%26aufirst%3DM.%2BA.%26aulast%3DBriand%26aufirst%3DC.%26aulast%3DGr%25C3%25BCtter%26aufirst%3DM.%2BG.%26atitle%3DCrystal%2520structure%2520of%2520the%2520multidrug%2520exporter%2520MexB%2520from%2520Pseudomonas%2520aeruginosa%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D2009%26volume%3D389%26spage%3D134%26epage%3D145%26doi%3D10.1016%2Fj.jmb.2009.04.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Pieroni, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tipparaju, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lun, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sturm, A. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bishai, W. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kozikowski, A. P.</span><span> </span><span class="NLM_article-title">Pyrido[1,2-a]benzimidazole-based agents active against tuberculosis (TB), multidrug-resistant (MDR) TB and extensively drug-resistant (XDR) TB</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">334</span><span class="NLM_x">–</span> <span class="NLM_lpage">342</span><span class="refDoi"> DOI: 10.1002/cmdc.201000490</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00415&amp;key=10.1002%2Fcmdc.201000490" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2011&pages=334-342&issue=2&author=M.+Pieroniauthor=S.+Tipparajuauthor=S.+Lunauthor=Y.+Songauthor=A.+W.+Sturmauthor=W.+R.+Bishaiauthor=A.+P.+Kozikowski&title=Pyrido%5B1%2C2-a%5Dbenzimidazole-based+agents+active+against+tuberculosis+%28TB%29%2C+multidrug-resistant+%28MDR%29+TB+and+extensively+drug-resistant+%28XDR%29+TB&doi=10.1002%2Fcmdc.201000490"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201000490&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201000490%26sid%3Dliteratum%253Aachs%26aulast%3DPieroni%26aufirst%3DM.%26aulast%3DTipparaju%26aufirst%3DS.%26aulast%3DLun%26aufirst%3DS.%26aulast%3DSong%26aufirst%3DY.%26aulast%3DSturm%26aufirst%3DA.%2BW.%26aulast%3DBishai%26aufirst%3DW.%2BR.%26aulast%3DKozikowski%26aufirst%3DA.%2BP.%26atitle%3DPyrido%255B1%252C2-a%255Dbenzimidazole-based%2520agents%2520active%2520against%2520tuberculosis%2520%2528TB%2529%252C%2520multidrug-resistant%2520%2528MDR%2529%2520TB%2520and%2520extensively%2520drug-resistant%2520%2528XDR%2529%2520TB%26jtitle%3DChemMedChem%26date%3D2011%26volume%3D6%26issue%3D2%26spage%3D334%26epage%3D342%26doi%3D10.1002%2Fcmdc.201000490" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Laird, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bullen, C. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenbloom, D. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hill, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Durand, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siliciano, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siliciano, R. F.</span><span> </span><span class="NLM_article-title">Ex vivo analysis identifies effective HIV-1 latency-reversing drug combinations</span> <span class="citation_source-journal">J. Clin. Invest.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">125</span><span class="NLM_x">, </span> <span class="NLM_fpage">1901</span><span class="NLM_x">–</span> <span class="NLM_lpage">1912</span><span class="refDoi"> DOI: 10.1172/JCI80142</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00415&amp;key=10.1172%2FJCI80142" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00415&amp;key=25822022" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00415&amp;key=1%3ACAS%3A280%3ADC%252BC2MnovFCntA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=125&publication_year=2015&pages=1901-1912&author=G.+M.+Lairdauthor=C.+K.+Bullenauthor=D.+I.+Rosenbloomauthor=A.+R.+Martinauthor=A.+L.+Hillauthor=C.+M.+Durandauthor=J.+D.+Silicianoauthor=R.+F.+Siliciano&title=Ex+vivo+analysis+identifies+effective+HIV-1+latency-reversing+drug+combinations&doi=10.1172%2FJCI80142"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Ex vivo analysis identifies effective HIV-1 latency-reversing drug combinations</span></div><div class="casAuthors">Laird Gregory M; Bullen C Korin; Rosenbloom Daniel I S; Martin Alyssa R; Hill Alison L; Durand Christine M; Siliciano Janet D; Siliciano Robert F</div><div class="citationInfo"><span class="NLM_cas:title">The Journal of clinical investigation</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">125</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1901-12</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Reversal of HIV-1 latency by small molecules is a potential cure strategy.  This approach will likely require effective drug combinations to achieve high levels of latency reversal.  Using resting CD4+ T cells (rCD4s) from infected individuals, we developed an experimental and theoretical framework to identify effective latency-reversing agent (LRA) combinations.  Utilizing ex vivo assays for intracellular HIV-1 mRNA and virion production, we compared 2-drug combinations of leading candidate LRAs and identified multiple combinations that effectively reverse latency.  We showed that protein kinase C agonists in combination with bromodomain inhibitor JQ1 or histone deacetylase inhibitors robustly induce HIV-1 transcription and virus production when directly compared with maximum reactivation by T cell activation.  Using the Bliss independence model to quantitate combined drug effects, we demonstrated that these combinations synergize to induce HIV-1 transcription.  This robust latency reversal occurred without release of proinflammatory cytokines by rCD4s.  To extend the clinical utility of our findings, we applied a mathematical model that estimates in vivo changes in plasma HIV-1 RNA from ex vivo measurements of virus production.  Our study reconciles diverse findings from previous studies, establishes a quantitative experimental approach to evaluate combinatorial LRA efficacy, and presents a model to predict in vivo responses to LRAs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSJ1yUqFoXEC1MGsG_HTXYFfW6udTcc2eY9y2nhEoG5VLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2MnovFCntA%253D%253D&md5=5a842b7f2d36db04176cd6796bda18b4</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1172%2FJCI80142&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1172%252FJCI80142%26sid%3Dliteratum%253Aachs%26aulast%3DLaird%26aufirst%3DG.%2BM.%26aulast%3DBullen%26aufirst%3DC.%2BK.%26aulast%3DRosenbloom%26aufirst%3DD.%2BI.%26aulast%3DMartin%26aufirst%3DA.%2BR.%26aulast%3DHill%26aufirst%3DA.%2BL.%26aulast%3DDurand%26aufirst%3DC.%2BM.%26aulast%3DSiliciano%26aufirst%3DJ.%2BD.%26aulast%3DSiliciano%26aufirst%3DR.%2BF.%26atitle%3DEx%2520vivo%2520analysis%2520identifies%2520effective%2520HIV-1%2520latency-reversing%2520drug%2520combinations%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2015%26volume%3D125%26spage%3D1901%26epage%3D1912%26doi%3D10.1172%2FJCI80142" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10a','cit10b'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref100':['cit100'],'ref17':['cit17a','cit17b'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref23':['cit23a','cit23b'],'ref24':['cit24a','cit24b'],'ref25':['cit25'],'ref26':['cit26a','cit26b'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 75 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Yu Jia Tan, Ming Li, Gregory Adrian Gunawan, Samuel Agyei Nyantakyi, Thomas Dick, Mei-Lin Go, <span class="NLM_string-name hlFld-ContribAuthor">Yulin Lam</span>. </span><span class="cited-content_cbyCitation_article-title">Amide–Amine Replacement in Indole-2-carboxamides Yields Potent Mycobactericidal Agents with Improved Water Solubility. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2021,</strong> <em>12 </em>
                                    (5)
                                     , 704-712. <a href="https://doi.org/10.1021/acsmedchemlett.0c00588" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.0c00588</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.0c00588&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.0c00588%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DAmide%2525E2%252580%252593Amine%252BReplacement%252Bin%252BIndole-2-carboxamides%252BYields%252BPotent%252BMycobactericidal%252BAgents%252Bwith%252BImproved%252BWater%252BSolubility%26aulast%3DTan%26aufirst%3DYu%2BJia%26date%3D2021%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D07112020%26date%3D11112020%26date%3D16112020%26volume%3D12%26issue%3D5%26spage%3D704%26epage%3D712" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Mary Jackson, Casey M. Stevens, Lei Zhang, Helen I. Zgurskaya, <span class="NLM_string-name hlFld-ContribAuthor">Michael Niederweis</span>. </span><span class="cited-content_cbyCitation_article-title">Transporters Involved in the Biogenesis and Functionalization of the Mycobacterial Cell Envelope. </span><span class="cited-content_cbyCitation_journal-name">Chemical Reviews</span><span> <strong>2021,</strong> <em>121 </em>
                                    (9)
                                     , 5124-5157. <a href="https://doi.org/10.1021/acs.chemrev.0c00869" title="DOI URL">https://doi.org/10.1021/acs.chemrev.0c00869</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.chemrev.0c00869&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.chemrev.0c00869%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Reviews%26atitle%3DTransporters%252BInvolved%252Bin%252Bthe%252BBiogenesis%252Band%252BFunctionalization%252Bof%252Bthe%252BMycobacterial%252BCell%252BEnvelope%26aulast%3DJackson%26aufirst%3DMary%26date%3D2021%26date%3D2020%26date%3D2020%26date%3D14082020%26date%3D10112020%26volume%3D121%26issue%3D9%26spage%3D5124%26epage%3D5157" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Philip A. Klenotic, Mitchell A. Moseng, Christopher E. Morgan, <span class="NLM_string-name hlFld-ContribAuthor">Edward W. Yu</span>. </span><span class="cited-content_cbyCitation_article-title">Structural and Functional Diversity of Resistance–Nodulation–Cell Division Transporters. </span><span class="cited-content_cbyCitation_journal-name">Chemical Reviews</span><span> <strong>2021,</strong> <em>121 </em>
                                    (9)
                                     , 5378-5416. <a href="https://doi.org/10.1021/acs.chemrev.0c00621" title="DOI URL">https://doi.org/10.1021/acs.chemrev.0c00621</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.chemrev.0c00621&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.chemrev.0c00621%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Reviews%26atitle%3DStructural%252Band%252BFunctional%252BDiversity%252Bof%252BResistance%2525E2%252580%252593Nodulation%2525E2%252580%252593Cell%252BDivision%252BTransporters%26aulast%3DKlenotic%26aufirst%3DPhilip%2BA.%26date%3D2021%26date%3D2020%26date%3D2020%26date%3D16062020%26date%3D19112020%26volume%3D121%26issue%3D9%26spage%3D5378%26epage%3D5416" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Yue Weng, Bo Ding, Yunqing Liu, Chunlan Song, Lo-Ying Chan, <span class="NLM_string-name hlFld-ContribAuthor">Chien-Wei Chiang</span>. </span><span class="cited-content_cbyCitation_article-title">Late-Stage Photoredox C–H Amidation of N-Unprotected Indole Derivatives: Access to N-(Indol-2-yl)amides. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2021,</strong> <em>23 </em>
                                    (7)
                                     , 2710-2714. <a href="https://doi.org/10.1021/acs.orglett.1c00609" title="DOI URL">https://doi.org/10.1021/acs.orglett.1c00609</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.1c00609&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.1c00609%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DLate-Stage%252BPhotoredox%252BC%2525E2%252580%252593H%252BAmidation%252Bof%252BN-Unprotected%252BIndole%252BDerivatives%25253A%252BAccess%252Bto%252BN-%252528Indol-2-yl%252529amides%26aulast%3DWeng%26aufirst%3DYue%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D19022021%26date%3D22032021%26volume%3D23%26issue%3D7%26spage%3D2710%26epage%3D2714" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Shipra Grover, Curtis A. Engelhart, Esther Pérez-Herrán, Wei Li, Katherine A. Abrahams, Kadamba Papavinasasundaram, James M. Bean, Christopher M. Sassetti, Alfonso Mendoza-Losana, Gurdyal S. Besra, Mary Jackson, <span class="NLM_string-name hlFld-ContribAuthor">Dirk Schnappinger</span>. </span><span class="cited-content_cbyCitation_article-title">Two-Way Regulation of MmpL3 Expression Identifies and Validates Inhibitors of MmpL3 Function in Mycobacterium tuberculosis. </span><span class="cited-content_cbyCitation_journal-name">ACS Infectious Diseases</span><span> <strong>2021,</strong> <em>7 </em>
                                    (1)
                                     , 141-152. <a href="https://doi.org/10.1021/acsinfecdis.0c00675" title="DOI URL">https://doi.org/10.1021/acsinfecdis.0c00675</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsinfecdis.0c00675&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsinfecdis.0c00675%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Infectious%2520Diseases%26atitle%3DTwo-Way%252BRegulation%252Bof%252BMmpL3%252BExpression%252BIdentifies%252Band%252BValidates%252BInhibitors%252Bof%252BMmpL3%252BFunction%252Bin%252BMycobacterium%252Btuberculosis%26aulast%3DGrover%26aufirst%3DShipra%26date%3D2021%26date%3D2020%26date%3D2020%26date%3D28092020%26date%3D15122020%26volume%3D7%26issue%3D1%26spage%3D141%26epage%3D152" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Vadim Makarov, Elena Salina, Robert C. Reynolds, Phyo Phyo Kyaw Zin, <span class="NLM_string-name hlFld-ContribAuthor">Sean Ekins</span>. </span><span class="cited-content_cbyCitation_article-title">Molecule Property Analyses of Active Compounds for Mycobacterium tuberculosis. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (17)
                                     , 8917-8955. <a href="https://doi.org/10.1021/acs.jmedchem.9b02075" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b02075</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b02075&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b02075%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DMolecule%252BProperty%252BAnalyses%252Bof%252BActive%252BCompounds%252Bfor%252BMycobacterium%252Btuberculosis%26aulast%3DMakarov%26aufirst%3DVadim%26date%3D2020%26date%3D2020%26date%3D2019%26date%3D13122019%26date%3D20042020%26date%3D07042020%26volume%3D63%26issue%3D17%26spage%3D8917%26epage%3D8955" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Wei Li, Casey M. Stevens, Amitkumar N. Pandya, Zbigniew Darzynkiewicz, Pankaj Bhattarai, Weiwei Tong, Mercedes Gonzalez-Juarrero, E. Jeffrey North, Helen I. Zgurskaya, <span class="NLM_string-name hlFld-ContribAuthor">Mary Jackson</span>. </span><span class="cited-content_cbyCitation_article-title">Direct Inhibition of MmpL3 by Novel Antitubercular Compounds. </span><span class="cited-content_cbyCitation_journal-name">ACS Infectious Diseases</span><span> <strong>2019,</strong> <em>5 </em>
                                    (6)
                                     , 1001-1012. <a href="https://doi.org/10.1021/acsinfecdis.9b00048" title="DOI URL">https://doi.org/10.1021/acsinfecdis.9b00048</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsinfecdis.9b00048&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsinfecdis.9b00048%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Infectious%2520Diseases%26atitle%3DDirect%252BInhibition%252Bof%252BMmpL3%252Bby%252BNovel%252BAntitubercular%252BCompounds%26aulast%3DLi%26aufirst%3DWei%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D05022019%26date%3D28032019%26date%3D18032019%26volume%3D5%26issue%3D6%26spage%3D1001%26epage%3D1012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Zhen Wang, Min Zhang, Jin Wang, <span class="NLM_string-name hlFld-ContribAuthor">Haitao Ji</span>. </span><span class="cited-content_cbyCitation_article-title">Optimization of Peptidomimetics as Selective Inhibitors for the β-Catenin/T-Cell Factor Protein–Protein Interaction. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (7)
                                     , 3617-3635. <a href="https://doi.org/10.1021/acs.jmedchem.9b00147" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b00147</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b00147&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b00147%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DOptimization%252Bof%252BPeptidomimetics%252Bas%252BSelective%252BInhibitors%252Bfor%252Bthe%252B%2525CE%2525B2-Catenin%25252FT-Cell%252BFactor%252BProtein%2525E2%252580%252593Protein%252BInteraction%26aulast%3DWang%26aufirst%3DZhen%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D24012019%26date%3D21032019%26date%3D11032019%26volume%3D62%26issue%3D7%26spage%3D3617%26epage%3D3635" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xianfeng  Li</span>, <span class="hlFld-ContribAuthor ">Vincent  Hernandez</span>, <span class="hlFld-ContribAuthor ">Fernando L.  Rock</span>, <span class="hlFld-ContribAuthor ">Wai  Choi</span>, <span class="hlFld-ContribAuthor ">Yvonne S. L.  Mak</span>, <span class="hlFld-ContribAuthor ">Manisha  Mohan</span>, <span class="hlFld-ContribAuthor ">Weimin  Mao</span>, <span class="hlFld-ContribAuthor ">Yasheen  Zhou</span>, <span class="hlFld-ContribAuthor ">Eric E.  Easom</span>, <span class="hlFld-ContribAuthor ">Jacob J.  Plattner</span>, <span class="hlFld-ContribAuthor ">Wuxin  Zou</span>, <span class="hlFld-ContribAuthor ">Esther  Pérez-Herrán</span>, <span class="hlFld-ContribAuthor ">Ilaria  Giordano</span>, <span class="hlFld-ContribAuthor ">Alfonso  Mendoza-Losana</span>, <span class="hlFld-ContribAuthor ">Carlos  Alemparte</span>, <span class="hlFld-ContribAuthor ">Joaquín  Rullas</span>, <span class="hlFld-ContribAuthor ">Iñigo  Angulo-Barturen</span>, <span class="hlFld-ContribAuthor ">Sabrinia  Crouch</span>, <span class="hlFld-ContribAuthor ">Fátima  Ortega</span>, <span class="hlFld-ContribAuthor ">David  Barros</span>, and <span class="hlFld-ContribAuthor ">M. R. K.  Alley</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of a Potent and Specific M. tuberculosis Leucyl-tRNA Synthetase Inhibitor: (S)-3-(Aminomethyl)-4-chloro-7-(2-hydroxyethoxy)benzo[c][1,2]oxaborol-1(3H)-ol (GSK656). </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (19)
                                     , 8011-8026. <a href="https://doi.org/10.1021/acs.jmedchem.7b00631" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b00631</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b00631&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b00631%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Ba%252BPotent%252Band%252BSpecific%252BM.%252Btuberculosis%252BLeucyl-tRNA%252BSynthetase%252BInhibitor%25253A%252B%252528S%252529-3-%252528Aminomethyl%252529-4-chloro-7-%2525282-hydroxyethoxy%252529benzo%25255Bc%25255D%25255B1%25252C2%25255Doxaborol-1%2525283H%252529-ol%252B%252528GSK656%252529%26aulast%3DLi%26aufirst%3DXianfeng%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D05052017%26date%3D27092017%26date%3D12102017%26volume%3D60%26issue%3D19%26spage%3D8011%26epage%3D8026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alan P.  Kozikowski</span>, <span class="hlFld-ContribAuthor ">Oluseye K.  Onajole</span>, <span class="hlFld-ContribAuthor ">Jozef  Stec</span>, <span class="hlFld-ContribAuthor ">Christian  Dupont</span>, <span class="hlFld-ContribAuthor ">Albertus  Viljoen</span>, <span class="hlFld-ContribAuthor ">Matthias  Richard</span>, <span class="hlFld-ContribAuthor ">Tridib  Chaira</span>, <span class="hlFld-ContribAuthor ">Shichun  Lun</span>, <span class="hlFld-ContribAuthor ">William  Bishai</span>, <span class="hlFld-ContribAuthor ">V. Samuel  Raj</span>, <span class="hlFld-ContribAuthor ">Diane  Ordway</span>, and <span class="hlFld-ContribAuthor ">Laurent  Kremer</span>  . </span><span class="cited-content_cbyCitation_article-title">Targeting Mycolic Acid Transport by Indole-2-carboxamides for the Treatment of Mycobacterium abscessus Infections. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (13)
                                     , 5876-5888. <a href="https://doi.org/10.1021/acs.jmedchem.7b00582" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b00582</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b00582&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b00582%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DTargeting%252BMycolic%252BAcid%252BTransport%252Bby%252BIndole-2-carboxamides%252Bfor%252Bthe%252BTreatment%252Bof%252BMycobacterium%252Babscessus%252BInfections%26aulast%3DKozikowski%26aufirst%3DAlan%2BP.%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D14042017%26date%3D15062017%26date%3D13072017%26date%3D02062017%26volume%3D60%26issue%3D13%26spage%3D5876%26epage%3D5888" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jiaul  Hoque</span>, <span class="hlFld-ContribAuthor ">Mohini M.  Konai</span>, <span class="hlFld-ContribAuthor ">Shanola S.  Sequeira</span>, <span class="hlFld-ContribAuthor ">Sandip  Samaddar</span>, and <span class="hlFld-ContribAuthor ">Jayanta  Haldar</span>  . </span><span class="cited-content_cbyCitation_article-title">Antibacterial and Antibiofilm Activity of Cationic Small Molecules with Spatial Positioning of Hydrophobicity: An in Vitro and in Vivo Evaluation. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>59 </em>
                                    (23)
                                     , 10750-10762. <a href="https://doi.org/10.1021/acs.jmedchem.6b01435" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b01435</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b01435&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b01435%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DAntibacterial%252Band%252BAntibiofilm%252BActivity%252Bof%252BCationic%252BSmall%252BMolecules%252Bwith%252BSpatial%252BPositioning%252Bof%252BHydrophobicity%25253A%252BAn%252Bin%252BVitro%252Band%252Bin%252BVivo%252BEvaluation%26aulast%3DHoque%26aufirst%3DJiaul%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D02102016%26date%3D16112016%26date%3D08122016%26date%3D04112016%26volume%3D59%26issue%3D23%26spage%3D10750%26epage%3D10762" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Anna  Egorova</span>, <span class="hlFld-ContribAuthor ">Mary  Jackson</span>, <span class="hlFld-ContribAuthor ">Victor  Gavrilyuk</span>, <span class="hlFld-ContribAuthor ">Vadim  Makarov</span>. </span><span class="cited-content_cbyCitation_article-title">Pipeline of anti‐
              Mycobacterium abscessus
              small molecules: Repurposable drugs and promising novel chemical entities. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Research Reviews</span><span> <strong>2021,</strong> <em>41 </em>
                                    (4)
                                     , 2350-2387. <a href="https://doi.org/10.1002/med.21798" title="DOI URL">https://doi.org/10.1002/med.21798</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/med.21798&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fmed.21798%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Research%2520Reviews%26atitle%3DPipeline%252Bof%252Banti%2525E2%252580%252590%252BMycobacterium%252Babscessus%252Bsmall%252Bmolecules%25253A%252BRepurposable%252Bdrugs%252Band%252Bpromising%252Bnovel%252Bchemical%252Bentities%26aulast%3DEgorova%26aufirst%3DAnna%26date%3D2021%26date%3D2021%26volume%3D41%26issue%3D4%26spage%3D2350%26epage%3D2387" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Oliver  Adams</span>, <span class="hlFld-ContribAuthor ">Justin C.  Deme</span>, <span class="hlFld-ContribAuthor ">Joanne L.  Parker</span>, <span class="hlFld-ContribAuthor ">Philip W.  Fowler</span>, <span class="hlFld-ContribAuthor ">Susan M.  Lea</span>, <span class="hlFld-ContribAuthor ">Simon  Newstead</span>. </span><span class="cited-content_cbyCitation_article-title">Cryo-EM structure and resistance landscape of M. tuberculosis MmpL3: An emergent therapeutic target. </span><span class="cited-content_cbyCitation_journal-name">Structure</span><span> <strong>2021,</strong> <em>44 </em><a href="https://doi.org/10.1016/j.str.2021.06.013" title="DOI URL">https://doi.org/10.1016/j.str.2021.06.013</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.str.2021.06.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.str.2021.06.013%26sid%3Dliteratum%253Aachs%26jtitle%3DStructure%26atitle%3DCryo-EM%252Bstructure%252Band%252Bresistance%252Blandscape%252Bof%252BM.%2525C2%2525A0tuberculosis%252BMmpL3%25253A%252BAn%252Bemergent%252Btherapeutic%252Btarget%26aulast%3DAdams%26aufirst%3DOliver%26date%3D2021%26volume%3D44" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shahinda S. R.  Alsayed</span>, <span class="hlFld-ContribAuthor ">Shichun  Lun</span>, <span class="hlFld-ContribAuthor ">Alan  Payne</span>, <span class="hlFld-ContribAuthor ">William R.  Bishai</span>, <span class="hlFld-ContribAuthor ">Hendra  Gunosewoyo</span>. </span><span class="cited-content_cbyCitation_article-title">Facile synthesis and antimycobacterial activity of isoniazid, pyrazinamide and ciprofloxacin derivatives. </span><span class="cited-content_cbyCitation_journal-name">Chemical Biology & Drug Design</span><span> <strong>2021,</strong> <em>97 </em>
                                    (6)
                                     , 1137-1150. <a href="https://doi.org/10.1111/cbdd.13836" title="DOI URL">https://doi.org/10.1111/cbdd.13836</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/cbdd.13836&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fcbdd.13836%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Biology%2520%2526%2520Drug%2520Design%26atitle%3DFacile%252Bsynthesis%252Band%252Bantimycobacterial%252Bactivity%252Bof%252Bisoniazid%25252C%252Bpyrazinamide%252Band%252Bciprofloxacin%252Bderivatives%26aulast%3DAlsayed%26aufirst%3DShahinda%2BS.%2BR.%26date%3D2021%26date%3D2021%26volume%3D97%26issue%3D6%26spage%3D1137%26epage%3D1150" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shahinda S. R.  Alsayed</span>, <span class="hlFld-ContribAuthor ">Shichun  Lun</span>, <span class="hlFld-ContribAuthor ">Anders W.  Bailey</span>, <span class="hlFld-ContribAuthor ">Amreena  Suri</span>, <span class="hlFld-ContribAuthor ">Chiang-Ching  Huang</span>, <span class="hlFld-ContribAuthor ">Mauro  Mocerino</span>, <span class="hlFld-ContribAuthor ">Alan  Payne</span>, <span class="hlFld-ContribAuthor ">Simone Treiger  Sredni</span>, <span class="hlFld-ContribAuthor ">William R.  Bishai</span>, <span class="hlFld-ContribAuthor ">Hendra  Gunosewoyo</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and evaluation of novel indole-2-carboxamides for growth inhibition of
              Mycobacterium tuberculosis
              and paediatric brain tumour cells. </span><span class="cited-content_cbyCitation_journal-name">RSC Advances</span><span> <strong>2021,</strong> <em>11 </em>
                                    (26)
                                     , 15497-15511. <a href="https://doi.org/10.1039/D0RA10728J" title="DOI URL">https://doi.org/10.1039/D0RA10728J</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0RA10728J&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0RA10728J%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Advances%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bevaluation%252Bof%252Bnovel%252Bindole-2-carboxamides%252Bfor%252Bgrowth%252Binhibition%252Bof%252BMycobacterium%252Btuberculosis%252Band%252Bpaediatric%252Bbrain%252Btumour%252Bcells%26aulast%3DAlsayed%26aufirst%3DShahinda%2BS.%2BR.%26date%3D2021%26date%3D2021%26volume%3D11%26issue%3D26%26spage%3D15497%26epage%3D15511" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sangmi  Oh</span>, <span class="hlFld-ContribAuthor ">Lena  Trifonov</span>, <span class="hlFld-ContribAuthor ">Veena D.  Yadav</span>, <span class="hlFld-ContribAuthor ">Clifton E.  Barry</span>, <span class="hlFld-ContribAuthor ">Helena I.  Boshoff</span>. </span><span class="cited-content_cbyCitation_article-title">Tuberculosis Drug Discovery: A Decade of Hit Assessment for Defined Targets. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Cellular and Infection Microbiology</span><span> <strong>2021,</strong> <em>11 </em><a href="https://doi.org/10.3389/fcimb.2021.611304" title="DOI URL">https://doi.org/10.3389/fcimb.2021.611304</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fcimb.2021.611304&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffcimb.2021.611304%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Cellular%2520and%2520Infection%2520Microbiology%26atitle%3DTuberculosis%252BDrug%252BDiscovery%25253A%252BA%252BDecade%252Bof%252BHit%252BAssessment%252Bfor%252BDefined%252BTargets%26aulast%3DOh%26aufirst%3DSangmi%26date%3D2021%26date%3D2021%26volume%3D11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dorababu  Atukuri</span>, <span class="hlFld-ContribAuthor ">Rutu  Gunjal</span>, <span class="hlFld-ContribAuthor ">Nagaraj  Holagundi</span>, <span class="hlFld-ContribAuthor ">Bibiashabi  Korlahalli</span>, <span class="hlFld-ContribAuthor ">Sanjeevini  Gangannavar</span>, <span class="hlFld-ContribAuthor ">Kirankumar  Akkasali</span>. </span><span class="cited-content_cbyCitation_article-title">Contribution of
              
                N
                ‐heterocycles
              
              towards anti‐tubercular drug discovery (2014–2019); predicted and reengineered molecular frameworks. </span><span class="cited-content_cbyCitation_journal-name">Drug Development Research</span><span> <strong>2021,</strong> <em>24 </em><a href="https://doi.org/10.1002/ddr.21809" title="DOI URL">https://doi.org/10.1002/ddr.21809</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ddr.21809&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fddr.21809%26sid%3Dliteratum%253Aachs%26jtitle%3DDrug%2520Development%2520Research%26atitle%3DContribution%252Bof%252BN%252B%2525E2%252580%252590heterocycles%252Btowards%252Banti%2525E2%252580%252590tubercular%252Bdrug%252Bdiscovery%252B%2525282014%2525E2%252580%2525932019%252529%25253B%252Bpredicted%252Band%252Breengineered%252Bmolecular%252Bframeworks%26aulast%3DAtukuri%26aufirst%3DDorababu%26date%3D2021%26date%3D2021%26volume%3D24" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nikhil Baliram  Gaikwad</span>, <span class="hlFld-ContribAuthor ">Pathan  Afroz</span>, <span class="hlFld-ContribAuthor ">Mohammad Naiyaz  Ahmad</span>, <span class="hlFld-ContribAuthor ">Grace  Kaul</span>, <span class="hlFld-ContribAuthor ">Manjulika  Shukla</span>, <span class="hlFld-ContribAuthor ">Srinivas  Nanduri</span>, <span class="hlFld-ContribAuthor ">Arunava  Dasgupta</span>, <span class="hlFld-ContribAuthor ">Sidharth  Chopra</span>, <span class="hlFld-ContribAuthor ">Venkata Madhavi  Yaddanapudi</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis, in vitro and in silico evaluation of new 3-phenyl-4,5-dihydroisoxazole-5-carboxamides active against drug-resistant mycobacterium tuberculosis. </span><span class="cited-content_cbyCitation_journal-name">Journal of Molecular Structure</span><span> <strong>2021,</strong> <em>1227 </em>, 129545. <a href="https://doi.org/10.1016/j.molstruc.2020.129545" title="DOI URL">https://doi.org/10.1016/j.molstruc.2020.129545</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.molstruc.2020.129545&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.molstruc.2020.129545%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Molecular%2520Structure%26atitle%3DDesign%25252C%252Bsynthesis%25252C%252Bin%252Bvitro%252Band%252Bin%252Bsilico%252Bevaluation%252Bof%252Bnew%252B3-phenyl-4%25252C5-dihydroisoxazole-5-carboxamides%252Bactive%252Bagainst%252Bdrug-resistant%252Bmycobacterium%252Btuberculosis%26aulast%3DGaikwad%26aufirst%3DNikhil%2BBaliram%26date%3D2021%26volume%3D1227%26spage%3D129545" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Gholamabbas  Chehardoli</span>, <span class="hlFld-ContribAuthor ">Asrin  Bahmani</span>. </span><span class="cited-content_cbyCitation_article-title">Synthetic strategies, SAR studies, and computer modeling of indole 2 and 3-carboxamides as the strong enzyme inhibitors: a review. </span><span class="cited-content_cbyCitation_journal-name">Molecular Diversity</span><span> <strong>2021,</strong> <em>25 </em>
                                    (1)
                                     , 535-550. <a href="https://doi.org/10.1007/s11030-020-10061-x" title="DOI URL">https://doi.org/10.1007/s11030-020-10061-x</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11030-020-10061-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11030-020-10061-x%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Diversity%26atitle%3DSynthetic%252Bstrategies%25252C%252BSAR%252Bstudies%25252C%252Band%252Bcomputer%252Bmodeling%252Bof%252Bindole%252B2%252Band%252B3-carboxamides%252Bas%252Bthe%252Bstrong%252Benzyme%252Binhibitors%25253A%252Ba%252Breview%26aulast%3DChehardoli%26aufirst%3DGholamabbas%26date%3D2021%26date%3D2020%26volume%3D25%26issue%3D1%26spage%3D535%26epage%3D550" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shahinda S.R.  Alsayed</span>, <span class="hlFld-ContribAuthor ">Shichun  Lun</span>, <span class="hlFld-ContribAuthor ">Alan  Payne</span>, <span class="hlFld-ContribAuthor ">William R.  Bishai</span>, <span class="hlFld-ContribAuthor ">Hendra  Gunosewoyo</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and antimycobacterial evaluation of novel adamantane and adamantanol analogues effective against drug-resistant tuberculosis. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2021,</strong> <em>106 </em>, 104486. <a href="https://doi.org/10.1016/j.bioorg.2020.104486" title="DOI URL">https://doi.org/10.1016/j.bioorg.2020.104486</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2020.104486&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2020.104486%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bantimycobacterial%252Bevaluation%252Bof%252Bnovel%252Badamantane%252Band%252Badamantanol%252Banalogues%252Beffective%252Bagainst%252Bdrug-resistant%252Btuberculosis%26aulast%3DAlsayed%26aufirst%3DShahinda%2BS.R.%26date%3D2021%26volume%3D106%26spage%3D104486" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nikhil B.  Gaikwad</span>, <span class="hlFld-ContribAuthor ">Krishna  Nirmale</span>, <span class="hlFld-ContribAuthor ">Santosh K.  Sahoo</span>, <span class="hlFld-ContribAuthor ">Mohammad N.  Ahmad</span>, <span class="hlFld-ContribAuthor ">Grace  Kaul</span>, <span class="hlFld-ContribAuthor ">Manjulika  Shukla</span>, <span class="hlFld-ContribAuthor ">Srinivas  Nanduri</span>, <span class="hlFld-ContribAuthor ">Arunava  Das Gupta</span>, <span class="hlFld-ContribAuthor ">Sidharth  Chopra</span>, <span class="hlFld-ContribAuthor ">Madhavi V.  Yaddanapudi</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis, in silico, and in vitro evaluation of 3‐phenylpyrazole acetamide derivatives as antimycobacterial agents. </span><span class="cited-content_cbyCitation_journal-name">Archiv der Pharmazie</span><span> <strong>2020,</strong> <em>69 </em><a href="https://doi.org/10.1002/ardp.202000349" title="DOI URL">https://doi.org/10.1002/ardp.202000349</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ardp.202000349&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fardp.202000349%26sid%3Dliteratum%253Aachs%26jtitle%3DArchiv%2520der%2520Pharmazie%26atitle%3DDesign%25252C%252Bsynthesis%25252C%252Bin%252Bsilico%25252C%252Band%252Bin%252Bvitro%252Bevaluation%252Bof%252B3%2525E2%252580%252590phenylpyrazole%252Bacetamide%252Bderivatives%252Bas%252Bantimycobacterial%252Bagents%26aulast%3DGaikwad%26aufirst%3DNikhil%2BB.%26date%3D2020%26date%3D2020%26volume%3D69" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sumit  Kumar</span>, <span class="hlFld-ContribAuthor ">Anu  Saini</span>, <span class="hlFld-ContribAuthor ">Jenny  Legac</span>, <span class="hlFld-ContribAuthor ">Philip J.  Rosenthal</span>, <span class="hlFld-ContribAuthor ">Raghu  Raj</span>, <span class="hlFld-ContribAuthor ">Vipan  Kumar</span>. </span><span class="cited-content_cbyCitation_article-title">Amalgamating Isatin/Indole/Nitroimidazole with 7‐chloroquinolines
              via
              azide‐alkyne cycloaddition: Synthesis, anti‐plasmodial, and cytotoxic evaluation. </span><span class="cited-content_cbyCitation_journal-name">Chemical Biology & Drug Design</span><span> <strong>2020,</strong> <em>96 </em>
                                    (6)
                                     , 1355-1361. <a href="https://doi.org/10.1111/cbdd.13738" title="DOI URL">https://doi.org/10.1111/cbdd.13738</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/cbdd.13738&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fcbdd.13738%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Biology%2520%2526%2520Drug%2520Design%26atitle%3DAmalgamating%252BIsatin%25252FIndole%25252FNitroimidazole%252Bwith%252B7%2525E2%252580%252590chloroquinolines%252Bvia%252Bazide%2525E2%252580%252590alkyne%252Bcycloaddition%25253A%252BSynthesis%25252C%252Banti%2525E2%252580%252590plasmodial%25252C%252Band%252Bcytotoxic%252Bevaluation%26aulast%3DKumar%26aufirst%3DSumit%26date%3D2020%26date%3D2020%26volume%3D96%26issue%3D6%26spage%3D1355%26epage%3D1361" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Oluseye K.  Onajole</span>, <span class="hlFld-ContribAuthor ">Shichun  Lun</span>, <span class="hlFld-ContribAuthor ">Young Ju  Yun</span>, <span class="hlFld-ContribAuthor ">Damkam Y.  Langue</span>, <span class="hlFld-ContribAuthor ">Michelle  Jaskula‐Dybka</span>, <span class="hlFld-ContribAuthor ">Adrian  Flores</span>, <span class="hlFld-ContribAuthor ">Eriel  Frazier</span>, <span class="hlFld-ContribAuthor ">Ashle C.  Scurry</span>, <span class="hlFld-ContribAuthor ">Ambernice  Zavala</span>, <span class="hlFld-ContribAuthor ">Karen R.  Arreola</span>, <span class="hlFld-ContribAuthor ">Bryce  Pierzchalski</span>, <span class="hlFld-ContribAuthor ">A. Jean‐Luc  Ayitou</span>, <span class="hlFld-ContribAuthor ">William R.  Bishai</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis, and biological evaluation of novel imidazo[
              1,2‐a
              ]pyridinecarboxamides as potent anti‐tuberculosis agents. </span><span class="cited-content_cbyCitation_journal-name">Chemical Biology & Drug Design</span><span> <strong>2020,</strong> <em>96 </em>
                                    (6)
                                     , 1362-1371. <a href="https://doi.org/10.1111/cbdd.13739" title="DOI URL">https://doi.org/10.1111/cbdd.13739</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/cbdd.13739&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fcbdd.13739%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Biology%2520%2526%2520Drug%2520Design%26atitle%3DDesign%25252C%252Bsynthesis%25252C%252Band%252Bbiological%252Bevaluation%252Bof%252Bnovel%252Bimidazo%25255B%252B1%25252C2%2525E2%252580%252590a%252B%25255Dpyridinecarboxamides%252Bas%252Bpotent%252Banti%2525E2%252580%252590tuberculosis%252Bagents%26aulast%3DOnajole%26aufirst%3DOluseye%2BK.%26date%3D2020%26date%3D2020%26volume%3D96%26issue%3D6%26spage%3D1362%26epage%3D1371" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jue‐Ying  Li</span>, <span class="hlFld-ContribAuthor ">Xiao‐Feng  Sun</span>, <span class="hlFld-ContribAuthor ">Jing‐Jing  Li</span>, <span class="hlFld-ContribAuthor ">Fen  Yu</span>, <span class="hlFld-ContribAuthor ">Yi  Zhang</span>, <span class="hlFld-ContribAuthor ">Xiu‐Juan  Huang</span>, <span class="hlFld-ContribAuthor ">Feng‐Xia  Jiang</span>. </span><span class="cited-content_cbyCitation_article-title">The antimalarial activity of indole alkaloids and hybrids. </span><span class="cited-content_cbyCitation_journal-name">Archiv der Pharmazie</span><span> <strong>2020,</strong> <em>353 </em>
                                    (11)
                                     , 2000131. <a href="https://doi.org/10.1002/ardp.202000131" title="DOI URL">https://doi.org/10.1002/ardp.202000131</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ardp.202000131&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fardp.202000131%26sid%3Dliteratum%253Aachs%26jtitle%3DArchiv%2520der%2520Pharmazie%26atitle%3DThe%252Bantimalarial%252Bactivity%252Bof%252Bindole%252Balkaloids%252Band%252Bhybrids%26aulast%3DLi%26aufirst%3DJue%25E2%2580%2590Ying%26date%3D2020%26date%3D2020%26volume%3D353%26issue%3D11%26spage%3D2000131" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Matthew B.  McNeil</span>, <span class="hlFld-ContribAuthor ">Theresa  O’Malley</span>, <span class="hlFld-ContribAuthor ">Devon  Dennison</span>, <span class="hlFld-ContribAuthor ">Catherine D.  Shelton</span>, <span class="hlFld-ContribAuthor ">Bjorn  Sunde</span>, <span class="hlFld-ContribAuthor ">Tanya  Parish</span>, . </span><span class="cited-content_cbyCitation_article-title">Multiple Mutations in Mycobacterium tuberculosis MmpL3 Increase Resistance to MmpL3 Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">mSphere</span><span> <strong>2020,</strong> <em>5 </em>
                                    (5)
                                     <a href="https://doi.org/10.1128/mSphere.00985-20" title="DOI URL">https://doi.org/10.1128/mSphere.00985-20</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1128/mSphere.00985-20&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1128%2FmSphere.00985-20%26sid%3Dliteratum%253Aachs%26jtitle%3DmSphere%26atitle%3DMultiple%252BMutations%252Bin%252BMycobacterium%252Btuberculosis%252BMmpL3%252BIncrease%252BResistance%252Bto%252BMmpL3%252BInhibitors%26aulast%3DMcNeil%26aufirst%3DMatthew%2BB.%26date%3D2020%26volume%3D5%26issue%3D5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jigar P.  Sethiya</span>, <span class="hlFld-ContribAuthor ">Melanie A.  Sowards</span>, <span class="hlFld-ContribAuthor ">Mary  Jackson</span>, <span class="hlFld-ContribAuthor ">Elton Jeffrey  North</span>. </span><span class="cited-content_cbyCitation_article-title">MmpL3 Inhibition: A New Approach to Treat Nontuberculous Mycobacterial Infections. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Molecular Sciences</span><span> <strong>2020,</strong> <em>21 </em>
                                    (17)
                                     , 6202. <a href="https://doi.org/10.3390/ijms21176202" title="DOI URL">https://doi.org/10.3390/ijms21176202</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ijms21176202&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fijms21176202%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Molecular%2520Sciences%26atitle%3DMmpL3%252BInhibition%25253A%252BA%252BNew%252BApproach%252Bto%252BTreat%252BNontuberculous%252BMycobacterial%252BInfections%26aulast%3DSethiya%26aufirst%3DJigar%2BP.%26date%3D2020%26date%3D2020%26volume%3D21%26issue%3D17%26spage%3D6202" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Min  Shao</span>, <span class="hlFld-ContribAuthor ">Matthew  McNeil</span>, <span class="hlFld-ContribAuthor ">Gregory M.  Cook</span>, <span class="hlFld-ContribAuthor ">Xiaoyun  Lu</span>. </span><span class="cited-content_cbyCitation_article-title">MmpL3 inhibitors as antituberculosis drugs. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>200 </em>, 112390. <a href="https://doi.org/10.1016/j.ejmech.2020.112390" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112390</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112390&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112390%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DMmpL3%252Binhibitors%252Bas%252Bantituberculosis%252Bdrugs%26aulast%3DShao%26aufirst%3DMin%26date%3D2020%26volume%3D200%26spage%3D112390" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiaolin  Yang</span>, <span class="hlFld-ContribAuthor ">Tianyu  Hu</span>, <span class="hlFld-ContribAuthor ">Xiuna  Yang</span>, <span class="hlFld-ContribAuthor ">Wenqing  Xu</span>, <span class="hlFld-ContribAuthor ">Haitao  Yang</span>, <span class="hlFld-ContribAuthor ">Luke W.  Guddat</span>, <span class="hlFld-ContribAuthor ">Bing  Zhang</span>, <span class="hlFld-ContribAuthor ">Zihe  Rao</span>. </span><span class="cited-content_cbyCitation_article-title">Structural Basis for the Inhibition of Mycobacterial MmpL3 by NITD-349 and SPIRO. </span><span class="cited-content_cbyCitation_journal-name">Journal of Molecular Biology</span><span> <strong>2020,</strong> <em>432 </em>
                                    (16)
                                     , 4426-4434. <a href="https://doi.org/10.1016/j.jmb.2020.05.019" title="DOI URL">https://doi.org/10.1016/j.jmb.2020.05.019</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jmb.2020.05.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jmb.2020.05.019%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Molecular%2520Biology%26atitle%3DStructural%252BBasis%252Bfor%252Bthe%252BInhibition%252Bof%252BMycobacterial%252BMmpL3%252Bby%252BNITD-349%252Band%252BSPIRO%26aulast%3DYang%26aufirst%3DXiaolin%26date%3D2020%26volume%3D432%26issue%3D16%26spage%3D4426%26epage%3D4434" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Harun  Patel</span>, <span class="hlFld-ContribAuthor ">Iqrar  Ahmad</span>, <span class="hlFld-ContribAuthor ">Harsha  Jadhav</span>, <span class="hlFld-ContribAuthor ">Rahul  Pawara</span>, <span class="hlFld-ContribAuthor ">Anand  Mundada</span>, <span class="hlFld-ContribAuthor ">Matin  Shaikh</span>, <span class="hlFld-ContribAuthor ">Sanjay  Surana</span>. </span><span class="cited-content_cbyCitation_article-title">Extensively Drug-resistant Tuberculosis (XDR-TB)-inhibitors to Overcome the Scourge of Drug-resistant Tuberculosis: a Perspective. </span><span class="cited-content_cbyCitation_journal-name">Reviews and Advances in Chemistry</span><span> <strong>2020,</strong> <em>10 </em>
                                    (3-4)
                                     , 112-139. <a href="https://doi.org/10.1134/S2079978020030048" title="DOI URL">https://doi.org/10.1134/S2079978020030048</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1134/S2079978020030048&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1134%2FS2079978020030048%26sid%3Dliteratum%253Aachs%26jtitle%3DReviews%2520and%2520Advances%2520in%2520Chemistry%26atitle%3DExtensively%252BDrug-resistant%252BTuberculosis%252B%252528XDR-TB%252529-inhibitors%252Bto%252BOvercome%252Bthe%252BScourge%252Bof%252BDrug-resistant%252BTuberculosis%25253A%252Ba%252BPerspective%26aulast%3DPatel%26aufirst%3DHarun%26date%3D2020%26date%3D2021%26volume%3D10%26issue%3D3-4%26spage%3D112%26epage%3D139" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Gauri S.  Shetye</span>, <span class="hlFld-ContribAuthor ">Scott G.  Franzblau</span>, <span class="hlFld-ContribAuthor ">Sanghyun  Cho</span>. </span><span class="cited-content_cbyCitation_article-title">New tuberculosis drug targets, their inhibitors, and potential therapeutic impact. </span><span class="cited-content_cbyCitation_journal-name">Translational Research</span><span> <strong>2020,</strong> <em>220 </em>, 68-97. <a href="https://doi.org/10.1016/j.trsl.2020.03.007" title="DOI URL">https://doi.org/10.1016/j.trsl.2020.03.007</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.trsl.2020.03.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.trsl.2020.03.007%26sid%3Dliteratum%253Aachs%26jtitle%3DTranslational%2520Research%26atitle%3DNew%252Btuberculosis%252Bdrug%252Btargets%25252C%252Btheir%252Binhibitors%25252C%252Band%252Bpotential%252Btherapeutic%252Bimpact%26aulast%3DShetye%26aufirst%3DGauri%2BS.%26date%3D2020%26volume%3D220%26spage%3D68%26epage%3D97" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ruoqiong  Cao</span>, <span class="hlFld-ContribAuthor ">Hicret  Islamoglu</span>, <span class="hlFld-ContribAuthor ">Garrett  Teskey</span>, <span class="hlFld-ContribAuthor ">Karo  Gyurjian</span>, <span class="hlFld-ContribAuthor ">Rachel  Abrahem</span>, <span class="hlFld-ContribAuthor ">Oluseye K.  Onajole</span>, <span class="hlFld-ContribAuthor ">Shichun  Lun</span>, <span class="hlFld-ContribAuthor ">William  Bishai</span>, <span class="hlFld-ContribAuthor ">Alan P.  Kozikowski</span>, <span class="hlFld-ContribAuthor ">Marcel P.  Fraix</span>, <span class="hlFld-ContribAuthor ">Airani  Sathananthan</span>, <span class="hlFld-ContribAuthor ">Li  Zhong</span>, <span class="hlFld-ContribAuthor ">Jozef  Stec</span>, <span class="hlFld-ContribAuthor ">Vishwanath  Venketaraman</span>. </span><span class="cited-content_cbyCitation_article-title">The preclinical candidate indole-2-carboxamide improves immune responses to Mycobacterium tuberculosis infection in healthy subjects and individuals with type 2 diabetes. </span><span class="cited-content_cbyCitation_journal-name">International Microbiology</span><span> <strong>2020,</strong> <em>23 </em>
                                    (2)
                                     , 161-170. <a href="https://doi.org/10.1007/s10123-019-00086-0" title="DOI URL">https://doi.org/10.1007/s10123-019-00086-0</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s10123-019-00086-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs10123-019-00086-0%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Microbiology%26atitle%3DThe%252Bpreclinical%252Bcandidate%252Bindole-2-carboxamide%252Bimproves%252Bimmune%252Bresponses%252Bto%252BMycobacterium%252Btuberculosis%252Binfection%252Bin%252Bhealthy%252Bsubjects%252Band%252Bindividuals%252Bwith%252Btype%252B2%252Bdiabetes%26aulast%3DCao%26aufirst%3DRuoqiong%26date%3D2020%26date%3D2019%26volume%3D23%26issue%3D2%26spage%3D161%26epage%3D170" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lyudmila A.  Sviridova</span>, <span class="hlFld-ContribAuthor ">Polina S.  Protopopova</span>, <span class="hlFld-ContribAuthor ">Mikhail G.  Akimov</span>, <span class="hlFld-ContribAuthor ">Maria S.  Dudina</span>, <span class="hlFld-ContribAuthor ">Elizaveta K.  Melnikova</span>, <span class="hlFld-ContribAuthor ">Konstantin A.  Kochetkov</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of new physiologically active (2-oxoimidazolidin-5-yl)indoles. </span><span class="cited-content_cbyCitation_journal-name">Mendeleev Communications</span><span> <strong>2020,</strong> <em>30 </em>
                                    (3)
                                     , 347-349. <a href="https://doi.org/10.1016/j.mencom.2020.05.029" title="DOI URL">https://doi.org/10.1016/j.mencom.2020.05.029</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.mencom.2020.05.029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.mencom.2020.05.029%26sid%3Dliteratum%253Aachs%26jtitle%3DMendeleev%2520Communications%26atitle%3DSynthesis%252Bof%252Bnew%252Bphysiologically%252Bactive%252B%2525282-oxoimidazolidin-5-yl%252529indoles%26aulast%3DSviridova%26aufirst%3DLyudmila%2BA.%26date%3D2020%26volume%3D30%26issue%3D3%26spage%3D347%26epage%3D349" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Clément  Raynaud</span>, <span class="hlFld-ContribAuthor ">Wassim  Daher</span>, <span class="hlFld-ContribAuthor ">Françoise  Roquet-Banères</span>, <span class="hlFld-ContribAuthor ">Matt D.  Johansen</span>, <span class="hlFld-ContribAuthor ">Jozef  Stec</span>, <span class="hlFld-ContribAuthor ">Oluseye K.  Onajole</span>, <span class="hlFld-ContribAuthor ">Diane  Ordway</span>, <span class="hlFld-ContribAuthor ">Alan P.  Kozikowski</span>, <span class="hlFld-ContribAuthor ">Laurent  Kremer</span>. </span><span class="cited-content_cbyCitation_article-title">Synergistic Interactions of Indole-2-Carboxamides and β-Lactam Antibiotics against Mycobacterium abscessus. </span><span class="cited-content_cbyCitation_journal-name">Antimicrobial Agents and Chemotherapy</span><span> <strong>2020,</strong> <em>64 </em>
                                    (5)
                                     <a href="https://doi.org/10.1128/AAC.02548-19" title="DOI URL">https://doi.org/10.1128/AAC.02548-19</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1128/AAC.02548-19&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1128%2FAAC.02548-19%26sid%3Dliteratum%253Aachs%26jtitle%3DAntimicrobial%2520Agents%2520and%2520Chemotherapy%26atitle%3DSynergistic%252BInteractions%252Bof%252BIndole-2-Carboxamides%252Band%252B%2525CE%2525B2-Lactam%252BAntibiotics%252Bagainst%252BMycobacterium%252Babscessus%26aulast%3DRaynaud%26aufirst%3DCl%25C3%25A9ment%26date%3D2020%26volume%3D64%26issue%3D5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bahareh  Sadeghi</span>, <span class="hlFld-ContribAuthor ">Seyed Anis  Mousavi</span>. </span><span class="cited-content_cbyCitation_article-title">Preparation and Characterization of Nano-coc-OSO
              3
              H as a Novel Nanocatalyst for the One-Pot Synthesis of Spirooxindoles. </span><span class="cited-content_cbyCitation_journal-name">Polycyclic Aromatic Compounds</span><span> <strong>2020,</strong> <em>8 </em>, 1-13. <a href="https://doi.org/10.1080/10406638.2020.1737828" title="DOI URL">https://doi.org/10.1080/10406638.2020.1737828</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/10406638.2020.1737828&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F10406638.2020.1737828%26sid%3Dliteratum%253Aachs%26jtitle%3DPolycyclic%2520Aromatic%2520Compounds%26atitle%3DPreparation%252Band%252BCharacterization%252Bof%252BNano-coc-OSO%252B3%252BH%252Bas%252Ba%252BNovel%252BNanocatalyst%252Bfor%252Bthe%252BOne-Pot%252BSynthesis%252Bof%252BSpirooxindoles%26aulast%3DSadeghi%26aufirst%3DBahareh%26date%3D2020%26date%3D2020%26volume%3D8%26spage%3D1%26epage%3D13" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhen  Zhang</span>, <span class="hlFld-ContribAuthor ">Ying‐Lin  Gu</span>, <span class="hlFld-ContribAuthor ">Zheng‐Yang  Wang</span>, <span class="hlFld-ContribAuthor ">Huan‐Nan  Wang</span>, <span class="hlFld-ContribAuthor ">Yan  Zhao</span>, <span class="hlFld-ContribAuthor ">Xue‐Mei  Chu</span>, <span class="hlFld-ContribAuthor ">Chun‐Yan  Zhang</span>, <span class="hlFld-ContribAuthor ">Mao‐Cai  Yan</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and biological evaluation of novel indoleamide derivatives as antioxidative and antitumor agents. </span><span class="cited-content_cbyCitation_journal-name">Journal of Heterocyclic Chemistry</span><span> <strong>2020,</strong> <em>57 </em>
                                    (3)
                                     , 1165-1172. <a href="https://doi.org/10.1002/jhet.3853" title="DOI URL">https://doi.org/10.1002/jhet.3853</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/jhet.3853&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fjhet.3853%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Heterocyclic%2520Chemistry%26atitle%3DSynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Bnovel%252Bindoleamide%252Bderivatives%252Bas%252Bantioxidative%252Band%252Bantitumor%252Bagents%26aulast%3DZhang%26aufirst%3DZhen%26date%3D2020%26date%3D2020%26volume%3D57%26issue%3D3%26spage%3D1165%26epage%3D1172" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shahinda S. R.  Alsayed</span>, <span class="hlFld-ContribAuthor ">Shichun  Lun</span>, <span class="hlFld-ContribAuthor ">Giuseppe  Luna</span>, <span class="hlFld-ContribAuthor ">Chau Chun  Beh</span>, <span class="hlFld-ContribAuthor ">Alan D.  Payne</span>, <span class="hlFld-ContribAuthor ">Neil  Foster</span>, <span class="hlFld-ContribAuthor ">William R.  Bishai</span>, <span class="hlFld-ContribAuthor ">Hendra  Gunosewoyo</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis, and biological evaluation of novel arylcarboxamide derivatives as anti-tubercular agents. </span><span class="cited-content_cbyCitation_journal-name">RSC Advances</span><span> <strong>2020,</strong> <em>10 </em>
                                    (13)
                                     , 7523-7540. <a href="https://doi.org/10.1039/C9RA10663D" title="DOI URL">https://doi.org/10.1039/C9RA10663D</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C9RA10663D&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC9RA10663D%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Advances%26atitle%3DDesign%25252C%252Bsynthesis%25252C%252Band%252Bbiological%252Bevaluation%252Bof%252Bnovel%252Barylcarboxamide%252Bderivatives%252Bas%252Banti-tubercular%252Bagents%26aulast%3DAlsayed%26aufirst%3DShahinda%2BS.%2BR.%26date%3D2020%26date%3D2020%26volume%3D10%26issue%3D13%26spage%3D7523%26epage%3D7540" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Srikanth  Gatadi</span>, <span class="hlFld-ContribAuthor ">Srinivas  Nanduri</span>. </span><span class="cited-content_cbyCitation_article-title">New potential drug leads against MDR-MTB: A short review. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2020,</strong> <em>95 </em>, 103534. <a href="https://doi.org/10.1016/j.bioorg.2019.103534" title="DOI URL">https://doi.org/10.1016/j.bioorg.2019.103534</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2019.103534&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2019.103534%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DNew%252Bpotential%252Bdrug%252Bleads%252Bagainst%252BMDR-MTB%25253A%252BA%252Bshort%252Breview%26aulast%3DGatadi%26aufirst%3DSrikanth%26date%3D2020%26volume%3D95%26spage%3D103534" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nader G.  Khaligh</span>, <span class="hlFld-ContribAuthor ">Hanna  Abbo</span>, <span class="hlFld-ContribAuthor ">Salam J.J.  Titinchi</span>, <span class="hlFld-ContribAuthor ">Mohd R.  Johan</span>. </span><span class="cited-content_cbyCitation_article-title">An Overview of Recent Advances in Biological and Pharmaceutical Developments of Fluoro-containing Drugs. </span><span class="cited-content_cbyCitation_journal-name">Current Organic Chemistry</span><span> <strong>2020,</strong> <em>23 </em>
                                    (26)
                                     , 2916-2944. <a href="https://doi.org/10.2174/1385272824666191213123930" title="DOI URL">https://doi.org/10.2174/1385272824666191213123930</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/1385272824666191213123930&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F1385272824666191213123930%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Organic%2520Chemistry%26atitle%3DAn%252BOverview%252Bof%252BRecent%252BAdvances%252Bin%252BBiological%252Band%252BPharmaceutical%252BDevelopments%252Bof%252BFluoro-containing%252BDrugs%26aulast%3DKhaligh%26aufirst%3DNader%2BG.%26date%3D2020%26volume%3D23%26issue%3D26%26spage%3D2916%26epage%3D2944" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Punniyakoti Veeraveedu  Thanikachalam</span>, <span class="hlFld-ContribAuthor ">Rahul Kumar  Maurya</span>, <span class="hlFld-ContribAuthor ">Vishali  Garg</span>, <span class="hlFld-ContribAuthor ">Vikramdeep  Monga</span>. </span><span class="cited-content_cbyCitation_article-title">An insight into the medicinal perspective of synthetic analogs of indole: A review. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>180 </em>, 562-612. <a href="https://doi.org/10.1016/j.ejmech.2019.07.019" title="DOI URL">https://doi.org/10.1016/j.ejmech.2019.07.019</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2019.07.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2019.07.019%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DAn%252Binsight%252Binto%252Bthe%252Bmedicinal%252Bperspective%252Bof%252Bsynthetic%252Banalogs%252Bof%252Bindole%25253A%252BA%252Breview%26aulast%3DThanikachalam%26aufirst%3DPunniyakoti%2BVeeraveedu%26date%3D2019%26volume%3D180%26spage%3D562%26epage%3D612" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Gökçe  Cihan-Üstündağ</span>, <span class="hlFld-ContribAuthor ">Lieve  Naesens</span>, <span class="hlFld-ContribAuthor ">Dilek  Şatana</span>, <span class="hlFld-ContribAuthor ">Gonca  Erköse-Genç</span>, <span class="hlFld-ContribAuthor ">Emel  Mataracı-Kara</span>, <span class="hlFld-ContribAuthor ">Gültaze  Çapan</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis, antitubercular and antiviral properties of new spirocyclic indole derivatives. </span><span class="cited-content_cbyCitation_journal-name">Monatshefte für Chemie - Chemical Monthly</span><span> <strong>2019,</strong> <em>150 </em>
                                    (8)
                                     , 1533-1544. <a href="https://doi.org/10.1007/s00706-019-02457-9" title="DOI URL">https://doi.org/10.1007/s00706-019-02457-9</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00706-019-02457-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00706-019-02457-9%26sid%3Dliteratum%253Aachs%26jtitle%3DMonatshefte%2520f%25C3%25BCr%2520Chemie%2520-%2520Chemical%2520Monthly%26atitle%3DDesign%25252C%252Bsynthesis%25252C%252Bantitubercular%252Band%252Bantiviral%252Bproperties%252Bof%252Bnew%252Bspirocyclic%252Bindole%252Bderivatives%26aulast%3DCihan-%25C3%259Cst%25C3%25BCnda%25C4%259F%26aufirst%3DG%25C3%25B6k%25C3%25A7e%26date%3D2019%26date%3D2019%26volume%3D150%26issue%3D8%26spage%3D1533%26epage%3D1544" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Archana  Kumari</span>, <span class="hlFld-ContribAuthor ">Rajesh K.  Singh</span>. </span><span class="cited-content_cbyCitation_article-title">Medicinal chemistry of indole derivatives: Current to future therapeutic prospectives. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2019,</strong> <em>89 </em>, 103021. <a href="https://doi.org/10.1016/j.bioorg.2019.103021" title="DOI URL">https://doi.org/10.1016/j.bioorg.2019.103021</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2019.103021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2019.103021%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DMedicinal%252Bchemistry%252Bof%252Bindole%252Bderivatives%25253A%252BCurrent%252Bto%252Bfuture%252Btherapeutic%252Bprospectives%26aulast%3DKumari%26aufirst%3DArchana%26date%3D2019%26volume%3D89%26spage%3D103021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Matthew B.  McNeil</span>, <span class="hlFld-ContribAuthor ">Gregory M.  Cook</span>. </span><span class="cited-content_cbyCitation_article-title">Utilization of CRISPR Interference To Validate MmpL3 as a Drug Target in
              Mycobacterium tuberculosis. </span><span class="cited-content_cbyCitation_journal-name">Antimicrobial Agents and Chemotherapy</span><span> <strong>2019,</strong> <em>63 </em>
                                    (8)
                                     <a href="https://doi.org/10.1128/AAC.00629-19" title="DOI URL">https://doi.org/10.1128/AAC.00629-19</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1128/AAC.00629-19&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1128%2FAAC.00629-19%26sid%3Dliteratum%253Aachs%26jtitle%3DAntimicrobial%2520Agents%2520and%2520Chemotherapy%26atitle%3DUtilization%252Bof%252BCRISPR%252BInterference%252BTo%252BValidate%252BMmpL3%252Bas%252Ba%252BDrug%252BTarget%252Bin%252BMycobacterium%252Btuberculosis%26aulast%3DMcNeil%26aufirst%3DMatthew%2BB.%26date%3D2019%26volume%3D63%26issue%3D8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shichun  Lun</span>, <span class="hlFld-ContribAuthor ">Rokeya  Tasneen</span>, <span class="hlFld-ContribAuthor ">Tridib  Chaira</span>, <span class="hlFld-ContribAuthor ">Jozef  Stec</span>, <span class="hlFld-ContribAuthor ">Oluseye K.  Onajole</span>, <span class="hlFld-ContribAuthor ">Tian J.  Yang</span>, <span class="hlFld-ContribAuthor ">Christopher B.  Cooper</span>, <span class="hlFld-ContribAuthor ">Khisi  Mdluli</span>, <span class="hlFld-ContribAuthor ">Paul J.  Converse</span>, <span class="hlFld-ContribAuthor ">Eric L.  Nuermberger</span>, <span class="hlFld-ContribAuthor ">V. Samuel  Raj</span>, <span class="hlFld-ContribAuthor ">Alan  Kozikowski</span>, <span class="hlFld-ContribAuthor ">William R.  Bishai</span>. </span><span class="cited-content_cbyCitation_article-title">Advancing the Therapeutic Potential of Indoleamides for Tuberculosis. </span><span class="cited-content_cbyCitation_journal-name">Antimicrobial Agents and Chemotherapy</span><span> <strong>2019,</strong> <em>63 </em>
                                    (7)
                                     <a href="https://doi.org/10.1128/AAC.00343-19" title="DOI URL">https://doi.org/10.1128/AAC.00343-19</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1128/AAC.00343-19&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1128%2FAAC.00343-19%26sid%3Dliteratum%253Aachs%26jtitle%3DAntimicrobial%2520Agents%2520and%2520Chemotherapy%26atitle%3DAdvancing%252Bthe%252BTherapeutic%252BPotential%252Bof%252BIndoleamides%252Bfor%252BTuberculosis%26aulast%3DLun%26aufirst%3DShichun%26date%3D2019%26volume%3D63%26issue%3D7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Allison  Fay</span>, <span class="hlFld-ContribAuthor ">Nadine  Czudnochowski</span>, <span class="hlFld-ContribAuthor ">Jeremy M.  Rock</span>, <span class="hlFld-ContribAuthor ">Jeffrey R.  Johnson</span>, <span class="hlFld-ContribAuthor ">Nevan J.  Krogan</span>, <span class="hlFld-ContribAuthor ">Oren  Rosenberg</span>, <span class="hlFld-ContribAuthor ">Michael S.  Glickman</span>, . </span><span class="cited-content_cbyCitation_article-title">Two Accessory Proteins Govern MmpL3 Mycolic Acid Transport in Mycobacteria. </span><span class="cited-content_cbyCitation_journal-name">mBio</span><span> <strong>2019,</strong> <em>10 </em>
                                    (3)
                                     <a href="https://doi.org/10.1128/mBio.00850-19" title="DOI URL">https://doi.org/10.1128/mBio.00850-19</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1128/mBio.00850-19&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1128%2FmBio.00850-19%26sid%3Dliteratum%253Aachs%26jtitle%3DmBio%26atitle%3DTwo%252BAccessory%252BProteins%252BGovern%252BMmpL3%252BMycolic%252BAcid%252BTransport%252Bin%252BMycobacteria%26aulast%3DFay%26aufirst%3DAllison%26date%3D2019%26volume%3D10%26issue%3D3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Matthew B.  McNeil</span>, <span class="hlFld-ContribAuthor ">Somsundaram  Chettiar</span>, <span class="hlFld-ContribAuthor ">Divya  Awasthi</span>, <span class="hlFld-ContribAuthor ">Tanya  Parish</span>. </span><span class="cited-content_cbyCitation_article-title">Cell wall inhibitors increase the accumulation of rifampicin in Mycobacterium tuberculosis. </span><span class="cited-content_cbyCitation_journal-name">Access Microbiology</span><span> <strong>2019,</strong> <em>1 </em>
                                    (1)
                                     <a href="https://doi.org/10.1099/acmi.0.000006" title="DOI URL">https://doi.org/10.1099/acmi.0.000006</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1099/acmi.0.000006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1099%2Facmi.0.000006%26sid%3Dliteratum%253Aachs%26jtitle%3DAccess%2520Microbiology%26atitle%3DCell%252Bwall%252Binhibitors%252Bincrease%252Bthe%252Baccumulation%252Bof%252Brifampicin%252Bin%252BMycobacterium%252Btuberculosis%26aulast%3DMcNeil%26aufirst%3DMatthew%2BB.%26date%3D2019%26volume%3D1%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Amit N.  Pandya</span>, <span class="hlFld-ContribAuthor ">Pavan K.  Prathipati</span>, <span class="hlFld-ContribAuthor ">Pooja  Hegde</span>, <span class="hlFld-ContribAuthor ">Wei  Li</span>, <span class="hlFld-ContribAuthor ">Kyle F.  Graham</span>, <span class="hlFld-ContribAuthor ">Subhra  Mandal</span>, <span class="hlFld-ContribAuthor ">Kristen M.  Drescher</span>, <span class="hlFld-ContribAuthor ">Christopher J.  Destache</span>, <span class="hlFld-ContribAuthor ">Diane  Ordway</span>, <span class="hlFld-ContribAuthor ">Mary  Jackson</span>, <span class="hlFld-ContribAuthor ">E. Jeffrey  North</span>. </span><span class="cited-content_cbyCitation_article-title">Indole-2-Carboxamides Are Active against
              Mycobacterium abscessus
              in a Mouse Model of Acute Infection. </span><span class="cited-content_cbyCitation_journal-name">Antimicrobial Agents and Chemotherapy</span><span> <strong>2019,</strong> <em>63 </em>
                                    (3)
                                     <a href="https://doi.org/10.1128/AAC.02245-18" title="DOI URL">https://doi.org/10.1128/AAC.02245-18</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1128/AAC.02245-18&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1128%2FAAC.02245-18%26sid%3Dliteratum%253Aachs%26jtitle%3DAntimicrobial%2520Agents%2520and%2520Chemotherapy%26atitle%3DIndole-2-Carboxamides%252BAre%252BActive%252Bagainst%252BMycobacterium%252Babscessus%252Bin%252Ba%252BMouse%252BModel%252Bof%252BAcute%252BInfection%26aulast%3DPandya%26aufirst%3DAmit%2BN.%26date%3D2019%26volume%3D63%26issue%3D3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Clinton G. L.  Veale</span>. </span><span class="cited-content_cbyCitation_article-title">Unpacking the Pathogen Box—An Open Source Tool for Fighting Neglected Tropical Disease. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2019,</strong> <em>14 </em>
                                    (4)
                                     , 386-453. <a href="https://doi.org/10.1002/cmdc.201800755" title="DOI URL">https://doi.org/10.1002/cmdc.201800755</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.201800755&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.201800755%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DUnpacking%252Bthe%252BPathogen%252BBox%2525E2%252580%252594An%252BOpen%252BSource%252BTool%252Bfor%252BFighting%252BNeglected%252BTropical%252BDisease%26aulast%3DVeale%26aufirst%3DClinton%2BG.%2BL.%26date%3D2019%26date%3D2019%26volume%3D14%26issue%3D4%26spage%3D386%26epage%3D453" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mamadou  Daffé</span>, <span class="hlFld-ContribAuthor ">Annaïk  Quémard</span>, <span class="hlFld-ContribAuthor ">Hedia  Marrakchi</span>. </span><span class="cited-content_cbyCitation_article-title">Mycolic Acids: From Chemistry to Biology. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2019,</strong>,, 181-216. <a href="https://doi.org/10.1007/978-3-319-50430-8_18" title="DOI URL">https://doi.org/10.1007/978-3-319-50430-8_18</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-3-319-50430-8_18&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-3-319-50430-8_18%26sid%3Dliteratum%253Aachs%26atitle%3DMycolic%252BAcids%25253A%252BFrom%252BChemistry%252Bto%252BBiology%26aulast%3DDaff%25C3%25A9%26aufirst%3DMamadou%26date%3D2019%26date%3D2019%26spage%3D181%26epage%3D216%26pub%3DSpringer%2520International%2520Publishing%26atitle%3DBiogenesis%252Bof%252BFatty%252BAcids%25252C%252BLipids%252Band%252BMembranes%26aulast%3DGeiger%26aufirst%3DOtto%26date%3D2019%26volume%3D2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bing  Zhang</span>, <span class="hlFld-ContribAuthor ">Jun  Li</span>, <span class="hlFld-ContribAuthor ">Xiaolin  Yang</span>, <span class="hlFld-ContribAuthor ">Lijie  Wu</span>, <span class="hlFld-ContribAuthor ">Jia  Zhang</span>, <span class="hlFld-ContribAuthor ">Yang  Yang</span>, <span class="hlFld-ContribAuthor ">Yao  Zhao</span>, <span class="hlFld-ContribAuthor ">Lu  Zhang</span>, <span class="hlFld-ContribAuthor ">Xiuna  Yang</span>, <span class="hlFld-ContribAuthor ">Xiaobao  Yang</span>, <span class="hlFld-ContribAuthor ">Xi  Cheng</span>, <span class="hlFld-ContribAuthor ">Zhijie  Liu</span>, <span class="hlFld-ContribAuthor ">Biao  Jiang</span>, <span class="hlFld-ContribAuthor ">Hualiang  Jiang</span>, <span class="hlFld-ContribAuthor ">Luke W.  Guddat</span>, <span class="hlFld-ContribAuthor ">Haitao  Yang</span>, <span class="hlFld-ContribAuthor ">Zihe  Rao</span>. </span><span class="cited-content_cbyCitation_article-title">Crystal Structures of Membrane Transporter MmpL3, an Anti-TB Drug Target. </span><span class="cited-content_cbyCitation_journal-name">Cell</span><span> <strong>2019,</strong> <em>176 </em>
                                    (3)
                                     , 636-648.e13. <a href="https://doi.org/10.1016/j.cell.2019.01.003" title="DOI URL">https://doi.org/10.1016/j.cell.2019.01.003</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.cell.2019.01.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.cell.2019.01.003%26sid%3Dliteratum%253Aachs%26jtitle%3DCell%26atitle%3DCrystal%252BStructures%252Bof%252BMembrane%252BTransporter%252BMmpL3%25252C%252Ban%252BAnti-TB%252BDrug%252BTarget%26aulast%3DZhang%26aufirst%3DBing%26date%3D2019%26volume%3D176%26issue%3D3%26spage%3D636%26epage%3D648.e13" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yogesh D.  Mane</span>, <span class="hlFld-ContribAuthor ">Smita S.  Patil</span>, <span class="hlFld-ContribAuthor ">Dhanraj O.  Biradar</span>, <span class="hlFld-ContribAuthor ">Bhimrao C.  Khade</span>. </span><span class="cited-content_cbyCitation_article-title">5-Bromo-1-(4-chlorobenzyl)-1H-indole-2-carboxamides as new potent antibacterial agents. </span><span class="cited-content_cbyCitation_journal-name">Heterocyclic Communications</span><span> <strong>2018,</strong> <em>24 </em>
                                    (6)
                                     , 327-332. <a href="https://doi.org/10.1515/hc-2018-0107" title="DOI URL">https://doi.org/10.1515/hc-2018-0107</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1515/hc-2018-0107&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1515%2Fhc-2018-0107%26sid%3Dliteratum%253Aachs%26jtitle%3DHeterocyclic%2520Communications%26atitle%3D5-Bromo-1-%2525284-chlorobenzyl%252529-1H-indole-2-carboxamides%252Bas%252Bnew%252Bpotent%252Bantibacterial%252Bagents%26aulast%3DMane%26aufirst%3DYogesh%2BD.%26date%3D2018%26volume%3D24%26issue%3D6%26spage%3D327%26epage%3D332" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Valentin  Trofimov</span>, <span class="hlFld-ContribAuthor ">Sébastien  Kicka</span>, <span class="hlFld-ContribAuthor ">Sabrina  Mucaria</span>, <span class="hlFld-ContribAuthor ">Nabil  Hanna</span>, <span class="hlFld-ContribAuthor ">Fernando  Ramon-Olayo</span>, <span class="hlFld-ContribAuthor ">Laura Vela-Gonzalez  Del Peral</span>, <span class="hlFld-ContribAuthor ">Joël  Lelièvre</span>, <span class="hlFld-ContribAuthor ">Lluís  Ballell</span>, <span class="hlFld-ContribAuthor ">Leonardo  Scapozza</span>, <span class="hlFld-ContribAuthor ">Gurdyal S.  Besra</span>, <span class="hlFld-ContribAuthor ">Jonathan A. G.  Cox</span>, <span class="hlFld-ContribAuthor ">Thierry  Soldati</span>. </span><span class="cited-content_cbyCitation_article-title">Antimycobacterial drug discovery using Mycobacteria-infected amoebae identifies anti-infectives and new molecular targets. </span><span class="cited-content_cbyCitation_journal-name">Scientific Reports</span><span> <strong>2018,</strong> <em>8 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/s41598-018-22228-6" title="DOI URL">https://doi.org/10.1038/s41598-018-22228-6</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41598-018-22228-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41598-018-22228-6%26sid%3Dliteratum%253Aachs%26jtitle%3DScientific%2520Reports%26atitle%3DAntimycobacterial%252Bdrug%252Bdiscovery%252Busing%252BMycobacteria-infected%252Bamoebae%252Bidentifies%252Banti-infectives%252Band%252Bnew%252Bmolecular%252Btargets%26aulast%3DTrofimov%26aufirst%3DValentin%26date%3D2018%26date%3D2018%26volume%3D8%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mary A.  De Groote</span>, <span class="hlFld-ContribAuthor ">Thale C.  Jarvis</span>, <span class="hlFld-ContribAuthor ">Christina  Wong</span>, <span class="hlFld-ContribAuthor ">James  Graham</span>, <span class="hlFld-ContribAuthor ">Teresa  Hoang</span>, <span class="hlFld-ContribAuthor ">Casey L.  Young</span>, <span class="hlFld-ContribAuthor ">Wendy  Ribble</span>, <span class="hlFld-ContribAuthor ">Joshua  Day</span>, <span class="hlFld-ContribAuthor ">Wei  Li</span>, <span class="hlFld-ContribAuthor ">Mary  Jackson</span>, <span class="hlFld-ContribAuthor ">Mercedes  Gonzalez-Juarrero</span>, <span class="hlFld-ContribAuthor ">Xicheng  Sun</span>, <span class="hlFld-ContribAuthor ">Urs A.  Ochsner</span>. </span><span class="cited-content_cbyCitation_article-title">Optimization and Lead Selection of Benzothiazole Amide Analogs Toward a Novel Antimycobacterial Agent. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Microbiology</span><span> <strong>2018,</strong> <em>9 </em><a href="https://doi.org/10.3389/fmicb.2018.02231" title="DOI URL">https://doi.org/10.3389/fmicb.2018.02231</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fmicb.2018.02231&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffmicb.2018.02231%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Microbiology%26atitle%3DOptimization%252Band%252BLead%252BSelection%252Bof%252BBenzothiazole%252BAmide%252BAnalogs%252BToward%252Ba%252BNovel%252BAntimycobacterial%252BAgent%26aulast%3DDe%2BGroote%26aufirst%3DMary%2BA.%26date%3D2018%26date%3D2018%26volume%3D9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Giorgia  Mori</span>, <span class="hlFld-ContribAuthor ">Beatrice Silvia  Orena</span>, <span class="hlFld-ContribAuthor ">Clara  Franch</span>, <span class="hlFld-ContribAuthor ">Lesley A.  Mitchenall</span>, <span class="hlFld-ContribAuthor ">Adwait Anand  Godbole</span>, <span class="hlFld-ContribAuthor ">Liliana  Rodrigues</span>, <span class="hlFld-ContribAuthor ">Clara  Aguilar-Pérez</span>, <span class="hlFld-ContribAuthor ">Júlia  Zemanová</span>, <span class="hlFld-ContribAuthor ">Stanislav  Huszár</span>, <span class="hlFld-ContribAuthor ">Martin  Forbak</span>, <span class="hlFld-ContribAuthor ">Thomas R.  Lane</span>, <span class="hlFld-ContribAuthor ">Mohamad  Sabbah</span>, <span class="hlFld-ContribAuthor ">Nathalie  Deboosere</span>, <span class="hlFld-ContribAuthor ">Rosangela  Frita</span>, <span class="hlFld-ContribAuthor ">Alexandre  Vandeputte</span>, <span class="hlFld-ContribAuthor ">Eik  Hoffmann</span>, <span class="hlFld-ContribAuthor ">Riccardo  Russo</span>, <span class="hlFld-ContribAuthor ">Nancy  Connell</span>, <span class="hlFld-ContribAuthor ">Courtney  Veilleux</span>, <span class="hlFld-ContribAuthor ">Rajiv K.  Jha</span>, <span class="hlFld-ContribAuthor ">Pradeep  Kumar</span>, <span class="hlFld-ContribAuthor ">Joel S.  Freundlich</span>, <span class="hlFld-ContribAuthor ">Priscille  Brodin</span>, <span class="hlFld-ContribAuthor ">Jose Antonio  Aínsa</span>, <span class="hlFld-ContribAuthor ">Valakunja  Nagaraja</span>, <span class="hlFld-ContribAuthor ">Anthony  Maxwell</span>, <span class="hlFld-ContribAuthor ">Katarína  Mikušová</span>, <span class="hlFld-ContribAuthor ">Maria Rosalia  Pasca</span>, <span class="hlFld-ContribAuthor ">Sean  Ekins</span>. </span><span class="cited-content_cbyCitation_article-title">The EU approved antimalarial pyronaridine shows antitubercular activity and synergy with rifampicin, targeting RNA polymerase. </span><span class="cited-content_cbyCitation_journal-name">Tuberculosis</span><span> <strong>2018,</strong> <em>112 </em>, 98-109. <a href="https://doi.org/10.1016/j.tube.2018.08.004" title="DOI URL">https://doi.org/10.1016/j.tube.2018.08.004</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tube.2018.08.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tube.2018.08.004%26sid%3Dliteratum%253Aachs%26jtitle%3DTuberculosis%26atitle%3DThe%252BEU%252Bapproved%252Bantimalarial%252Bpyronaridine%252Bshows%252Bantitubercular%252Bactivity%252Band%252Bsynergy%252Bwith%252Brifampicin%25252C%252Btargeting%252BRNA%252Bpolymerase%26aulast%3DMori%26aufirst%3DGiorgia%26date%3D2018%26volume%3D112%26spage%3D98%26epage%3D109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Adrian  Richter</span>, <span class="hlFld-ContribAuthor ">Angelika  Strauch</span>, <span class="hlFld-ContribAuthor ">Joseph  Chao</span>, <span class="hlFld-ContribAuthor ">Mary  Ko</span>, <span class="hlFld-ContribAuthor ">Yossef  Av-Gay</span>. </span><span class="cited-content_cbyCitation_article-title">Screening of Preselected Libraries Targeting Mycobacterium abscessus for Drug Discovery. </span><span class="cited-content_cbyCitation_journal-name">Antimicrobial Agents and Chemotherapy</span><span> <strong>2018,</strong> <em>62 </em>
                                    (9)
                                     <a href="https://doi.org/10.1128/AAC.00828-18" title="DOI URL">https://doi.org/10.1128/AAC.00828-18</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1128/AAC.00828-18&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1128%2FAAC.00828-18%26sid%3Dliteratum%253Aachs%26jtitle%3DAntimicrobial%2520Agents%2520and%2520Chemotherapy%26atitle%3DScreening%252Bof%252BPreselected%252BLibraries%252BTargeting%252BMycobacterium%252Babscessus%252Bfor%252BDrug%252BDiscovery%26aulast%3DRichter%26aufirst%3DAdrian%26date%3D2018%26volume%3D62%26issue%3D9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Haiyan  Chen</span>, <span class="hlFld-ContribAuthor ">Wenjing  Wang</span>, <span class="hlFld-ContribAuthor ">Xiaoyi  Zhang</span>, <span class="hlFld-ContribAuthor ">Shan  Liu</span>, <span class="hlFld-ContribAuthor ">Yaonan  Wang</span>, <span class="hlFld-ContribAuthor ">Haimei  Zhu</span>, <span class="hlFld-ContribAuthor ">Jianhui  Wu</span>, <span class="hlFld-ContribAuthor ">Yuji  Wang</span>, <span class="hlFld-ContribAuthor ">Ming  Zhao</span>, <span class="hlFld-ContribAuthor ">Shiqi  Peng</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of DEBIC to correlate P-selectin inhibition and DNA intercalation in cancer therapy and complicated thrombosis. </span><span class="cited-content_cbyCitation_journal-name">Oncotarget</span><span> <strong>2018,</strong> <em>9 </em>
                                    (63)
                                     , 32119-32133. <a href="https://doi.org/10.18632/oncotarget.23151" title="DOI URL">https://doi.org/10.18632/oncotarget.23151</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.18632/oncotarget.23151&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.18632%2Foncotarget.23151%26sid%3Dliteratum%253Aachs%26jtitle%3DOncotarget%26atitle%3DDiscovery%252Bof%252BDEBIC%252Bto%252Bcorrelate%252BP-selectin%252Binhibition%252Band%252BDNA%252Bintercalation%252Bin%252Bcancer%252Btherapy%252Band%252Bcomplicated%252Bthrombosis%26aulast%3DChen%26aufirst%3DHaiyan%26date%3D2018%26date%3D2017%26volume%3D9%26issue%3D63%26spage%3D32119%26epage%3D32133" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wei  Li</span>, <span class="hlFld-ContribAuthor ">Amira  Yazidi</span>, <span class="hlFld-ContribAuthor ">Amitkumar N.  Pandya</span>, <span class="hlFld-ContribAuthor ">Pooja  Hegde</span>, <span class="hlFld-ContribAuthor ">Weiwei  Tong</span>, <span class="hlFld-ContribAuthor ">Vinicius  Calado Nogueira de Moura</span>, <span class="hlFld-ContribAuthor ">E. Jeffrey  North</span>, <span class="hlFld-ContribAuthor ">Jurgen  Sygusch</span>, <span class="hlFld-ContribAuthor ">Mary  Jackson</span>. </span><span class="cited-content_cbyCitation_article-title">MmpL3 as a Target for the Treatment of Drug-Resistant Nontuberculous Mycobacterial Infections. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Microbiology</span><span> <strong>2018,</strong> <em>9 </em><a href="https://doi.org/10.3389/fmicb.2018.01547" title="DOI URL">https://doi.org/10.3389/fmicb.2018.01547</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fmicb.2018.01547&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffmicb.2018.01547%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Microbiology%26atitle%3DMmpL3%252Bas%252Ba%252BTarget%252Bfor%252Bthe%252BTreatment%252Bof%252BDrug-Resistant%252BNontuberculous%252BMycobacterial%252BInfections%26aulast%3DLi%26aufirst%3DWei%26date%3D2018%26date%3D2018%26volume%3D9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Huiqing  Zheng</span>, <span class="hlFld-ContribAuthor ">John T.  Williams</span>, <span class="hlFld-ContribAuthor ">Garry B.  Coulson</span>, <span class="hlFld-ContribAuthor ">Elizabeth R.  Haiderer</span>, <span class="hlFld-ContribAuthor ">Robert B.  Abramovitch</span>. </span><span class="cited-content_cbyCitation_article-title">HC2091 Kills Mycobacterium tuberculosis by Targeting the MmpL3 Mycolic Acid Transporter. </span><span class="cited-content_cbyCitation_journal-name">Antimicrobial Agents and Chemotherapy</span><span> <strong>2018,</strong> <em>62 </em>
                                    (7)
                                     <a href="https://doi.org/10.1128/AAC.02459-17" title="DOI URL">https://doi.org/10.1128/AAC.02459-17</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1128/AAC.02459-17&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1128%2FAAC.02459-17%26sid%3Dliteratum%253Aachs%26jtitle%3DAntimicrobial%2520Agents%2520and%2520Chemotherapy%26atitle%3DHC2091%252BKills%252BMycobacterium%252Btuberculosis%252Bby%252BTargeting%252Bthe%252BMmpL3%252BMycolic%252BAcid%252BTransporter%26aulast%3DZheng%26aufirst%3DHuiqing%26date%3D2018%26volume%3D62%26issue%3D7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">André  Campaniço</span>, <span class="hlFld-ContribAuthor ">Rui  Moreira</span>, <span class="hlFld-ContribAuthor ">Francisca  Lopes</span>. </span><span class="cited-content_cbyCitation_article-title">Drug discovery in tuberculosis. New drug targets and antimycobacterial agents. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>150 </em>, 525-545. <a href="https://doi.org/10.1016/j.ejmech.2018.03.020" title="DOI URL">https://doi.org/10.1016/j.ejmech.2018.03.020</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2018.03.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2018.03.020%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDrug%252Bdiscovery%252Bin%252Btuberculosis.%252BNew%252Bdrug%252Btargets%252Band%252Bantimycobacterial%252Bagents%26aulast%3DCampani%25C3%25A7o%26aufirst%3DAndr%25C3%25A9%26date%3D2018%26volume%3D150%26spage%3D525%26epage%3D545" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Pinapeddavari  Mayuri</span>, <span class="hlFld-ContribAuthor ">Sheng-Tung  Huang</span>, <span class="hlFld-ContribAuthor ">Veerappan  Mani</span>, <span class="hlFld-ContribAuthor ">Annamalai Senthil  Kumar</span>. </span><span class="cited-content_cbyCitation_article-title">A new organic redox species-indole tetraone trapped MWCNT modified electrode prepared by in-situ electrochemical oxidation of indole for a bifunctional electrocatalysis and simultaneous flow injection electroanalysis of hydrazine and hydrogen peroxide. </span><span class="cited-content_cbyCitation_journal-name">Electrochimica Acta</span><span> <strong>2018,</strong> <em>268 </em>, 150-162. <a href="https://doi.org/10.1016/j.electacta.2018.02.107" title="DOI URL">https://doi.org/10.1016/j.electacta.2018.02.107</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.electacta.2018.02.107&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.electacta.2018.02.107%26sid%3Dliteratum%253Aachs%26jtitle%3DElectrochimica%2520Acta%26atitle%3DA%252Bnew%252Borganic%252Bredox%252Bspecies-indole%252Btetraone%252Btrapped%252BMWCNT%252Bmodified%252Belectrode%252Bprepared%252Bby%252Bin-situ%252Belectrochemical%252Boxidation%252Bof%252Bindole%252Bfor%252Ba%252Bbifunctional%252Belectrocatalysis%252Band%252Bsimultaneous%252Bflow%252Binjection%252Belectroanalysis%252Bof%252Bhydrazine%252Band%252Bhydrogen%252Bperoxide%26aulast%3DMayuri%26aufirst%3DPinapeddavari%26date%3D2018%26volume%3D268%26spage%3D150%26epage%3D162" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Giovanna  Poce</span>, <span class="hlFld-ContribAuthor ">Martina  Cocozza</span>, <span class="hlFld-ContribAuthor ">Salvatore  Alfonso</span>, <span class="hlFld-ContribAuthor ">Sara  Consalvi</span>, <span class="hlFld-ContribAuthor ">Giulia  Venditti</span>, <span class="hlFld-ContribAuthor ">Raquel  Fernandez-Menendez</span>, <span class="hlFld-ContribAuthor ">Robert H.  Bates</span>, <span class="hlFld-ContribAuthor ">David  Barros Aguirre</span>, <span class="hlFld-ContribAuthor ">Lluis  Ballell</span>, <span class="hlFld-ContribAuthor ">Alessandro  De Logu</span>, <span class="hlFld-ContribAuthor ">Giulio  Vistoli</span>, <span class="hlFld-ContribAuthor ">Mariangela  Biava</span>. </span><span class="cited-content_cbyCitation_article-title">In vivo potent BM635 analogue with improved drug-like properties. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>145 </em>, 539-550. <a href="https://doi.org/10.1016/j.ejmech.2017.12.075" title="DOI URL">https://doi.org/10.1016/j.ejmech.2017.12.075</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2017.12.075&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2017.12.075%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DIn%2525C2%2525A0vivo%252Bpotent%252BBM635%252Banalogue%252Bwith%252Bimproved%252Bdrug-like%252Bproperties%26aulast%3DPoce%26aufirst%3DGiovanna%26date%3D2018%26volume%3D145%26spage%3D539%26epage%3D550" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ashruba B.  Danne</span>, <span class="hlFld-ContribAuthor ">Amit S.  Choudhari</span>, <span class="hlFld-ContribAuthor ">Shakti  Chakraborty</span>, <span class="hlFld-ContribAuthor ">Dhiman  Sarkar</span>, <span class="hlFld-ContribAuthor ">Vijay M.  Khedkar</span>, <span class="hlFld-ContribAuthor ">Bapurao B.  Shingate</span>. </span><span class="cited-content_cbyCitation_article-title">Triazole–diindolylmethane conjugates as new antitubercular agents: synthesis, bioevaluation, and molecular docking. </span><span class="cited-content_cbyCitation_journal-name">MedChemComm</span><span> <strong>2018,</strong> <em>9 </em>
                                    (7)
                                     , 1114-1130. <a href="https://doi.org/10.1039/C8MD00055G" title="DOI URL">https://doi.org/10.1039/C8MD00055G</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C8MD00055G&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC8MD00055G%26sid%3Dliteratum%253Aachs%26jtitle%3DMedChemComm%26atitle%3DTriazole%2525E2%252580%252593diindolylmethane%252Bconjugates%252Bas%252Bnew%252Bantitubercular%252Bagents%25253A%252Bsynthesis%25252C%252Bbioevaluation%25252C%252Band%252Bmolecular%252Bdocking%26aulast%3DDanne%26aufirst%3DAshruba%2BB.%26date%3D2018%26date%3D2018%26volume%3D9%26issue%3D7%26spage%3D1114%26epage%3D1130" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yu  Luo</span>, <span class="hlFld-ContribAuthor ">Yang  He</span>, <span class="hlFld-ContribAuthor ">Lianlian  Fan</span>, <span class="hlFld-ContribAuthor ">Haoting  Zhu</span>, <span class="hlFld-ContribAuthor ">Xiaolin  Li</span>, <span class="hlFld-ContribAuthor ">Pu  Zhou</span>. </span><span class="cited-content_cbyCitation_article-title">A Practical Synthesis of 2-Substituted 5-Bromoindoles. </span><span class="cited-content_cbyCitation_journal-name">HETEROCYCLES</span><span> <strong>2018,</strong> <em>96 </em>
                                    (6)
                                     , 1067. <a href="https://doi.org/10.3987/COM-18-13893" title="DOI URL">https://doi.org/10.3987/COM-18-13893</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3987/COM-18-13893&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3987%2FCOM-18-13893%26sid%3Dliteratum%253Aachs%26jtitle%3DHETEROCYCLES%26atitle%3DA%252BPractical%252BSynthesis%252Bof%252B2-Substituted%252B5-Bromoindoles%26aulast%3DLuo%26aufirst%3DYu%26date%3D2018%26volume%3D96%26issue%3D6%26spage%3D1067" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Paweł  Borowiecki</span>, <span class="hlFld-ContribAuthor ">Iwona  Justyniak</span>, <span class="hlFld-ContribAuthor ">Zbigniew  Ochal</span>. </span><span class="cited-content_cbyCitation_article-title">Lipase-catalyzed kinetic resolution approach toward enantiomerically enriched 1-(β-hydroxypropyl)indoles. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron: Asymmetry</span><span> <strong>2017,</strong> <em>28 </em>
                                    (12)
                                     , 1717-1732. <a href="https://doi.org/10.1016/j.tetasy.2017.10.010" title="DOI URL">https://doi.org/10.1016/j.tetasy.2017.10.010</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tetasy.2017.10.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tetasy.2017.10.010%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%253A%2520Asymmetry%26atitle%3DLipase-catalyzed%252Bkinetic%252Bresolution%252Bapproach%252Btoward%252Benantiomerically%252Benriched%252B1-%252528%2525CE%2525B2-hydroxypropyl%252529indoles%26aulast%3DBorowiecki%26aufirst%3DPawe%25C5%2582%26date%3D2017%26volume%3D28%26issue%3D12%26spage%3D1717%26epage%3D1732" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Guilherme  Fernandes</span>, <span class="hlFld-ContribAuthor ">Chung  Man Chin</span>, <span class="hlFld-ContribAuthor ">Jean  Dos Santos</span>. </span><span class="cited-content_cbyCitation_article-title">Advances in Drug Discovery of New Antitubercular Multidrug-Resistant Compounds. </span><span class="cited-content_cbyCitation_journal-name">Pharmaceuticals</span><span> <strong>2017,</strong> <em>10 </em>
                                    (4)
                                     , 51. <a href="https://doi.org/10.3390/ph10020051" title="DOI URL">https://doi.org/10.3390/ph10020051</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ph10020051&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fph10020051%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmaceuticals%26atitle%3DAdvances%252Bin%252BDrug%252BDiscovery%252Bof%252BNew%252BAntitubercular%252BMultidrug-Resistant%252BCompounds%26aulast%3DFernandes%26aufirst%3DGuilherme%26date%3D2017%26date%3D2017%26volume%3D10%26issue%3D4%26spage%3D51" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Albertus  Viljoen</span>, <span class="hlFld-ContribAuthor ">Jean-Louis  Herrmann</span>, <span class="hlFld-ContribAuthor ">Oluseye K.  Onajole</span>, <span class="hlFld-ContribAuthor ">Jozef  Stec</span>, <span class="hlFld-ContribAuthor ">Alan P.  Kozikowski</span>, <span class="hlFld-ContribAuthor ">Laurent  Kremer</span>. </span><span class="cited-content_cbyCitation_article-title">Controlling Extra- and Intramacrophagic Mycobacterium abscessus by Targeting Mycolic Acid Transport. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Cellular and Infection Microbiology</span><span> <strong>2017,</strong> <em>7 </em><a href="https://doi.org/10.3389/fcimb.2017.00388" title="DOI URL">https://doi.org/10.3389/fcimb.2017.00388</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fcimb.2017.00388&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffcimb.2017.00388%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Cellular%2520and%2520Infection%2520Microbiology%26atitle%3DControlling%252BExtra-%252Band%252BIntramacrophagic%252BMycobacterium%252Babscessus%252Bby%252BTargeting%252BMycolic%252BAcid%252BTransport%26aulast%3DViljoen%26aufirst%3DAlbertus%26date%3D2017%26date%3D2017%26volume%3D7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nicholas D.  Franz</span>, <span class="hlFld-ContribAuthor ">Juan Manuel  Belardinelli</span>, <span class="hlFld-ContribAuthor ">Michael A.  Kaminski</span>, <span class="hlFld-ContribAuthor ">Louis C.  Dunn</span>, <span class="hlFld-ContribAuthor ">Vinicius  Calado Nogueira de Moura</span>, <span class="hlFld-ContribAuthor ">Michael A.  Blaha</span>, <span class="hlFld-ContribAuthor ">Dan D.  Truong</span>, <span class="hlFld-ContribAuthor ">Wei  Li</span>, <span class="hlFld-ContribAuthor ">Mary  Jackson</span>, <span class="hlFld-ContribAuthor ">E. Jeffrey  North</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and evaluation of indole-2-carboxamides with pan anti-mycobacterial activity. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2017,</strong> <em>25 </em>
                                    (14)
                                     , 3746-3755. <a href="https://doi.org/10.1016/j.bmc.2017.05.015" title="DOI URL">https://doi.org/10.1016/j.bmc.2017.05.015</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2017.05.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2017.05.015%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bevaluation%252Bof%252Bindole-2-carboxamides%252Bwith%252Bpan%252Banti-mycobacterial%252Bactivity%26aulast%3DFranz%26aufirst%3DNicholas%2BD.%26date%3D2017%26volume%3D25%26issue%3D14%26spage%3D3746%26epage%3D3755" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Matthew B.  McNeil</span>, <span class="hlFld-ContribAuthor ">Devon  Dennison</span>, <span class="hlFld-ContribAuthor ">Tanya  Parish</span>. </span><span class="cited-content_cbyCitation_article-title">Mutations in MmpL3 alter membrane potential, hydrophobicity and antibiotic susceptibility in Mycobacterium smegmatis. </span><span class="cited-content_cbyCitation_journal-name">Microbiology</span><span> <strong>2017,</strong> <em>163 </em>
                                    (7)
                                     , 1065-1070. <a href="https://doi.org/10.1099/mic.0.000498" title="DOI URL">https://doi.org/10.1099/mic.0.000498</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1099/mic.0.000498&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1099%2Fmic.0.000498%26sid%3Dliteratum%253Aachs%26jtitle%3DMicrobiology%26atitle%3DMutations%252Bin%252BMmpL3%252Balter%252Bmembrane%252Bpotential%25252C%252Bhydrophobicity%252Band%252Bantibiotic%252Bsusceptibility%252Bin%252BMycobacterium%252Bsmegmatis%26aulast%3DMcNeil%26aufirst%3DMatthew%2BB.%26date%3D2017%26volume%3D163%26issue%3D7%26spage%3D1065%26epage%3D1070" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rukmankesh  Mehra</span>, <span class="hlFld-ContribAuthor ">Inshad Ali  Khan</span>, <span class="hlFld-ContribAuthor ">Amit  Nargotra</span>. </span><span class="cited-content_cbyCitation_article-title">Anti-tubercular drug discovery: in silico implications and challenges. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Pharmaceutical Sciences</span><span> <strong>2017,</strong> <em>104 </em>, 1-15. <a href="https://doi.org/10.1016/j.ejps.2017.03.028" title="DOI URL">https://doi.org/10.1016/j.ejps.2017.03.028</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejps.2017.03.028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejps.2017.03.028%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Pharmaceutical%2520Sciences%26atitle%3DAnti-tubercular%252Bdrug%252Bdiscovery%25253A%252Bin%252Bsilico%252Bimplications%252Band%252Bchallenges%26aulast%3DMehra%26aufirst%3DRukmankesh%26date%3D2017%26volume%3D104%26spage%3D1%26epage%3D15" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wei  Li</span>, <span class="hlFld-ContribAuthor ">Andrea  Sanchez-Hidalgo</span>, <span class="hlFld-ContribAuthor ">Victoria  Jones</span>, <span class="hlFld-ContribAuthor ">Vinicius Calado Nogueira  de Moura</span>, <span class="hlFld-ContribAuthor ">E. Jeffrey  North</span>, <span class="hlFld-ContribAuthor ">Mary  Jackson</span>. </span><span class="cited-content_cbyCitation_article-title">Synergistic Interactions of MmpL3 Inhibitors with Antitubercular Compounds
              In Vitro. </span><span class="cited-content_cbyCitation_journal-name">Antimicrobial Agents and Chemotherapy</span><span> <strong>2017,</strong> <em>61 </em>
                                    (4)
                                     <a href="https://doi.org/10.1128/AAC.02399-16" title="DOI URL">https://doi.org/10.1128/AAC.02399-16</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1128/AAC.02399-16&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1128%2FAAC.02399-16%26sid%3Dliteratum%253Aachs%26jtitle%3DAntimicrobial%2520Agents%2520and%2520Chemotherapy%26atitle%3DSynergistic%252BInteractions%252Bof%252BMmpL3%252BInhibitors%252Bwith%252BAntitubercular%252BCompounds%252BIn%252BVitro%26aulast%3DLi%26aufirst%3DWei%26date%3D2017%26volume%3D61%26issue%3D4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Vinayak  Singh</span>, <span class="hlFld-ContribAuthor ">Valerie  Mizrahi</span>. </span><span class="cited-content_cbyCitation_article-title">Identification and validation of novel drug targets in Mycobacterium tuberculosis. </span><span class="cited-content_cbyCitation_journal-name">Drug Discovery Today</span><span> <strong>2017,</strong> <em>22 </em>
                                    (3)
                                     , 503-509. <a href="https://doi.org/10.1016/j.drudis.2016.09.010" title="DOI URL">https://doi.org/10.1016/j.drudis.2016.09.010</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.drudis.2016.09.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.drudis.2016.09.010%26sid%3Dliteratum%253Aachs%26jtitle%3DDrug%2520Discovery%2520Today%26atitle%3DIdentification%252Band%252Bvalidation%252Bof%252Bnovel%252Bdrug%252Btargets%252Bin%252BMycobacterium%252Btuberculosis%26aulast%3DSingh%26aufirst%3DVinayak%26date%3D2017%26volume%3D22%26issue%3D3%26spage%3D503%26epage%3D509" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kirsty J.  McLean</span>, <span class="hlFld-ContribAuthor ">Andrew W.  Munro</span>. </span><span class="cited-content_cbyCitation_article-title">Drug targeting of heme proteins in Mycobacterium tuberculosis. </span><span class="cited-content_cbyCitation_journal-name">Drug Discovery Today</span><span> <strong>2017,</strong> <em>22 </em>
                                    (3)
                                     , 566-575. <a href="https://doi.org/10.1016/j.drudis.2016.11.004" title="DOI URL">https://doi.org/10.1016/j.drudis.2016.11.004</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.drudis.2016.11.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.drudis.2016.11.004%26sid%3Dliteratum%253Aachs%26jtitle%3DDrug%2520Discovery%2520Today%26atitle%3DDrug%252Btargeting%252Bof%252Bheme%252Bproteins%252Bin%252BMycobacterium%252Btuberculosis%26aulast%3DMcLean%26aufirst%3DKirsty%2BJ.%26date%3D2017%26volume%3D22%26issue%3D3%26spage%3D566%26epage%3D575" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yogesh D.  Mane</span>, <span class="hlFld-ContribAuthor ">Yuvaraj P.  Sarnikar</span>, <span class="hlFld-ContribAuthor ">Santosh M.  Surwase</span>, <span class="hlFld-ContribAuthor ">Dhanraj O.  Biradar</span>, <span class="hlFld-ContribAuthor ">Pratapsinha B.  Gorepatil</span>, <span class="hlFld-ContribAuthor ">Vishnu S.  Shinde</span>, <span class="hlFld-ContribAuthor ">Bhimrao C.  Khade</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis, and antimicrobial activity of novel 5-substituted indole-2-carboxamide derivatives. </span><span class="cited-content_cbyCitation_journal-name">Research on Chemical Intermediates</span><span> <strong>2017,</strong> <em>43 </em>
                                    (2)
                                     , 1253-1275. <a href="https://doi.org/10.1007/s11164-016-2696-3" title="DOI URL">https://doi.org/10.1007/s11164-016-2696-3</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11164-016-2696-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11164-016-2696-3%26sid%3Dliteratum%253Aachs%26jtitle%3DResearch%2520on%2520Chemical%2520Intermediates%26atitle%3DDesign%25252C%252Bsynthesis%25252C%252Band%252Bantimicrobial%252Bactivity%252Bof%252Bnovel%252B5-substituted%252Bindole-2-carboxamide%252Bderivatives%26aulast%3DMane%26aufirst%3DYogesh%2BD.%26date%3D2017%26date%3D2016%26volume%3D43%26issue%3D2%26spage%3D1253%26epage%3D1275" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ute F.  Röhrig</span>, <span class="hlFld-ContribAuthor ">Vincent  Zoete</span>, <span class="hlFld-ContribAuthor ">Olivier  Michielin</span>. </span><span class="cited-content_cbyCitation_article-title">Inhibitors of the Kynurenine Pathway. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2017,</strong>,, 371-371. <a href="https://doi.org/10.1007/7355_2017_22" title="DOI URL">https://doi.org/10.1007/7355_2017_22</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/7355_2017_22&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F7355_2017_22%26sid%3Dliteratum%253Aachs%26atitle%3DInhibitors%252Bof%252Bthe%252BKynurenine%252BPathway%26aulast%3DR%25C3%25B6hrig%26aufirst%3DUte%2BF.%26date%3D2017%26spage%3D371%26epage%3D371%26pub%3DSpringer%2520International%2520Publishing%26atitle%3DCancer%252BII%26aulast%3DWaring%26aufirst%3DMichael%2BJ.%26date%3D2018%26volume%3D28" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mamadou  Daffé</span>, <span class="hlFld-ContribAuthor ">Annaïk  Quémard</span>, <span class="hlFld-ContribAuthor ">Hedia  Marrakchi</span>. </span><span class="cited-content_cbyCitation_article-title">Mycolic Acids: From Chemistry to Biology. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2017,</strong>,, 1-36. <a href="https://doi.org/10.1007/978-3-319-43676-0_18-1" title="DOI URL">https://doi.org/10.1007/978-3-319-43676-0_18-1</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-3-319-43676-0_18-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-3-319-43676-0_18-1%26sid%3Dliteratum%253Aachs%26atitle%3DMycolic%252BAcids%25253A%252BFrom%252BChemistry%252Bto%252BBiology%26aulast%3DDaff%25C3%25A9%26aufirst%3DMamadou%26date%3D2017%26date%3D2017%26spage%3D1%26epage%3D36%26pub%3DSpringer%2520International%2520Publishing%26atitle%3DBiogenesis%252Bof%252BFatty%252BAcids%25252C%252BLipids%252Band%252BMembranes%26aulast%3DGeiger%26aufirst%3DOtto%26date%3D2017%26volume%3D2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shuling  Yu</span>, <span class="hlFld-ContribAuthor ">Kun  Hu</span>, <span class="hlFld-ContribAuthor ">Julin  Gong</span>, <span class="hlFld-ContribAuthor ">Linjun  Qi</span>, <span class="hlFld-ContribAuthor ">Jianghe  Zhu</span>, <span class="hlFld-ContribAuthor ">Yetong  Zhang</span>, <span class="hlFld-ContribAuthor ">Tianxing  Cheng</span>, <span class="hlFld-ContribAuthor ">Jiuxi  Chen</span>. </span><span class="cited-content_cbyCitation_article-title">Palladium-catalyzed tandem addition/cyclization in aqueous medium: synthesis of 2-arylindoles. </span><span class="cited-content_cbyCitation_journal-name">Organic & Biomolecular Chemistry</span><span> <strong>2017,</strong> <em>15 </em>
                                    (20)
                                     , 4300-4307. <a href="https://doi.org/10.1039/C7OB00572E" title="DOI URL">https://doi.org/10.1039/C7OB00572E</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C7OB00572E&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC7OB00572E%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520%2526%2520Biomolecular%2520Chemistry%26atitle%3DPalladium-catalyzed%252Btandem%252Baddition%25252Fcyclization%252Bin%252Baqueous%252Bmedium%25253A%252Bsynthesis%252Bof%252B2-arylindoles%26aulast%3DYu%26aufirst%3DShuling%26date%3D2017%26date%3D2017%26volume%3D15%26issue%3D20%26spage%3D4300%26epage%3D4307" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00415/20160708/images/medium/jm-2016-004153_0011.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00415/20160708/images/large/jm-2016-004153_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00415&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00415/20160708/images/medium/jm-2016-004153_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00415/20160708/images/large/jm-2016-004153_0002.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Hit compound <b>1</b>, lead compounds <b>2</b> and <b>3</b>, and strategy for additional chemical modifications of the indole-2-carboxamide scaffold <b>3</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00415/20160708/images/large/jm-2016-004153_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00415&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00415/20160708/images/medium/jm-2016-004153_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00415/20160708/images/large/jm-2016-004153_0007.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Indole-2-carboxamides<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00415/20160708/images/large/jm-2016-004153_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00415&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) EDC·HCl, HOBt, corresponding amines, Et<sub>3</sub>N, CH<sub>2</sub>Cl<sub>2</sub>, rt, 12–16 h; (b) ethyl bromoacetate, K<sub>2</sub>CO<sub>3</sub>, acetone, 60 °C, overnight; (c) DMFDMA, microwave, 150 °C, 10 min; (d) AlCl<sub>3</sub>, CH<sub>2</sub>Cl<sub>2</sub>, 24 h, rt; (e) LiOH, EtOH, reflux, 3 h; (f) 10% Pd/C, MeOH/EtOAc (4:1), H<sub>2</sub>.</p></p></figure><figure data-id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00415/20160708/images/medium/jm-2016-004153_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00415/20160708/images/large/jm-2016-004153_0008.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Analogs Containing Indole and Benzothiazole Skeleton<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00415/20160708/images/large/jm-2016-004153_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00415&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) EDC·HCl, HOBt, NH<sub>4</sub>Cl, Et<sub>3</sub>N, CH<sub>2</sub>Cl<sub>2</sub>, rt, 12–16 h; (b) LiAlH<sub>4</sub>, THF, reflux, overnight; (c) EDC·HCl, HOBt, cycloheptanecarboxylic acid, Et<sub>3</sub>N, CH<sub>2</sub>Cl<sub>2</sub>, rt, 12–16 h; (d) cycloheptanecarbonyl chloride, CH<sub>2</sub>Cl<sub>2</sub>, rt, overnight.</p></p></figure><figure data-id="fig2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00415/20160708/images/medium/jm-2016-004153_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00415/20160708/images/large/jm-2016-004153_0013.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Activity of selected indole-2-carboxamides in the SIT assay.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00415/20160708/images/large/jm-2016-004153_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00415&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00415/20160708/images/medium/jm-2016-004153_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00415/20160708/images/large/jm-2016-004153_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. <i>In vivo</i> efficacy comparisons of compounds <b>26</b> and <b>2</b> in a mouse infection model. After aerosol <i><i>Mtb</i></i> infection with 10<sup>3</sup> CFU, mice were treated orally with 12.5, 25, 50, and 100 mg/kg of <b>26</b> or <b>2</b> daily. EMB was at 100 mg/(kg·d). Lung CFU counts were determined on days 1, 14, and 28 (5 mice/grp).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00415/20160708/images/large/jm-2016-004153_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00415&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00415/20160708/images/medium/jm-2016-004153_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00415/20160708/images/large/jm-2016-004153_0004.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Bliss synergy model using rifampin and <b>26</b>. Compound <b>26</b> synergizes with rifampin in an acute mouse infection and chemotherapy model.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00415/20160708/images/large/jm-2016-004153_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00415&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00415/20160708/images/medium/jm-2016-004153_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00415/20160708/images/large/jm-2016-004153_0005.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Cartoon structure of the MmpL3 homology model as colored by N (blue) to C (red) sequence. The bound inhibitor <b>3</b> is also depicted as the gray-colored CPK model.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00415/20160708/images/large/jm-2016-004153_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00415&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00415/20160708/images/medium/jm-2016-004153_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00415/20160708/images/large/jm-2016-004153_0006.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Main interactions stabilizing the putative MmpL3 complex with compounds <b>3</b> (A), <b>21</b> (B), and <b>26</b> (C).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00415/20160708/images/large/jm-2016-004153_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00415&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i74">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_25702" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_25702" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 29 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">World Health Organization</span><span> </span><span class="NLM_article-title">Global Tuberculosis Report 2015</span>. <a href="http://www.who.int/tb/publications/global_report/en/" class="extLink">http://www.who.int/tb/publications/global_report/en/</a>, Accessed November 11,<span class="NLM_x"> </span><span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=World+Health+Organization&title=Global+Tuberculosis+Report+2015"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26aulast%3D%26atitle%3DGlobal%2520Tuberculosis%2520Report%25202015%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><a href="http://www.tballiance.org/why/economic-impact.php" class="extLink">http://www.tballiance.org/why/economic-impact.php</a>, Accessed November 11,<span class="NLM_x"> </span><span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=http%3A%2F%2Fwww.tballiance.org%2Fwhy%2Feconomic-impact.php%2C+Accessed+November+11%2C+2015."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Koul, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arnoult, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lounis, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guillemont, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andries, K.</span><span> </span><span class="NLM_article-title">The challenge of new drug discovery for tuberculosis</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">469</span><span class="NLM_x"> (</span><span class="NLM_issue">7331</span><span class="NLM_x">) </span> <span class="NLM_fpage">483</span><span class="NLM_x">–</span> <span class="NLM_lpage">490</span><span class="refDoi"> DOI: 10.1038/nature09657</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00415&amp;key=10.1038%2Fnature09657" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=469&publication_year=2011&pages=483-490&issue=7331&author=A.+Koulauthor=E.+Arnoultauthor=N.+Lounisauthor=J.+Guillemontauthor=K.+Andries&title=The+challenge+of+new+drug+discovery+for+tuberculosis&doi=10.1038%2Fnature09657"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1038%2Fnature09657&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature09657%26sid%3Dliteratum%253Aachs%26aulast%3DKoul%26aufirst%3DA.%26aulast%3DArnoult%26aufirst%3DE.%26aulast%3DLounis%26aufirst%3DN.%26aulast%3DGuillemont%26aufirst%3DJ.%26aulast%3DAndries%26aufirst%3DK.%26atitle%3DThe%2520challenge%2520of%2520new%2520drug%2520discovery%2520for%2520tuberculosis%26jtitle%3DNature%26date%3D2011%26volume%3D469%26issue%3D7331%26spage%3D483%26epage%3D490%26doi%3D10.1038%2Fnature09657" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><a href="http://www.newtbdrugs.org/pipeline.php" class="extLink">http://www.newtbdrugs.org/pipeline.php</a>, Accessed November 11,<span class="NLM_x"> </span><span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=http%3A%2F%2Fwww.newtbdrugs.org%2Fpipeline.php%2C+Accessed+November+11%2C+2015."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">U.S. Food and Drug Administration</span><span class="NLM_x">. </span><a href="http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm333695.htm" class="extLink">http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm333695.htm</a> 2012, Accessed November 11,<span class="NLM_x"> </span><span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=U.S.+Food+and+Drug+Administration.+http%3A%2F%2Fwww.fda.gov%2FNewsEvents%2FNewsroom%2FPressAnnouncements%2Fucm333695.htm+2012%2C+Accessed+November+11%2C+2015."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26aulast%3D%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">European Medicines Agency</span><span class="NLM_x">. </span><a href="http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2013/11/news_detail_001972.jsp&amp;mid=WC0b01ac058004d5c1" class="extLink">http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2013/11/news_detail_001972.jsp&mid=WC0b01ac058004d5c1</a> 2013, Accessed November 11,<span class="NLM_x"> </span><span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=European+Medicines+Agency.+http%3A%2F%2Fwww.ema.europa.eu%2Fema%2Findex.jsp%3Fcurl%3Dpages%2Fnews_and_events%2Fnews%2F2013%2F11%2Fnews_detail_001972.jsp%26mid%3DWC0b01ac058004d5c1+2013%2C+Accessed+November+11%2C+2015."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26aulast%3D%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Cox, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laessig, K.</span><span> </span><span class="NLM_article-title">FDA approval of bedaquiline—the benefit-risk balance for drug-resistant tuberculosis</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">371</span><span class="NLM_x"> (</span><span class="NLM_issue">8</span><span class="NLM_x">) </span> <span class="NLM_fpage">689</span><span class="NLM_x">–</span> <span class="NLM_lpage">691</span><span class="refDoi"> DOI: 10.1056/NEJMp1314385</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00415&amp;key=10.1056%2FNEJMp1314385" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00415&amp;key=25140952" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00415&amp;key=1%3ACAS%3A528%3ADC%252BC2MXnvVWltLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=371&publication_year=2014&pages=689-691&issue=8&author=E.+Coxauthor=K.+Laessig&title=FDA+approval+of+bedaquiline%E2%80%94the+benefit-risk+balance+for+drug-resistant+tuberculosis&doi=10.1056%2FNEJMp1314385"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">FDA approval of bedaquiline - the benefit-risk balance for drug-resistant tuberculosis</span></div><div class="casAuthors">Cox, Edward; Laessig, Katherine</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">371</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">689-691</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">1533-4406</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoXrYdnneoFJ7Vg90H21EOLACvtfcHk0ljQmNxgBW98xg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXnvVWltLg%253D&md5=238837d8aa1edd289a3f720a18ccf337</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1056%2FNEJMp1314385&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMp1314385%26sid%3Dliteratum%253Aachs%26aulast%3DCox%26aufirst%3DE.%26aulast%3DLaessig%26aufirst%3DK.%26atitle%3DFDA%2520approval%2520of%2520bedaquiline%25E2%2580%2594the%2520benefit-risk%2520balance%2520for%2520drug-resistant%2520tuberculosis%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2014%26volume%3D371%26issue%3D8%26spage%3D689%26epage%3D691%26doi%3D10.1056%2FNEJMp1314385" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Domenech, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barry, C. E.,  III</span><span> </span><span class="NLM_article-title">Contribution of the <i>Mycobacterium tuberculosis</i> MmpL protein family to virulence and drug resistance</span> <span class="citation_source-journal">Infect. Immun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">73</span><span class="NLM_x"> (</span><span class="NLM_issue">6</span><span class="NLM_x">) </span> <span class="NLM_fpage">3492</span><span class="NLM_x">–</span> <span class="NLM_lpage">3501</span><span class="refDoi"> DOI: 10.1128/IAI.73.6.3492-3501.2005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00415&amp;key=10.1128%2FIAI.73.6.3492-3501.2005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00415&amp;key=15908378" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00415&amp;key=1%3ACAS%3A528%3ADC%252BD2MXkvFCns70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=2005&pages=3492-3501&issue=6&author=P.+Domenechauthor=M.+B.+Reedauthor=C.+E.+Barry&title=Contribution+of+the+Mycobacterium+tuberculosis+MmpL+protein+family+to+virulence+and+drug+resistance&doi=10.1128%2FIAI.73.6.3492-3501.2005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Contribution of the Mycobacterium tuberculosis MmpL protein family to virulence and drug resistance</span></div><div class="casAuthors">Domenech, Pilar; Reed, Michael B.; Barry, Clifton E., III</div><div class="citationInfo"><span class="NLM_cas:title">Infection and Immunity</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">73</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">3492-3501</span>CODEN:
                <span class="NLM_cas:coden">INFIBR</span>;
        ISSN:<span class="NLM_cas:issn">0019-9567</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">The genome sequence of Mycobacterium tuberculosis revealed the presence of 12 membrane proteins proposed to have a function in the transport of lipids.  Insertional inactivation of 11 of these has revealed that only 1 (MmpL3) is apparently essential for viability.  Five of these proteins are conserved within the genome of Mycobacterium leprae.  The drug susceptibilities of these 11 mutants to a broad spectrum of agents are unaltered, suggesting that unlike their function in other organisms, these proteins do not play a significant role in intrinsic drug resistance.  Each of these mutants was assessed for growth kinetics and lethality in a murine low-dose aerosol model of tuberculosis, and four were found to be impaired in one or both measures of virulence.  Two of these, with mutations of MmpL4 and the previously characterized MmpL7, which transports phthiocerol dimycocerosate, were found to have both impaired growth kinetics and impaired lethality.  Mutants with inactivation of MmpL8, which transports a precursor of the sulfatides, or MmpL11, which transports an unknown substrate, were found to establish infection normally but to be significantly attenuated for lethality in time-to-death studies.  These studies support the concept that MmpL-mediated lipid secretion both contributes to the innate ability of the pathogen to survive intracellularly and also contributes directly to the host-pathogen dialogue that dets. the ultimate outcome of infection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp03L6daMmyALVg90H21EOLACvtfcHk0ljQmNxgBW98xg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXkvFCns70%253D&md5=97189c7bd3a6a8c5ca6d9fcac98161a2</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1128%2FIAI.73.6.3492-3501.2005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FIAI.73.6.3492-3501.2005%26sid%3Dliteratum%253Aachs%26aulast%3DDomenech%26aufirst%3DP.%26aulast%3DReed%26aufirst%3DM.%2BB.%26aulast%3DBarry%26aufirst%3DC.%2BE.%26atitle%3DContribution%2520of%2520the%2520Mycobacterium%2520tuberculosis%2520MmpL%2520protein%2520family%2520to%2520virulence%2520and%2520drug%2520resistance%26jtitle%3DInfect.%2520Immun.%26date%3D2005%26volume%3D73%26issue%3D6%26spage%3D3492%26epage%3D3501%26doi%3D10.1128%2FIAI.73.6.3492-3501.2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Owens, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chim, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graves, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harmston, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iniguez, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Contreras, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liptak, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goulding, C. W.</span><span> </span><span class="NLM_article-title">The Mycobacterium tuberculosis secreted protein Rv0203 transfers heme to membrane proteins MmpL3 and MmpL11</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">288</span><span class="NLM_x"> (</span><span class="NLM_issue">30</span><span class="NLM_x">) </span> <span class="NLM_fpage">21714</span><span class="NLM_x">–</span> <span class="NLM_lpage">21728</span><span class="refDoi"> DOI: 10.1074/jbc.M113.453076</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00415&amp;key=10.1074%2Fjbc.M113.453076" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=288&publication_year=2013&pages=21714-21728&issue=30&author=C.+P.+Owensauthor=N.+Chimauthor=A.+B.+Gravesauthor=C.+A.+Harmstonauthor=A.+Iniguezauthor=H.+Contrerasauthor=M.+D.+Liptakauthor=C.+W.+Goulding&title=The+Mycobacterium+tuberculosis+secreted+protein+Rv0203+transfers+heme+to+membrane+proteins+MmpL3+and+MmpL11&doi=10.1074%2Fjbc.M113.453076"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M113.453076&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M113.453076%26sid%3Dliteratum%253Aachs%26aulast%3DOwens%26aufirst%3DC.%2BP.%26aulast%3DChim%26aufirst%3DN.%26aulast%3DGraves%26aufirst%3DA.%2BB.%26aulast%3DHarmston%26aufirst%3DC.%2BA.%26aulast%3DIniguez%26aufirst%3DA.%26aulast%3DContreras%26aufirst%3DH.%26aulast%3DLiptak%26aufirst%3DM.%2BD.%26aulast%3DGoulding%26aufirst%3DC.%2BW.%26atitle%3DThe%2520Mycobacterium%2520tuberculosis%2520secreted%2520protein%2520Rv0203%2520transfers%2520heme%2520to%2520membrane%2520proteins%2520MmpL3%2520and%2520MmpL11%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2013%26volume%3D288%26issue%3D30%26spage%3D21714%26epage%3D21728%26doi%3D10.1074%2Fjbc.M113.453076" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Belisle, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vissa, V. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sievert, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takayama, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brennan, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Besra, G. S.</span><span> </span><span class="NLM_article-title">Role of the major antigen of <i>Mycobacterium tuberculosis</i> in cell wall biogenesis</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">276</span><span class="NLM_x">, </span> <span class="NLM_fpage">1420</span><span class="NLM_x">–</span> <span class="NLM_lpage">1422</span><span class="refDoi"> DOI: 10.1126/science.276.5317.1420</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00415&amp;key=10.1126%2Fscience.276.5317.1420" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00415&amp;key=9162010" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00415&amp;key=1%3ACAS%3A528%3ADyaK2sXjsFOjtLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=276&publication_year=1997&pages=1420-1422&author=J.+T.+Belisleauthor=V.+D.+Vissaauthor=T.+Sievertauthor=K.+Takayamaauthor=P.+J.+Brennanauthor=G.+S.+Besra&title=Role+of+the+major+antigen+of+Mycobacterium+tuberculosis+in+cell+wall+biogenesis&doi=10.1126%2Fscience.276.5317.1420"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10aR"><div class="casContent"><span class="casTitleNuber">10a</span><div class="casTitle"><span class="NLM_cas:atitle">Role of the major antigen of Mycobacterium tuberculosis in cell wall biogenesis</span></div><div class="casAuthors">Belisle, John T.; Vissa, Varalakshmi D.; Sievert, Todd; Takayama, Kuni; Brennan, Patrick J.; Besra, Gurdyal S.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, D. C.)</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">276</span>
        (<span class="NLM_cas:issue">5317</span>),
    <span class="NLM_cas:pages">1420-1422</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">The dominant exported proteins and protective antigens of Mycobacterium tuberculosis are a triad of related gene products called the antigen 85 (Ag85) complex.  Each has also been implicated in disease pathogenesis through its fibronectin-binding capacities.  A carboxylesterase domain was found within the amino acid sequences of Ag85A, B, and C, and each protein acted as a mycolyltransferase involved in the final stages of mycobacterial cell wall assembly, as shown by direct enzyme assay and site-directed mutagenesis.  Furthermore, the use of an antagonist (6-azido-6-deoxy-α,α'-trehalose) of this activity demonstrates that these proteins are essential and potential targets for new antimycobacterial drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoTmxZDea6XgbVg90H21EOLACvtfcHk0liBfVIcEky0mQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXjsFOjtLg%253D&md5=b810258a42304fcb17cd57b2308aee85</span></div><a href="/servlet/linkout?suffix=cit10a&amp;dbid=16384&amp;doi=10.1126%2Fscience.276.5317.1420&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.276.5317.1420%26sid%3Dliteratum%253Aachs%26aulast%3DBelisle%26aufirst%3DJ.%2BT.%26aulast%3DVissa%26aufirst%3DV.%2BD.%26aulast%3DSievert%26aufirst%3DT.%26aulast%3DTakayama%26aufirst%3DK.%26aulast%3DBrennan%26aufirst%3DP.%2BJ.%26aulast%3DBesra%26aufirst%3DG.%2BS.%26atitle%3DRole%2520of%2520the%2520major%2520antigen%2520of%2520Mycobacterium%2520tuberculosis%2520in%2520cell%2520wall%2520biogenesis%26jtitle%3DScience%26date%3D1997%26volume%3D276%26spage%3D1420%26epage%3D1422%26doi%3D10.1126%2Fscience.276.5317.1420" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit10b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Puech, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guilhot, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perez, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tropis, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Armitige, L. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gicquel, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daffé, M.</span><span> </span><span class="NLM_article-title">, Evidence for a partial redundancy of the fibronectin-binding proteins for the transfer of mycoloyl residues onto the cell wall arabinogalactan termini of <i>Mycobacterium tuberculosis</i></span> <span class="citation_source-journal">Mol. Microbiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">1109</span><span class="NLM_x">–</span> <span class="NLM_lpage">1122</span><span class="refDoi"> DOI: 10.1046/j.1365-2958.2002.02953.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00415&amp;key=10.1046%2Fj.1365-2958.2002.02953.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00415&amp;key=12010501" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00415&amp;key=1%3ACAS%3A528%3ADC%252BD38XktlGgsLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2002&pages=1109-1122&author=V.+Puechauthor=C.+Guilhotauthor=E.+Perezauthor=M.+Tropisauthor=L.+Y.+Armitigeauthor=B.+Gicquelauthor=M.+Daff%C3%A9&title=%2C+Evidence+for+a+partial+redundancy+of+the+fibronectin-binding+proteins+for+the+transfer+of+mycoloyl+residues+onto+the+cell+wall+arabinogalactan+termini+of+Mycobacterium+tuberculosis&doi=10.1046%2Fj.1365-2958.2002.02953.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10bR"><div class="casContent"><span class="casTitleNuber">10b</span><div class="casTitle"><span class="NLM_cas:atitle">Evidence for a partial redundancy of the fibronectin-binding proteins for the transfer of mycoloyl residues onto the cell wall arabinogalactan termini of Mycobacterium tuberculosis</span></div><div class="casAuthors">Puech, Virginie; Guilhot, Christophe; Perez, Esther; Tropis, Marielle; Armitige, Lisa Y.; Gicquel, Brigitte; Daffe, Mamadou</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Microbiology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1109-1122</span>CODEN:
                <span class="NLM_cas:coden">MOMIEE</span>;
        ISSN:<span class="NLM_cas:issn">0950-382X</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Science Ltd.</span>)
        </div><div class="casAbstract">M. tuberculosis produces a series of major secreted proteins, the fibronectin-binding proteins (Fbps), also known as the antigen 85 complex, that are believed to play an essential role in the pathogenesis of tuberculosis through their mycoloyltransferase activity required for maintaining the integrity of the bacterial cell envelope.  Four different fbp genes are found in the genome of M. tuberculosis, but the reason for the existence of these Fbps sharing the same substrate specificity in vitro in mycobacteria is unknown.  We have shown previously that, in the heterologous host, Corynebacterium glutamicum, FbpA, FbpB and FbpC can all add mycoloyl residues to the cell wall arabinogalactan and that, in M. tuberculosis, the cell wall mycoloylation decreases by 40% when fbpC is knocked out.  To investigate whether the remaining 60% mycoloylation came from the activity of FbpA and/or FbpB, fbpA- and fbpB-inactivated mutant strains were biochem. characterized and compared with the previously studied fbpC-disrupted mutant.  Unexpectedly, both mutants produced normally mycoloylated cell walls.  Overprodn. of FbpA, FbpB or FbpC, but not FbpD, in the fbpC-inactivated mutant strain of M. tuberculosis restored both the cell wall-linked mycolate defect and the outer cell envelope permeability barrier property.  These results are consistent with all 3 enzymes being involved in cell wall mycoloylation and FbpC playing a more crit. role than the others or, alternatively, FbpC is able to compensate for FbpA and FbpB in ways that these enzymes cannot compensate for FbpC, pointing to a partial redundancy of Fbps.  In sharp contrast, FbpD does not appear to be an active mycoloyltransferase enzyme, as it cannot complement the fbpC-inactivated mutant.  Most importantly, application of Smith degrdn. to the cell walls of transformants demonstrated that the multiple Fbp enzymes are redundant rather than specific for the various arabinogalactan mycoloylation regions.  Neither FbpA nor FbpB attaches mycoloyl residues to specific sites but, like FbpC, each enzyme transfers mycoloyl residues onto the 4 sites present in the arabinogalactan non-reducing end hexaarabinosides.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGprs9TH3THPLrVg90H21EOLACvtfcHk0ljZzHYtOi7YvQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XktlGgsLo%253D&md5=5335adf86936032ddfd1aac59335c7bb</span></div><a href="/servlet/linkout?suffix=cit10b&amp;dbid=16384&amp;doi=10.1046%2Fj.1365-2958.2002.02953.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1365-2958.2002.02953.x%26sid%3Dliteratum%253Aachs%26aulast%3DPuech%26aufirst%3DV.%26aulast%3DGuilhot%26aufirst%3DC.%26aulast%3DPerez%26aufirst%3DE.%26aulast%3DTropis%26aufirst%3DM.%26aulast%3DArmitige%26aufirst%3DL.%2BY.%26aulast%3DGicquel%26aufirst%3DB.%26aulast%3DDaff%25C3%25A9%26aufirst%3DM.%26atitle%3D%252C%2520Evidence%2520for%2520a%2520partial%2520redundancy%2520of%2520the%2520fibronectin-binding%2520proteins%2520for%2520the%2520transfer%2520of%2520mycoloyl%2520residues%2520onto%2520the%2520cell%2520wall%2520arabinogalactan%2520termini%2520of%2520Mycobacterium%2520tuberculosis%26jtitle%3DMol.%2520Microbiol.%26date%3D2002%26volume%3D44%26spage%3D1109%26epage%3D1122%26doi%3D10.1046%2Fj.1365-2958.2002.02953.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Kalscheuer, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weinrick, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Veeraraghavan, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Besra, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobs, W. R. J.</span><span> </span><span class="NLM_article-title">Trehalose-recycling ABC transporter LpqY-SugA-SugB-SugC is essential for virulence of <i>Mycobacterium tuberculosis</i></span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">107</span><span class="NLM_x"> (</span><span class="NLM_issue">50</span><span class="NLM_x">) </span> <span class="NLM_fpage">21761</span><span class="NLM_x">–</span> <span class="NLM_lpage">21766</span><span class="refDoi"> DOI: 10.1073/pnas.1014642108</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00415&amp;key=10.1073%2Fpnas.1014642108" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=107&publication_year=2010&pages=21761-21766&issue=50&author=R.+Kalscheuerauthor=B.+Weinrickauthor=U.+Veeraraghavanauthor=G.+S.+Besraauthor=W.+R.+J.+Jacobs&title=Trehalose-recycling+ABC+transporter+LpqY-SugA-SugB-SugC+is+essential+for+virulence+of+Mycobacterium+tuberculosis&doi=10.1073%2Fpnas.1014642108"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1014642108&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1014642108%26sid%3Dliteratum%253Aachs%26aulast%3DKalscheuer%26aufirst%3DR.%26aulast%3DWeinrick%26aufirst%3DB.%26aulast%3DVeeraraghavan%26aufirst%3DU.%26aulast%3DBesra%26aufirst%3DG.%2BS.%26aulast%3DJacobs%26aufirst%3DW.%2BR.%2BJ.%26atitle%3DTrehalose-recycling%2520ABC%2520transporter%2520LpqY-SugA-SugB-SugC%2520is%2520essential%2520for%2520virulence%2520of%2520Mycobacterium%2520tuberculosis%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2010%26volume%3D107%26issue%3D50%26spage%3D21761%26epage%3D21766%26doi%3D10.1073%2Fpnas.1014642108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Cole, S. T.</span><span> </span><span class="NLM_article-title">Infectious diseases: transporter targeted in tuberculosis</span> <span class="citation_source-journal">Nat. Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">326</span><span class="NLM_x">–</span> <span class="NLM_lpage">327</span><span class="refDoi"> DOI: 10.1038/nchembio.918</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00415&amp;key=10.1038%2Fnchembio.918" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00415&amp;key=22426192" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00415&amp;key=1%3ACAS%3A528%3ADC%252BC38XktVaku70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2012&pages=326-327&author=S.+T.+Cole&title=Infectious+diseases%3A+transporter+targeted+in+tuberculosis&doi=10.1038%2Fnchembio.918"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Infectious diseases Transporter targeted in tuberculosis</span></div><div class="casAuthors">Cole, Stewart T.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">326-327</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The cell wall of tubercle bacilli is targeted by many drugs.  A new adamantyl urea compd. unveils MmpL3, a member of the resistance, nodulation, and division protein family, as the long-sought trehalose monomycolate transporter, essential for translocation of mycolic acids into the cell envelope.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGok4notky3RHrVg90H21EOLACvtfcHk0ljZzHYtOi7YvQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XktVaku70%253D&md5=9335f1db7767be2e9b3ec08d60f0dd53</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.918&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.918%26sid%3Dliteratum%253Aachs%26aulast%3DCole%26aufirst%3DS.%2BT.%26atitle%3DInfectious%2520diseases%253A%2520transporter%2520targeted%2520in%2520tuberculosis%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2012%26volume%3D8%26spage%3D326%26epage%3D327%26doi%3D10.1038%2Fnchembio.918" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Tullius, M. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harmston, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Owens, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chim, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morse, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McMath, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iniguez, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kimmey, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sawaya, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whitelegge, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horwitz, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goulding, C. W.</span><span> </span><span class="NLM_article-title">Discovery and characterization of a unique mycobacterial heme acquisition system</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">108</span><span class="NLM_x"> (</span><span class="NLM_issue">12</span><span class="NLM_x">) </span> <span class="NLM_fpage">5051</span><span class="NLM_x">–</span> <span class="NLM_lpage">5056</span><span class="refDoi"> DOI: 10.1073/pnas.1009516108</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00415&amp;key=10.1073%2Fpnas.1009516108" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00415&amp;key=21383189" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00415&amp;key=1%3ACAS%3A528%3ADC%252BC3MXktVChsbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=108&publication_year=2011&pages=5051-5056&issue=12&author=M.+V.+Tulliusauthor=C.+A.+Harmstonauthor=C.+P.+Owensauthor=N.+Chimauthor=R.+P.+Morseauthor=L.+M.+McMathauthor=A.+Iniguezauthor=J.+M.+Kimmeyauthor=M.+R.+Sawayaauthor=J.+P.+Whiteleggeauthor=M.+A.+Horwitzauthor=C.+W.+Goulding&title=Discovery+and+characterization+of+a+unique+mycobacterial+heme+acquisition+system&doi=10.1073%2Fpnas.1009516108"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and characterization of a unique mycobacterial heme acquisition system</span></div><div class="casAuthors">Tullius, Michael V.; Harmston, Christine A.; Owens, Cedric P.; Chim, Nicholas; Morse, Robert P.; McMath, Lisa M.; Iniguez, Angelina; Kimmey, Jacqueline M.; Sawaya, Michael R.; Whitelegge, Julian P.; Horwitz, Marcus A.; Goulding, Celia W.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">108</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">5051-5056, S5051/1-S5051/18</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Mycobacterium tuberculosis must import iron from its host for survival, and its siderophore-dependent iron acquisition pathways are well established.  Here we demonstrate a newly characterized pathway, whereby M. tuberculosis can use free heme and heme from Hb as an iron source.  Significantly, we identified the genomic region, Rv0202c-Rv0207c, responsible for the passage of heme iron across the mycobacterial membrane.  Key players of this heme uptake system were characterized including a secreted protein and two transmembrane proteins, all three specific to mycobacteria.  Furthermore, the crystal structure of the key heme carrier protein Rv0203 was found to have a unique fold.  The discovery of a unique mycobacterial heme acquisition pathway opens new avenues of exploration into mycobacterial therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqI_2E5hobkjbVg90H21EOLACvtfcHk0lixyoc59Lz9Iw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXktVChsbw%253D&md5=ed7cbd79a3ed917f9dab3a86f306962d</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1009516108&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1009516108%26sid%3Dliteratum%253Aachs%26aulast%3DTullius%26aufirst%3DM.%2BV.%26aulast%3DHarmston%26aufirst%3DC.%2BA.%26aulast%3DOwens%26aufirst%3DC.%2BP.%26aulast%3DChim%26aufirst%3DN.%26aulast%3DMorse%26aufirst%3DR.%2BP.%26aulast%3DMcMath%26aufirst%3DL.%2BM.%26aulast%3DIniguez%26aufirst%3DA.%26aulast%3DKimmey%26aufirst%3DJ.%2BM.%26aulast%3DSawaya%26aufirst%3DM.%2BR.%26aulast%3DWhitelegge%26aufirst%3DJ.%2BP.%26aulast%3DHorwitz%26aufirst%3DM.%2BA.%26aulast%3DGoulding%26aufirst%3DC.%2BW.%26atitle%3DDiscovery%2520and%2520characterization%2520of%2520a%2520unique%2520mycobacterial%2520heme%2520acquisition%2520system%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2011%26volume%3D108%26issue%3D12%26spage%3D5051%26epage%3D5056%26doi%3D10.1073%2Fpnas.1009516108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Li, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Upadhyay, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fontes, F. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">North, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crans, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grzegorzewicz, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Franzblau, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crick, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jackson, M.</span><span> </span><span class="NLM_article-title">Novel insights into the mechanism of inhibition of MmpL3, a target of multiple pharmacophores in <i>Mycobacterium tuberculosis</i></span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x"> (</span><span class="NLM_issue">11</span><span class="NLM_x">) </span> <span class="NLM_fpage">6413</span><span class="NLM_x">–</span> <span class="NLM_lpage">6423</span><span class="refDoi"> DOI: 10.1128/AAC.03229-14</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00415&amp;key=10.1128%2FAAC.03229-14" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2014&pages=6413-6423&issue=11&author=W.+Liauthor=A.+Upadhyayauthor=F.+L.+Fontesauthor=E.+J.+Northauthor=Y.+Wangauthor=D.+C.+Cransauthor=A.+E.+Grzegorzewiczauthor=V.+Jonesauthor=S.+G.+Franzblauauthor=R.+E.+Leeauthor=D.+C.+Crickauthor=M.+Jackson&title=Novel+insights+into+the+mechanism+of+inhibition+of+MmpL3%2C+a+target+of+multiple+pharmacophores+in+Mycobacterium+tuberculosis&doi=10.1128%2FAAC.03229-14"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1128%2FAAC.03229-14&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.03229-14%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DW.%26aulast%3DUpadhyay%26aufirst%3DA.%26aulast%3DFontes%26aufirst%3DF.%2BL.%26aulast%3DNorth%26aufirst%3DE.%2BJ.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DCrans%26aufirst%3DD.%2BC.%26aulast%3DGrzegorzewicz%26aufirst%3DA.%2BE.%26aulast%3DJones%26aufirst%3DV.%26aulast%3DFranzblau%26aufirst%3DS.%2BG.%26aulast%3DLee%26aufirst%3DR.%2BE.%26aulast%3DCrick%26aufirst%3DD.%2BC.%26aulast%3DJackson%26aufirst%3DM.%26atitle%3DNovel%2520insights%2520into%2520the%2520mechanism%2520of%2520inhibition%2520of%2520MmpL3%252C%2520a%2520target%2520of%2520multiple%2520pharmacophores%2520in%2520Mycobacterium%2520tuberculosis%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2014%26volume%3D58%26issue%3D11%26spage%3D6413%26epage%3D6423%26doi%3D10.1128%2FAAC.03229-14" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Onajole, O. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pieroni, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tipparaju, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lun, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stec, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gunosewoyo, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ammerman, N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bishai, W. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kozikowski, A. P.</span><span> </span><span class="NLM_article-title">Preliminary structure-activity relationships and biological evaluation of novel antitubercular indolecarboxamide derivatives against drug-susceptible and drug-resistant <i>Mycobacterium tuberculosis</i> strains</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x"> (</span><span class="NLM_issue">10</span><span class="NLM_x">) </span> <span class="NLM_fpage">4093</span><span class="NLM_x">–</span> <span class="NLM_lpage">4103</span><span class="refDoi"> DOI: 10.1021/jm4003878</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm4003878" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=4093-4103&issue=10&author=O.+K.+Onajoleauthor=M.+Pieroniauthor=S.+K.+Tipparajuauthor=S.+Lunauthor=J.+Stecauthor=G.+Chenauthor=H.+Gunosewoyoauthor=H.+Guoauthor=N.+C.+Ammermanauthor=W.+R.+Bishaiauthor=A.+P.+Kozikowski&title=Preliminary+structure-activity+relationships+and+biological+evaluation+of+novel+antitubercular+indolecarboxamide+derivatives+against+drug-susceptible+and+drug-resistant+Mycobacterium+tuberculosis+strains&doi=10.1021%2Fjm4003878"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1021%2Fjm4003878&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm4003878%26sid%3Dliteratum%253Aachs%26aulast%3DOnajole%26aufirst%3DO.%2BK.%26aulast%3DPieroni%26aufirst%3DM.%26aulast%3DTipparaju%26aufirst%3DS.%2BK.%26aulast%3DLun%26aufirst%3DS.%26aulast%3DStec%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DG.%26aulast%3DGunosewoyo%26aufirst%3DH.%26aulast%3DGuo%26aufirst%3DH.%26aulast%3DAmmerman%26aufirst%3DN.%2BC.%26aulast%3DBishai%26aufirst%3DW.%2BR.%26aulast%3DKozikowski%26aufirst%3DA.%2BP.%26atitle%3DPreliminary%2520structure-activity%2520relationships%2520and%2520biological%2520evaluation%2520of%2520novel%2520antitubercular%2520indolecarboxamide%2520derivatives%2520against%2520drug-susceptible%2520and%2520drug-resistant%2520Mycobacterium%2520tuberculosis%2520strains%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26issue%3D10%26spage%3D4093%26epage%3D4103%26doi%3D10.1021%2Fjm4003878" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Lun, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Onajole, O. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pieroni, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gunosewoyo, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tipparaju, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ammerman, N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kozikowski, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bishai, W. R.</span><span> </span><span class="NLM_article-title">Indoleamides are active against drug-resistant <i>Mycobacterium tuberculosis</i></span> <span class="citation_source-journal">Nat. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">2907</span><span class="refDoi"> DOI: 10.1038/ncomms3907</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00415&amp;key=10.1038%2Fncomms3907" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00415&amp;key=24352433" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00415&amp;key=1%3ACAS%3A280%3ADC%252BC2c3oslKgtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=2907&author=S.+Lunauthor=H.+Guoauthor=O.+K.+Onajoleauthor=M.+Pieroniauthor=H.+Gunosewoyoauthor=G.+Chenauthor=S.+K.+Tipparajuauthor=N.+C.+Ammermanauthor=A.+P.+Kozikowskiauthor=W.+R.+Bishai&title=Indoleamides+are+active+against+drug-resistant+Mycobacterium+tuberculosis&doi=10.1038%2Fncomms3907"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Indoleamides are active against drug-resistant Mycobacterium tuberculosis</span></div><div class="casAuthors">Lun Shichun; Guo Haidan; Onajole Oluseye K; Gunosewoyo Hendra; Chen Gang; Kozikowski Alan P; Pieroni Marco; Tipparaju Suresh K; Ammerman Nicole C; Bishai William R</div><div class="citationInfo"><span class="NLM_cas:title">Nature communications</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">2907</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Responsible for nearly two million deaths each year, the infectious disease tuberculosis remains a serious global health challenge.  The emergence of multidrug- and extensively drug-resistant strains of Mycobacterium tuberculosis confounds control efforts, and new drugs with novel molecular targets are desperately needed.  Here we describe lead compounds, the indoleamides, with potent activity against both drug-susceptible and drug-resistant strains of M. tuberculosis by targeting the mycolic acid transporter MmpL3.  We identify a single mutation in mmpL3, which confers high resistance to the indoleamide class while remaining susceptible to currently used first- and second-line tuberculosis drugs, indicating a lack of cross-resistance.  Importantly, an indoleamide derivative exhibits dose-dependent antimycobacterial activity when orally administered to M. tuberculosis-infected mice.  The bioavailability of the indoleamides, combined with their ability to kill tubercle bacilli, indicates great potential for translational developments of this structure class for the treatment of drug-resistant tuberculosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR4ame_FVdejL7NkxioyDXTfW6udTcc2eaE7_Z2MYOvNrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2c3oslKgtw%253D%253D&md5=29323f5b10dff540b38973491545d1c5</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1038%2Fncomms3907&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms3907%26sid%3Dliteratum%253Aachs%26aulast%3DLun%26aufirst%3DS.%26aulast%3DGuo%26aufirst%3DH.%26aulast%3DOnajole%26aufirst%3DO.%2BK.%26aulast%3DPieroni%26aufirst%3DM.%26aulast%3DGunosewoyo%26aufirst%3DH.%26aulast%3DChen%26aufirst%3DG.%26aulast%3DTipparaju%26aufirst%3DS.%2BK.%26aulast%3DAmmerman%26aufirst%3DN.%2BC.%26aulast%3DKozikowski%26aufirst%3DA.%2BP.%26aulast%3DBishai%26aufirst%3DW.%2BR.%26atitle%3DIndoleamides%2520are%2520active%2520against%2520drug-resistant%2520Mycobacterium%2520tuberculosis%26jtitle%3DNat.%2520Commun.%26date%3D2013%26volume%3D4%26spage%3D2907%26doi%3D10.1038%2Fncomms3907" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref100"><div class="reference"><strong class="refLabel"><a href="#ref100" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit100"><span><span class="NLM_contrib-group">Bishai, W.R.; Lun, S.; Guo, H.; Kozikowski, A.; Onajole, O.; Stec, J.</span><span> </span><span class="NLM_article-title">Inhibitors of drug-resistant mycobacterium tuberculosis</span>. WO/2015/164482</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Bishai%2C+W.R.%3B+Lun%2C+S.%3B+Guo%2C+H.%3B+Kozikowski%2C+A.%3B+Onajole%2C+O.%3B+Stec%2C+J.+Inhibitors+of+drug-resistant+mycobacterium+tuberculosis.+WO%2F2015%2F164482"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit100&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBishai%26aufirst%3DW.R.%26atitle%3DInhibitors%2520of%2520drug-resistant%2520mycobacterium%2520tuberculosis" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit17a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Andrews, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parks, L. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spence, K. D.</span><span> </span><span class="NLM_article-title">Some effects of douglas fir terpenes on certain microorganisms</span> <span class="citation_source-journal">Appl. Environ. Microbiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1980</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">301</span><span class="NLM_x">–</span> <span class="NLM_lpage">304</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=1980&pages=301-304&issue=2&author=R.+E.+Andrewsauthor=L.+W.+Parksauthor=K.+D.+Spence&title=Some+effects+of+douglas+fir+terpenes+on+certain+microorganisms"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAndrews%26aufirst%3DR.%2BE.%26aulast%3DParks%26aufirst%3DL.%2BW.%26aulast%3DSpence%26aufirst%3DK.%2BD.%26atitle%3DSome%2520effects%2520of%2520douglas%2520fir%2520terpenes%2520on%2520certain%2520microorganisms%26jtitle%3DAppl.%2520Environ.%2520Microbiol.%26date%3D1980%26volume%3D40%26issue%3D2%26spage%3D301%26epage%3D304" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit17b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Sikkema, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Bont, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poolman, B.</span><span> </span><span class="NLM_article-title">Mechanisms of membrane toxicity of hydrocarbons</span> <span class="citation_source-journal">Microbiol Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">201</span><span class="NLM_x">–</span> <span class="NLM_lpage">222</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00415&amp;key=10.1128%2FMMBR.59.2.201-222.1995" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00415&amp;key=7603409" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00415&amp;key=1%3ACAS%3A528%3ADyaK2MXms1SntLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=1995&pages=201-222&issue=2&author=J.+Sikkemaauthor=J.+A.+de+Bontauthor=B.+Poolman&title=Mechanisms+of+membrane+toxicity+of+hydrocarbons"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17bR"><div class="casContent"><span class="casTitleNuber">18b</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanisms of membrane toxicity of hydrocarbons</span></div><div class="casAuthors">Sikkema, Jan; de Bont, Jan A. M.; Poolman, Bert</div><div class="citationInfo"><span class="NLM_cas:title">Microbiological Reviews</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">201-22</span>CODEN:
                <span class="NLM_cas:coden">MBRED3</span>;
        ISSN:<span class="NLM_cas:issn">0146-0749</span>.
    </div><div class="casAbstract">A review and discussion with 366 refs. on the toxicity of cyclic hydrocarbons to microorganisms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoY_TX2o7EQsLVg90H21EOLACvtfcHk0lhgZG1bV-Ljxg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXms1SntLw%253D&md5=a43ce359b8dcf9e3967368dcadfccc54</span></div><a href="/servlet/linkout?suffix=cit17b&amp;dbid=16384&amp;doi=10.1128%2FMMBR.59.2.201-222.1995&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMMBR.59.2.201-222.1995%26sid%3Dliteratum%253Aachs%26aulast%3DSikkema%26aufirst%3DJ.%26aulast%3Dde%2BBont%26aufirst%3DJ.%2BA.%26aulast%3DPoolman%26aufirst%3DB.%26atitle%3DMechanisms%2520of%2520membrane%2520toxicity%2520of%2520hydrocarbons%26jtitle%3DMicrobiol%2520Rev.%26date%3D1995%26volume%3D59%26issue%3D2%26spage%3D201%26epage%3D222" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Kondreddi, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiricek, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rao, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lakshminarayana, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Camacho, L. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rao, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herve, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bifani, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, N. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuhen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goh, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chatterjee, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dick, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diagana, T. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manjunatha, U. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, P. W.</span><span> </span><span class="NLM_article-title">Design, synthesis, and biological evaluation of indole-2-carboxamides: a promising class of antituberculosis agents</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x"> (</span><span class="NLM_issue">21</span><span class="NLM_x">) </span> <span class="NLM_fpage">8849</span><span class="NLM_x">–</span> <span class="NLM_lpage">8859</span><span class="refDoi"> DOI: 10.1021/jm4012774</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm4012774" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=8849-8859&issue=21&author=R.+R.+Kondreddiauthor=J.+Jiricekauthor=S.+P.+Raoauthor=S.+B.+Lakshminarayanaauthor=L.+R.+Camachoauthor=R.+Raoauthor=M.+Herveauthor=P.+Bifaniauthor=N.+L.+Maauthor=K.+Kuhenauthor=A.+Gohauthor=A.+K.+Chatterjeeauthor=T.+Dickauthor=T.+T.+Diaganaauthor=U.+H.+Manjunathaauthor=P.+W.+Smith&title=Design%2C+synthesis%2C+and+biological+evaluation+of+indole-2-carboxamides%3A+a+promising+class+of+antituberculosis+agents&doi=10.1021%2Fjm4012774"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Fjm4012774&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm4012774%26sid%3Dliteratum%253Aachs%26aulast%3DKondreddi%26aufirst%3DR.%2BR.%26aulast%3DJiricek%26aufirst%3DJ.%26aulast%3DRao%26aufirst%3DS.%2BP.%26aulast%3DLakshminarayana%26aufirst%3DS.%2BB.%26aulast%3DCamacho%26aufirst%3DL.%2BR.%26aulast%3DRao%26aufirst%3DR.%26aulast%3DHerve%26aufirst%3DM.%26aulast%3DBifani%26aufirst%3DP.%26aulast%3DMa%26aufirst%3DN.%2BL.%26aulast%3DKuhen%26aufirst%3DK.%26aulast%3DGoh%26aufirst%3DA.%26aulast%3DChatterjee%26aufirst%3DA.%2BK.%26aulast%3DDick%26aufirst%3DT.%26aulast%3DDiagana%26aufirst%3DT.%2BT.%26aulast%3DManjunatha%26aufirst%3DU.%2BH.%26aulast%3DSmith%26aufirst%3DP.%2BW.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520biological%2520evaluation%2520of%2520indole-2-carboxamides%253A%2520a%2520promising%2520class%2520of%2520antituberculosis%2520agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26issue%3D21%26spage%3D8849%26epage%3D8859%26doi%3D10.1021%2Fjm4012774" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Rao, S. P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lakshminarayana, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kondreddi, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herve, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Camacho, L. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bifani, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalapala, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiricek, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, N. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tan, B. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ng, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nanjundappa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ravindran, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seah, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thayalan, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lim, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, B. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goh, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barnes, W. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gagaring, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chatterjee, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pethe, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuhen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feng, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Babu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blasco, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beer, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weaver, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dartois, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glynne, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dick, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, P. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diagana, T. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manjunatha, U. H.</span><span> </span><span class="NLM_article-title">Indolcarboxamide is a preclinical candidate for treating multidrug-resistant tuberculosis</span> <span class="citation_source-journal">Sci. Transl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x"> (</span><span class="NLM_issue">214</span><span class="NLM_x">) </span> <span class="NLM_fpage">214ra168</span><span class="refDoi"> DOI: 10.1126/scitranslmed.3007355</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00415&amp;key=10.1126%2Fscitranslmed.3007355" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00415&amp;key=24307692" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2013&pages=214ra168&issue=214&author=S.+P.+S.+Raoauthor=S.+B.+Lakshminarayanaauthor=R.+R.+Kondreddiauthor=M.+Herveauthor=L.+R.+Camachoauthor=P.+Bifaniauthor=S.+K.+Kalapalaauthor=J.+Jiricekauthor=N.+L.+Maauthor=B.+H.+Tanauthor=S.+H.+Ngauthor=M.+Nanjundappaauthor=S.+Ravindranauthor=P.+G.+Seahauthor=P.+Thayalanauthor=S.+H.+Limauthor=B.+H.+Leeauthor=A.+Gohauthor=W.+S.+Barnesauthor=Z.+Chenauthor=K.+Gagaringauthor=A.+K.+Chatterjeeauthor=K.+Petheauthor=K.+Kuhenauthor=J.+Walkerauthor=G.+Fengauthor=S.+Babuauthor=L.+Zhangauthor=F.+Blascoauthor=D.+Beerauthor=M.+Weaverauthor=V.+Dartoisauthor=R.+Glynneauthor=T.+Dickauthor=P.+W.+Smithauthor=T.+T.+Diaganaauthor=U.+H.+Manjunatha&title=Indolcarboxamide+is+a+preclinical+candidate+for+treating+multidrug-resistant+tuberculosis&doi=10.1126%2Fscitranslmed.3007355"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1126%2Fscitranslmed.3007355&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscitranslmed.3007355%26sid%3Dliteratum%253Aachs%26aulast%3DRao%26aufirst%3DS.%2BP.%2BS.%26aulast%3DLakshminarayana%26aufirst%3DS.%2BB.%26aulast%3DKondreddi%26aufirst%3DR.%2BR.%26aulast%3DHerve%26aufirst%3DM.%26aulast%3DCamacho%26aufirst%3DL.%2BR.%26aulast%3DBifani%26aufirst%3DP.%26aulast%3DKalapala%26aufirst%3DS.%2BK.%26aulast%3DJiricek%26aufirst%3DJ.%26aulast%3DMa%26aufirst%3DN.%2BL.%26aulast%3DTan%26aufirst%3DB.%2BH.%26aulast%3DNg%26aufirst%3DS.%2BH.%26aulast%3DNanjundappa%26aufirst%3DM.%26aulast%3DRavindran%26aufirst%3DS.%26aulast%3DSeah%26aufirst%3DP.%2BG.%26aulast%3DThayalan%26aufirst%3DP.%26aulast%3DLim%26aufirst%3DS.%2BH.%26aulast%3DLee%26aufirst%3DB.%2BH.%26aulast%3DGoh%26aufirst%3DA.%26aulast%3DBarnes%26aufirst%3DW.%2BS.%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DGagaring%26aufirst%3DK.%26aulast%3DChatterjee%26aufirst%3DA.%2BK.%26aulast%3DPethe%26aufirst%3DK.%26aulast%3DKuhen%26aufirst%3DK.%26aulast%3DWalker%26aufirst%3DJ.%26aulast%3DFeng%26aufirst%3DG.%26aulast%3DBabu%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DBlasco%26aufirst%3DF.%26aulast%3DBeer%26aufirst%3DD.%26aulast%3DWeaver%26aufirst%3DM.%26aulast%3DDartois%26aufirst%3DV.%26aulast%3DGlynne%26aufirst%3DR.%26aulast%3DDick%26aufirst%3DT.%26aulast%3DSmith%26aufirst%3DP.%2BW.%26aulast%3DDiagana%26aufirst%3DT.%2BT.%26aulast%3DManjunatha%26aufirst%3DU.%2BH.%26atitle%3DIndolcarboxamide%2520is%2520a%2520preclinical%2520candidate%2520for%2520treating%2520multidrug-resistant%2520tuberculosis%26jtitle%3DSci.%2520Transl.%2520Med.%26date%3D2013%26volume%3D5%26issue%3D214%26spage%3D214ra168%26doi%3D10.1126%2Fscitranslmed.3007355" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Chopra, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsuyama, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tran, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malerich, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wan, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Franzblau, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lun, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maiga, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bishai, W. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Madrid, P. B.</span><span> </span><span class="NLM_article-title">Evaluation of gyrase B as a drug target in <i>Mycobacterium tuberculosis</i></span> <span class="citation_source-journal">J. Antimicrob. Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">415</span><span class="NLM_x">–</span> <span class="NLM_lpage">421</span><span class="refDoi"> DOI: 10.1093/jac/dkr449</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00415&amp;key=10.1093%2Fjac%2Fdkr449" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00415&amp;key=22052686" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00415&amp;key=1%3ACAS%3A528%3ADC%252BC38Xos12qsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2012&pages=415-421&author=S.+Chopraauthor=K.+Matsuyamaauthor=T.+Tranauthor=J.+P.+Malerichauthor=B.+Wanauthor=S.+G.+Franzblauauthor=S.+Lunauthor=H.+Guoauthor=M.+C.+Maigaauthor=W.+R.+Bishaiauthor=P.+B.+Madrid&title=Evaluation+of+gyrase+B+as+a+drug+target+in+Mycobacterium+tuberculosis&doi=10.1093%2Fjac%2Fdkr449"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Evaluation of gyrase B as a drug target in Mycobacterium tuberculosis</span></div><div class="casAuthors">Chopra, Sidharth; Matsuyama, Karen; Tran, Tran; Malerich, Jeremiah P.; Wan, Baojie; Franzblau, Scott G.; Lun, Shichun; Guo, Haidan; Maiga, Mariama C.; Bishai, William R.; Madrid, Peter B.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Antimicrobial Chemotherapy</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">415-421</span>CODEN:
                <span class="NLM_cas:coden">JACHDX</span>;
        ISSN:<span class="NLM_cas:issn">0305-7453</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">New classes of drugs are needed to treat tuberculosis (TB) in order to combat the emergence of resistance to existing agents and shorten the duration of therapy.  Targeting DNA gyrase is a clin. validated therapeutic approach using fluoroquinolone antibiotics to target the gyrase subunit A (GyrA) of the heterotetramer.  Increasing resistance to fluoroquinolones has driven interest in targeting the gyrase subunit B (GyrB), which has not been targeted for TB.  The biol. activities of two potent small-mol. inhibitors of GyrB have been characterized to validate its targeting as a therapeutic strategy for treating TB.  Novobiocin and aminobenzimidazole 1 (AB-1) were tested for their activity against Mycobacterium tuberculosis (Mtb) H37Rv and other mycobacteria.  AB-1 and novobiocin were also evaluated for their interaction with rifampicin and isoniazid as well as their potential for cytotoxicity.  Finally, AB-1 was tested for in vivo efficacy in a murine model of TB.  Novobiocin and AB-1 have both been shown to be active against Mtb with MIC values of 4 and 1 mg/L, resp.  Only AB-1 exhibited time-dependent bactericidal activity against drug-susceptible and drug-resistant mycobacteria, including a fluoroquinolone-resistant strain.  AB-1 had potent activity in the low oxygen recovery assay model for non-replicating persistent Mtb.  Addnl., AB-1 has no interaction with isoniazid and rifampicin, and has no cross-resistance with fluoroquinolones.  In a murine model of TB, AB-1 significantly reduced lung cfu counts in a dose-dependent manner.  Aminobenzimidazole inhibitors of GyrB exhibit many of the characteristics required for their consideration as a potential front-line antimycobacterial therapeutic.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr5lZPib9RqPrVg90H21EOLACvtfcHk0lgYBVn0hO0laA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xos12qsA%253D%253D&md5=61bac9b95aaf29c157f4eedeaf306561</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1093%2Fjac%2Fdkr449&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjac%252Fdkr449%26sid%3Dliteratum%253Aachs%26aulast%3DChopra%26aufirst%3DS.%26aulast%3DMatsuyama%26aufirst%3DK.%26aulast%3DTran%26aufirst%3DT.%26aulast%3DMalerich%26aufirst%3DJ.%2BP.%26aulast%3DWan%26aufirst%3DB.%26aulast%3DFranzblau%26aufirst%3DS.%2BG.%26aulast%3DLun%26aufirst%3DS.%26aulast%3DGuo%26aufirst%3DH.%26aulast%3DMaiga%26aufirst%3DM.%2BC.%26aulast%3DBishai%26aufirst%3DW.%2BR.%26aulast%3DMadrid%26aufirst%3DP.%2BB.%26atitle%3DEvaluation%2520of%2520gyrase%2520B%2520as%2520a%2520drug%2520target%2520in%2520Mycobacterium%2520tuberculosis%26jtitle%3DJ.%2520Antimicrob.%2520Chemother.%26date%3D2012%26volume%3D67%26spage%3D415%26epage%3D421%26doi%3D10.1093%2Fjac%2Fdkr449" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Ioerger, T. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">No, E.-G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Larsen, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobs, W. R.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pillay, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sturm, A. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sacchettini, J. C.</span><span> </span><span class="NLM_article-title">Genome analysis of multi- and extensively-drug-resistant tuberculosis from KwaZulu-Natal, South Africa</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">e7778</span><span class="refDoi"> DOI: 10.1371/journal.pone.0007778</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00415&amp;key=10.1371%2Fjournal.pone.0007778" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00415&amp;key=19890396" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2009&pages=e7778&author=T.+R.+Ioergerauthor=S.+Kooauthor=E.-G.+Noauthor=X.+Chenauthor=M.+H.+Larsenauthor=W.+R.+Jacobsauthor=M.+Pillayauthor=A.+W.+Sturmauthor=J.+C.+Sacchettini&title=Genome+analysis+of+multi-+and+extensively-drug-resistant+tuberculosis+from+KwaZulu-Natal%2C+South+Africa&doi=10.1371%2Fjournal.pone.0007778"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0007778&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0007778%26sid%3Dliteratum%253Aachs%26aulast%3DIoerger%26aufirst%3DT.%2BR.%26aulast%3DKoo%26aufirst%3DS.%26aulast%3DNo%26aufirst%3DE.-G.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DLarsen%26aufirst%3DM.%2BH.%26aulast%3DJacobs%26aufirst%3DW.%2BR.%26aulast%3DPillay%26aufirst%3DM.%26aulast%3DSturm%26aufirst%3DA.%2BW.%26aulast%3DSacchettini%26aufirst%3DJ.%2BC.%26atitle%3DGenome%2520analysis%2520of%2520multi-%2520and%2520extensively-drug-resistant%2520tuberculosis%2520from%2520KwaZulu-Natal%252C%2520South%2520Africa%26jtitle%3DPLoS%2520One%26date%3D2009%26volume%3D4%26spage%3De7778%26doi%3D10.1371%2Fjournal.pone.0007778" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Bliss, C. I.</span><span> </span><span class="NLM_article-title">The toxicity of poisons applied jointly</span> <span class="citation_source-journal">Ann. Appl. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1939</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">585</span><span class="NLM_x">–</span> <span class="NLM_lpage">615</span><span class="refDoi"> DOI: 10.1111/j.1744-7348.1939.tb06990.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00415&amp;key=10.1111%2Fj.1744-7348.1939.tb06990.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00415&amp;key=1%3ACAS%3A528%3ADyaH3cXhtFWq" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=1939&pages=585-615&author=C.+I.+Bliss&title=The+toxicity+of+poisons+applied+jointly&doi=10.1111%2Fj.1744-7348.1939.tb06990.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23aR"><div class="casContent"><span class="casTitleNuber">23a</span><div class="casTitle"><span class="NLM_cas:atitle">The toxicity of poisons applied jointly</span></div><div class="casAuthors">Bliss, C. I.</div><div class="citationInfo"><span class="NLM_cas:title">Annals of Applied Biology</span>
        (<span class="NLM_cas:date">1939</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">585-615</span>CODEN:
                <span class="NLM_cas:coden">AABIAV</span>;
        ISSN:<span class="NLM_cas:issn">0003-4746</span>.
    </div><div class="casAbstract">Methods for the statistical analysis of toxicity data from poisons administered jointly to animals are described.  Types of joint action recognized are: independent joint action; similar joint action; synergistic action.  Each is discussed and the statistical treatment is illustrated by an example from the entomological literature.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrv_A_4Ot3F57Vg90H21EOLACvtfcHk0lgYBVn0hO0laA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaH3cXhtFWq&md5=5223d96533ab5d38d94127751e2ded82</span></div><a href="/servlet/linkout?suffix=cit23a&amp;dbid=16384&amp;doi=10.1111%2Fj.1744-7348.1939.tb06990.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1744-7348.1939.tb06990.x%26sid%3Dliteratum%253Aachs%26aulast%3DBliss%26aufirst%3DC.%2BI.%26atitle%3DThe%2520toxicity%2520of%2520poisons%2520applied%2520jointly%26jtitle%3DAnn.%2520Appl.%2520Biol.%26date%3D1939%26volume%3D26%26spage%3D585%26epage%3D615%26doi%3D10.1111%2Fj.1744-7348.1939.tb06990.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit23b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Greco, W. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bravo, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parsons, J. C.</span><span> </span><span class="NLM_article-title">The search for synergy: a critical review from a response surface perspective</span> <span class="citation_source-journal">Pharmacol. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">331</span><span class="NLM_x">–</span> <span class="NLM_lpage">385</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00415&amp;key=7568331" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00415&amp;key=1%3ACAS%3A280%3ADyaK28%252FjsFSgtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=1995&pages=331-385&author=W.+R.+Grecoauthor=G.+Bravoauthor=J.+C.+Parsons&title=The+search+for+synergy%3A+a+critical+review+from+a+response+surface+perspective"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23bR"><div class="casContent"><span class="casTitleNuber">23b</span><div class="casTitle"><span class="NLM_cas:atitle">The search for synergy: a critical review from a response surface perspective</span></div><div class="casAuthors">Greco W R; Bravo G; Parsons J C</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological reviews</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">331-85</span>
        ISSN:<span class="NLM_cas:issn">0031-6997</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRXywHk-SVAkdenUz0lpNqnfW6udTcc2eZB0q3V09UjMLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK28%252FjsFSgtQ%253D%253D&md5=80f1b0c8e20e587625a5d68339d30709</span></div><a href="/servlet/linkout?suffix=cit23b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGreco%26aufirst%3DW.%2BR.%26aulast%3DBravo%26aufirst%3DG.%26aulast%3DParsons%26aufirst%3DJ.%2BC.%26atitle%3DThe%2520search%2520for%2520synergy%253A%2520a%2520critical%2520review%2520from%2520a%2520response%2520surface%2520perspective%26jtitle%3DPharmacol.%2520Rev.%26date%3D1995%26volume%3D47%26spage%3D331%26epage%3D385" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Branch, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adedoyin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frye, R. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romkes, M.</span><span> </span><span class="NLM_article-title"><i>In vivo</i> modulation of CYP enzymes by quinidine and rifampin</span> <span class="citation_source-journal">Clin. Pharmacol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">68</span><span class="NLM_x">, </span> <span class="NLM_fpage">401</span><span class="NLM_x">–</span> <span class="NLM_lpage">411</span><span class="refDoi"> DOI: 10.1067/mcp.2000.110561</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00415&amp;key=10.1067%2Fmcp.2000.110561" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00415&amp;key=11061580" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00415&amp;key=1%3ACAS%3A528%3ADC%252BD3cXot1Wjtrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2000&pages=401-411&author=R.+A.+Branchauthor=A.+Adedoyinauthor=R.+F.+Fryeauthor=J.+W.+Wilsonauthor=M.+Romkes&title=In+vivo+modulation+of+CYP+enzymes+by+quinidine+and+rifampin&doi=10.1067%2Fmcp.2000.110561"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24aR"><div class="casContent"><span class="casTitleNuber">24a</span><div class="casTitle"><span class="NLM_cas:atitle">In vivo modulation of CYP enzymes by quinidine and rifampin</span></div><div class="casAuthors">Branch, Robert A.; Adedoyin, Adedayo; Frye, Reginald F.; Wilson, John W.; Romkes, Marjorie</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Pharmacology & Therapeutics (St. Louis)</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">68</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">401-411</span>CODEN:
                <span class="NLM_cas:coden">CLPTAT</span>;
        ISSN:<span class="NLM_cas:issn">0009-9236</span>.
    
            (<span class="NLM_cas:orgname">Mosby, Inc.</span>)
        </div><div class="casAbstract">This study investigated the effect of 3 and 28 days of treatment with quinidine (200 mg daily) and rifampin (600 mg daily) on the activities of 4 cytochrome P (CYP) 450 enzymes and N-acetyltransferase in healthy young male volunteers receiving a cocktail of drug probes, including caffeine, mephenytoin, debrisoquine, and dapsone.  Quinidine selectively and almost completely inhibited the activity of CYP2D6 from day 3 through day 28 without affecting any of the other enzymes tested.  Rifampin showed evidence of time-dependent induction of the activities of all the oxidative routes of metab. measured but decreased the acetylation ratio in fast acetylators.  The quinidine/rifampin combination resulted in selective CYP2D6 inhibition and induction of all the other enzymes evaluated, suggesting that predictable complex interactions occur with the drug combination.  These observations illustrate the value of simultaneous assessment of the effect of modulators on the activities of multiple specific enzymes with the drug cocktail approach.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrep0k1tcxlpLVg90H21EOLACvtfcHk0lgoKFjEA3V3kg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXot1Wjtrw%253D&md5=8ca341e25bf178005f9c11aa823aca02</span></div><a href="/servlet/linkout?suffix=cit24a&amp;dbid=16384&amp;doi=10.1067%2Fmcp.2000.110561&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1067%252Fmcp.2000.110561%26sid%3Dliteratum%253Aachs%26aulast%3DBranch%26aufirst%3DR.%2BA.%26aulast%3DAdedoyin%26aufirst%3DA.%26aulast%3DFrye%26aufirst%3DR.%2BF.%26aulast%3DWilson%26aufirst%3DJ.%2BW.%26aulast%3DRomkes%26aufirst%3DM.%26atitle%3DIn%2520vivo%2520modulation%2520of%2520CYP%2520enzymes%2520by%2520quinidine%2520and%2520rifampin%26jtitle%3DClin.%2520Pharmacol.%2520Ther.%26date%3D2000%26volume%3D68%26spage%3D401%26epage%3D411%26doi%3D10.1067%2Fmcp.2000.110561" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit24b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Baciewicz, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chrisman, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finch, C. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Self, T. H.</span><span> </span><span class="NLM_article-title">Update on rifampin, rifabutin, and rifapentine drug interactions</span> <span class="citation_source-journal">Curr. Med. Res. Opin.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">12</span><span class="refDoi"> DOI: 10.1185/03007995.2012.747952</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00415&amp;key=10.1185%2F03007995.2012.747952" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00415&amp;key=23136913" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00415&amp;key=1%3ACAS%3A528%3ADC%252BC38XhvVynsLjP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2013&pages=1-12&author=A.+M.+Baciewiczauthor=C.+R.+Chrismanauthor=C.+K.+Finchauthor=T.+H.+Self&title=Update+on+rifampin%2C+rifabutin%2C+and+rifapentine+drug+interactions&doi=10.1185%2F03007995.2012.747952"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24bR"><div class="casContent"><span class="casTitleNuber">24b</span><div class="casTitle"><span class="NLM_cas:atitle">Update on rifampin, rifabutin, and rifapentine drug interactions</span></div><div class="casAuthors">Baciewicz, Anne M.; Chrisman, Cary R.; Finch, Christopher K.; Self, Timothy H.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medical Research and Opinion</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-12</span>CODEN:
                <span class="NLM_cas:coden">CMROCX</span>;
        ISSN:<span class="NLM_cas:issn">0300-7995</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Background: Rifampin is a potent inducer of both cytochrome P 450 oxidative enzymes and the P-glycoprotein transport system.  Among numerous well documented, clin. significant interactions, examples include warfarin, oral contraceptives, itraconazole, digoxin, verapamil, simvastatin, and human immunodeficiency virus-related protease inhibitors.  Rifabutin reduces serum concns. of antiretroviral agents, but less so than rifampin.  Rifapentine is also an inducer of drug metab.  Methods: A literature search of English language journals from 2008 to March 2012 was completed using several databases, including PubMed, EMBASE, and SCOPUS.  Search terms included rifampin, rifabutin, rifapentine AND drug interactions.  Findings: Examples of clin. relevant interactions with rifampin demonstrated by recent reports include posaconazole, voriconazole, oxycodone, risperidone, mirodenafil, and ebastine.  Conclusions: To avoid a reduced therapeutic response, therapeutic failure, or toxic reactions when rifampin, rifabutin, or rifapentine are added to or discontinued from medication regimens, clinicians need to be aware of these interactions.  Recent studies have indicated that other transporter systems play a role in these drug interactions.  As reports of rifampin drug interactions continue to grow, this review is a reminder to clinicians to be vigilant.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqV6-1hI_PPv7Vg90H21EOLACvtfcHk0lhV2Uj_XPvoDg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhvVynsLjP&md5=44d0f28ae743f4695b23b1a243fb0271</span></div><a href="/servlet/linkout?suffix=cit24b&amp;dbid=16384&amp;doi=10.1185%2F03007995.2012.747952&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1185%252F03007995.2012.747952%26sid%3Dliteratum%253Aachs%26aulast%3DBaciewicz%26aufirst%3DA.%2BM.%26aulast%3DChrisman%26aufirst%3DC.%2BR.%26aulast%3DFinch%26aufirst%3DC.%2BK.%26aulast%3DSelf%26aufirst%3DT.%2BH.%26atitle%3DUpdate%2520on%2520rifampin%252C%2520rifabutin%252C%2520and%2520rifapentine%2520drug%2520interactions%26jtitle%3DCurr.%2520Med.%2520Res.%2520Opin.%26date%3D2013%26volume%3D29%26spage%3D1%26epage%3D12%26doi%3D10.1185%2F03007995.2012.747952" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Finch, C. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chrisman, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baciewicz, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Self, T. H.</span><span> </span><span class="NLM_article-title">Rifampin and rifabutin drug interactions: an update</span> <span class="citation_source-journal">Arch. Intern. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">162</span><span class="NLM_x">, </span> <span class="NLM_fpage">985</span><span class="NLM_x">–</span> <span class="NLM_lpage">992</span><span class="refDoi"> DOI: 10.1001/archinte.162.9.985</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00415&amp;key=10.1001%2Farchinte.162.9.985" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=162&publication_year=2002&pages=985-992&author=C.+K.+Finchauthor=C.+R.+Chrismanauthor=A.+M.+Baciewiczauthor=T.+H.+Self&title=Rifampin+and+rifabutin+drug+interactions%3A+an+update&doi=10.1001%2Farchinte.162.9.985"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1001%2Farchinte.162.9.985&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1001%252Farchinte.162.9.985%26sid%3Dliteratum%253Aachs%26aulast%3DFinch%26aufirst%3DC.%2BK.%26aulast%3DChrisman%26aufirst%3DC.%2BR.%26aulast%3DBaciewicz%26aufirst%3DA.%2BM.%26aulast%3DSelf%26aufirst%3DT.%2BH.%26atitle%3DRifampin%2520and%2520rifabutin%2520drug%2520interactions%253A%2520an%2520update%26jtitle%3DArch.%2520Intern.%2520Med.%26date%3D2002%26volume%3D162%26spage%3D985%26epage%3D992%26doi%3D10.1001%2Farchinte.162.9.985" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Acosta, E. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kendall, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gerber, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alston-Smith, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koletar, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zolopa, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agarwala, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Child, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bertz, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hosey, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haas, D. W.</span><span> </span><span class="NLM_article-title">Effect of concomitantly administered rifampin on the pharmacokinetics and safety of atazanavir administered twice daily</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">3104</span><span class="NLM_x">–</span> <span class="NLM_lpage">3110</span><span class="refDoi"> DOI: 10.1128/AAC.00341-07</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00415&amp;key=10.1128%2FAAC.00341-07" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2007&pages=3104-3110&author=E.+P.+Acostaauthor=M.+A.+Kendallauthor=J.+G.+Gerberauthor=B.+Alston-Smithauthor=S.+L.+Koletarauthor=A.+R.+Zolopaauthor=S.+Agarwalaauthor=M.+Childauthor=R.+Bertzauthor=L.+Hoseyauthor=D.+W.+Haas&title=Effect+of+concomitantly+administered+rifampin+on+the+pharmacokinetics+and+safety+of+atazanavir+administered+twice+daily&doi=10.1128%2FAAC.00341-07"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26a&amp;dbid=16384&amp;doi=10.1128%2FAAC.00341-07&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.00341-07%26sid%3Dliteratum%253Aachs%26aulast%3DAcosta%26aufirst%3DE.%2BP.%26aulast%3DKendall%26aufirst%3DM.%2BA.%26aulast%3DGerber%26aufirst%3DJ.%2BG.%26aulast%3DAlston-Smith%26aufirst%3DB.%26aulast%3DKoletar%26aufirst%3DS.%2BL.%26aulast%3DZolopa%26aufirst%3DA.%2BR.%26aulast%3DAgarwala%26aufirst%3DS.%26aulast%3DChild%26aufirst%3DM.%26aulast%3DBertz%26aufirst%3DR.%26aulast%3DHosey%26aufirst%3DL.%26aulast%3DHaas%26aufirst%3DD.%2BW.%26atitle%3DEffect%2520of%2520concomitantly%2520administered%2520rifampin%2520on%2520the%2520pharmacokinetics%2520and%2520safety%2520of%2520atazanavir%2520administered%2520twice%2520daily%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2007%26volume%3D51%26spage%3D3104%26epage%3D3110%26doi%3D10.1128%2FAAC.00341-07" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit26b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Kirby, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collier, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kharasch, E. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whittington, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thummel, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Unadkat, J. D.</span><span> </span><span class="NLM_article-title">Complex drug interactions of the HIV protease inhibitors 3: effect of simultaneous or staggered dosing of digoxin and ritonavir, nelfinavir, rifampin, or bupropion</span> <span class="citation_source-journal">Drug Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">610</span><span class="NLM_x">–</span> <span class="NLM_lpage">616</span><span class="refDoi"> DOI: 10.1124/dmd.111.042705</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00415&amp;key=10.1124%2Fdmd.111.042705" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2012&pages=610-616&author=B.+J.+Kirbyauthor=A.+C.+Collierauthor=E.+D.+Kharaschauthor=D.+Whittingtonauthor=K.+E.+Thummelauthor=J.+D.+Unadkat&title=Complex+drug+interactions+of+the+HIV+protease+inhibitors+3%3A+effect+of+simultaneous+or+staggered+dosing+of+digoxin+and+ritonavir%2C+nelfinavir%2C+rifampin%2C+or+bupropion&doi=10.1124%2Fdmd.111.042705"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26b&amp;dbid=16384&amp;doi=10.1124%2Fdmd.111.042705&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.111.042705%26sid%3Dliteratum%253Aachs%26aulast%3DKirby%26aufirst%3DB.%2BJ.%26aulast%3DCollier%26aufirst%3DA.%2BC.%26aulast%3DKharasch%26aufirst%3DE.%2BD.%26aulast%3DWhittington%26aufirst%3DD.%26aulast%3DThummel%26aufirst%3DK.%2BE.%26aulast%3DUnadkat%26aufirst%3DJ.%2BD.%26atitle%3DComplex%2520drug%2520interactions%2520of%2520the%2520HIV%2520protease%2520inhibitors%25203%253A%2520effect%2520of%2520simultaneous%2520or%2520staggered%2520dosing%2520of%2520digoxin%2520and%2520ritonavir%252C%2520nelfinavir%252C%2520rifampin%252C%2520or%2520bupropion%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2012%26volume%3D40%26spage%3D610%26epage%3D616%26doi%3D10.1124%2Fdmd.111.042705" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Sennhauser, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bukowska, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Briand, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grütter, M. G.</span><span> </span><span class="NLM_article-title">Crystal structure of the multidrug exporter MexB from <i>Pseudomonas aeruginosa</i></span> <span class="citation_source-journal">J. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">389</span><span class="NLM_x">, </span> <span class="NLM_fpage">134</span><span class="NLM_x">–</span> <span class="NLM_lpage">145</span><span class="refDoi"> DOI: 10.1016/j.jmb.2009.04.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00415&amp;key=10.1016%2Fj.jmb.2009.04.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00415&amp;key=19361527" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00415&amp;key=1%3ACAS%3A528%3ADC%252BD1MXls12gtro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=389&publication_year=2009&pages=134-145&author=G.+Sennhauserauthor=M.+A.+Bukowskaauthor=C.+Briandauthor=M.+G.+Gr%C3%BCtter&title=Crystal+structure+of+the+multidrug+exporter+MexB+from+Pseudomonas+aeruginosa&doi=10.1016%2Fj.jmb.2009.04.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal Structure of the Multidrug Exporter MexB from Pseudomonas aeruginosa</span></div><div class="casAuthors">Sennhauser, Gaby; Bukowska, Magdalena A.; Briand, Christophe; Grutter, Markus G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Biology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">389</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">134-145</span>CODEN:
                <span class="NLM_cas:coden">JMOBAK</span>;
        ISSN:<span class="NLM_cas:issn">0022-2836</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">We report here the crystal structure of the Pseudomonas aeruginosa multidrug exporter MexB, an intensively studied member of the resistance-nodulation-cell division family of secondary active transporters, at 3.0 Å.  MexB forms an asym. homotrimer where each subunit adopts a different conformation representing three snapshots of the transport cycle similar to the recently detd. structures of its close homolog AcrB from Escherichia coli, so far the sole structurally characterized member of the superfamily.  As for AcrB, the conformations of two subunits can be clearly assigned to either the binding step or the extrusion step in the transport process.  Unexpectedly, a remarkable conformational shift in the third subunit is obsd. in MexB, which has potential implications for the assembly of the tripartite MexAB-OprM drug efflux system.  Furthermore, an n-dodecyl--maltoside mol. was found bound to the internal multidrug-binding cavity, which might indicate that MexB binds and transports detergent mols. as substrates.  As the only missing piece of the puzzle in the MexAB-OprM system, the X-ray structure of MexB completes the mol. picture of the major pump mediating intrinsic and acquired multidrug resistance in P. aeruginosa.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqQ7gfz_c1UWrVg90H21EOLACvtfcHk0lhvJm502gYTVQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXls12gtro%253D&md5=d658bb00316652146c1d3965200fe05f</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1016%2Fj.jmb.2009.04.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jmb.2009.04.001%26sid%3Dliteratum%253Aachs%26aulast%3DSennhauser%26aufirst%3DG.%26aulast%3DBukowska%26aufirst%3DM.%2BA.%26aulast%3DBriand%26aufirst%3DC.%26aulast%3DGr%25C3%25BCtter%26aufirst%3DM.%2BG.%26atitle%3DCrystal%2520structure%2520of%2520the%2520multidrug%2520exporter%2520MexB%2520from%2520Pseudomonas%2520aeruginosa%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D2009%26volume%3D389%26spage%3D134%26epage%3D145%26doi%3D10.1016%2Fj.jmb.2009.04.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Pieroni, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tipparaju, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lun, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sturm, A. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bishai, W. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kozikowski, A. P.</span><span> </span><span class="NLM_article-title">Pyrido[1,2-a]benzimidazole-based agents active against tuberculosis (TB), multidrug-resistant (MDR) TB and extensively drug-resistant (XDR) TB</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">334</span><span class="NLM_x">–</span> <span class="NLM_lpage">342</span><span class="refDoi"> DOI: 10.1002/cmdc.201000490</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00415&amp;key=10.1002%2Fcmdc.201000490" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2011&pages=334-342&issue=2&author=M.+Pieroniauthor=S.+Tipparajuauthor=S.+Lunauthor=Y.+Songauthor=A.+W.+Sturmauthor=W.+R.+Bishaiauthor=A.+P.+Kozikowski&title=Pyrido%5B1%2C2-a%5Dbenzimidazole-based+agents+active+against+tuberculosis+%28TB%29%2C+multidrug-resistant+%28MDR%29+TB+and+extensively+drug-resistant+%28XDR%29+TB&doi=10.1002%2Fcmdc.201000490"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201000490&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201000490%26sid%3Dliteratum%253Aachs%26aulast%3DPieroni%26aufirst%3DM.%26aulast%3DTipparaju%26aufirst%3DS.%26aulast%3DLun%26aufirst%3DS.%26aulast%3DSong%26aufirst%3DY.%26aulast%3DSturm%26aufirst%3DA.%2BW.%26aulast%3DBishai%26aufirst%3DW.%2BR.%26aulast%3DKozikowski%26aufirst%3DA.%2BP.%26atitle%3DPyrido%255B1%252C2-a%255Dbenzimidazole-based%2520agents%2520active%2520against%2520tuberculosis%2520%2528TB%2529%252C%2520multidrug-resistant%2520%2528MDR%2529%2520TB%2520and%2520extensively%2520drug-resistant%2520%2528XDR%2529%2520TB%26jtitle%3DChemMedChem%26date%3D2011%26volume%3D6%26issue%3D2%26spage%3D334%26epage%3D342%26doi%3D10.1002%2Fcmdc.201000490" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Laird, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bullen, C. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenbloom, D. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hill, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Durand, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siliciano, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siliciano, R. F.</span><span> </span><span class="NLM_article-title">Ex vivo analysis identifies effective HIV-1 latency-reversing drug combinations</span> <span class="citation_source-journal">J. Clin. Invest.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">125</span><span class="NLM_x">, </span> <span class="NLM_fpage">1901</span><span class="NLM_x">–</span> <span class="NLM_lpage">1912</span><span class="refDoi"> DOI: 10.1172/JCI80142</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00415&amp;key=10.1172%2FJCI80142" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00415&amp;key=25822022" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00415&amp;key=1%3ACAS%3A280%3ADC%252BC2MnovFCntA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=125&publication_year=2015&pages=1901-1912&author=G.+M.+Lairdauthor=C.+K.+Bullenauthor=D.+I.+Rosenbloomauthor=A.+R.+Martinauthor=A.+L.+Hillauthor=C.+M.+Durandauthor=J.+D.+Silicianoauthor=R.+F.+Siliciano&title=Ex+vivo+analysis+identifies+effective+HIV-1+latency-reversing+drug+combinations&doi=10.1172%2FJCI80142"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Ex vivo analysis identifies effective HIV-1 latency-reversing drug combinations</span></div><div class="casAuthors">Laird Gregory M; Bullen C Korin; Rosenbloom Daniel I S; Martin Alyssa R; Hill Alison L; Durand Christine M; Siliciano Janet D; Siliciano Robert F</div><div class="citationInfo"><span class="NLM_cas:title">The Journal of clinical investigation</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">125</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1901-12</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Reversal of HIV-1 latency by small molecules is a potential cure strategy.  This approach will likely require effective drug combinations to achieve high levels of latency reversal.  Using resting CD4+ T cells (rCD4s) from infected individuals, we developed an experimental and theoretical framework to identify effective latency-reversing agent (LRA) combinations.  Utilizing ex vivo assays for intracellular HIV-1 mRNA and virion production, we compared 2-drug combinations of leading candidate LRAs and identified multiple combinations that effectively reverse latency.  We showed that protein kinase C agonists in combination with bromodomain inhibitor JQ1 or histone deacetylase inhibitors robustly induce HIV-1 transcription and virus production when directly compared with maximum reactivation by T cell activation.  Using the Bliss independence model to quantitate combined drug effects, we demonstrated that these combinations synergize to induce HIV-1 transcription.  This robust latency reversal occurred without release of proinflammatory cytokines by rCD4s.  To extend the clinical utility of our findings, we applied a mathematical model that estimates in vivo changes in plasma HIV-1 RNA from ex vivo measurements of virus production.  Our study reconciles diverse findings from previous studies, establishes a quantitative experimental approach to evaluate combinatorial LRA efficacy, and presents a model to predict in vivo responses to LRAs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSJ1yUqFoXEC1MGsG_HTXYFfW6udTcc2eYV5eN3GxmcJbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2MnovFCntA%253D%253D&md5=5a842b7f2d36db04176cd6796bda18b4</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1172%2FJCI80142&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1172%252FJCI80142%26sid%3Dliteratum%253Aachs%26aulast%3DLaird%26aufirst%3DG.%2BM.%26aulast%3DBullen%26aufirst%3DC.%2BK.%26aulast%3DRosenbloom%26aufirst%3DD.%2BI.%26aulast%3DMartin%26aufirst%3DA.%2BR.%26aulast%3DHill%26aufirst%3DA.%2BL.%26aulast%3DDurand%26aufirst%3DC.%2BM.%26aulast%3DSiliciano%26aufirst%3DJ.%2BD.%26aulast%3DSiliciano%26aufirst%3DR.%2BF.%26atitle%3DEx%2520vivo%2520analysis%2520identifies%2520effective%2520HIV-1%2520latency-reversing%2520drug%2520combinations%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2015%26volume%3D125%26spage%3D1901%26epage%3D1912%26doi%3D10.1172%2FJCI80142" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-2"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i71"><a href="/doi/suppl/10.1021/acs.jmedchem.6b00415">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_00016"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.6b00415">10.1021/acs.jmedchem.6b00415</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Purity of the tested compounds and details on molecular model generation and optimization, and docking simulations (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.6b00415/suppl_file/jm6b00415_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Machine-readable representations of compounds and primary data (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.6b00415/suppl_file/jm6b00415_si_002.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b00415/suppl_file/jm6b00415_si_001.pdf">jm6b00415_si_001.pdf (1.42 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b00415/suppl_file/jm6b00415_si_002.csv">jm6b00415_si_002.csv (2.48 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.6b00415&amp;pbContext=%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.6b00415%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2016.59.issue-13%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.6b00415" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                5MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"6799a76768293d6c","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
